<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article" xml:lang="EN"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Chem Rev</journal-id><journal-id journal-id-type="iso-abbrev">Chem. Rev</journal-id><journal-id journal-id-type="publisher-id">cr</journal-id><journal-id journal-id-type="coden">chreay</journal-id><journal-title-group><journal-title>Chemical Reviews</journal-title></journal-title-group><issn pub-type="ppub">0009-2665</issn><issn pub-type="epub">1520-6890</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5408752</article-id><article-id pub-id-type="doi">10.1021/acs.chemrev.6b00591</article-id><article-categories><subj-group><subject>Review</subject></subj-group></article-categories><title-group><article-title>Mechanistic Understanding of Lanthipeptide Biosynthetic
Enzymes</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Repka</surname><given-names>Lindsay
M.</given-names></name><xref rid="affath1" ref-type="aff">&#x02020;</xref><xref rid="notes-1" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Chekan</surname><given-names>Jonathan R.</given-names></name><xref rid="affath1" ref-type="aff">&#x02021;</xref><xref rid="notes-1" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath3"><name><surname>Nair</surname><given-names>Satish K.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="affath1" ref-type="aff">&#x02021;</xref><xref rid="affath1" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath4"><name><surname>van der Donk</surname><given-names>Wilfred A.</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="affath1" ref-type="aff">&#x02020;</xref><xref rid="affath1" ref-type="aff">&#x02021;</xref></contrib><aff id="affath1"><sup>&#x02020;</sup>Howard Hughes Medical Institute and Department of Chemistry, <sup>&#x02021;</sup>Department of Biochemistry, and <sup>&#x000a7;</sup>Center for Biophysics
and Computational Biology, <institution>University of
Illinois at Urbana&#x02212;Champaign</institution>, 600 South Mathews Avenue, Urbana, Illinois 61801, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>s-nair@life.uiuc.edu</email>.</corresp><corresp id="cor2"><label>*</label>E-mail: <email>vddonk@illinois.edu</email>.</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>01</month><year>2017</year></pub-date><pub-date pub-type="ppub"><day>26</day><month>04</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>01</month><year>2018</year></pub-date><volume>117</volume><issue>8</issue><issue-title>Unusual Enzymology in Natural Products Synthesis</issue-title><fpage>5457</fpage><lpage>5520</lpage><history><date date-type="received"><day>29</day><month>08</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 American Chemical Society</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0054" id="ab-tgr1"/></p><p>Lanthipeptides
are ribosomally synthesized and post-translationally
modified peptides (RiPPs) that display a wide variety of biological
activities, from antimicrobial to antiallodynic. Lanthipeptides that
display antimicrobial activity are called lantibiotics. The post-translational
modification reactions of lanthipeptides include dehydration of Ser
and Thr residues to dehydroalanine and dehydrobutyrine, a transformation
that is carried out in three unique ways in different classes of lanthipeptides.
In a cyclization process, Cys residues then attack the dehydrated
residues to generate the lanthionine and methyllanthionine thioether
cross-linked amino acids from which lanthipeptides derive their name.
The resulting polycyclic peptides have constrained conformations that
confer their biological activities. After installation of the characteristic
thioether cross-links, tailoring enzymes introduce additional post-translational
modifications that are unique to each lanthipeptide and that fine-tune
their activities and/or stability. This review focuses on studies
published over the past decade that have provided much insight into
the mechanisms of the enzymes that carry out the post-translational
modifications.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>cr6b00591</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>cr-2016-00591e</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>The name lanthipeptide
is a short-hand nomenclature for lanthionine-containing
peptides,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> with lanthipeptides having antimicrobial
activities historically called lantibiotics.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> A lanthionine is a bis-amino-bis acid in which two alanine residues
are linked by a thioether group that connects their &#x003b2;-carbons
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). When incorporated
into a peptide chain via both the amino and acid groups, a lanthionine
results in a thioether cross-link. Installation of lanthionine residues
is accomplished through enzymatic post-translational modifications
on peptide substrates. Although genes encoding homologues of lanthipeptide
biosynthetic enzymes are also present in some archaea and in higher
eukaryotes including mammals,<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref></sup> lanthipeptide detection
and isolation is thus far restricted to bacteria. The increase in
the number of characterized lanthipeptides as a result of the bacterial
genome sequencing projects has led to the realization that their functions
are not limited to antimicrobial activities but also include antifungal,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> morphogenetic,<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> antiviral,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> antinociceptive,<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> and
antiallodynic functions.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> As a result,
lanthipeptide derivatives are undergoing therapeutic evaluation<sup><xref ref-type="bibr" rid="ref11">11</xref>&#x02212;<xref ref-type="bibr" rid="ref25">25</xref></sup> and have been used for imaging applications.<sup><xref ref-type="bibr" rid="ref26">26</xref>&#x02212;<xref ref-type="bibr" rid="ref34">34</xref></sup> Lanthipeptide biosynthetic gene clusters are particularly found
in the genomes of many genera of Firmicutes, Actinobacteria, Proteobacteria,
Bacteroidetes, and Cyanobacteria.<sup><xref ref-type="bibr" rid="ref35">35</xref>&#x02212;<xref ref-type="bibr" rid="ref37">37</xref></sup></p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Structures of the thioether
cross-links and dehydro amino acids
that are characteristic for lanthipeptides. Under each chemical structure
is shown a shorthand notation used in this review. At present, two
different diastereomers of both Lan and MeLan have been found in natural
lanthipeptides, whereas for Dhb and Lab only one diastereomer has
been reported thus far. A methyl-substituted Lab (MeLab) has recently
been identified and its stereochemistry is unknown. In all drawings
of cross-links, atoms originating from Ser/Thr are shown in red, whereas
atoms originating from Cys are shown in blue. Abu: &#x003b1;-aminobutyric
acid.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0001" id="gr1" position="float"/></fig><p>The mechanism by which the thioether
cross-links are formed is
what unifies this family of compounds. For all lanthipeptides, these
linkages are introduced by a post-translational modification process
that first involves the dehydration of Ser and Thr residues to 2,3-didehydroalanine
(Dha) and 2,3-didehydrobutyrine (Dhb) residues, respectively (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). As discussed in
this review, the manner of dehydration can be quite different, which
is one of the criteria for dividing lanthipeptides into different
classes. The thioether structure is then generated by 1,4-conjugate
addition of a Cys onto a dehydro amino acid. The resultant enolate
can be protonated to produce either a lanthionine (Lan) from Ser or
a methyllanthionine (MeLan) from Thr (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Alternatively, the initially formed enolate
can attack another dehydro amino acid to produce a carbon&#x02013;carbon
cross-link and a second enolate. Upon protonation, the structure that
now introduces two cross-links and contains an &#x003b1;,&#x003b1;-disubstituted
amino acid at its center is called a labionin (Lab) when formed from
one Cys and two Ser residues,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> or methyllabionin
(MeLab) when formed from one Cys, a central Thr, and an N-terminal
Ser (<xref rid="fig1" ref-type="fig">Figures <xref rid="fig1" ref-type="fig">1</xref></xref> and <xref rid="fig2" ref-type="fig">2</xref>).<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> At present, no labionin-like
structures have been reported in which the electrophile in the second
conjugate addition was a Dhb. The lanthipeptide family encompasses
any peptide containing a (methyl)lanthionine or a (methyl)labionin
provided it is made by dehydration of Ser/Thr and subsequent attack
by a Cys residue onto a dehydro amino acid. Thioether cross-links
are also found in other peptide natural products, but their biosynthesis
does not involve this specific sequence of events and they have therefore
not been included in the lanthipeptide family.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup></p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Post-translational
modification reactions leading to the formation
of (Me)Lan or (Me)Lab. Color coding as in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>. The stereochemistry for MeLab has not been
determined. X<sub>n</sub> = peptide of n amino acids. The stereochemistry
of (Me)Lan can be different from DL (see <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0002" id="gr2" position="float"/></fig><p>In principle, the conjugate addition process can form two
diastereomers
for Lan and four diastereomers for MeLan and Lab (when generated from
two Dha). In practice, thus far both diastereomers of Lan are indeed
found in naturally occurring lanthipeptides, but only two of the four
MeLan stereoisomers and one of the four Lab diastereomers have been
observed (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).
We emphasize that this situation may change, since for the majority
of lanthipeptides the stereochemistry has not been determined, and
only very recently was it recognized that more than one stereochemistry
can be generated for Lan/MeLan.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p><p>In this review we will use a stereochemical nomenclature that focuses
on the stereochemistry at the &#x003b1;-carbons of the former Ser/Thr
and Cys residues. We assign as L the stereochemistry that has the
original side chain in the same position as in Ser/Thr/Cys and as
D the stereochemistry in which the side chain occupies the epimeric
position. Thus, (2<italic>S</italic>,6<italic>R</italic>)-Lan will
be referred to as DL-Lan (D configuration at the former Ser/Thr and
L configuration at the former Cys), and (2<italic>S,</italic>4<italic>S,</italic>8<italic>R</italic>)-labionin will be referred to as LDL
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). This nomenclature
has the advantage that it immediately shows the net stereochemistry
of the attack of the enolate intermediate onto the electrophile (proton
for Lan and MeLan; Dha for Lab). For D stereochemistry this attack
is on the opposite face from where the original &#x003b1;-proton was
located in Ser/Thr.</p><p>The general pathway of lanthipeptide biosynthesis
was mostly established
by genetic studies in producing organisms that have been comprehensively
reviewed.<sup><xref ref-type="bibr" rid="ref39">39</xref>&#x02212;<xref ref-type="bibr" rid="ref45">45</xref></sup> Since the mid 2000s, advances in biochemical techniques, and more
recently the availability of large numbers of genomes, have helped
shape a molecular understanding of lanthipeptide biosynthesis that
now is increasingly utilized for engineering and synthetic biology
applications. In keeping with the theme of this issue, this review
will discuss the current knowledge of the details of the molecular
mechanisms utilized by the biosynthetic enzymes. We refer the reader
to other reviews and primary studies that discuss gene regulation,<sup><xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref46">46</xref>&#x02212;<xref ref-type="bibr" rid="ref62">62</xref></sup> mode of action,<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref55">55</xref>,<xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref63">63</xref>&#x02212;<xref ref-type="bibr" rid="ref67">67</xref></sup> or bioengineering of lanthipeptides.<sup><xref ref-type="bibr" rid="ref55">55</xref>,<xref ref-type="bibr" rid="ref68">68</xref>&#x02212;<xref ref-type="bibr" rid="ref111">111</xref></sup></p><sec id="sec1.1"><label>1.1</label><title>Ribosomally Synthesized and Post-Translationally
Modified Peptides (RiPPs)</title><p>Lanthipeptides are members of the
rapidly expanding RiPP family of natural products. The genome sequencing
efforts of the past decade have revealed that many classes of peptide
natural products that were initially believed to be made by nonribosomal
peptide synthetases are in fact made via a ribosomally synthesized
precursor peptide that is then heavily post-translationally modified.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> The direct link between the gene encoding the
precursor peptide and the final product renders RiPPs as low-hanging
fruits for genome mining exercises, because to a large extent the
general shapes of the final structure can be predicted. Based on the
frequency of their gene clusters in the currently available genomes,
lanthipeptides appear to be the largest group of RiPPs,<sup><xref ref-type="bibr" rid="ref112">112</xref>&#x02212;<xref ref-type="bibr" rid="ref115">115</xref></sup> although this conclusion may be biased by the genomes that have
been sequenced thus far. Whereas comprehensive reviews of lanthipeptides
in the mid 2000s discussed compounds that were all discovered via
activity-based purification,<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> many of the compounds
discussed in this review were discovered by applying genome mining
approaches<sup><xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref116">116</xref>&#x02212;<xref ref-type="bibr" rid="ref123">123</xref></sup> to lanthipeptide discovery. For these molecules, the biosynthetic
gene cluster was known before the compound, and the knowledge of the
cluster was often used to obtain the lanthipeptide.<sup><xref ref-type="bibr" rid="ref124">124</xref>&#x02212;<xref ref-type="bibr" rid="ref139">139</xref></sup> In addition to the high suitability of RiPPs for genome mining,
their gene-encoded origin also makes them uniquely accessible to biosynthetic
engineering by site-directed mutagenesis.</p><p>Although the spectrum
of post-translational modifications is diverse,<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref140">140</xref>&#x02212;<xref ref-type="bibr" rid="ref143">143</xref></sup> the overall biosynthetic pathways of RiPPs have a key common feature.
They almost always involve a precursor peptide that is much larger
than the final product, which is generated from the core peptide (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). The additional
sequence can be located at the N-terminus (a leader peptide),<sup><xref ref-type="bibr" rid="ref144">144</xref></sup> the C-terminus (a follower peptide),<sup><xref ref-type="bibr" rid="ref145">145</xref>&#x02212;<xref ref-type="bibr" rid="ref148">148</xref></sup> or at both sides of the core peptide (recognition sequences).<sup><xref ref-type="bibr" rid="ref149">149</xref></sup> These additional appendages that do not end
up in the final products have proven to be critical recognition sites
for many of the biosynthetic enzymes.<sup><xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup> The separation of substrate recognition from the
sites where the post-translational modifications take place have given
RiPP biosynthetic systems unique properties of very high substrate
tolerance. Indeed, as described in <xref rid="sec4.1" ref-type="other">section <xref rid="sec4.1" ref-type="other">4.1</xref></xref>, lanthipeptide core peptides can be hypervariable
and yet be substrates of a single enzyme.<sup><xref ref-type="bibr" rid="ref129">129</xref></sup> These properties provide even more tantalizing opportunities for
engineering.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>General biosynthetic pathway for RiPPs. For lanthipeptides,
thus
far no follower peptides have been reported. The general numbering
scheme for the precursor peptides is indicated.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0003" id="gr3" position="float"/></fig><p>For lanthipeptides, thus far only precursors that contain
leader
peptides have been reported. In this review, we will use the standardized
nomenclature recommended by the lanthipeptide community in 2013,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> which is summarized in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>. This nomenclature numbers residues in the
precursor peptides starting with the first residue of the core peptide.
Residues in the leader peptide are indicated with negative numbers
counting back from the junction between the leader peptide and core
peptide. In general, biosynthetic enzymes involved in lanthipeptide
biosynthesis have been given the generic prefix Lan,<sup><xref ref-type="bibr" rid="ref152">152</xref></sup> with a more specific descriptor for specific compounds
(e.g., Nis for nisin, Lct for lacticin 481, Cin for cinnamycin). With
few historical exceptions for cytolysin (CylL), subtilin (SpaS) and
SapB (RamS), the precursor peptides are designated LanA (NisA, LctA,
CinA, etc.) and the fully post-translationally modified precursor
peptide with the leader peptide still attached is designated mLanA.</p></sec><sec id="sec1.2"><label>1.2</label><title>Classification Systems</title><p>Many attempts
have been undertaken to systematically classify the various lanthipeptides,
from efforts that looked at the final structures<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> to schemes that focused on the biosynthetic machinery.<sup><xref ref-type="bibr" rid="ref153">153</xref></sup> In this review we adopt the latter, updated
with classes that were discovered after introduction of the initial
classification scheme, but we recognize that already exceptions of
currently structurally uncharacterized lanthipeptides can be found
in the sequenced genomes. As discussed in this review, at present
the distinct mechanisms of the dehydration reaction distinguish class
I&#x02013;IV. As more and more genomes are sequenced, it is highly
likely that a single classification scheme may not be possible, as
Nature has clearly shuffled biosynthetic genes, not only between lanthipeptide
classes, but even across different RiPP families (see <xref rid="sec2.2" ref-type="other">sections <xref rid="sec2.2" ref-type="other">2.2</xref></xref> and <xref rid="sec4.1" ref-type="other">4.1</xref>). Nevertheless, it is clear that 3&#x02013;4 quite different
strategies are used to biosynthesize the currently known lanthipeptides,
and subdividing this very large family of compounds by their biosynthetic
logic remains a useful means for classification.</p></sec></sec><sec id="sec2"><label>2</label><title>Class I Lanthipeptide Biosynthesis</title><sec id="sec2.1"><label>2.1</label><title>Overview</title><p>The class I lantibiotic
nisin produced by <italic>Lactococcus lactis</italic>, the founding
member of the lanthipeptide class of natural products, was discovered
in 1928 as a substance that inhibited the growth of <italic>Lactobacillus
bulgaricus.</italic>(<xref ref-type="bibr" rid="ref154">154</xref>) Although nisin
was initially incorrectly suggested to slow acid development in cheese,
subsequent demonstration of broad-spectrum bactericidal activity resulted
in renewed interest in the 1940s for its use in food preservation.
Investigations into its structure elucidation were instigated with
the identification of the &#x003b1;,&#x003b2;-unsaturated amino acids
Dha and Dhb in nisin<sup><xref ref-type="bibr" rid="ref155">155</xref></sup> and in subtilin,<sup><xref ref-type="bibr" rid="ref156">156</xref></sup> a structurally closely related lanthipeptide
produced by <italic>Bacillus subtilis</italic> ATCC 6633. Subsequent
efforts ultimately culminated in the determination of the chemical
structure of nisin by Gross and Morell in 1971 (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>).<sup><xref ref-type="bibr" rid="ref157">157</xref></sup> Concurrently,
Ingram observed that the levels of incorporation of radioactive Cys
into nisin in cultures of <italic>L. lactis</italic> correlated with
the addition of protein synthesis inhibitors,<sup><xref ref-type="bibr" rid="ref158">158</xref></sup> and proposed a ribosomal mechanism for lanthipeptide production
wherein Dha and Dhb are formed through the dehydration of Ser and
Thr, respectively, and subsequent intramolecular 1,4-conjugate addition
of Cys onto the dehydro amino acids would afford the characteristic
Lan and MeLan rings. Confirmation of a ribosomal origin for lanthipeptides
was firmly established in the late 1980s as sequences of several lantibiotic
biosynthetic clusters revealed the presence of genes that encode for
peptidic precursors of lanthipeptides, such as those for epidermin,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> subtilin,<sup><xref ref-type="bibr" rid="ref159">159</xref></sup> nisin,<sup><xref ref-type="bibr" rid="ref160">160</xref>&#x02212;<xref ref-type="bibr" rid="ref162">162</xref></sup> and gallidermin.<sup><xref ref-type="bibr" rid="ref163">163</xref></sup> Importantly, each
of these gene sequences codes for peptides that contain an N-terminal
leader sequence that is absent in the final products and a C-terminal
core sequence that contains codons for Ser, Thr, and Cys at the sites
of the post-translational modifications in the final products.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Structure of
the class I lanthipeptide nisin A (A) and its shorthand
structure representation (B) that is used throughout this review.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0004" id="gr4" position="float"/></fig><p>The chemical structure of nisin
consists of five thioether linkages
that define rings A-E, along with one Dhb and two Dha residues (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). The configurations
of the thioether rings were determined by reductive desulfurization,
which yielded D- and L-Ala from rings containing Lan, and D-&#x003b1;-aminobutyric
acid (D-Abu) and L-Ala from rings containing MeLan.<sup><xref ref-type="bibr" rid="ref157">157</xref></sup> Comparison of the retention times with authentic samples
identified the <italic>S</italic>-configuration at the &#x003b2;-position
of the latter.<sup><xref ref-type="bibr" rid="ref164">164</xref></sup> These data established
the stereochemistry of (2<italic>S</italic>,6<italic>R</italic>) for
the Lan residue and (2<italic>S</italic>,3<italic>S</italic>,6<italic>R</italic>) for the MeLan residues in nisin (<xref rid="fig1" ref-type="fig">Figures <xref rid="fig1" ref-type="fig">1</xref></xref> and <xref rid="fig4" ref-type="fig">4</xref>). To date,
all known structures of class I lanthipeptides have the same stereochemistry,
while other diastereomers have been observed in class II lanthipeptides
(<xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>).<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> Sequence-specific assignment of the <sup>1</sup>H NMR spectrum of subtilin showed that it contains a ring topology
similar to that observed for nisin (<xref rid="fig4" ref-type="fig">Figures <xref rid="fig4" ref-type="fig">4</xref></xref> and <xref rid="fig5" ref-type="fig">5</xref>).<sup><xref ref-type="bibr" rid="ref165">165</xref></sup></p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Structures of class I lanthipeptides including members
containing
tailoring modifications (olive green). Shorthand notations used for
each post-translational modification (PTM) are indicated. <italic>R</italic>-stereochemistry has been demonstrated for the lactyl group
in epilancin 15X (see <xref rid="sec2.6.1" ref-type="other">section <xref rid="sec2.6.1" ref-type="other">2.6.1</xref></xref>).<sup><xref ref-type="bibr" rid="ref171">171</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0005" id="gr5" position="float"/></fig><p>Introduction of the specific patterns of thioether cross-links
bestows upon lanthipeptides the ability to recognize specific molecular
targets with high specificity and selectivity (e.g., lipid II for
nisin,<sup><xref ref-type="bibr" rid="ref166">166</xref>&#x02212;<xref ref-type="bibr" rid="ref168">168</xref></sup> and phosphatidyl ethanolamine for cinnamycin<sup><xref ref-type="bibr" rid="ref169">169</xref>,<xref ref-type="bibr" rid="ref170">170</xref></sup>). Just as medicinal chemists optimize lead structures with synthetic
modifications, Nature has optimized the activity and specificity of
lanthipeptides within the ecological niche of the producer organism
by further tailoring reactions after installation of the characteristic
ring structures. Many of these modifications occur at the N- or C-termini
to increase the stability of the peptides or to change the overall
charge.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref171">171</xref></sup> Such post-translational modifications in
class I lanthipeptides include the installation of a C-terminal <italic>S</italic>-[(<italic>Z</italic>)-2-aminovinyl]-<sc>d</sc>-Cys (AviCys)
formed via an enethiol intermediate generated by the LanD oxidative
decarboxylase flavoproteins<sup><xref ref-type="bibr" rid="ref172">172</xref>,<xref ref-type="bibr" rid="ref173">173</xref></sup> as found in epidermin
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>), and the
reduction of a ketone to an alcohol during installation of an N-terminal
2-hydroxypropionate by LanO dehydrogenases,<sup><xref ref-type="bibr" rid="ref171">171</xref></sup> as found in epilancin 15x (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>).<sup><xref ref-type="bibr" rid="ref174">174</xref></sup> One of the most potent
lantibiotics identified to date is microbisporicin (also known as
NAI-107) produced by <italic>Microbispora</italic> sp. 107891 (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>), which shows potent
activity against several clinically relevant pathogenic bacteria.<sup><xref ref-type="bibr" rid="ref175">175</xref></sup> The chemical structure of this compound shows
two modifications not previously observed in lanthipeptides, specifically,
chlorination on a Trp residue and dihydroxylation of a Pro residue
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). <xref rid="sec2.6" ref-type="other">Section <xref rid="sec2.6" ref-type="other">2.6</xref></xref> will discuss
the enzymes involved in these tailoring reactions.</p><p>The biosynthesis
of nisin is encoded by a transcriptional operon
of 11 genes (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>) encoding the precursor peptide (<italic>nisA</italic>), three proteins
involved in post-translational modifications (<italic>nisB</italic>, <italic>nisC</italic>, and <italic>nisP</italic>), and an ATP-binding
cassette (ABC) type transporter (<italic>nisT</italic>), along with
genes encoding transcriptional regulators (<italic>nisR</italic> and <italic>nisK</italic>) and immunity proteins (<italic>nisI</italic> and <italic>nisFEG</italic>).<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> Comparisons with the
gene clusters for subtilin and epidermin, among others, show that
four genes (<italic>lanABCT</italic>) are common across various biosynthetic
clusters (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>).
Since <italic>lanC</italic> and <italic>lanT</italic> have more recently
also been found in clusters of class II lanthipeptides, the presence
of <italic>lanB</italic> is what uniquely defines class I lanthipeptides.
Notably, the NisA precursor peptide contains 57 residues, while the
product nisin is composed of 34 residues. Hence, the precursor peptide
comprises a 23-residue N-terminal leader sequence that is excised
from the final product and a 34-residue C-terminal core sequence where
the enzymatic modifications are installed (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>). The post-translational installation of
the (&#x003b2;-methyl)lanthionine rings is carried out by two enzymes:
NisB that catalyzes the dehydration of Ser and Thr residues in the
core peptide,<sup><xref ref-type="bibr" rid="ref176">176</xref></sup> and the NisC cyclase that
facilitates the intramolecular addition of Cys onto the resultant
dehydro amino acids to generate cyclic NisA with the leader still
attached (mNisA).<sup><xref ref-type="bibr" rid="ref177">177</xref></sup> The subtilisin-like
serine protease NisP removes the leader sequence from the post-translationally
modified core<sup><xref ref-type="bibr" rid="ref178">178</xref></sup> to yield the bioactive
final product. Two partially orthogonal systems confer immunity against
nisin to the producing organisms: the extracellularly located NisI
lipoprotein that binds and sequesters active nisin,<sup><xref ref-type="bibr" rid="ref179">179</xref></sup> and the NisFEG active transporter that is involved in nisin
extrusion.<sup><xref ref-type="bibr" rid="ref180">180</xref></sup></p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Biosynthetic gene clusters
of various class I lanthipeptides.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref161">161</xref>,<xref ref-type="bibr" rid="ref162">162</xref>,<xref ref-type="bibr" rid="ref181">181</xref>&#x02212;<xref ref-type="bibr" rid="ref184">184</xref></sup> See <xref rid="sec2.1" ref-type="other">section <xref rid="sec2.1" ref-type="other">2.1</xref></xref> and Abbreviations section for the general nomenclature of lanthipeptide
biosynthetic genes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0006" id="gr6" position="float"/></fig><fig id="fig7" position="float"><label>Figure 7</label><caption><p>Scheme showing the biosynthetic
route to nisin A. For clarity,
the process is shown as first completion of dehydration and then cyclization,
but this is not necessarily the case. The timing of the different
PTMs installed on the NisA precursor peptide is discussed in the text.
The FNLD motif in the leader peptide (bolded and underlined) is conserved
in other class I lanthipeptide leader peptides and appears important
in interactions with both NisB and NisC. The cyclization catalyzed
by NisC is reversible as shown by experiments involving resubjection
of mNisA to the cyclization conditions (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0007" id="gr7" position="float"/></fig><p>Genome mining studies have demonstrated that class I lanthipeptide
biosynthetic genes are widely distributed across various bacterial
phyla.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> Phylogenetic analysis of the distribution
of the LanC cyclases yields sequences that fall into three distinct
groups: group 1 found in Bacteroidetes and Proteobacteria, and groups
2 and 3 found in Actinobacteria and Firmicutes, respectively.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The latter two groups are related to one another
and are distinct from the group 1 sequences. Similar analysis of LanB
dehydratases shows that the sequences from Bacteroidetes and Proteobacteria
may be derived from Firmicutes, denoting possible differences in the
evolutionary origins of the LanBs versus the LanCs.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> While the phylogenetic distribution of LanBs does not completely
correlate with that of LanCs, enzymes that are from the same biosynthetic
cluster generally group into similar clades.</p><p>Class I lanthipeptides
may also be distinguished based on similarities
of their precursor peptides with members for which experimentally
structures have been established. In this classification, the molecules
may be demarcated into the nisin-like, epidermin-like, and Pep5-like
groups.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> This classification extends only
to the lanthipeptide itself and not to the genes in the clusters,
as similarities in the structures of the final products do not necessarily
reflect an equivalent similarity across the biosynthetic enzymes.
For example, although the sequences of the nisin and subtilin precursors
and products are similar, their associated LanC enzymes are only distantly
related.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The notion of the precursor
sequence possibly directing the final structure is further fortified
by experiments in which fusion of a class II core peptide onto the
class I NisA leader peptide resulted in processing by the nisin biosynthetic
enzymes to yield an antibacterial peptide, which presumably is the
natural product.<sup><xref ref-type="bibr" rid="ref185">185</xref></sup> Similarly, expression
of a chimeric peptide consisting of the subtilin leader and a combination
of the nisin and subtilin core peptides with the subtilin biosynthetic
machinery in <italic>B. subtilis</italic> produced a fully processed
product.<sup><xref ref-type="bibr" rid="ref186">186</xref></sup> Likewise, a chimera of the <italic>Staphylococcus epidermidis</italic> epilancin 15X core peptide and
the NisA leader peptide was processed by the nisin system to afford
a product with ring topology and bioactivity similar to epilancin
15X.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p></sec><sec id="sec2.2"><label>2.2</label><title>Dehydration
via Glutamylation</title><p>Although
the genes responsible for nisin<sup><xref ref-type="bibr" rid="ref182">182</xref></sup> and
subtilin<sup><xref ref-type="bibr" rid="ref183">183</xref></sup> production were first identified
in 1992, the mechanistic basis for Ser/Thr dehydration by any class
I LanB was not elucidated for another 20 years. One of the limiting
factors in the characterization of LanB enzymes was the lack of a
suitable heterologous expression and purification system for these
high molecular weight enzymes; for example, NisB is a 117 kDa protein.
In addition, identification of amphipathic &#x003b1;-helices in the
primary sequence and immuno-detection of NisB in vesicles of <italic>L. lactis</italic> lead to the expectation that NisB may be membrane
associated,<sup><xref ref-type="bibr" rid="ref182">182</xref></sup> which also stalled biochemical
efforts. Hence, early experiments were limited in mechanistic explorations,
and focused more on genetic characterization. Plasmid-based overexpression
of NisB in different nisin producing strains increased the efficiency
of dehydration of an engineered NisA variant.<sup><xref ref-type="bibr" rid="ref187">187</xref></sup> Additionally, expression of affinity-tagged NisA precursor
peptide in a <italic>nisB</italic> deletion strain yielded unmodified
peptide, while expression in a <italic>nisC</italic> deletion strain
yielded a product that had undergone dehydration but was not cyclized.<sup><xref ref-type="bibr" rid="ref188">188</xref>,<xref ref-type="bibr" rid="ref189">189</xref></sup> These data established that NisB carries out the dehydration on
the NisA precursor peptide, which is cyclized by NisC.</p><p>In the
early 2000s, coexpression of SpaB from <italic>B. subtilis</italic> ATCC 6633 (the subtilin producer) with the GroESL chaperones facilitated
purification of the enzyme in milligram quantities.<sup><xref ref-type="bibr" rid="ref190">190</xref></sup> However, multiple attempts to reconstitute in vitro activity
using the purified protein were unsuccessful. Nearly a decade later,
two different methodologies allowed for the production of soluble
NisB protein, facilitating functional analysis. First, homologous
expression of C-terminally polyhistidine tagged NisB in <italic>L.
lactis</italic> yielded soluble protein that could be purified from
the cytosol using affinity chromatography, and showed no propensity
for aggregation even after prolonged storage.<sup><xref ref-type="bibr" rid="ref191">191</xref></sup> Size-exclusion chromatography, combined with multiangle
static light scattering analyses, demonstrated that purified NisB
behaved as a homogeneous species with a mass consistent with that
of a protein dimer. Surface plasmon resonance experiments documented
that purified NisB interacted with the substrate precursor peptide,
as well as with the dehydrated NisA with affinities in the micromolar
range. In a second approach, coexpression of NisB along with the NisC
cyclase and the NisA precursor peptide in <italic>Escherichia coli</italic> enabled the production of authentic nisin.<sup><xref ref-type="bibr" rid="ref92">92</xref></sup> While the dehydratase produced in <italic>E. coli</italic> using
this coexpression strategy was not yet purified, the enzyme had to
be functional as the NisA precursor was dehydrated and cyclized in
vivo.</p><p>Based on the heterologous expression data, recombinant,
affinity-tagged
NisB was coexpressed with NisA in <italic>E. coli</italic>, facilitating
purification of the enzyme from the soluble fraction. Although in
vitro activity could not be demonstrated using purified components,
addition of crude <italic>E. coli</italic> cell extract, along with
ATP, MgCl<sub>2</sub>, and glutamate (the most abundant <italic>E.
coli</italic> metabolite) to reactions of NisB generated up to nine
dehydrations on the NisA precursor peptide.<sup><xref ref-type="bibr" rid="ref192">192</xref></sup> These studies established the first in vitro biochemically tractable
system that allowed monitoring of LanB dehydratase activity, facilitating
functional analysis of site-specific LanB variants, and access to
possible intermediates in the modification pathway. Ala-scanning mutational
analysis was used to identify the role of various polar residues in
NisB that are conserved among most LanB enzymes, to assess if any
of these residues play a role in the chemistry of dehydration. A group
of Ala variants that largely clustered to the N-terminus of NisB (Arg14,
Arg83, Arg87, Thr89, Asp121, Asp299, and Arg464) were inactive, suggesting
their importance for dehydratase activity. Intriguingly, while Ala
variants at residues located at the C-terminus of NisB (Arg786, Arg826,
and His961) did not produce a dehydrated product, these variants generated
NisA modified by multiple adducts of +129 Da as observed by mass spectrometry.<sup><xref ref-type="bibr" rid="ref192">192</xref></sup> The mass shift is consistent with the addition
of multiple glutamate residues on the NisA precursor peptide. Polyglutamylation
is a post-translational modification in which a free Glu is added
via its amino group onto the &#x003b3;-carboxylate of Glu residues forming
an isopeptide bond. Then the added Glu serves as a site for another
glutamylation, ultimately leading to polyglutamylation. This modification
has previously been observed and extensively studied in eukaryotic
tubulin.<sup><xref ref-type="bibr" rid="ref193">193</xref></sup></p><p>Incubation of glutamylated
NisA precursor with wild-type NisB dehydratase
resulted in elimination of the glutamate to yield a dehydrated product
(<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>), and this
elimination reaction did not require ATP, MgCl<sub>2</sub>, or <italic>E. coli</italic> cell extract.<sup><xref ref-type="bibr" rid="ref192">192</xref></sup> Thus,
glutamylation could not be on Glu residues but had to be on Ser/Thr
residues. These data also demonstrated that the glutamylated NisA
is an intermediate in the dehydration pathway, where esterification
via the O&#x003b3; of Ser/Thr would presumably activate the side chain
hydroxyl for subsequent &#x003b2;-elimination. Incubation of glutamylated
NisA with Ala variants at the N-terminus of NisB also resulted in
glutamate elimination. Collectively, these data suggest that the N-terminal
portion of NisB harbors the glutamylation activity, and the glutamate
elimination activity resides largely within the C-terminal portion
of the polypeptide. However, prior activation of Glu, via either the
&#x003b1;- or the side-chain carboxylate, would be required to catalyze
glutamate addition onto the side chain Ser/Thr of the precursor substrate,
but the NisB dehydratase did not demonstrate any Glu activation activity.</p><fig id="fig8" position="float"><label>Figure 8</label><caption><p>LanB enzymes
achieve dehydration by catalyzing a transesterification
reaction from glutamyl-tRNA<sup>Glu</sup> to the side chain of Ser/Thr
followed by &#x003b2;-elimination. Chemoselective activation by glutamate
via its &#x003b1;-carboxylate is illustrated here as has been demonstrated
for the nonlanthipeptide RiPP goadsporin.<sup><xref ref-type="bibr" rid="ref195">195</xref></sup> Conserved LanB residues predicted by mutagenesis studies on NisB
to be important for transesterification and elimination are shown
in gray. The exact roles of these residues remain to be established.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0008" id="gr8" position="float"/></fig><p>In order to elucidate the source
of activated Glu, <italic>E. coli</italic> extract was fractionated
into high and low molecular weight pools,
with activity only present in the high molecular weight fractions.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> Further separation of components using anion
exchange chromatography localized the bioactive component to a fraction
pool that absorbed strongly at 260 nm and was sensitive to treatment
with RNase.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> These data supported glutamyl-tRNA<sup>Glu</sup> as the source of activated Glu that is necessary for NisB
activity. A reconstitution experiment with purified NisB and NisA,
along with glutamyl-tRNA synthetase (GluRS) and tRNA<sup>Glu</sup> illustrated that the latter two are the constituents of <italic>E. coli</italic> extract that are necessary and sufficient for NisB
activity.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> Thus, NisB does not catalyze
aminoacylation of tRNA but rather utilizes the glutamyl-tRNA<sup>Glu</sup> that is available from the cellular pool. These data are consistent
with a mechanistic model in which LanB dehydratases activate the side
chain hydroxyls of Ser/Thr through the addition of a Glu residue derived
from glutamyl-tRNA<sup>Glu</sup>, and subsequently abstract the &#x003b1;
proton of the modified Ser/Thr to facilitate &#x003b2;-elimination to
yield the dehydro amino acid (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>). The use of negatively charged glutamyl-tRNA<sup>Glu</sup> as a cosubstrate may explain the observation that Ser/Thr
residues flanked by hydrophobic residues are better substrates for
dehydration than those flanked by polar and especially negatively
charged residues.<sup><xref ref-type="bibr" rid="ref74">74</xref>,<xref ref-type="bibr" rid="ref79">79</xref></sup></p><p>Although NisB could utilize
the <italic>E. coli</italic> glutamyl-tRNA<sup>Glu</sup> as a source
of activated Glu, the LanB from the NAI-107
producing organism <italic>Microbispora</italic> sp. 107891, MibB,
could not do so efficiently.<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> Reconstitution
of activity for MibB required the addition of the charged cognate
CUC anticodon tRNA<sup>Glu</sup> from the producing organism.<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> A comparison of the nucleotide sequence of <italic>Microbispora</italic> sp. 107891 tRNA<sup>Glu</sup> with that of <italic>E. coli</italic> tRNA<sup>Glu</sup> revealed differences in the acceptor
stem. A G73A single mutation and G73A/C72U double mutation were introduced
in the <italic>E. coli</italic> tRNA<sup>Glu</sup> acceptor stem to
reflect the sequence found in <italic>Microbispora</italic> sp. 107891
tRNA<sup>Glu</sup>. Notably, reactions using the G73A variant of <italic>E. coli</italic> tRNA<sup>Glu</sup> produced up to three dehydrations
in the MibA precursor peptide, whereas the G73A/C72U double variant
produced up to six dehydrations on the precursor.<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> Hence, the tRNA acceptor stem likely serves as a major
recognition determinant between the LanB dehydratase and its cognate
tRNA<sup>Glu</sup>.</p><p>Further insights into the function of the
LanB dehydratases were
afforded with the crystal structure of <italic>Microbispora</italic> sp. 107891 MibB<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> and of <italic>L.
lactis</italic> NisB in complex with the NisA precursor peptide.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> Both studies revealed that the LanB enzymes
have a didomain architecture consisting of an &#x0223c;800 residue
N-terminal domain and an &#x0223c;350 residue C-terminal domain (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>A). The structures
do not show resemblance to any other proteins in the Protein Data
Bank,<sup><xref ref-type="bibr" rid="ref197">197</xref></sup> and therefore constitute a new
fold. Although crystallization of the NisB-NisA complex utilized the
entire precursor peptide, and mass spectrometric analysis of dissolved
crystals confirmed the integrity of the dehydrated precursor, convincing
electron density could only be observed for Lys&#x02212;20 through
Lys&#x02212;9 of the leader peptide (see <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref> for leader peptide numbering scheme), indicating
that the remainder of the precursor is conformationally disordered
or that the enzyme has low affinity for this region.</p><fig id="fig9" position="float"><label>Figure 9</label><caption><p>(A) Structure of the
NisB homodimer bound to the NisA leader sequence
(cyan). The glutamylation domain (brown) and elimination domain (purple)
are indicated for one monomer, and the other protomer is colored in
gray. (B) Mapping of the electrostatic potential onto the surface
of the NisB monomer identified a basic patch (blue) in the vicinity
of the NisA leader (green) predicted to engage glutamyl-tRNA<sup>Glu</sup>. PDB ID 4WD9.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0009" id="gr9" position="float"/></fig><p>Mapping of electrostatic potentials
onto the surface of NisB identified
a large basic region in the glutamylation domain, which could engage
the tRNA<sup>Glu</sup> substrate (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>B). Manual docking of tRNA<sup>Glu</sup> from <italic>Thermus thermophilus</italic> at this patch positions the aminoacylated
CCA terminus in the direct vicinity of residues necessary for glutamylation.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> The NisB structure revealed that residues that
were identified via Ala-scanning mutational analysis as important
for glutamylation are distributed within a 10 &#x000c5; radius in the
N-terminal domain, and those important for &#x003b2;-elimination are
closely distributed within the C-terminal domain (<xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref>).<sup><xref ref-type="bibr" rid="ref192">192</xref>,<xref ref-type="bibr" rid="ref194">194</xref></sup> Analysis of NisB variants generated in a nisin producing strain
identified Tyr80 of NisB as a residue that is critical for dehydratase
activity, and the Y80F variant could bind the NisA precursor but did
not modify the substrate in vivo.<sup><xref ref-type="bibr" rid="ref198">198</xref></sup> One
possible role for Tyr80 is as a shuttle for glutamate from glutamyl-tRNA<sup>Glu</sup> to the NisA substrate. The crystal structure of the MibB
dehydratase shows an overall conservation of most structural features
present in NisB,<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> although some local
movements near the leader peptide-binding site are evident (see <xref rid="sec2.5" ref-type="other">section <xref rid="sec2.5" ref-type="other">2.5</xref></xref>).</p><fig id="fig10" position="float"><label>Figure 10</label><caption><p>Residues
identified by Ala-scanning mutational analysis that are
critical for (A) glutamylation and (B) glutamate elimination map to
the two different domains of NisB. The exact roles of these residues
remain to be established. PDB ID 4WD9.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0010" id="gr10" position="float"/></fig><p>Confirmation of the attachment of the Glu to the Ser/Thr
side chain
via its &#x003b1;-carboxylate was provided by a study on the nonlanthipeptide
goadsporin. The structure of this RiPP features several dehydro amino
acids,<sup><xref ref-type="bibr" rid="ref199">199</xref></sup> and its biosynthetic gene cluster
contains two open reading frames that would be consistent with one
gene that corresponds to a Glu-tRNA dependent glutamylation enzyme
and one that corresponds to a Glu elimination enzyme.<sup><xref ref-type="bibr" rid="ref200">200</xref></sup> Disruption of the latter in the producing organism
resulted in buildup of intermediates that were characterized by NMR
spectroscopy.<sup><xref ref-type="bibr" rid="ref195">195</xref></sup> These studies unambiguously
showed attachment of Glu via its &#x003b1;-carboxylate to the Ser side
chain. Similar &#x0201c;split&#x0201d; LanB systems are also present
in the biosynthetic gene clusters of thiopeptides (see review by Burkhart
et al. in this issue),<sup><xref ref-type="bibr" rid="ref201">201</xref></sup> another class
of RiPPs, and they have been shown to also utilize Glu-tRNA for dehydration
of Ser/Thr in their substrate peptides.<sup><xref ref-type="bibr" rid="ref202">202</xref>,<xref ref-type="bibr" rid="ref203">203</xref></sup> Split LanB enzymes are also found in some lanthipeptide biosynthetic
gene clusters<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> including one in <italic>Chitinophaga pinensis</italic> DSM 28390. This cluster produces the
pinensins (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>), the first antifungal lantibiotics and the first characterized
lanthipeptides from Bacteroidetes.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> With
now four LanB and LanB-like enzymes investigated from different genera,<sup><xref ref-type="bibr" rid="ref194">194</xref>&#x02212;<xref ref-type="bibr" rid="ref196">196</xref>,<xref ref-type="bibr" rid="ref202">202</xref></sup> the use of Glu-tRNA appears
to be a general requirement. These findings also explained a previous
report on the in vitro biosynthesis of nisin by expression of <italic>nisA</italic>, <italic>nisB</italic>, and <italic>nisC</italic> in
a cell-free translation system.<sup><xref ref-type="bibr" rid="ref204">204</xref></sup> This
experimental setup contained tRNAs, tRNA transferases, and all amino
acids, and hence nisin biosynthesis was observed. We also note that
esterification of Ser/Thr, instead of phosphorylation (see <xref rid="sec4.2" ref-type="other">sections <xref rid="sec4.2" ref-type="other">4.2</xref></xref> and <xref rid="sec5.2" ref-type="other">5.2</xref>), was already suggested back in 1991 as a potential
activation mechanism for dehydration.<sup><xref ref-type="bibr" rid="ref205">205</xref></sup> Why LanBs use Glu-tRNA and not another amino acyl-tRNA is currently
not understood. For an overview of the use of aminoacylated tRNA in
natural product biosynthesis, see the review by Gondry and co-workers
in this issue.<sup><xref ref-type="bibr" rid="ref206">206</xref></sup></p><p>To determine the
phylogenic distribution of LanB enzymes, a sequence
similarity network was constructed for this review with the Enzyme
Function Initiative-Enzyme Similarity Tool (EFI-EST)<sup><xref ref-type="bibr" rid="ref207">207</xref></sup> utilizing all members of the N-terminal Lantibiotic Dehydratase
family (Pfam 04738) from the UniProtKB database (version 2016_06; <xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>). After constructing
the network, all sequences that did not contain a C-terminal Lantibiotic
Dehydratase family domain (Pfam 14028) were removed, leaving only
complete LanB proteins containing both the N-terminal glutamylation
and C-terminal elimination domains (i.e., split LanBs and small LanBs<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> were removed). The relative similarity between
individual LanBs was assessed in Cytoscape<sup><xref ref-type="bibr" rid="ref208">208</xref></sup> at an alignment score threshold of 120 (&#x0223c;30% sequence identity).
Actinobacteria constitute the majority of the LanB sequences found
in the UniProtKB database and appear to be distributed into two major
groups. While the larger cluster is isolated from the clusters of
other phyla, the smaller cluster from Actinobacteria appears to be
related to LanBs found in Firmicutes. As for the Actinobacteria, LanBs
from Bacteroidetes are split into two major clusters. The larger of
these two is closely linked to LanBs from Proteobacteria, suggesting
a close lineage. Previous phylogenetic analysis of the LanC cyclase
enzymes showed that Bacteroidetes and Proteobacteria LanCs are closely
related and are distinct from LanCs from Actinobacteria and Firmicutes.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p><fig id="fig11" position="float"><label>Figure 11</label><caption><p>Sequence similarity network generated herein using EFI-EST
and
visualized in Cytoscape with an alignment score threshold of 120 (&#x0223c;30%
sequence identity) showing the distribution of LanB enzymes across
phyla. Each node represents protein sequences sharing &#x0003e;95% sequence
identity.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0011" id="gr11" position="float"/></fig></sec><sec id="sec2.3"><label>2.3</label><title>Cyclization</title><p>Formation of the lanthionine
ring is completed with the intramolecular attack of a Cys thiolate
onto the dehydro amino acid. Conjugate addition of nucleophiles to
dehydro amino acids is well characterized and, in principle, formation
of lanthionine rings could occur spontaneously at basic pH.<sup><xref ref-type="bibr" rid="ref209">209</xref>&#x02212;<xref ref-type="bibr" rid="ref211">211</xref></sup> However, attempts to recapitulate the correct ring topology of nisin
synthetically yielded a mixture of products. For example, an attempt
to form the AB ring system of nisin by biomimetic cyclization of a
synthetic model produced multiple products.<sup><xref ref-type="bibr" rid="ref212">212</xref></sup> These products were presumed to result from the faster cyclization
rate for lanthionines compared to methyllanthionines under nonenzymatic
conditions.<sup><xref ref-type="bibr" rid="ref213">213</xref></sup> Consequently, enzymatic
catalysis is required to overcome this intrinsic reactivity and facilitate
proper ring formation.</p><p>Initial characterization of the function
of a LanC cyclase was carried out via genetic studies of Pep5 biosynthesis,
wherein deletion of the C-terminal 231 residues of PepC from a biosynthetic
plasmid in the <italic>Staphylococcus epidermidis</italic> 5 producing
strain diminished formation of lanthionine rings.<sup><xref ref-type="bibr" rid="ref214">214</xref></sup> Isolation of intermediates from this strain demonstrated
that the Ser/Thr residues in the precursor peptide had undergone modification
but in most cases the Cys residues were intact. Studies of mutant
strains of <italic>S. epidermidis</italic> T&#x000fc;3298 that do not
produce epidermin revealed an intact biosynthetic pathway but with
mutations in the <italic>epiC</italic> gene, as plasmid complementation
with wild-type <italic>epiC</italic> restored lanthipeptide production.<sup><xref ref-type="bibr" rid="ref215">215</xref></sup> These data suggested that formation of the
thioether linkages is not spontaneous, and that the LanC cyclase is
required for the site-specific addition of Cys onto the dehydro amino
acid to achieve the proper ring topology.</p><p>The LanC cyclases
could be readily purified after overexpression
in an <italic>E. coli</italic> heterologous system, as first demonstrated
for EpiC from the epidermin cluster.<sup><xref ref-type="bibr" rid="ref216">216</xref></sup> However, in vitro characterization of LanC activity initially proved
challenging due to the lack of suitable quantities of the dehydrated
precursor substrate and the lack of a means to detect the cyclization
reaction, as there is no change in mass of the precursor peptide upon
thioether formation. Interestingly, sequencing of the nonproducer
mutants of <italic>S. epidermidis</italic> T&#x000fc;3298 described
above identified G131E or G245E mutations in EpiC (note that numbering
is adjusted from ref (<xref ref-type="bibr" rid="ref216">216</xref>) to correspond with the complete gene), and each of these residues
are in motifs conserved throughout LanCs and G245 is in the vicinity
of the predicted catalytic acid (His248) in the primary sequence.
The authors also noted that two Cys residues (Cys313 and Cys360 in
EpiC) are also conserved among LanCs,<sup><xref ref-type="bibr" rid="ref216">216</xref></sup> suggesting that these Cys may play a role in catalysis. In 2002,
analysis of affinity tagged NisA precursor expressed in mutant strains
of <italic>L. lactis</italic> that lacked NisC showed that the peptide
had undergone dehydration but not cyclization, confirming a role for
LanC enzymes in the cyclization reaction.<sup><xref ref-type="bibr" rid="ref188">188</xref></sup></p><p>Chemical analysis of two LanC enzymes (NisC and SpaC) purified
from a heterologous <italic>E. coli</italic> expression system indicated
that both enzymes contain stoichiometric amounts of zinc.<sup><xref ref-type="bibr" rid="ref217">217</xref></sup> Based on a functional role for zinc in maintaining
the reactivity of thiols at neutral pH in other alkylating enzymes,<sup><xref ref-type="bibr" rid="ref218">218</xref>,<xref ref-type="bibr" rid="ref219">219</xref></sup> the zinc in LanC was proposed to function as a Lewis acid to lower
the p<italic>K</italic><sub>a</sub> of the S&#x003b3; of Cys, enabling
the thiolate to participate in conjugate addition to Dha or Dhb residues.<sup><xref ref-type="bibr" rid="ref217">217</xref></sup> The in vitro reconstitution of NisC activity
was finally achieved using dehydrated NisA purified from a <italic>L. lactis</italic> strain that encoded the precursor peptide, dehydratase,
and transporter but lacked the gene for the cyclase.<sup><xref ref-type="bibr" rid="ref177">177</xref></sup> Thioether formation was monitored by mass spectral analysis
of the dehydrated NisA that was treated with a thiol-selective modification
agent. In the event, the dehydrated peptide was modified five times
indicating the presence of five free thiols, whereas peptide that
was treated with NisC did not show any mass shift, consistent with
a sample devoid of any free Cys as a result of five cyclizations.
Proteolytic removal of the leader peptide from the NisC-treated precursor
yielded a product that was bioactive against a nisin indicator strain,
suggesting that NisC installed the correct ring topology of nisin.<sup><xref ref-type="bibr" rid="ref177">177</xref></sup></p><p>The crystal structure of NisC revealed
an &#x003b1;,&#x003b1;-toroidal
fold containing a single zinc ion at the center of the toroid (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>A). Enzyme residues
Cys284, Cys330, and His331 coordinate the zinc ion (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>B),<sup><xref ref-type="bibr" rid="ref177">177</xref></sup> and these residues are very close in structure to the Gly residue
that corresponds to Gly245 in EpiC that was altered to Glu in a nonepidermin-producing
strain of <italic>S. epidermidis</italic> T&#x000fc;3298. The structure
also reveals a small extension adjacent to the zinc ion, which resemble
mammalian SH2 domains<sup><xref ref-type="bibr" rid="ref220">220</xref></sup> and may analogously
serve to bind the peptide substrate. However, there is currently no
evidence for a functional role of this SH2-like extension. More recently,
mammalian homologues of LanC proteins, termed LanCL (for &#x0201c;LanC-like&#x0201d;)
have been identified and characterized to similarly contain an active
site zinc (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>C).<sup><xref ref-type="bibr" rid="ref221">221</xref></sup></p><fig id="fig12" position="float"><label>Figure 12</label><caption><p>(A) Overall structure of the NisC cyclase
(PDB ID 2G0D) illustrating the
&#x003b1;,&#x003b1;-toroid (orange), and the SH2-like extension (blue
and purple). (B) Close-up view of NisC showing the zinc ligands and
other residues located in the active site. Residues derived from the
SH2-like domain are indicated in blue. (C) Active site of LanCL1 showing
coordination of enzyme residues (green) and GSH (red) to zinc (PDB
ID 3E73).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0012" id="gr12" position="float"/></fig><p>Site-specific mutations were introduced
at residues in the vicinity
of the zinc ion, which are conserved between NisC and the subtilin
cyclase SpaC, in order to probe their importance in catalysis (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>B). Activity for
SpaC was measured by detecting production of subtilin in vivo<sup><xref ref-type="bibr" rid="ref222">222</xref></sup> while the activity of NisC variants were monitored
by the bioactivity of products formed in vitro in reactions using
purified dehydrated NisA.<sup><xref ref-type="bibr" rid="ref223">223</xref></sup> Mutation of
the zinc-ligands Cys284, Cys330, or His331 in NisC, or the equivalent
SpaC residues, diminished zinc binding and eliminated cyclase activity.<sup><xref ref-type="bibr" rid="ref217">217</xref>,<xref ref-type="bibr" rid="ref222">222</xref>,<xref ref-type="bibr" rid="ref223">223</xref></sup> Additional active site variants
of NisC, including H212N, H212F, and D141N, retained affinity for
zinc but lacked activity, indicating a possible role for these residues
in acid/base catalysis.<sup><xref ref-type="bibr" rid="ref222">222</xref>,<xref ref-type="bibr" rid="ref223">223</xref></sup></p><p>The structural
and mutational data provide a plausible mechanistic
framework for LanC catalysis (<xref rid="fig13" ref-type="fig">Figure <xref rid="fig13" ref-type="fig">13</xref></xref>). Coordination of the Cys residue in the precursor
peptide by the catalytically requisite zinc ion lowers the p<italic>K</italic><sub>a</sub> to facilitate deprotonation, which may or
may not require a general base. For instance, in protein farnesyltransferase,
the p<italic>K</italic><sub>a</sub> of a Cys residue in the peptide
substrate is lowered from 8.3 to 6.4 upon binding to the zinc in the
enzyme active site.<sup><xref ref-type="bibr" rid="ref224">224</xref></sup> A role of the zinc
ion in thiol activation, rather than activation of the carbonyl group
in the dehydro amino acid electrophile, is supported by both the common
use of Zn<sup>2+</sup> for thiol activation in other proteins<sup><xref ref-type="bibr" rid="ref218">218</xref>,<xref ref-type="bibr" rid="ref219">219</xref>,<xref ref-type="bibr" rid="ref225">225</xref></sup> and the observation of a direct
interaction between the sulfur of Cys in glutathione (GSH) and the
zinc ion in the mammalian protein LanCL1 (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>C). Indeed, activation of thiols for nucleophilic
attack by zinc coordination is well supported by model studies with
small molecule metal complexes.<sup><xref ref-type="bibr" rid="ref226">226</xref>&#x02212;<xref ref-type="bibr" rid="ref237">237</xref></sup></p><fig id="fig13" position="float"><label>Figure 13</label><caption><p>Proposed mechanism of cyclization illustrated for the formation
of the B-ring of nisin. The active site acid (H-A) that protonates
the enolate is likely His212.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0013" id="gr13" position="float"/></fig><p>Upon ligation of the Cys thiol, the segment of the peptide
containing
the dehydrated residue targeted for cyclization would be directed
back toward the active site, perhaps through the SH2-like extension,
where the thiolate would attack the &#x003b2;-carbon of the dehydro
amino acid to generate an enolate. Subsequent protonation provides
the D-configuration at the &#x003b1;-carbon via a net anti addition
to account for the stereochemistry of MeLan in nisin (<xref rid="fig13" ref-type="fig">Figure <xref rid="fig13" ref-type="fig">13</xref></xref>). The shallow groove formed
at the center of the &#x003b1;-toroid may facilitate formation of thioether
linkages of different sizes (4&#x02013;7 amino acids in nisin, <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>). The identity of
residues that may deprotonate the thiol and/or protonate the enolate
has not been equivocally established. Mutation of His212 or its hydrogen-bonding
partner Asp141 in NisC abolished activity but the role of these residues
is unclear from the mutational analysis.<sup><xref ref-type="bibr" rid="ref223">223</xref></sup> More recent studies have shown that cyclization is reversible. In
particular, the class I cyclase NisC and the class II lanthipeptide
synthetase HalM2 can also catalyze ring opening (i.e., a retro-conjugate
addition) following abstraction of the &#x003b1; proton of the (methyl)lanthionine.<sup><xref ref-type="bibr" rid="ref238">238</xref></sup> Mutation of His791 in HalM2 (equivalent to
His212 in NisC) abolished this proton abstraction suggesting that
this residue acts as the base in the retro-conjugate addition. In
turn, this suggests that His212 in NisC is the acid that protonates
the enolate during ring formation. Mutations of two other conserved
amino acids in the active site, Y285F or R280A in NisC<sup><xref ref-type="bibr" rid="ref223">223</xref></sup> did not abolish in vitro cyclase activity,
suggesting they are not critical for catalysis. A more drastic mutation
of the corresponding Tyr in SpaC (Y304A) did result in loss of subtilin
production in vivo,<sup><xref ref-type="bibr" rid="ref222">222</xref></sup> with similar results
observed for the NisC-Y285A mutant.<sup><xref ref-type="bibr" rid="ref223">223</xref></sup></p><p>At present, it is not understood how the cyclization enzymes control
the formation of well-defined ring patterns with widely differing
ring sizes and sequences in just a single active site. The dehydrated
NisA intermediate shown in <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref> contains eight dehydro amino acids and five Cys residues.
As noted previously,<sup><xref ref-type="bibr" rid="ref150">150</xref></sup> the number of products
differing in ring topology that can be generated by a completely nonselective
cyclization process would be 6720, with the number going to at least
8.6 &#x000d7; 10<sup>5</sup> if stereochemistry is included. Yet, NisC
makes a single product. As discussed in the next section, one means
by which the enzyme may simplify the task is to alternate dehydration
and cyclization processes such that the number of dehydro amino acids
that each Cys has to differentiate is smaller. Another possibility
is that the substrate sequence has an inherent preference for certain
ring topologies. This hypothesis is especially supported from data
on class II lanthipeptides discussed in <xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>, but some class I systems also provide
support. For instance, ericin A and S are made by one set of class
I biosynthetic enzymes in <italic>Bacillus subtilis</italic> A1/3.<sup><xref ref-type="bibr" rid="ref239">239</xref></sup> The D ring of ericin S is linked to the E ring
similar to the topology found in subtilin whereas the D ring of ericin
A is intertwined with the C ring similar to the structure found in
microbisporicin (<xref rid="fig14" ref-type="fig">Figure <xref rid="fig14" ref-type="fig">14</xref></xref>). Thus, it appears that depending on the sequence of its
substrate, EriC can form products with different topologies.</p><fig id="fig14" position="float"><label>Figure 14</label><caption><p>Class I cyclase
EriC produces the lanthipeptides ericin S and ericin
A with different D and E ring topologies resembling those of subtilin
and microbisporicin, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0014" id="gr14" position="float"/></fig></sec><sec id="sec2.4"><label>2.4</label><title>Communication between Dehydration and Cyclization
Events</title><p>Early studies on nisin biosynthesis suggested the
existence of a multicomponent enzymatic complex, consisting of the
biosynthetic enzymes and the transporter NisT. Co-immunoprecipitation
experiments showed that the NisB dehydratase and the NisC cyclase
localize together at the cytoplasmic membrane, and likewise yeast
two-hybrid studies evidenced interactions between NisB and NisC and
between NisC and NisT.<sup><xref ref-type="bibr" rid="ref240">240</xref></sup> Similar analysis
of the subtilin biosynthetic enzymes indicated that the SpaB dehydratase,
SpaC cyclase, and the SpaT transporter may form a multiprotein complex
associated with the membrane.<sup><xref ref-type="bibr" rid="ref241">241</xref></sup> However,
the dehydration and cyclization activities are not mutually contingent,
as NisB can dehydrate substrates in the absence of all other modification
enzymes,<sup><xref ref-type="bibr" rid="ref192">192</xref>,<xref ref-type="bibr" rid="ref194">194</xref>,<xref ref-type="bibr" rid="ref242">242</xref></sup> and NisC can catalyze cyclization in the absence of other protein
or cellular components.<sup><xref ref-type="bibr" rid="ref177">177</xref></sup> Similarly, the
leader peptide protease NisP and the transporter NisT can function
independently (<xref rid="sec3" ref-type="other">section <xref rid="sec3" ref-type="other">3</xref></xref>).<sup><xref ref-type="bibr" rid="ref243">243</xref></sup></p><p>Although the above data suggest
that the individual activities may be decoupled, pulse-labeling experiments
(see <xref rid="sec3.1" ref-type="other">section <xref rid="sec3.1" ref-type="other">3.1</xref></xref>)
showed that the kinetics of NisA dehydration by NisB and subsequent
secretion by NisT are compromised in the absence of the NisC cyclase.<sup><xref ref-type="bibr" rid="ref189">189</xref></sup> The wild type efficiency could be restored
by expression of a catalytically inactive NisC mutant (H331A), suggesting
that it was interference with complex formation, and not lack of substrate
cyclization, that reduced the efficiency of dehydration/transport
in the absence of NisC.<sup><xref ref-type="bibr" rid="ref244">244</xref></sup> The functional
interplay between the dehydration and cyclization reactions was analyzed
in vivo using a plasmid-based expression system bearing NisA precursor
variants and NisBTC.<sup><xref ref-type="bibr" rid="ref244">244</xref></sup> Installation of
non-native Ser/Thr residues at positions immediately following the
thioether rings did not result in any significant additional dehydration
events, suggesting Ser/Thr at these positions are protected; this
protection could be removed by preventing formation of the rings by
additional mutagenesis.</p><p>These studies revealed that for the
nisin system the dehydrations
are largely independent of each other in the absence of NisC,<sup><xref ref-type="bibr" rid="ref244">244</xref></sup> and that additional dehydrations can take place
for new Ser/Thr residues that are introduced. However, in the presence
of NisC it appears that rings are installed before dehydration has
finished such that certain positions become protected from access
by the NisB dehydratase. The C-terminal positioning of these protected
Ser/Thr residues relative to the rings also suggests a mostly N- to
C-directionality of the NisA processing.<sup><xref ref-type="bibr" rid="ref189">189</xref></sup> An automated pattern-matching algorithm comparing experimental high-resolution
mass spectral data of in vitro generated intermediates against theoretical
spectra of hypothetical intermediates is also consistent with a mostly
N- to C-terminal directionality for the NisB dehydratase.<sup><xref ref-type="bibr" rid="ref245">245</xref></sup></p><p>Analogous results suggesting that cyclization
and dehydration are
at least partly alternating events proceeding with N-to-C-terminal
directionality were obtained using an inactive NisC mutant. Specifically,
expression of the wild-type NisA precursor with NisB and an inactive
NisC cyclase variant yielded a product with one additional Dha at
a position directly C-terminal to the E-ring in mNisA that is usually
not dehydrated by NisB (i.e., Ser29 in the NisA precursor, see <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>).<sup><xref ref-type="bibr" rid="ref244">244</xref></sup> These results suggest that E-ring formation prevents dehydration
of Ser29 by NisB. The observation that cyclization is interspersed
with dehydration is consistent with, but does not prove, a channeling
model in which the product from one enzyme is channeled to the next
enzyme without dissociation, possibly through a multienzyme complex
of NisB and NisC. As discussed in more detail in <xref rid="sec4.4" ref-type="other">section <xref rid="sec4.4" ref-type="other">4.4</xref></xref>, an alternative to channeling
would be a conformational sampling model.</p><p>Further details on
the mutual influences of dehydrations and cyclizations,
as well as on the directionality of processing, were elucidated through
in vitro studies of the biosynthesis of NAI-107.<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> Processing of the MibA precursor peptide in the presence
of only the MibB dehydratase resulted in up to 7 dehydrations. Mass
spectral analysis identified the expected dehydrated intermediates,
along with masses that corresponded to monoglutamylated MibA, which
were formed only after the accumulation of 5-fold dehydrated MibA.<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> Notably, upon addition of the MibC cyclase
to the reaction, the monoglutamylated intermediates were no longer
detected. These observations suggest that glutamate elimination is
slower from late stage intermediates than for early intermediates.
Use of an inactive MibC mutant did not prevent the formation of glutamylated
intermediates, and hence the elimination of these late stage intermediates
is facilitated by thioether formation. This observation is consistent
with the substrate alternating between modification in the dehydratase
and cyclase active sites, which may be facilitated by a multicomplex
assembly and, as described above for NisA, may involve channeling
or conformational sampling. Surprisingly, pattern-matching algorithmic
analysis of MibA processing by MibB suggested that dehydration does
not occur with an N- to C-terminal directionality, as observed for
nisin, but occurs in a nonlinear fashion.<sup><xref ref-type="bibr" rid="ref196">196</xref></sup> This nondirectional order of processing has also been observed for
class II<sup><xref ref-type="bibr" rid="ref246">246</xref></sup> and class III<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> lanthipeptide biosynthetic systems. Hence, there are significant
differences between individual lanthipeptide biosynthetic pathways,
with some having tightly coupled dehydration and cyclization processes
(e.g., NAI-107) and others where such tight coupling is not required
for producing the correct final products (e.g., nisin).</p></sec><sec id="sec2.5"><label>2.5</label><title>Leader Peptide Dependence and Recognition</title><p>As discussed
in the <xref rid="sec1" ref-type="other">Introduction</xref>, the sequences
of lanthipeptide precursor peptides may be demarcated into an N-terminal
leader sequence and a C-terminal core sequence (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Post-translational modifications are installed
on residues located in the core sequence, after which the leader sequence
is removed to afford the final natural product. The initial proposal
that the leader peptide may be involved in the biosynthetic process
was based on the observation that the leader sequence of the nisin
precursor peptide shares similar features with those of subtilin,
epidermin, and Pep5.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> Conceptually, the
leader sequence may facilitate biosynthesis by interacting with processing
enzymes, by assisting in the transport of the processed peptide product,
and/or by contributing to immunity within the producing organism.<sup><xref ref-type="bibr" rid="ref248">248</xref></sup> Experiments suggest that the leader sequence
of the fully modified NisA precursor does not directly interact with
the modified core peptide, either in solution or in lipid micelles,<sup><xref ref-type="bibr" rid="ref249">249</xref></sup> thus providing no evidence for a direct role
of the leader in the chemical transformations in the core peptide.</p><p>The leader peptide sequences of most class I lanthipeptides are
about 25 residues in length (e.g., 23 for the nisin leader peptide)
and generally contain acidic amino acids. Ala-scanning mutational
analysis of the leader sequence in the NisA precursor, carried out
using a plasmid-encoded gene in a nisin producing strain, identified
a four-residue motif, Phe&#x02212;18/Asn&#x02212;17/Leu&#x02212;16/Asp&#x02212;15
(hereafter FNLD, <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>), as critical for nisin production and secretion.<sup><xref ref-type="bibr" rid="ref248">248</xref>,<xref ref-type="bibr" rid="ref250">250</xref>,<xref ref-type="bibr" rid="ref251">251</xref></sup> Co-immunoprecipitation experiments<sup><xref ref-type="bibr" rid="ref252">252</xref></sup> and surface plasmon resonance analysis of the
interaction of variants of NisA<sup><xref ref-type="bibr" rid="ref191">191</xref></sup> demonstrated
the importance of the FNLD sequence for the direct interaction between
the NisB dehydratase and the NisA precursor. Isothermal titration
calorimetric studies demonstrated that the NisC cyclase also binds
to the NisA precursor with a <italic>K</italic><sub>d</sub> of 2.0
&#x003bc;M, regardless of whether the core is unmodified or processed,
and to the leader sequence with a <italic>K</italic><sub>d</sub> of
3.8 &#x003bc;M.<sup><xref ref-type="bibr" rid="ref253">253</xref></sup> Notably, the FNLD sequence
in the NisA precursor that is critical for engaging the NisB dehydratase
is also essential for binding to NisC, and Ala mutations at either
Phe&#x02212;18 or Leu&#x02212;16 completely abolished the interaction.
Co-immunoprecipitation studies indicated that other regions of the
leader may also be necessary for engaging the NisC cyclase.<sup><xref ref-type="bibr" rid="ref254">254</xref></sup> Although the leader peptide is sufficient for
interactions with the dehydratase and the cyclase individually, the
formation of a multienzyme complex that includes NisB and NisC appears
to require both the leader and the core sequence, but not necessarily
the modified residues.<sup><xref ref-type="bibr" rid="ref255">255</xref>,<xref ref-type="bibr" rid="ref256">256</xref></sup> Interestingly, in
vivo NisB can partially dehydrate the NisA core peptide without the
leader peptide and more efficiently when the leader peptide is coexpressed
in trans.<sup><xref ref-type="bibr" rid="ref255">255</xref></sup></p><p>The molecular basis
for the interaction between the nisin leader
peptide and the dehydratase was elucidated by the cocrystal structure
of the NisB-NisA complex.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> Electron density
could only be observed for residues Lys&#x02212;9 through Lys&#x02212;20
of the leader peptide (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>A), which includes the FNLD sequence (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>). Despite expectations based
on structure prediction tools that the leader sequence would bind
to the dehydratase as an amphipathic &#x003b1;-helix,<sup><xref ref-type="bibr" rid="ref257">257</xref></sup> the structural data revealed that the leader forms a &#x003b2;-strand
against a small winged helix-turn-helix motif located at the juncture
of the glutamylation domain and the glutamate elimination domain.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> A similar winged helix-turn-helix motif is
also observed in the structure of unrelated RiPP biosynthetic enzymes,
such as the cyanobactin heterocyclases,<sup><xref ref-type="bibr" rid="ref258">258</xref>,<xref ref-type="bibr" rid="ref259">259</xref></sup> PqqD, a peptide-binding protein from the pyrroloquinoline quinone
biosynthetic pathway,<sup><xref ref-type="bibr" rid="ref260">260</xref>,<xref ref-type="bibr" rid="ref261">261</xref></sup> and PaaA involved in pantocin
biosynthesis.<sup><xref ref-type="bibr" rid="ref262">262</xref></sup> Bioinformatic analysis
and binding studies established that domains of similar architecture
are responsible for leader peptide recognition in a wide array of
RiPP biosynthetic systems, including lasso peptides and thiopeptides.
The domain was therefore termed the RiPP Recognition Element (RRE).<sup><xref ref-type="bibr" rid="ref263">263</xref></sup> Interaction between the domain and the leader
peptide has been affirmed in the cocrystal structure of the cyanobactin
heterocyclase LynD in complex with the leader peptide of its substrate
(<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>B),<sup><xref ref-type="bibr" rid="ref259">259</xref></sup> and is also supported by mutagenesis studies
in a radical epimerase involved in proteusin biosynthesis,<sup><xref ref-type="bibr" rid="ref264">264</xref></sup> and binding studies on sactipeptide synthetases.<sup><xref ref-type="bibr" rid="ref265">265</xref></sup> Thus, leader peptide binding by the winged
helix-turn-helix domain appears to be widespread.</p><fig id="fig15" position="float"><label>Figure 15</label><caption><p>(A) Close-up view of
the interaction between the NisA leader sequence
(blue) and the NisB dehydratase (brown). (B) Comparison of the winged
helix-turn-helix leader-binding motifs in NisB and the cyanobactin
heterocyclase LynD, another RiPP biosynthetic enzyme (PDB ID 4V1T). (C) Superimposition
of NisB (brown and gray) with bound NisA leader (blue) and unliganded
MibB (red and purple, PDB ID 5EHK), focusing on the winged helix-turn-helix domain.
The black arrow illustrates the inward tilt of an ampipathic helix
in MibB relative to its counterpart in NisB that interacts with the
NisA leader peptide.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0015" id="gr15" position="float"/></fig><p>The interaction between NisB and the leader sequence of NisA
is
mediated largely through hydrophobic packing interactions. Within
the critical FNLD sequence of NisA, Phe&#x02212;18 is inserted into
a hydrophobic pocket in NisB composed of residues Val176, Val198,
Tyr202, Leu209, and Tyr213. Likewise, Leu&#x02212;16 from this motif
is bound in a hydrophobic pocket composed of Ile171, Tyr213, and Leu217.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> Lastly, Asp&#x02212;15 of the motif is within
hydrogen-bonding distance to Arg154 of NisB (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>A). Similar hydrophobic packing interactions
are observed in the engagement of the cyanobactin heterocyclase with
its cognate leader peptide,<sup><xref ref-type="bibr" rid="ref259">259</xref></sup> consistent
with prior mutational data that implicated several aliphatic residues
in the leader peptide as critical for interactions with this modification
enzyme.<sup><xref ref-type="bibr" rid="ref149">149</xref></sup> Mutational and deletion studies
suggest that the leader peptide of the precursor for mutacin 1140
may have a different recognition motif consisting of the EDLF sequence.<sup><xref ref-type="bibr" rid="ref266">266</xref></sup></p><p>The FNLD motif is located in the N-terminal
half of the leader
peptide. The C-terminal half does not appear to be important for specific
interactions with NisB as it is not observed in the NisA-NisB cocrystal
structure. However, replacing leader peptide residues four-at-a-time
with Ala<sub>4</sub> did result in less efficient substrates and in
some cases to lower amounts of NisB in pull-down experiments.<sup><xref ref-type="bibr" rid="ref254">254</xref></sup> Conversely, the amino acids at residues &#x02212;13
to &#x02212;8 of the leader peptide could be replaced by six His residues
without losing NisB activity.<sup><xref ref-type="bibr" rid="ref251">251</xref></sup> Hence,
although there may be some interactions with the surface of NisB,
generally speaking the C-terminal part of the leader peptide appears
to be a spacer<sup><xref ref-type="bibr" rid="ref251">251</xref></sup> that is required to bridge
the distance of the leader peptide binding site and the glutamylation
active site that is visualized by the crystal structure.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> Such a spacer region seems less important for
the glutamate elimination activity since a glutamylated core peptide
lacking the leader peptide was a substrate for NisB, resulting in
glutamate elimination.<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> As long as a
minimal distance between the leader peptide binding site and the glutamylation
active site is satisfied, dehydration can occur, even when the distance
is increased significantly as shown by studies where half of a second
core peptide fused at the end of NisA was modified by NisB.<sup><xref ref-type="bibr" rid="ref79">79</xref></sup> Similarly, Ser/Thr that are sufficiently spaced
from the FNLD motif do not need to be in register with the motif since
the intervening distance can be changed without losing the ability
of NisB to perform the correct dehydrations.<sup><xref ref-type="bibr" rid="ref267">267</xref></sup> Similar findings have also been reported for the class I lanthipeptide
mutacin 1140,<sup><xref ref-type="bibr" rid="ref268">268</xref></sup> as well as for class II
lanthipeptides<sup><xref ref-type="bibr" rid="ref269">269</xref>,<xref ref-type="bibr" rid="ref270">270</xref></sup> and class III systems.<sup><xref ref-type="bibr" rid="ref271">271</xref></sup></p><p>The structure of the MibB dehydratase
from <italic>Microbispora</italic> sp. 107891 has been determined
in the absence of the leader peptide.
A comparison of the MibB structure with that of the NisB-NisA complex
shows differences in domain orientations near the winged helix-turn-helix
motif, which may reflect conformational changes that accompany binding
of the leader sequence (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>C). In the NisB-NisA cocrystal structure, portions
of the leader peptide bind to a hydrophobic region containing several
residues from an amphipathic helix, while in the MibB structure the
equivalent helix is tilted inward such that the hydrophobic residues
are oriented toward the interior of the protein (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>C). This shift results in
compensatory movements of the elimination domain to form a more compact
overall structure. However, the lack of a MibB-MibA cocrystal structure
precludes any conclusion at present regarding the importance of these
conformational movements.</p></sec><sec id="sec2.6"><label>2.6</label><title>Tailoring Enzymes</title><p>In addition to
the characteristic thioether rings that define the lanthipeptides,
several class I molecules also contain additional tailoring modifications
installed by enzymes that are not generally found across biosynthetic
clusters. Biochemical studies of these tailoring modifications have
not received as much focus but continue to provide examples of novel
enzymology. Most tailoring reactions do not require the presence of
the leader peptide or take place after leader peptide removal.</p><sec id="sec2.6.1"><label>2.6.1</label><title>Dehydrogenation and Acetylation at the N-Terminus</title><p>A
subset of class I lanthipeptides, including epilancin 15X,<sup><xref ref-type="bibr" rid="ref171">171</xref></sup> epicidin 280,<sup><xref ref-type="bibr" rid="ref272">272</xref></sup> and epilancin K7 (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="fig16" ref-type="fig">16</xref>A),<sup><xref ref-type="bibr" rid="ref273">273</xref></sup> are characterized by the presence of a lactyl group (Lac) on the
N-terminus of the processed product. The corresponding precursor peptides
all contain a Ser residue immediately following the leader sequence,
which is converted to Dha by the cognate LanB dehydratase. Upon removal
of the leader peptide, the resultant N-terminal Dha1 presumably spontaneously
tautomerizes to an unstable imine, which then undergoes nonenzymatic
hydrolysis to generate a 2-oxopropionyl (pyruvyl) moiety, as has been
observed in the structure of lactocin S (see <xref rid="sec4.6.1" ref-type="other">section <xref rid="sec4.6.1" ref-type="other">4.6.1</xref></xref>)<sup><xref ref-type="bibr" rid="ref274">274</xref>,<xref ref-type="bibr" rid="ref275">275</xref></sup> and the pinensins (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>).<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Likewise, leader excision,
and nonenzymatic hydrolysis of the N-terminal Dhb in Pep5 leads to
the formation of a 2-oxobutyryl group (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>).<sup><xref ref-type="bibr" rid="ref276">276</xref></sup> Enzymatic
reduction of the 2-oxopropionate yields the 2-hydroxypropionate (lactyl)
cap observed in the structures of epilancin 15X,<sup><xref ref-type="bibr" rid="ref174">174</xref></sup> epilancin K7<sup><xref ref-type="bibr" rid="ref277">277</xref></sup> and epicidin
280.<sup><xref ref-type="bibr" rid="ref272">272</xref></sup> Elucidation of the biosynthetic
cluster of epicidin 280 identified a putative oxidoreductase (<italic>eciO</italic>) within the gene cluster, which may catalyze this enzymatic
reduction.<sup><xref ref-type="bibr" rid="ref272">272</xref></sup> Likewise, the biosynthetic
cluster of epilancin 15x evidenced a putative oxidoreductase (<italic>elxO</italic>).<sup><xref ref-type="bibr" rid="ref171">171</xref></sup></p><fig id="fig16" position="float"><label>Figure 16</label><caption><p>Tailoring modifications
in class I lanthipeptide biosynthesis include
installation of an N-terminal lactate (Lac) (A) and installation of
a C-terminal aminovinyl Cys (B). The structure shown for epicidin
280 is hypothetical and based on analogy to Pep5 but is known to contain
an N-terminal Lac.<sup><xref ref-type="bibr" rid="ref272">272</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0016" id="gr16" position="float"/></fig><p>Heterologous expression and purification of the putative
oxidoreductase
ElxO from the epilancin 15X biosynthetic cluster in <italic>Staphylococcus
epidermidis</italic> 15X154 facilitated reconstitution of enzymatic
activity.<sup><xref ref-type="bibr" rid="ref171">171</xref></sup> Although the physiological
substrate (dehydroepilancin 15X) could not be accessed, recombinant
ElxO catalyzed the reduction of a synthetic analog containing an N-terminal
pyruvyl group (Pyr) followed by five residues resembling the N-terminus
of the ElxA core peptide (Pyr-AAIVK; <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). Reduction of this synthetic substrate
to Lac required an NADPH cofactor, and LC-MS analysis using synthetic
standards assigned the stereochemical configuration of Lac as <italic>R</italic>.<sup><xref ref-type="bibr" rid="ref171">171</xref></sup> Characterization of the
substrate scope of ElxO, using a library of peptides, demonstrated
the enzyme as generally tolerant of amino acids that are appended
to the N-terminal Pyr, but some trends in scope were observed.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup> First, the <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m</sub> values increased with substrate length,
as peptides with 1&#x02013;3 residues were generally poor substrates
and a 13-residue peptide had a higher <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m</sub> compared to a peptide of 5 residues.
Furthermore, peptides with a longer N-terminal oxobutyryl modification
were accepted as substrates, but those with a shorter glyoxyl group
were not.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup> As ElxO tolerates amino acid
substitutions at residues following Pyr, the enzyme may have potential
as a biotechnological tool for the installation of N-terminal alcohols
on other lanthipeptides. For instance, incubation of ElxO with lactocin
S, which contains a native N-terminal pyruvyl moiety (see <xref rid="sec4.6.1" ref-type="other">section <xref rid="sec4.6.1" ref-type="other">4.6.1</xref></xref>),<sup><xref ref-type="bibr" rid="ref274">274</xref></sup> resulted in reduction to the alcohol product.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup></p><p>The crystal structure of ElxO in complex
with NADP(H) affirmed
its classification as a member of the short chain dehydrogenase/reductase
(SDR) family of oxidoreductases.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup> As
with other members of the SDR family, the architecture of ElxO is
built around a Rossmann-fold dinucleotide-binding motif (<xref rid="fig17" ref-type="fig">Figure <xref rid="fig17" ref-type="fig">17</xref></xref>A). The NADP(H)
cofactor binds in an extended conformation. Other SDR enzymes utilize
a catalytic Tyr that acts as both a general acid and base, flanked
by an adjacent Lys that lowers the p<italic>K</italic><sub>a</sub> of the Tyr, and a Ser that polarizes the substrate carbonyl.<sup><xref ref-type="bibr" rid="ref279">279</xref></sup> The active site of ElxO indicates that Ser139,
Tyr153, and Lys157 could function in these roles (<xref rid="fig17" ref-type="fig">Figure <xref rid="fig17" ref-type="fig">17</xref></xref>B), and mutations of any of
these residues resulted in a strong reduction of the reaction rate,
reflecting their importance in catalysis. In the proposed catalytic
mechanism, Tyr153 and Ser139 activate the N-terminal carbonyl of the
substrate through hydrogen bonding, creating an environment that facilitates
hydride transfer from NADPH to the <italic>Si</italic>-face of the
carbonyl to produce the <italic>R</italic>-Lac product. A long groove
is present along the enzyme surface adjacent to the NADP(H)-binding
site and likely harbors the peptide-binding site (<xref rid="fig17" ref-type="fig">Figure <xref rid="fig17" ref-type="fig">17</xref></xref>C).</p><fig id="fig17" position="float"><label>Figure 17</label><caption><p>(A) Structure of the
ElxO oxidoreductase involved in N-terminal
Lac installation. (B) Close-up view of the active site showing critical
residues and bound NADP(H) (yellow). (C) Electrostatic surface view
of the structure illustrating an obvious groove that may be involved
in binding to the peptide substrate. PDB ID 4QEC.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0017" id="gr17" position="float"/></fig><p>Another novel tailoring modification that was recently
discovered
in the natural product paenibacillin is N-terminal acetylation.<sup><xref ref-type="bibr" rid="ref280">280</xref>,<xref ref-type="bibr" rid="ref281">281</xref></sup> The putative paenibacillin biosynthetic cluster from <italic>Paenibacillus
polymyxa</italic> OSY-DF contains genes that encode for canonical
class I lanthipeptide proteins, including LanBCT, along with a precursor
peptide bearing the FNLD motif. Inactivation of the <italic>lanB</italic> gene by targeted mutagenesis eliminated production of paenibacillin,
confirming a role in biosynthesis. The gene cluster also encodes a
29-kDa polypeptide (PaeN) that bears sequence similarity with the
TraX enzymes involved in N-acetylation of Ala in the F-pilin in <italic>E. coli</italic>.<sup><xref ref-type="bibr" rid="ref282">282</xref></sup> However, biochemical
verification of PaeN activity has not yet been carried out. While
the order of installation of the modifications has not been determined,
the acetylation must occur after thioether formation as the target
N-Ala residue is only exposed upon excision of the leader peptide.</p></sec><sec id="sec2.6.2"><label>2.6.2</label><title>Oxidative Decarboxylation at the C-Terminus</title><p>Several lanthipeptides, including epidermin, gallidermin, NAI-107,
and mutacin 1140 contain the amino acid <italic>S</italic>-[(<italic>Z</italic>)-2-aminovinyl]-<sc>d</sc>-cysteine (AviCys) at their C-termini
(<xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref> and <xref rid="fig16" ref-type="fig">16</xref>B). This modification was first identified through
structural elucidation of epidermin from <italic>S. epidermidis</italic> T&#x000fc;3298,<sup><xref ref-type="bibr" rid="ref173">173</xref></sup> and subsequent heterologous
expression of the <italic>epiD</italic> gene from the corresponding
biosynthetic cluster produced a yellow flavoprotein that was presumed
to function in AviCys formation.<sup><xref ref-type="bibr" rid="ref172">172</xref></sup> Reconstitution
studies of EpiD, using either the precursor peptide EpiA<sup><xref ref-type="bibr" rid="ref283">283</xref></sup> or a synthetic peptide corresponding to the
epidermin core,<sup><xref ref-type="bibr" rid="ref284">284</xref></sup> indicated a loss of
46 Da from the substrate corresponding to the loss of CO<sub>2</sub> and two H atoms. These studies confirmed that EpiD carries out oxidative
decarboxylation of the C-terminal Cys, to produce a (<italic>Z</italic>)-enethiol product. As the mechanism of LanD enzymes has been previously
reviewed,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> it will only briefly be discussed.</p><p>Detailed analysis of the substrate specificity for EpiD demonstrates
that the decarboxylation reaction does not require the leader sequence,<sup><xref ref-type="bibr" rid="ref285">285</xref></sup> and studies using several truncated variants
of the epidermin core sequence localized the terminal four residues
of EpiA (SYCC) as the minimal substrate for EpiD.<sup><xref ref-type="bibr" rid="ref284">284</xref></sup> Modifications to the peptide C-terminus, such as ethylation,
prevented oxidative decarboxylation, indicating that a free carboxy
terminus is required.<sup><xref ref-type="bibr" rid="ref284">284</xref></sup> Mutational analysis
of EpiD,<sup><xref ref-type="bibr" rid="ref286">286</xref></sup> along with the cocrystal structure
with a peptide substrate (<xref rid="fig18" ref-type="fig">Figure <xref rid="fig18" ref-type="fig">18</xref></xref>),<sup><xref ref-type="bibr" rid="ref287">287</xref></sup> provides the basis
for a plausible mechanism for AviCys installation. The flavin cofactor
(FMN in EpiD) first oxidizes the terminal Cys to a thioaldehyde, followed
by spontaneous decarboxylation to form the thioenolate.<sup><xref ref-type="bibr" rid="ref287">287</xref>,<xref ref-type="bibr" rid="ref288">288</xref></sup> Attack of this enethiol onto the Dha residue, possibly catalyzed
by the EpiC cyclase, would yield the AviCys product. EpiD as well
as the homologous enzymes MrsD and MibD involved in mersacidin and
NAI-107 biosynthesis,<sup><xref ref-type="bibr" rid="ref289">289</xref>&#x02212;<xref ref-type="bibr" rid="ref291">291</xref></sup> respectively, have sequence homology with
enzymes that carry out two reactions during the biosynthesis of 4&#x02032;-phosphopantetheine
in coenzyme A biosynthesis. These latter enzymes first catalyze flavin-dependent
oxidative decarboxylation of a Cys similarly to the LanD proteins,
and subsequently reduce the resulting aminoethenethiol group to the
corresponding 2-mercaptoethylamine. This class of proteins, including
LanD, has been named the homo-oligomeric flavin-containing Cys decarboxylase
(HFCD) family.<sup><xref ref-type="bibr" rid="ref286">286</xref>,<xref ref-type="bibr" rid="ref292">292</xref></sup> Mechanistic studies on the enzymes
involved in biosynthesis of 4&#x02032;-phosphopantetheine are consistent
with the proposed mechanism of LanD proteins.<sup><xref ref-type="bibr" rid="ref293">293</xref>&#x02212;<xref ref-type="bibr" rid="ref296">296</xref></sup></p><fig id="fig18" position="float"><label>Figure 18</label><caption><p>(A) Structure of the EpiD flavoprotein homotrimer involved in AviCys
installation. (B) Close-up view of the FMN (yellow) cofactor in the
vicinity of a bound short peptide substrate (purple). PDB ID 1G5Q.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0018" id="gr18" position="float"/></fig><p>It should be noted that AviCys residues are also
observed in two
other classes of RiPP natural products, namely linaridins<sup><xref ref-type="bibr" rid="ref297">297</xref>,<xref ref-type="bibr" rid="ref298">298</xref></sup> and thioviridamides.<sup><xref ref-type="bibr" rid="ref299">299</xref></sup> Although linaridins
such as cypemycin<sup><xref ref-type="bibr" rid="ref297">297</xref></sup> and grisemycin<sup><xref ref-type="bibr" rid="ref298">298</xref></sup> contain the dehydro amino acid Dhb, the biosynthetic
gene clusters for these molecules do not encode obvious homologues
of either the lanthipeptide dehydratase that is necessary for installation
of the Dha/Dhb or the lanthipeptide cyclase implicated in AviCys formation.
CypD from the cypemycin cluster is also a member of the HFCD family
and catalyzes oxidative decarboxylation of the terminal Cys to yield
the enethiolate.<sup><xref ref-type="bibr" rid="ref297">297</xref></sup> However, subsequent
attack of the enethiolate to a Dha to yield the AviCys occurs through
a mechanism that has yet to be established. The thioviridamide biosynthetic
cluster<sup><xref ref-type="bibr" rid="ref300">300</xref></sup> likewise contains a HFCD family
gene (<italic>tvaF</italic>) but lacks any homologues of the LanB
and LanC enzymes.</p></sec><sec id="sec2.6.3"><label>2.6.3</label><title>Trp Halogenation and
Pro Hydroxylation</title><p>The lanthipeptide NAI-107 exhibits potent
antibacterial activity
against many Gram-positive pathogens<sup><xref ref-type="bibr" rid="ref175">175</xref></sup> and has demonstrated efficacy in experimental models of infection.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> The compound consists of a complex of related
molecules produced by <italic>Microbispor</italic>a sp. 107891, and
these all contain two modifications not previously reported in lanthipeptides,
namely halogenation on Trp and (di)hydroxylation on Pro (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>).<sup><xref ref-type="bibr" rid="ref175">175</xref></sup> The two predominant congeners differ in the presence of
one or two hydroxyl groups on Pro14 of the final product. The biosynthetic
gene cluster of microbisporicin encodes the expected cadre of class
I lanthipeptide biosynthetic enzymes, including the MibB dehydratase,
the MibC cyclase, and the MibT transporter in addition to the substrate
MibA.<sup><xref ref-type="bibr" rid="ref301">301</xref></sup> The cluster also contains additional
genes that are presumed to install the two novel modifications, based
on sequence similarities with enzymes that catalyze similar reactions.
Specifically, the MibH and MibS proteins are similar to flavin-dependent
halogenases and their corresponding flavin reductases that together
catalyze halogenation in an FADH<sub>2</sub>-dependent manner.<sup><xref ref-type="bibr" rid="ref302">302</xref></sup> Recent in vitro studies confirmed that MibH
catalyzes the chlorination at Trp4 of MibA and that MibS provides
reduced FAD.<sup><xref ref-type="bibr" rid="ref291">291</xref></sup> MibH is the first halogenase
that acts on Trp embedded in a peptide sequence as all prior Trp halogenases
acted either on free tryptophan or tryptophan (or its analogs) tethered
to coenzyme A or a carrier protein.<sup><xref ref-type="bibr" rid="ref302">302</xref></sup> The
crystal structure of MibH was determined, revealing a much larger
binding cavity than previously characterized Trp halogenases.<sup><xref ref-type="bibr" rid="ref291">291</xref></sup> This finding explains the very high substrate
specificity of MibH, which requires preinstallation of the thioether
rings in the substrate MibA for chlorination activity. Interestingly,
inclusion of KBr in the production medium of the NAI-107 producer
yielded bromination (rather than chlorination) on Trp4 of the mature
lanthipeptide, suggesting some flexibility in the halogenase.<sup><xref ref-type="bibr" rid="ref303">303</xref></sup> The MibO polypeptide shows similarities to
cytochrome P450 enzymes, and is likely responsible for hydroxylation
of Pro14.<sup><xref ref-type="bibr" rid="ref301">301</xref></sup> Biochemical characterization
of the hydroxylase has yet to be reported.</p></sec></sec><sec id="sec2.7"><label>2.7</label><title>Immunity Proteins</title><p>Organisms that
produce natural products that are bioactive against other closely
related strains must protect themselves against toxicity from the
final product. As most lanthipeptides are not active until removal
of the leader sequence,<sup><xref ref-type="bibr" rid="ref248">248</xref>,<xref ref-type="bibr" rid="ref304">304</xref></sup> coupling of leader
excision to active transport provides a level of innate defense. Two
other strategies have been adopted by strains that produce class I
lanthipeptides to afford immunity, and these include active transport
to avert unwanted build-up and sequestering of the mature lanthipeptide
in the extracellular environment. Lipid II is the target of many lanthipeptides
including nisin,<sup><xref ref-type="bibr" rid="ref166">166</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup> mersacidin,<sup><xref ref-type="bibr" rid="ref305">305</xref></sup> lacticin 481/nukacin ISK-1,<sup><xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref306">306</xref></sup> and many
two-component lantibiotics<sup><xref ref-type="bibr" rid="ref307">307</xref>&#x02212;<xref ref-type="bibr" rid="ref309">309</xref></sup> (and their structural analogs).
Lipid II is present both on the cytoplasmic side of the membrane and,
after translocation, on the extracellular side. Thus, immunity needs
to be provided both intracellularly and extracellularly. Lanthipeptide
efflux from producing organisms is mediated by the LanFEG complex,
an integral membrane ABC type transport system. Disruption of either <italic>nisE</italic> and/or <italic>nisF</italic> in <italic>L. lactis</italic> does not affect the ability to produce nisin but results in an increase
in susceptibility, confirming their role in immunity.<sup><xref ref-type="bibr" rid="ref310">310</xref>,<xref ref-type="bibr" rid="ref311">311</xref></sup> However, the <italic>lanFEG</italic> locus is not associated with
some class I lantibiotic clusters, such as the Pep5<sup><xref ref-type="bibr" rid="ref214">214</xref></sup> and epicidin<sup><xref ref-type="bibr" rid="ref272">272</xref></sup> clusters. Hence,
the LanFEG transporter system is not a universal mechanism of immunity.</p><p>The LanI proteins are thought to provide immunity to producing
strains by sequestering the extracellularly secreted product. Some
LanI proteins contain a consensus signal sequence for export, followed
by an N-terminal Cys,<sup><xref ref-type="bibr" rid="ref312">312</xref></sup> which is modified
by a diacylglycerol membrane anchor<sup><xref ref-type="bibr" rid="ref313">313</xref></sup> to
localize the polypeptide on the cell surface.<sup><xref ref-type="bibr" rid="ref314">314</xref>,<xref ref-type="bibr" rid="ref315">315</xref></sup> Expression of NisI in <italic>L. lactis</italic> &#x00394;<italic>lanI</italic> enabled a significant increase in resistance to nisin.<sup><xref ref-type="bibr" rid="ref312">312</xref></sup> Conversely, knockout of <italic>nisI</italic> in <italic>L. lactis</italic> producing strains rendered them much
more susceptible to nisin.<sup><xref ref-type="bibr" rid="ref310">310</xref></sup> For more
discussion of genetic experiments aimed to understand lantibiotic
immunity, we refer the reader to several reviews on this topic<sup><xref ref-type="bibr" rid="ref316">316</xref>&#x02212;<xref ref-type="bibr" rid="ref318">318</xref></sup> and focus here only on the systems for which structural information
has recently been reported.</p><p>The solution NMR structures of SpaI,<sup><xref ref-type="bibr" rid="ref319">319</xref></sup> NisI,<sup><xref ref-type="bibr" rid="ref320">320</xref></sup> and MlbQ<sup><xref ref-type="bibr" rid="ref321">321</xref></sup> provide some rationale for the mode of actions
of these
proteins. The structure of the 16.8 kDa SpaI protein from <italic>B. subtilis</italic> showed a new fold consisting of a six-stranded
antiparallel twisted &#x003b2; sheet architecture (<xref rid="fig19" ref-type="fig">Figure <xref rid="fig19" ref-type="fig">19</xref></xref>A). However, the construct
used for structural work lacked the N-terminal 17 residues and did
not confer immunity.<sup><xref ref-type="bibr" rid="ref319">319</xref></sup> The deleted region
consists largely of basic Lys residues, suggesting that these N-terminal
17 residues play a role in stabilizing the interaction between SpaI
and the acidic head groups of membrane phospholipids. The subsequent
NMR structure of the 25.8 kDa NisI from <italic>L. lactis</italic> revealed a two-domain architecture consisting of tandem repeats
of a seven-stranded &#x003b2; sheet fold resembling the fold in SpaI
(<xref rid="fig19" ref-type="fig">Figure <xref rid="fig19" ref-type="fig">19</xref></xref>A). Each
domain could be individually aligned with the structure of SpaI despite
a lack of any notable similarity in sequence. Binding of NisI to nisin
was observed by titrating in nisin and monitoring changes in the chemical
shifts of NisI, which showed that nisin binds to the C-terminal domain
of NisI (<italic>K</italic><sub>d</sub> of 22 &#x003bc;M), presumably
along an extended hydrophobic patch. Structure-based mutational analysis
suggested a role for Tyr153 and Asp155 of NisI in mediating binding
to nisin.<sup><xref ref-type="bibr" rid="ref320">320</xref></sup></p><fig id="fig19" position="float"><label>Figure 19</label><caption><p>(A) Solution NMR structures
showing the overall folds of the SpaI
(PDB ID 2LVL), NisI (PDB ID 2N2E and 2N32)
and MlbQ resistance proteins (PDB ID 2MVO). The fold of MlbQ is distinct from those
of SpaI and NisI. (B) Crystal structure of the <italic>S. agalactiae</italic> nisin resistance protein (<italic>Sa</italic>NSR). PDB ID 4Y68.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0019" id="gr19" position="float"/></fig><p>The MlbQ polypeptide is a small lipoprotein from
the NAI-107 biosynthetic
gene cluster in <italic>Microbispora</italic> ATCC PTA-5024 that confers
specific resistance to NAI-107-like lantibiotics.<sup><xref ref-type="bibr" rid="ref321">321</xref></sup> Like the coordinated immunity provided by LanI and LanEFG
proteins, protection against NAI-107 like lantibiotics is conferred
by several proteins, MlbJQYX.<sup><xref ref-type="bibr" rid="ref321">321</xref></sup> Although
MlbQ sequesters NAI-107 and functions analogously to NisI and SpaI,
its structure shows a novel topology consisting of four &#x003b2; strands
topped by two short helices (<xref rid="fig19" ref-type="fig">Figure <xref rid="fig19" ref-type="fig">19</xref></xref>A). Despite the lack of structural similarities, MlbQ
also contains an extended hydrophobic patch where the lanthipeptide
may bind. However, the molecular details as to how these proteins
recognize their cognate lantibiotics are still undetermined. Similarly,
the molecular mechanism of immunity is not understood in systems where <italic>nisEFG</italic> and <italic>nisI</italic> homologues are missing
(e.g. ref (<xref ref-type="bibr" rid="ref171">171</xref>)).</p><p>Several strains of <italic>L. lactis</italic> that do not produce
nisin have been shown to encode for a different type of resistance
system.<sup><xref ref-type="bibr" rid="ref322">322</xref>,<xref ref-type="bibr" rid="ref323">323</xref></sup> The resistance protein NSR is a protease
that cleaves the C-terminal six residues from nisin, resulting in
a significant reduction in bactericidal activity.<sup><xref ref-type="bibr" rid="ref324">324</xref></sup> More recently this system has also been found in pathogens.
An operon in <italic>Streptococcus agalactiae</italic> that confers
20-fold resistance against nisin when expressed in <italic>L. lactis</italic> contains genes for an ABC-type transporter and a membrane-associated
NSR (<italic>Sa</italic>NSR).<sup><xref ref-type="bibr" rid="ref325">325</xref></sup> The crystal
structure of <italic>Sa</italic>NSR consists of an S41 C-terminal
serine endopeptidase fold<sup><xref ref-type="bibr" rid="ref326">326</xref></sup> with an appended
N-terminal helical bundle and protease capping domains (<xref rid="fig19" ref-type="fig">Figure <xref rid="fig19" ref-type="fig">19</xref></xref>B).<sup><xref ref-type="bibr" rid="ref327">327</xref></sup> Modeling studies suggest that the C-terminal
residues of the nisin substrate could be positioned in a hydrophobic
tunnel formed between the capping and protease domains. Enzymatic
activity was contingent on the D and E rings of nisin because <italic>Sa</italic>NSR could not process nisin variants that lacked these
last two rings.</p></sec></sec><sec id="sec3"><label>3</label><title>Proteases and Export in Class
I and II Lanthipeptides</title><p>The late stages of lanthipeptide
biosynthesis involve proteolytic
cleavage of the leader peptide and export. The leader peptide is often
necessary to direct the secretion of the modified peptide out of the
producing organism, after which the leader peptide is removed to furnish
the mature peptide, but sometimes proteolysis precedes secretion (vide
infra). Two general strategies have been employed to accomplish these
two tasks. The first discussed in <xref rid="sec3.1" ref-type="other">section <xref rid="sec3.1" ref-type="other">3.1</xref></xref> was long thought to be characteristic
for class I lanthipeptides and involves dedicated LanT transporters
and LanP proteases. However, more recently, genomes especially in
Proteobacteria<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> and Bacteroidetes<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> have been sequenced that contain class I lanthipeptide
biosynthetic gene clusters with a bifunctional transporter/protease.
For many years such bifunctional transporter/proteases were thought
to be characteristic of class II lanthipeptides. Conversely, LanP
proteins were long confined to class I lanthipeptides. The only exception
was lactocin S, a class II lanthipeptide encoded by a gene cluster
that contains genes for a dedicated LanT transporter and LanP protease.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> However, <italic>lanP</italic> genes are now
regularly detected in class II gene clusters (<xref rid="sec3.2" ref-type="other">section <xref rid="sec3.2" ref-type="other">3.2</xref></xref>). Since distinction between class I and
class II lanthipeptides based on proteolysis and transport no longer
holds, both classses are discussed here in one section. The class
II lantibiotic cinnamycin produced by <italic>Streptomyces cinnamoneus
cinnamoneus</italic> DSM 40005 is unusual as its leader peptide appears
to be removed by a protease of the general secretory (Sec) system.<sup><xref ref-type="bibr" rid="ref328">328</xref></sup> In fact, at present, lanthipeptide-specific
proteases are very frequently absent from biosynthetic gene clusters
in streptomycetes.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup></p><sec id="sec3.1"><label>3.1</label><title>Leader
Peptide Removal and Export by Independent
Proteases and Transporters</title><p>As noted in <xref rid="sec2.1" ref-type="other">section <xref rid="sec2.1" ref-type="other">2.1</xref></xref>, sequencing of the subtilin<sup><xref ref-type="bibr" rid="ref183">183</xref></sup> and nisin<sup><xref ref-type="bibr" rid="ref182">182</xref></sup> biosynthetic
clusters identified genes for LanT that showed sequence similarity
to integral membrane transporters, suggesting that the polypeptide
was a dedicated transporter for export of the mLanA. More detailed
analysis of the primary sequence showed strong conservation of the
SpaT sequence with multidrug transporters and the transporter that
when mutated causes cystic-fibrosis.<sup><xref ref-type="bibr" rid="ref329">329</xref></sup> Especially characteristic are the two Walker-motif sequences involved
in ATP-binding, indicating that LanTs fall within the ABC family of
transporters.<sup><xref ref-type="bibr" rid="ref330">330</xref></sup> Genetic deletion of the <italic>spaT</italic> gene in the subtilin-producing <italic>B. subtilis</italic> ATCC 6633 strain resulted in cell agglutination and a loss of viability,
presumably as the result of intracellular accumulation of subtilin.<sup><xref ref-type="bibr" rid="ref183">183</xref></sup> Likewise, deletion of <italic>pepT</italic> from a plasmid directing the production of Pep5 in a <italic>S.
epidermidis</italic> host reduced production of the lantibiotic to
about 10% of that produced by a strain containing the intact plasmid.<sup><xref ref-type="bibr" rid="ref214">214</xref></sup> Lanthipeptides could also be detected in other <italic>lanT</italic> deletion strains, as evidenced in variant-producing
strains of mutacin 1140<sup><xref ref-type="bibr" rid="ref268">268</xref></sup> and epidermin,<sup><xref ref-type="bibr" rid="ref181">181</xref></sup> (as well the class II lanthipeptide lacticin
481<sup><xref ref-type="bibr" rid="ref331">331</xref></sup>). It is currently unclear how these
compounds are exported when their LanTs are missing. Conversely, NisT
is essential for nisin export as disruption of <italic>nisT</italic> prevented nisin transport.<sup><xref ref-type="bibr" rid="ref332">332</xref></sup></p><p>Immuno-detection
using antibodies against the leader peptide, coupled with mass spectrometric
analysis of culture supernatants, was used to determine the substrate
tolerance of the NisT transporter in <italic>L. lactis</italic> strains
bearing plasmids with various combinations of nisin biosynthetic enzymes.<sup><xref ref-type="bibr" rid="ref243">243</xref></sup> An expression strain with a plasmid containing
only the genes encoding the transporter and the precursor peptide
was capable of exporting unmodified precursor, indicating that the
lanthionine rings were not required for export. Likewise, the strain
also exported chimeras of the leader sequence fused to various biologically
active peptides, demonstrating that the NisT transporter is broadly
tolerant of substrates, as long as the leader peptide is present.<sup><xref ref-type="bibr" rid="ref243">243</xref></sup> However, kinetic analysis of peptide extrusion
using expression strains pulse-labeled with [<sup>35</sup>S]-Met indicated
that deletion of the NisB dehydratase significantly reduces the precursor
export, and a substrate-channeling mechanism between the biosynthetic
enzymes and the transporter has been invoked to explain these observations.<sup><xref ref-type="bibr" rid="ref189">189</xref></sup> Biochemical evidence for such a multiprotein
complex with the transporter has not yet been established, but, as
noted in <xref rid="sec2.4" ref-type="other">section <xref rid="sec2.4" ref-type="other">2.4</xref></xref>, yeast two-hybrid studies have suggested a physical interaction
of NisC and NisT, and NisC and NisB, and co-immunoprecipitation studies
indicated interactions between NisB and NisC and suggested a membrane
localization for both.<sup><xref ref-type="bibr" rid="ref240">240</xref></sup> Similar results
were also reported for subtilin biosynthesis in <italic>B. subtilis.</italic>(<xref ref-type="bibr" rid="ref241">241</xref>)</p><p>The leader peptide-dependence
of the transporter is consistent
with removal of the leader peptide after export of the modified peptide
for most class I lanthipeptides. There are two different groups of
lanthipeptide proteases that are found in the corresponding biosynthetic
clusters. The nisin leader protease NisP is the first characterized
class I leader protease,<sup><xref ref-type="bibr" rid="ref178">178</xref></sup> and is a member
of the S8 clade of subtilisin-like proteases.<sup><xref ref-type="bibr" rid="ref333">333</xref></sup> Sequence analysis identified four regions in the NisP polypeptide
including an N-terminal 22-residue signal peptide, a prodomain consisting
of residues Glu23 through Arg195, a serine protease catalytic domain
encompassing Ser224 through Arg566, and a C-terminal &#x0223c;110-residue
peptide that contains a canonical LPxTG sorting signal to anchor the
polypeptide to the cell wall of the producer <italic>L. lactis</italic> via amidation of Thr655 with a pentaglycyl murein peptidoglycan.<sup><xref ref-type="bibr" rid="ref334">334</xref></sup> The C-terminal anchoring peptide can also be
excised from NisP by autoproteolysis, likely freeing it from the cell
wall.<sup><xref ref-type="bibr" rid="ref335">335</xref></sup></p><p>The crystal structure of
the catalytic domain of the NisP protease
has been determined to 1.1 &#x000c5; resolution, revealing a fold that
is similar to that observed for other S8 proteases (<xref rid="fig20" ref-type="fig">Figure <xref rid="fig20" ref-type="fig">20</xref></xref>A).<sup><xref ref-type="bibr" rid="ref335">335</xref></sup> Although the sequence of the prodomain was included in the protein
construct used for crystallization, the reported structure consists
only of the serine protease catalytic domain composed of Ser224 through
Arg566. SDS-PAGE analysis of dissolved crystals revealed that the
protein had undergone proteolytic degradation in situ, facilitating
crystallization of the resultant fragment consisting of residues 224&#x02013;566.
The crystal structure revealed a canonical catalytic triad consisting
of Asp259, His306, and Ser512 positioned along a heart-shaped open
cleft on the protein surface.<sup><xref ref-type="bibr" rid="ref335">335</xref></sup> The NisP
active site is flanked by electron density consistent with the sequence
of the C-terminal region comprising Ala635 through Arg647, suggesting
that autocatalytic processing may separate the protein from the membrane-anchoring
C-terminal region to liberate NisP from the cell wall.<sup><xref ref-type="bibr" rid="ref335">335</xref></sup> A common feature among canonical S8 proteases
is a rearrangement of a high-affinity calcium-binding loop in the
N-terminal prodomain to displace it away from the active site following
autoprocessing, resulting in a stable structure and explaining the
calcium-dependent activity of these enzymes.<sup><xref ref-type="bibr" rid="ref336">336</xref></sup> Yet, the prodomain is absent in the reported NisP structure, suggesting
that perhaps the catalytic domain is stable in its absence. However,
at present no additional details are available that may rationalize
this observation.<sup><xref ref-type="bibr" rid="ref335">335</xref></sup></p><fig id="fig20" position="float"><label>Figure 20</label><caption><p>(A) Overall structure
of the NisP catalytic domain. PDB ID 4MZD. (B) Docking model
of the unmodified NisA peptide (green) onto the NisP active site (pink)
evidencing steric clashes that may explain the substrate preference
of NisP for mNisA. (C) Structure of the LicP protease including the
prodomain. PDB ID 4ZOQ.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0020" id="gr20" position="float"/></fig><p>Sequence alignments of NisA with
other nisin-like precursor peptides
identified a conserved Gly-Ala-(Xxx)<sub>2</sub>-Arg-Ile motif, wherein
NisP cleaves between the Arg and Ile residues.<sup><xref ref-type="bibr" rid="ref248">248</xref></sup> Mutational analysis of NisA variants demonstrated that
precursors in which Ala had been altered to Asp resulted in products
that had undergone post-translational modifications but from which
the leader sequence was not excised.<sup><xref ref-type="bibr" rid="ref248">248</xref></sup> Likewise, mutation of the Arg in this motif to a Gln yielded a modified
peptide product with an intact leader. Tryptic removal of the leader
peptide from the product of the Ala variant strain afforded a peptide
with bioactivity comparable to that of authentic nisin. These experiments
confirmed that leader removal must occur only after export of the
modified peptide, and is the last step in the maturation of fully
bioactive nisin.</p><p>The substrate tolerance of NisP was further
explored through mass-spectrometric
analysis of in vitro activity of NisP-expressing cells on a series
of modified NisA peptides.<sup><xref ref-type="bibr" rid="ref243">243</xref></sup> Treatment
of fully modified NisA (mNisA) with cells displaying NisP resulted
in facile removal of the leader sequence. However, NisP was unable
to cleave the leader sequence from either unmodified NisA or a precursor
containing dehydro amino acids but lacking the lanthionine rings.
These experiments demonstrate that fully modified nisin with the thioether
linkages is the true substrate for the NisP protease. Similar substrate
specificity has been reported for the LanP involved in production
of mutacin 1140.<sup><xref ref-type="bibr" rid="ref268">268</xref></sup> A manual docking model
of the unmodified NisA peptide into the NisP active site suggests
that the installation of ring A in nisin may be necessary to induce
peptide curvature that avoids steric clashes with the enzyme (<xref rid="fig20" ref-type="fig">Figure <xref rid="fig20" ref-type="fig">20</xref></xref>B).<sup><xref ref-type="bibr" rid="ref337">337</xref></sup> Studies monitoring the timing of secretion
by NisT and leader peptide removal by NisP indicate that these two
processes are not tightly coupled.<sup><xref ref-type="bibr" rid="ref189">189</xref></sup></p><p>A second type of class I lanthipeptide LanP proteases was identified
as part of the cluster responsible for the production of epilancin
15X.<sup><xref ref-type="bibr" rid="ref171">171</xref></sup> Like NisP, the leader protease
from this cluster, ElxP, is a canonical S8-peptidase family serine
protease. However, unlike NisP that functions only on substrates with
the lanthionine bridges installed, recombinant ElxP can catalyze leader
peptide removal from linear, unmodified ElxA precursor peptide<sup><xref ref-type="bibr" rid="ref171">171</xref>,<xref ref-type="bibr" rid="ref278">278</xref></sup> (although it remains to be established if the modified peptide is
a better substrate than the precursor). Residues that likely comprise
the catalytic triad of ElxP (Asp27, His62, and Ser240) were identified
based on sequence similarities with other characterized LanP proteases
and subtilisin family members.<sup><xref ref-type="bibr" rid="ref171">171</xref></sup></p><p>Two distinguishing characteristics differentiate the ElxP structure
from the NisP group of class I lanthipeptide leader proteases. First,
the primary sequence lacks an N-terminal secretion signal and the
C-terminal LPxTG sorting signal suggesting that ElxP is located in
the cytoplasm. The cytoplasmic localization of ElxP suggests that
the ElxA leader is removed prior to extrusion of the mature lanthipeptide
outside of the cell, although this has not yet been definitively established.
If so, the transporter ElxT would not require a leader peptide (see <xref rid="sec3.2" ref-type="other">section <xref rid="sec3.2" ref-type="other">3.2</xref></xref> for discussion
of transporters). Second, the recognition sequence in ElxA flanking
the cleavage site is distinct from that for NisP and related signal
proteases. An alignment of the ElxA leader sequence with those of
other homologous precursor peptides showed a conserved Asp/Glu-Leu/Val-(Xxx)<sub>2</sub>-Gln-Ser/Thr sequence at the C-terminus of the leader sequence
that is distinct from the Gly-Ala-(Xxx)<sub>2</sub>-Arg-Ile motif
found in NisA and related precursors. The Ser/Thr residue in the ElxA
motif is dehydrated by the corresponding LanB dehydratase and ElxP
cleaves after the Gln residue.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup> Ala-scanning
mutational analysis of the ElxA leader peptide revealed that mutations
at Asp, Leu, or Gln of the motif resulted in a significant reduction
in cleavage efficiency by ElxP as determined by mass spectrometric
analysis.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup> Michaelis&#x02013;Menten kinetic
constants determined for the Gln and Leu ElxA variants indicated that <italic>k</italic><sub>cat</sub> was decreased by more than 10-fold compared
to native ElxA, while the <italic>K</italic><sub>m</sub> was largely
unchanged.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup> Conversely, Ala mutations
at the two intervening residues within this motif had no effect on
proteolytic efficiency. Notably, although the NisA precursor is not
a substrate for ElxP, insertion of the Asp-Leu-(Xxx)<sub>2</sub>-Gln-Ala
motif present in ElxA (where the Ala mimics the Dha found in processed
ElxA precursor) into the NisA precursor yielded a chimeric peptide
that was readily cleaved by ElxP.<sup><xref ref-type="bibr" rid="ref278">278</xref></sup></p></sec><sec id="sec3.2"><label>3.2</label><title>Leader Peptide Removal and Export by Bifunctional
Enzymes</title><p>While independent proteases and transporters carry
out the processing of most class I lanthipeptides, some class I lanthipeptide
and most class II lanthipeptide clusters contain a single polypeptide
that harbors both protease and transport activities. These bifunctional
LanT proteins are members of the ABC-transporter maturation and secretion
(AMS) protein family.<sup><xref ref-type="bibr" rid="ref338">338</xref>,<xref ref-type="bibr" rid="ref339">339</xref></sup> For instance, the biosynthetic
cluster of the class II lanthipeptide lactococcin DR (identical to
lacticin 481, <xref rid="sec4.2" ref-type="other">section <xref rid="sec4.2" ref-type="other">4.2</xref></xref>) from <italic>L. lactis</italic> subsp. <italic>lactis</italic> ADRIA 85LO30 encodes a protein featuring a high level of sequence
similarity to ATP-dependent transporters<sup><xref ref-type="bibr" rid="ref340">340</xref></sup> but that also encompasses an N-terminal domain with homology to
members of the C39 family of papain-like Cys proteases.<sup><xref ref-type="bibr" rid="ref341">341</xref></sup> Historically, these bifunctional transporters
with a protease domain have been given the same LanT designation as
the transporters without a protease domain, which is somewhat unfortunate
since it does not provide immediate indication about the type of protein.
Analogously to how the multifunctional class III lanthipeptide synthetases
have been named LanKC (for kinase and cyclase), we suggest calling
the transporters that contain a protease domain LanT<sub>p</sub> (for
transporter and protease). We use the subscript p rather than capital
P (i.e., LanTP) to avoid confusion with LanT + LanP, and to follow
the guidelines of the American Society of Microbiology. In the remainder
of the review we will use this nomenclature.</p><p>The leader sequences
of lactococcin DR, as well as those of streptococcin A-FF22,<sup><xref ref-type="bibr" rid="ref342">342</xref></sup> salivaricin A,<sup><xref ref-type="bibr" rid="ref343">343</xref></sup> and enterococcal cytolysin,<sup><xref ref-type="bibr" rid="ref344">344</xref></sup> show strong
similarities with other nonlanthipeptide bacteriocins that are generally
cleaved after two conserved glycine residues.<sup><xref ref-type="bibr" rid="ref338">338</xref></sup> Mutations at either of the two Gly in the MutA precursor
peptide abolish both proteolytic processing and export of mutacin
II (<xref rid="fig21" ref-type="fig">Figure <xref rid="fig21" ref-type="fig">21</xref></xref>).<sup><xref ref-type="bibr" rid="ref345">345</xref></sup> This cleavage motif, which also includes GA
and GS sequences as variations, has been named the double-Gly motif.</p><fig id="fig21" position="float"><label>Figure 21</label><caption><p>Structures
of bovicin HJ50, nukacin ISK-1, and mutacin II. For
the first two compounds, the protease activity of the cognate bifunctional
LanT<sub>p</sub>s has been reconstituted. Bovicin HJ50 incorporates
a disulfide tailoring modification (<xref rid="sec4.6" ref-type="other">section <xref rid="sec4.6" ref-type="other">4.6</xref></xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0021" id="gr21" position="float"/></fig><p>Characterization of the processing of the nonlantibiotic
bacteriocin
lactococcin G revealed that the LagD AMS transporter also harbored
the leader peptide excision activity, which was mapped to the N-terminal
150 residues of the polypeptide.<sup><xref ref-type="bibr" rid="ref338">338</xref></sup> Subsequent
characterization of the isolated protease domains of the ComA AMS
transporter involved in quorum sensing,<sup><xref ref-type="bibr" rid="ref346">346</xref></sup> and of the CvaB AMS transporter of the colicin V secretion system,<sup><xref ref-type="bibr" rid="ref347">347</xref></sup> as well as genetic experiments on the LcnC
transporter involved in the biosynthesis of other lactococcins,<sup><xref ref-type="bibr" rid="ref339">339</xref></sup> established the general architecture for this
class of ABC-type bacteriocin transporters. The crystal structure
of the protease domain of ComA revealed an overall fold that resembled
the papain-like C39 family of Cys proteases, as predicted from the
primary sequence.<sup><xref ref-type="bibr" rid="ref348">348</xref></sup> Docking studies with
a model ComC leader peptide are consistent with the leader peptide
binding as an amphipathic &#x003b1;-helix in a hydrophobic groove adjacent
to the active site, thus positioning the double Gly motif in the enzyme&#x02019;s
active site.</p><p>Full reconstitution of in vitro protease activity
for a lanthipeptide
AMS protein was established through the characterization of the N-terminal
150-residue protease domain of the LctT transporter (= LctT<sub>p</sub> in the nomenclature used in this review) involved in the processing
of the class II lanthipeptide lacticin 481.<sup><xref ref-type="bibr" rid="ref349">349</xref></sup> Unlike the NisP-type class I stand-alone proteases, leader cleavage
from the LctA precursor peptide was not contingent on installation
of the lanthionine rings. Although the LctT<sub>p</sub> protease domain
could remove the leader sequence from full-length LctA precursor peptide,
a truncated 10-residue substrate, corresponding to Asp&#x02212;6 through
Ser4 of the substrate, was not processed. Likewise, replacement of
residues in the leader sequence with Pro also compromised activity.<sup><xref ref-type="bibr" rid="ref349">349</xref></sup> These studies are consistent with the expectation
that a helical conformation of the leader sequence is critical for
substrate recognition by the protease. Protease activity has also
been established for the N-terminal 150 amino acids of BovT<sub>p</sub>, which removed the leader peptide from mBovA to generate the lantibiotic
bovicin HJ50 (<xref rid="fig21" ref-type="fig">Figure <xref rid="fig21" ref-type="fig">21</xref></xref>).<sup><xref ref-type="bibr" rid="ref350">350</xref></sup></p><p>Based on the sequence similarity
to other AMS transporters and
to papain-like proteases, the catalytic triad of the protease domain
of LctT<sub>p</sub> was proposed to consist of Asp106, His90, and
Cys12. Both the C12A and C12S variants were devoid of activity but
mutations at Asp106 had no effect on activity, suggesting that this
residue is not essential for catalysis.<sup><xref ref-type="bibr" rid="ref349">349</xref></sup> Surprisingly, although the H90A variant was active, this mutant
cleaved the substrate peptide at a different site, suggesting that
this residue may play a role in site specificity of amide bond hydrolysis.
A mutation at the equivalent His in the protease domain of ComC<sup><xref ref-type="bibr" rid="ref346">346</xref></sup> or CvaB<sup><xref ref-type="bibr" rid="ref347">347</xref></sup> resulted
in loss of catalytic activity.</p><p>AMS proteins are quite tolerant
of the cargo they transport and
proteolyze. Peptide chimeras, in which the LctA leader peptide was
appended to different core peptides, were processed at varying rates
by the LctT<sub>p</sub> protease domain suggesting some role of the
core sequence on substrate processing.<sup><xref ref-type="bibr" rid="ref349">349</xref></sup> Similarly, the LtnT<sub>p</sub> AMS transporter involved in biosynthesis
of lacticin 3147 has been shown to secrete various noncognate peptides
attached to the LtnA2 leader peptide and to remove the leader peptide
in the process.<sup><xref ref-type="bibr" rid="ref351">351</xref></sup> The presence of the
class II lanthionine synthetase LtnM2 (<xref rid="sec4" ref-type="other">section <xref rid="sec4" ref-type="other">4</xref></xref>) was not required for transport by LtnT<sub>p</sub>. Substrate tolerance is also demonstrated by AMS proteins
that have more than one substrate such as the transporters HalT<sub>p</sub><sup><xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref125">125</xref></sup> and LicT<sub>p</sub><sup><xref ref-type="bibr" rid="ref103">103</xref></sup> that each transport two different modified
peptides (mHalA1 and mHalA2 for HalT<sub>p</sub> and mLicA1 and mLicA2
for LicT<sub>p</sub>, see <xref rid="fig22" ref-type="fig">Figure <xref rid="fig22" ref-type="fig">22</xref></xref>), and the transporter ProcT<sub>p</sub> that presumably
secretes all 30 of its substrates (<xref rid="sec4.1" ref-type="other">section <xref rid="sec4.1" ref-type="other">4.1</xref></xref>).<sup><xref ref-type="bibr" rid="ref129">129</xref></sup> Not only
are these transporters tolerant of the various cargo peptides, they
also demonstrate relaxed specificity with regard to the leader peptides
since the leader peptides of the individual precursors of two-component
peptides are quite diverse,<sup><xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup> and these transporters
can even act on noncognate leader peptides.<sup><xref ref-type="bibr" rid="ref77">77</xref></sup> Based on sequence homology and site-directed mutagenesis experiments,
an ELX<sub>n</sub>BXG-G/A/S (B is a hydrophobic residue, n = 2&#x02013;8)
at the end of the leader peptide appears important for proteolytic
cleavage.<sup><xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref349">349</xref></sup></p><p>The topology of AMS proteins
has been investigated showing that
the protease domain is located at the cytoplasmic side of the membrane.<sup><xref ref-type="bibr" rid="ref339">339</xref>,<xref ref-type="bibr" rid="ref352">352</xref></sup> Yeast two-hybrid studies demonstrated a physical interaction between
NukT<sub>p</sub> and NukM involved in the biosynthesis of the class
II lantibiotic nukacin ISK-1 (<xref rid="fig21" ref-type="fig">Figure <xref rid="fig21" ref-type="fig">21</xref></xref>).<sup><xref ref-type="bibr" rid="ref353">353</xref></sup> This study also suggested
that like for class I lanthipeptides, the biosynthetic enzymes NukM
and NukT<sub>p</sub> can function independently in vitro and in heterologous
expression systems but physiologically may be in a membrane-localized
multienzyme complex. Expression of full-length NukT<sub>p</sub> in
inside-out membrane vesicles showed that mNukA, but not unmodified
NukA, was a substrate for proteolysis.<sup><xref ref-type="bibr" rid="ref354">354</xref></sup> Interestingly, this study also showed that adenosine triphosphate
(ATP) was required for proteolysis, suggesting a tight coupling between
the transport domain and the protease domain of NukT<sub>p</sub>.
Indeed, mutations in the conserved Walker motifs and H-loop of the
ATP-binding domain of NukT<sub>p</sub> resulted not only in accumulation
of mNukA inside the cells, indicating disruption of transport activity,
but also in abolishment of leader peptide removal.<sup><xref ref-type="bibr" rid="ref352">352</xref></sup> Similar observations were also made with inside-out vesicles.
Analogously, mutations to the catalytic residues in the C39 protease
domain interfered with both proteolysis and transport.<sup><xref ref-type="bibr" rid="ref352">352</xref></sup> Thus, although isolated C39 protease domains
of AMS proteins have proteolytic activity and do not need ATP, for
intact AMS proteins, proteolysis and transport appear to be cooperative.</p><p>The crystal structures of a putative AMS protein provide insights
into the transport cycle of LanT<sub>p</sub> and other transporters
in this family.<sup><xref ref-type="bibr" rid="ref355">355</xref></sup> At present, the function
of this peptidase-containing ATP-binding cassette transporter from <italic>Clostridium thermocellum</italic> that was identified by genome mining
is not known, but it seems to be associated with a 90-residue precursor
peptide containing a 24 amino acid leader peptide ending in GG. The
architecture of the transporter consists of three domains, an N-terminal
peptidase domain, a six-helical transmembrane domain (TMD), and a
C-terminal nucleotide-binding domain (NBD) (<xref rid="fig23" ref-type="fig">Figure <xref rid="fig23" ref-type="fig">23</xref></xref>). Structures were obtained both in the
absence and presence of an inert nucleotide analog, revealing two
conformations of the transporter (<xref rid="fig23" ref-type="fig">Figure <xref rid="fig23" ref-type="fig">23</xref></xref>A,B). In the absence of bound nucleotide,
the structure reveals an inward-facing conformation wherein the transmembrane
helices of the homodimer form an open tunnel that is oriented toward
the active site of the peptidase domain. This state would position
the core peptide within the tunnel and orient the double Gly sequence
of the leader toward the peptidase domain. Nucleotide binding induces
a rotation of the C-terminal nucleotide-binding domains to close the
transmembrane tunnel. This conformational reorganization displaces
the peptidase domains, which may help facilitate translocation, and
subsequent release, of the cleaved core peptide across the membrane.<sup><xref ref-type="bibr" rid="ref355">355</xref></sup> In the nucleotide-bound structure, the transmembrane
tunnel is empty and not open to the outside, but if a core peptide
were in the cavity, it might induce formation of an extracellular
gate. The authors also noted that unlike the tunnel of the general
Sec system, which transports unfolded extended polypeptide chains
or small helices, the transmembrane cavity of the AMS protein is large
enough to accommodate a small folded protein.<sup><xref ref-type="bibr" rid="ref355">355</xref></sup> Presumably, this also extends to a post-translationally
modified core peptide in the case of RiPPs.</p><fig id="fig22" position="float"><label>Figure 22</label><caption><p>Biosynthesis of the
two-component lantibiotic lichenicidin. The
structures of Lic&#x003b1; and Lic&#x003b2; were assigned by NMR and MS
analyses.<sup><xref ref-type="bibr" rid="ref363">363</xref></sup> LicT<sub>p</sub> acts on both
peptides to remove the entire leader peptide of Lic&#x003b1; and all
but six C-terminal residues, NDVNPE (bolded and underlined), of Lic&#x003b2;.
The latter are recognized by LicP in the final proteolysis step. The
stereochemistry of the Lic&#x003b2; A-ring is unknown but predicted
to be LL as it derives from a Dhx-Dhx-Xxx-Xxx-Cys motif (Dhx = Dha/Dhb; <xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>). For discussion
of the LanM proteins, see <xref rid="sec4" ref-type="other">section <xref rid="sec4" ref-type="other">4</xref></xref>. For clarity, the process is shown as first completion
of dehydration and then cyclization, but this is not necessarily the
case. For instance, for the related two-component lantibiotic haloduracin,
cyclization commences before dehydration is completed.<sup><xref ref-type="bibr" rid="ref364">364</xref>,<xref ref-type="bibr" rid="ref365">365</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0023" id="gr22" position="float"/></fig><p>This model explains the general
tolerance of transporters like
NisT and ProcT<sub>p</sub> with respect to the cargo peptides (engineered
in the case of NisT<sup><xref ref-type="bibr" rid="ref243">243</xref></sup> and 30 different
natural peptides for ProcT<sub>p</sub>,<sup><xref ref-type="bibr" rid="ref129">129</xref></sup> see <xref rid="sec4.1" ref-type="other">section <xref rid="sec4.1" ref-type="other">4.1</xref></xref>). The model in which the core peptide first backs into the tunnel
can also explain more substrate-restricted systems that require the
post-translationally modified cognate peptide if the tunnel has shape
and/or charge complementarity to the post-translationally modified
peptide. Unlike the observations mentioned above for NukT<sub>p</sub>,<sup><xref ref-type="bibr" rid="ref354">354</xref></sup> the protease domain of the AMS protein
from <italic>C. thermocellum</italic> was active in the absence of
ATP.<sup><xref ref-type="bibr" rid="ref355">355</xref></sup> Instead, proteolysis was actually
inhibited by ATP binding, because the cytoplasmic opening is closed
in the ATP bound state. In this ATP-bound state the protease domains
are displaced from the membrane-spanning and nucleotide binding domains
and in this conformation the protease domains exhibit similar low
level activity as observed with excised C39 protease domains. Indeed,
in trans addition of the protease domain to the TMD-NBD fragment of
the <italic>C. thermocellum</italic> protein increased the proteolytic
activity, presumably by reconstituting a complete protein.<sup><xref ref-type="bibr" rid="ref355">355</xref></sup> Thus, like the NukT<sub>p</sub> study, the
crystallographic and biochemical characterization of the AMS protein
from <italic>C. thermocellum</italic> shows strong cooperativity between
the nucleotide-binding domain and the protease domain. One possible
explanation for the observed dependence of ATP for proteolysis in
the NukT<sub>p</sub> study is that during the first turnover perhaps
the cleaved nukacin ISK-1 may be trapped in the transmembrane tunnel
and ATP hydrolysis is required to reset the system that recognizes
the full length mNukA. Indeed, the system from <italic>C. thermocellum</italic> was only inhibited by ATP in the absence of Mg<sup>2+</sup>.<sup><xref ref-type="bibr" rid="ref355">355</xref></sup></p><p>With the discovery of lanthipeptide gene
clusters in genomes of
Gram-negative bacteria, another variation of the multifunctional transporter-protease
has come to light. Several of the lanthipeptide gene clusters in Cyanobacteria,
Bacteroidetes, and Proteobacteria contain in addition to a LanT<sub>p</sub> a series of proteins that appear to resemble type 1 protein
secretion systems.<sup><xref ref-type="bibr" rid="ref356">356</xref></sup> These clusters encode
a protein from the major facilitator superfamily (MFS) that would
be localized in the inner membrane,<sup><xref ref-type="bibr" rid="ref357">357</xref>&#x02212;<xref ref-type="bibr" rid="ref359">359</xref></sup> a HlyD-type protein
that would span the periplasm, and a TolC-dependent efflux pump that
would be localized in the outer membrane. At present it has not yet
been investigated how this secretion system would interact with the
LanT<sub>p</sub>, but a model has been proposed.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p><p>A few class II lanthipeptide biosynthetic clusters
contain genes
that encode for both an AMS protease-transporter and a stand-alone
S8 subtilisin-like LanP protease. Examples include the clusters encoding
the enterococcal cytolysin,<sup><xref ref-type="bibr" rid="ref360">360</xref></sup> cerecidin,<sup><xref ref-type="bibr" rid="ref133">133</xref></sup> carnolysin,<sup><xref ref-type="bibr" rid="ref361">361</xref></sup> and
lichenicidin.<sup><xref ref-type="bibr" rid="ref91">91</xref></sup> In these clusters, the
modified precursor peptide is first partially processed by the LanT<sub>p</sub> to remove the leader peptide at the double Gly motif, and
subsequently processed by the LanP protease to trim additional remaining
residues to elaborate the final product,<sup><xref ref-type="bibr" rid="ref360">360</xref></sup> as illustrated in <xref rid="fig22" ref-type="fig">Figure <xref rid="fig22" ref-type="fig">22</xref></xref> for lichenicidin &#x003b2;.<sup><xref ref-type="bibr" rid="ref91">91</xref></sup> The
crystal structure of LicP, the LanP involved in the final processing
of lichenicidin &#x003b2;, shows an overall structure similar to other
S8 type subtilisin-like Ser proteases (<xref rid="fig20" ref-type="fig">Figure <xref rid="fig20" ref-type="fig">20</xref></xref>C).<sup><xref ref-type="bibr" rid="ref362">362</xref></sup> LicP is
autocatalytically processed to a prodomain and a catalytic domain
as in the case of NisP, but the crystal structure of LicP contains
both domains and thus provides insights into the protease activation
mechanism. Maturation of subtilisin and related proteases proceeds
by the displacement and subsequent stabilization of the N-terminus
of the catalytic domain through interactions with a requisite calcium
ion. In LicP, the equivalent calcium-binding site is replaced with
a hydrophobic pocket, and stabilization is achieved by the displacement
of Trp111 of the catalytic domain into this pocket.<sup><xref ref-type="bibr" rid="ref362">362</xref></sup></p><fig id="fig23" position="float"><label>Figure 23</label><caption><p>Homodimeric structure of the AMS family protease/transporter
from <italic>C. thermocellum</italic> determined in the absence (A)
and presence
(B) of an inert nucleotide analog. The transmembrane domain is colored
in dark and light green and the nucleotide-binding domain is colored
in dark and light orange. The protease domain shown in dark and light
blue is not ordered in the nucleotide bound structure, and is presumably
directed away from the core of the transporter. In the absence of
nucleotide, the entrance to the transmembrane tunnel is situated at
the interface with the protease domain and positions the active site
residues right at the gateway. A close-up view of the active site
residues of the protease domain is shown in the inset box. PDB ID 4S0F and 4RY2.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0022" id="gr23" position="float"/></fig><p>Processing of the mLicA2 precursor peptide by the
LicT<sub>p</sub> C39 protease-transporter after the double Gly sequence
of the leader
generates an NDVNPE sequence appended to the core, and the LicP S8
protease then removes these six residues to produce the mature product
(<xref rid="fig22" ref-type="fig">Figure <xref rid="fig22" ref-type="fig">22</xref></xref>).<sup><xref ref-type="bibr" rid="ref91">91</xref></sup> Reconstitution
of LicP activity in vitro demonstrated that the protease is fairly
tolerant to alterations with regard to the substrate peptide, and
can excise the leader from full-length linear LicA2 precursor peptide,
a partly proteolyzed precursor peptide (containing the DVNPE sequence),
and a processed full-length precursor containing the (methyl)lanthionine
rings.<sup><xref ref-type="bibr" rid="ref362">362</xref></sup> The activity toward unmodified
precursor peptides is reminiscent of that observed for ElxP but is
notably distinct from the substrate requirements of NisP, which only
cleaves the leader sequences from fully modified precursors. However,
LicP processed the lanthionine-bearing peptide much faster than the
unmodified peptide.<sup><xref ref-type="bibr" rid="ref362">362</xref></sup> LicP could also
process a number of synthetic peptide substrates of variable sequences
incorporating the NDVNPE recognition sequence, and its tolerance toward
peptide substrates with divergent amino acids in the P&#x02032; sites
may be exploited for biotechnology.<sup><xref ref-type="bibr" rid="ref362">362</xref></sup></p></sec></sec><sec id="sec4"><label>4</label><title>Class II Lanthipeptide Biosynthesis</title><sec id="sec4.1"><label>4.1</label><title>Overview</title><p>In the mid 1990s, the gene
clusters of lacticin 481 (then also called lactococcin DR) and the
enterococcal cytolysin were sequenced and it was discovered that they
did not encode LanB and LanC proteins.<sup><xref ref-type="bibr" rid="ref340">340</xref>,<xref ref-type="bibr" rid="ref344">344</xref></sup> Instead,
apparent fusion proteins were present that contained a C-terminal
domain that had homology with the LanC proteins,<sup><xref ref-type="bibr" rid="ref344">344</xref></sup> but N-terminal domains that did not show any obvious sequence
homology with known proteins in the database. These proteins were
designated the general term LanM,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> and
they form the basis for classifying lanthipeptides in class II. For
many years, another distinguishing feature of biosynthetic gene clusters
of class II lanthipeptides was the presence of a member of the AMS
protein family.<sup><xref ref-type="bibr" rid="ref338">338</xref></sup> These LanT<sub>p</sub> proteins contain an N-terminal papain-like C39 protease domain discussed
in <xref rid="sec3.2" ref-type="other">section <xref rid="sec3.2" ref-type="other">3.2</xref></xref> that
typically cleaves after a double Gly motif. But as more and more genomes
have become available, genes encoding AMS proteins are also found
in gene clusters of class I lanthipeptides and the manner in which
the leader peptide is removed is becoming less uniform. Although some
mixing of class I and II biosynthetic genes is starting to appear,
for instance clusters that contain both <italic>lanM</italic> and <italic>lanC</italic> genes (see <xref rid="fig24" ref-type="fig">Figure <xref rid="fig24" ref-type="fig">24</xref></xref>),<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> at present it is still
possible to use the presence of a LanB protein as the defining feature
of class I lanthipeptides and the presence of a LanM protein for inclusion
with class II lanthipeptides. Like the LanB proteins, which show up
in gene clusters of other RiPPs,<sup><xref ref-type="bibr" rid="ref195">195</xref>,<xref ref-type="bibr" rid="ref202">202</xref>,<xref ref-type="bibr" rid="ref366">366</xref></sup> LanM proteins also make appearances in other RiPP
clusters, most notably the polytheonamides,<sup><xref ref-type="bibr" rid="ref367">367</xref></sup> and also in clusters that appear to encode a new class of RiPPs
that contain D-amino acids (see <xref rid="sec4.6.1" ref-type="other">section <xref rid="sec4.6.1" ref-type="other">4.6.1</xref></xref>).</p><fig id="fig24" position="float"><label>Figure 24</label><caption><p>Sequence similarity network of LanMs
generated herein using EFI-EST
and visualized in Cytoscape with an alignment score threshold of 110
(&#x0223c;35% sequence identity). Each node represents protein sequences
sharing 100% sequence identity. LanMs discussed throughout this review
are indicated. The enzymes containing three Cys as Zn<sup>2+</sup> ligands (&#x0201c;CCG&#x0201d; group) are mostly found within the
dashed circle. Enzymes from clusters that contain both LanM and LanC
enzymes (e.g., a cluster from <italic>Streptomyces globisporus</italic> C-1027) group together.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0024" id="gr24" position="float"/></fig><p>Phylogenetic analysis of LanM enzymes was completed for this
review
using a sequence similarity network (SSN) (<xref rid="fig24" ref-type="fig">Figure <xref rid="fig24" ref-type="fig">24</xref></xref>). Sequences for the network were accessed
by a 5000 sequence return, two-iteration Position-Specific Iterated
BLAST (PSI-BLAST) of the lanthipeptide synthetase CylM (accession
number AAK67266.1). The SSN was built using the online Enzyme Function
Initiative-Enzyme Similarity Tool (EFI-EST)<sup><xref ref-type="bibr" rid="ref207">207</xref></sup> using the 1811 sequences obtained from PSI-BLAST that had both an
E-value of &#x02264;e<sup>&#x02013;18</sup> and were &#x02265;500 amino
acids in length. The 100% identity representative node network, which
contains 1687 nodes, was visualized in Cytoscape<sup><xref ref-type="bibr" rid="ref208">208</xref></sup> with an alignment score threshold of 110 (&#x0223c;35% sequence
identity).</p><p>As described in more detail in the following sections,
LanM proteins
are bifunctional enzymes that carry out both dehydration and cyclization
of the substrate. The currently known LanM proteins can be divided
into clusters and the main cluster is clearly subdivided into different
groups (<xref rid="fig24" ref-type="fig">Figure <xref rid="fig24" ref-type="fig">24</xref></xref>).<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Although the differences between these groups
are throughout the protein sequence, the most eye-catching differences
can be found in the cyclization domain and will be discussed in <xref rid="sec4.3" ref-type="other">section <xref rid="sec4.3" ref-type="other">4.3</xref></xref>. One group
comprises the majority of LanMs from Cyanobacteria<sup><xref ref-type="bibr" rid="ref368">368</xref></sup> and many of its members are encoded near multiple putative
LanA substrates and thus predicted to have high substrate tolerance
as was first demonstrated for ProcM, encoded in <italic>Prochlorococcus</italic> MIT9313.<sup><xref ref-type="bibr" rid="ref129">129</xref></sup> The genome of this organism
codes for 30 substrate peptides (ProcAs) with strongly conserved,
long leader peptides (&#x0223c;70 amino acids), but relatively short
and highly diverse core peptides (<xref rid="fig25" ref-type="fig">Figure <xref rid="fig25" ref-type="fig">25</xref></xref>). One precursor gene is truncated and may
be a pseudogene.<sup><xref ref-type="bibr" rid="ref368">368</xref></sup> ProcM dehydrates and
cyclizes all ProcA peptides tested thus far (18)<sup><xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref368">368</xref></sup> and turns them into products with single ring topologies.<sup><xref ref-type="bibr" rid="ref369">369</xref></sup> Remarkably, these ring topologies are highly
diverse (<xref rid="fig26" ref-type="fig">Figure <xref rid="fig26" ref-type="fig">26</xref></xref>),<sup><xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref370">370</xref></sup> raising the intriguing question of how one
enzyme can make so many different products. <xref rid="sec4.3" ref-type="other">Section <xref rid="sec4.3" ref-type="other">4.3</xref></xref> will provide a potential answer to this
question. The leader peptides of the ProcA substrates belong to a
large family of peptides resembling Nif11 nitrogen-fixing proteins
(N11P) that was first identified in a bioinformatic study.<sup><xref ref-type="bibr" rid="ref371">371</xref></sup> These Nif11 peptides are not only found as
leader peptides on lanthipeptide precursor peptides but also for other
classes of RiPPs.<sup><xref ref-type="bibr" rid="ref372">372</xref></sup> Another widespread
family of RiPP precursors from Cyanobacteria,<sup><xref ref-type="bibr" rid="ref368">368</xref></sup> which includes putative lanthipeptides, have unusually
long nitrile hydratase-like leader peptide (NHLP) sequences.<sup><xref ref-type="bibr" rid="ref367">367</xref>,<xref ref-type="bibr" rid="ref371">371</xref></sup> The evolutionary and functional significance, if any, of these sequence
homologies is currently not clear.</p><fig id="fig25" position="float"><label>Figure 25</label><caption><p>ProcM has 30 putative substrates, 29
of which contain Cys residues
in the core peptide. One substrate, ProcAT.1, has a truncated leader
peptide. Fully conserved identical residues in the leader peptide
are shown in dark orange and fully conserved similar residues are
shown in green. Cys residues in the core peptide are shown in blue
and Ser/Thr residues in purple.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0025" id="gr25" position="float"/></fig><fig id="fig26" position="float"><label>Figure 26</label><caption><p>Six structurally characterized prochlorosins demonstrate the diverse
ring topologies installed by ProcM.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0026" id="gr26" position="float"/></fig></sec><sec id="sec4.2"><label>4.2</label><title>Dehydration via Phosphorylation</title><p>Early
gene disruption experiments in the clusters encoding lacticin 481
and the enterococcal cytolysin suggested the LanM proteins were essential
for lanthipeptide maturation.<sup><xref ref-type="bibr" rid="ref340">340</xref>,<xref ref-type="bibr" rid="ref344">344</xref></sup> The C-terminal domain
that displays sequence homology with LanC proteins (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>) was postulated to be responsible
for the cyclization step. However, the manner in which the dehydration
was catalyzed, presumably by the N-terminal domain, was not clear.
In 2004, in vitro experiments demonstrated that the LctM protein was
indeed capable of converting the precursor peptide LctA into a fully
dehydrated and cyclized intermediate, which after leader peptide removal
provided lacticin 481 (<xref rid="fig27" ref-type="fig">Figure <xref rid="fig27" ref-type="fig">27</xref></xref>),<sup><xref ref-type="bibr" rid="ref304">304</xref></sup> the founding member
of a large group of class II lanthipeptides with similar structures.<sup><xref ref-type="bibr" rid="ref373">373</xref></sup> The process required ATP and Mg<sup>2+</sup>, and follow-up experiments with inefficient substrate analogs resulted
in buildup of intermediates that were phosphorylated on the Ser and
Thr residues destined for dehydration.<sup><xref ref-type="bibr" rid="ref374">374</xref></sup> Experiments with synthetic phosphorylated LctA peptides demonstrated
that the enzyme can eliminate the phosphate group to convert phosphoSer
(pSer) and phosphoThr (pThr) into Dha and Dhb, respectively. Thus,
class II LanM enzymes utilize a very different mechanism for activation
of the side chain hydroxyl groups of Ser/Thr from the glutamylation
strategy discussed in <xref rid="sec2.2" ref-type="other">section <xref rid="sec2.2" ref-type="other">2.2</xref></xref> for class I LanB dehydratases (<xref rid="fig28" ref-type="fig">Figure <xref rid="fig28" ref-type="fig">28</xref></xref>).</p><fig id="fig27" position="float"><label>Figure 27</label><caption><p>Biosynthesis of lacticin 481. For clarity,
the process is shown
as first completion of dehydration and then cyclization, but this
is not actually the case since cyclization commences before dehydration
is completed.<sup><xref ref-type="bibr" rid="ref375">375</xref></sup> See <xref rid="sec4.5" ref-type="other">section <xref rid="sec4.5" ref-type="other">4.5</xref></xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0027" id="gr27" position="float"/></fig><fig id="fig28" position="float"><label>Figure 28</label><caption><p>Dehydration during biosynthesis of class II lanthipeptides involves
phosphorylation followed by phosphate elimination with anti stereoselectivity
in all cases for which the stereochemistry has been investigated.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0028" id="gr28" position="float"/></fig><p>Interestingly, the elimination
of the phosphate group from pSer
and pThr required ADP, suggesting that the phosphorylation and elimination
steps might take place in the same active site. In this model, elimination
of the phosphate might require ADP to bind deeper in the active site
pocket to set up the required environment for binding the phosphorylated
peptide. Also noteworthy, phosphorylated peptides are typically not
observed during in vitro reactions with class II enzymes, suggesting
that phosphate elimination is faster than dissociation of the intermediate
phosphopeptide.</p><p>Although these studies revealed the molecular
mechanism of dehydration,
how the enzyme catalyzes these chemical transformations remained mostly
enigmatic. Mutagenesis experiments on LctM in which all conserved
amino acids with side chains that could be involved in catalysis<sup><xref ref-type="bibr" rid="ref376">376</xref></sup> were mutated revealed several amino acids that
appeared to be important for the phosphorylation step, including Asp242
and Asp259.<sup><xref ref-type="bibr" rid="ref377">377</xref></sup> Two other amino acid residues,
Arg399 and Thr405, were shown to be important for elimination of the
phosphate, and one residue, Lys159, appeared to be involved in both
phosphorylation and phosphate elimination.<sup><xref ref-type="bibr" rid="ref377">377</xref>,<xref ref-type="bibr" rid="ref378">378</xref></sup> A model was proposed that made analogies to the mechanism of Ser/Thr
protein kinases, but at the sequence level no homology with such proteins
was detected. The importance of these same residues was later also
confirmed by mutagenesis of BovM involved in bovicin HJ50 biosynthesis<sup><xref ref-type="bibr" rid="ref379">379</xref></sup> and ProcM involved in the production of prochlorosins.<sup><xref ref-type="bibr" rid="ref380">380</xref></sup> More recently, the mutagenesis experiments
were placed in a structural context with the first X-ray structure
of a LanM protein, the CylM protein that generates both peptides of
the enterococcal cytolysin (<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref>). It was fitting for this protein to be the first
structurally characterized LanM since it was also one of the first
family members for which the sequence was determined in 1994.<sup><xref ref-type="bibr" rid="ref344">344</xref></sup></p><fig id="fig29" position="float"><label>Figure 29</label><caption><p>Biosynthesis of both peptides that make up
cytolysin. For clarity,
the process is shown as first completion of dehydration and then cyclization,
but the order of the PTMs is currently not known.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0029" id="gr29" position="float"/></fig><p>Cytolysin is a member of the two-component lantibiotics.
This group
of peptides displays maximum activity when two different post-translationally
modified peptides are administered together.<sup><xref ref-type="bibr" rid="ref381">381</xref></sup> For most two-component lantibiotics, one peptide, called the &#x003b1;-peptide,
binds to lipid II and the second &#x003b2;-peptide is believed to bind
to this complex to form pores in the bacterial membrane.<sup><xref ref-type="bibr" rid="ref270">270</xref>,<xref ref-type="bibr" rid="ref307">307</xref>,<xref ref-type="bibr" rid="ref309">309</xref>,<xref ref-type="bibr" rid="ref382">382</xref>,<xref ref-type="bibr" rid="ref383">383</xref></sup> Thus far, two-component lantibiotics
are confined to class II lanthipeptides, although some systems are
present in actinobacterial genomes that could possibly be two-component
lanthipeptides spanning two different classes.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> For most two-component lantibiotics, two different LanM
enzymes carry out the dehydrations and cyclizations of two different
LanA substrates that have divergent leader and core peptides, with
little or no crossover (e.g., <xref rid="fig22" ref-type="fig">Figure <xref rid="fig22" ref-type="fig">22</xref></xref> for
lichenicidin).<sup><xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref381">381</xref>,<xref ref-type="bibr" rid="ref384">384</xref>,<xref ref-type="bibr" rid="ref385">385</xref></sup> CylM is an exception in that it modifies both substrate peptides,
CylL<sub>S</sub> and CylL<sub>L</sub> (<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref>).<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref386">386</xref></sup> Two other unusual
aspects of the enterococcal cytolysin related to its bioactivity are
that it functions as a virulence peptide that lyses mammalian cells
including immune cells during infection,<sup><xref ref-type="bibr" rid="ref387">387</xref></sup> and that it has neither sequence nor structural homology with the
two-component lanthipeptides that bind lipid II (e.g., compare <xref rid="fig22" ref-type="fig">Figures <xref rid="fig22" ref-type="fig">22</xref></xref> and <xref rid="fig29" ref-type="fig">29</xref>).</p><p>As
anticipated based on sequence analysis, the structure of CylM
contains two domains, an N-terminal dehydration domain and a C-terminal
cyclization domain (<xref rid="fig30" ref-type="fig">Figure <xref rid="fig30" ref-type="fig">30</xref></xref>A).<sup><xref ref-type="bibr" rid="ref388">388</xref></sup> The two domains do not interact
much with each other, explaining the observation by several laboratories
that dehydration and cyclization activity of LanMs can be achieved
independently by expressing the two domains individually.<sup><xref ref-type="bibr" rid="ref369">369</xref>,<xref ref-type="bibr" rid="ref375">375</xref>,<xref ref-type="bibr" rid="ref388">388</xref>&#x02212;<xref ref-type="bibr" rid="ref390">390</xref></sup> As expected, the cyclization domain has a structure similar to that
of NisC described in <xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref> and will be discussed further in the next section.
Unexpectedly, however, the overall fold of the dehydration domain
bears strong resemblance to that of eukaryotic lipid kinases and lipid-kinase
like protein kinases.<sup><xref ref-type="bibr" rid="ref388">388</xref></sup> Although the overall
fold has clear structural homology, a structure-based alignment showed
that the secondary structural elements are connected in a unique manner.
Nevertheless, homology detection and structure prediction by profile
HMM-HMM (hidden Markov model) alignments<sup><xref ref-type="bibr" rid="ref391">391</xref></sup> performed for this review does identify the structural homology
between LanM enzymes and lipid kinases. The CylM structure contains
the typical N- and C-terminal lobes of Ser/Thr protein kinases, but
also the characteristic k&#x003b1;10 and k&#x003b1;11 helices usually
found in lipid kinases and lipid kinase-like protein kinases (<xref rid="fig30" ref-type="fig">Figure <xref rid="fig30" ref-type="fig">30</xref></xref>). Compared with
canonical lipid kinases like phosphoinositide 3-kinase (PI3K), the
CylM dehydration domain is significantly larger and contains several
additional subdomains. One of those is the kinase-activation (KA)
domain that plays at least two important roles, providing catalytic
residues to the active site and ordering the activation loop.</p><fig id="fig30" position="float"><label>Figure 30</label><caption><p>(A) Structure
of the CylM class II lanthipeptide synthetase showing
the dehydration domain (green) and cyclization domain (orange). (B)
Close-up view of the dehydration active site showing critical active
site residues and bound nucleotide. (C) and (D) Color-coded diagrams
highlighting in (C) the N- and C-terminal kinase lobes (blue and red)
as well as the k&#x003b1;10 and k&#x003b1;11 helices (yellow), and in
(D) the LanM specific KA-domain (purple), activation loop (red), and
capping helices (brown). PDB ID 5DZT.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0030" id="gr30" position="float"/></fig><p>The two residues mentioned above that were identified by
site-directed
mutagenesis in other LanM proteins as being critical for phosphate
elimination, Arg506 and Thr512 in CylM numbering (<xref rid="fig30" ref-type="fig">Figure <xref rid="fig30" ref-type="fig">30</xref></xref>B), are located in the KA
domain. Indeed mutagenesis of these two residues in CylM again resulted
in mutant enzymes that still carried out phosphorylation but were
strongly impaired in phosphate elimination. The side chains of these
two residues insert into an active site that otherwise looks strikingly
similar to typical kinases, with Asp252 and His254 on the P-loop that
activate the phosphate to be transferred from ATP to the substrate,
and Asp347 and His349 on the C-lobe that accept a proton from the
Ser/Thr nucleophile of the substrate. The active site also contains
Lys274, which in other kinases binds to the &#x003b3;-phosphate of ATP
to guide it to the phosphoryl acceptor. As noted above, mutagenesis
of this residue in LctM slowed down both phosphorylation and phosphate
elimination, suggesting the Lys still engages the phosphate group
after phosphoryl transfer and facilitates elimination by stabilizing
the leaving group. The active site is completed with a series of conserved
residues including Asn352 and Asp364 that likely interact with the
nucleotide, possibly mediated by a Mg<sup>2+</sup> ion. Since the
structure only contained AMP and not the peptide substrate, details
of the active site organization in the transition states of the two
chemical transformations are not available, but a possible model is
shown in <xref rid="fig31" ref-type="fig">Figure <xref rid="fig31" ref-type="fig">31</xref></xref>. The CylM structure confirmed that phosphorylation and elimination
take place in overlapping active sites, and explains why ADP needs
to be present for elimination of the phosphate from exogenously supplied
phosphorylated peptides.<sup><xref ref-type="bibr" rid="ref365">365</xref>,<xref ref-type="bibr" rid="ref374">374</xref></sup></p><fig id="fig31" position="float"><label>Figure 31</label><caption><p>Proposed mechanism of
phosphorylation and phosphate elimination
by CylM based on mutagenesis studies. In the absence of a cocrystal
structure, many details are still missing. For instance, the interactions
of Asp252/His254 with the nucleotide phosphate could be mediated via
a Mg<sup>2+</sup>. Not shown are Asn352, Asp364, and Glu366, which
also appear to engage the nucleotide phosphates.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0031" id="gr31" position="float"/></fig><p>The second role of the KA domain is to orient the activation
loop.
In canonical lipid kinases this loop is disordered in the absence
of substrate or other specific interacting proteins. Phosphorylation
or autophosphorylation of residues in the activation loop often results
in an ordering of the loop to adopt a productive conformation for
substrate binding and catalysis. In CylM, the activation loop is well
ordered via multiple interactions between residues in the KA domain
and the loop (<xref rid="fig30" ref-type="fig">Figure <xref rid="fig30" ref-type="fig">30</xref></xref>D). The KA domain is, in turn, held in place by interactions with
a set of helices termed the capping helices. Both the KA domain and
these capping helices are currently unique to LanM proteins, and the
overall topology that results in a well-ordered activation loop may
explain why LanM enzymes essentially have constitutive kinase activity.
At present there is no evidence for autophosphorylation as an activation
mechanism.<sup><xref ref-type="bibr" rid="ref392">392</xref></sup> One question that remained
unanswered with the structure of CylM is where the leader peptide
binds. The enzyme does not contain an obvious winged helix-turn-helix
motif that engages the leader peptide in class I lanthipeptides and
many other RiPP biosynthetic enzymes (<xref rid="sec2.5" ref-type="other">section <xref rid="sec2.5" ref-type="other">2.5</xref></xref>), nor does it have the SH2-like domain
identified in NisC that may interact with the substrate (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>). CylM does
contain a subdomain inserted in the cyclization domain that may be
important for substrate binding (see <xref rid="sec4.3.1" ref-type="other">section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>).</p><p>Several other residues have
been reported to be important for LanM
activity based on mutagenesis studies. These include Tyr230, Glu266,
Glu446, and Gln495 in BovM (corresponding to Tyr330, Glu366, Glu555,
and Gln611 in CylM).<sup><xref ref-type="bibr" rid="ref379">379</xref></sup> Inspection of the
CylM structure only suggests a clear role for Glu366, which may stabilize
ATP. The other residues are not close to the phosphorylation/elimination
active site. Furthermore, mutation of Ile254, Leu290, and Leu597 in
BovM resulted in an 5 to 7-fold decrease in affinity for the substrate
BovA.<sup><xref ref-type="bibr" rid="ref379">379</xref></sup> The basis for the loss of affinity
is currently not known, and mapping these residues on the CylM structure
does not provide clear clues as to where substrate leader peptide
binding occurs. The N-terminal dehydratase domain has been expressed
individually and carries out dehydration of the CylL substrates, suggesting
that leader peptide binding for the dehydration reaction would take
place in the N-terminal domain.<sup><xref ref-type="bibr" rid="ref388">388</xref></sup></p></sec><sec id="sec4.3"><label>4.3</label><title>Cyclization</title><p>The cyclization events
in lanthipeptide biosynthesis require remarkable control over regio-
and stereoselectivity. Studies geared toward understanding the cyclization
mechanism and selectivity started with class I LanC enzymes (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>) but have recently
become an intense focus in class II lanthipeptide research in light
of several unanticipated developments. First, the class II lanthipeptide
synthetase ProcM was shown to have 29 predicted substrates that appear
to undergo selective cyclization to afford a single ring topology
per substrate, with the individual topologies being highly diverse
(<xref rid="fig25" ref-type="fig">Figure <xref rid="fig25" ref-type="fig">25</xref></xref> and <xref rid="fig26" ref-type="fig">26</xref>; ProcM has 30 substrates but one does not have
Cys residues and hence cannot cyclize).<sup><xref ref-type="bibr" rid="ref129">129</xref></sup> Second, the two-component class II lanthipeptide cytolysin was reported
to contain (Me)Lan with both DL- and LL stereochemistry (<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref>), constituting
the first characterized example of non-DL-stereochemistry in a lanthipeptide.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> A single enzyme, CylM, catalyzes the formation
of both DL and LL (Me)Lan in the same peptide with high stereoselectivity.<sup><xref ref-type="bibr" rid="ref393">393</xref></sup> Subsequently, similar observations were made
for the class II lanthipeptides carnolysin,<sup><xref ref-type="bibr" rid="ref361">361</xref></sup> haloduracin,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> geobacillin II,<sup><xref ref-type="bibr" rid="ref394">394</xref></sup> and the flavecins.<sup><xref ref-type="bibr" rid="ref137">137</xref></sup> These observations and the remarkable substrate tolerance of ProcM-like
proteins imply an even greater plasticity of the cyclization catalysts
than the already impressive control discussed in <xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>.</p><p>While the various
solutions for the dehydration step in lanthipeptide biosynthesis are
interesting for their evolutionary origins, chemically, the dehydration
reaction is not too challenging. However, control over a set of cyclizations
to give one final lanthipeptide product of defined ring topology and
stereochemistry catalyzed by a single enzyme with one active site
is highly impressive, and that level of control currently cannot be
achieved in synthetic organic chemistry. Consider the number of potential
products that could arise from cyclization of dehydrated CylL<sub>L</sub>, the precursor to the large peptide of cytolysin (<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref>). Dehydrated CylL<sub>L</sub> contains three cysteines and 7 dehydro amino acids. If all
cysteines form rings, cyclization could lead to 210 possible constitutional
isomers without considering stereochemistry. If DL- and LL-stereochemistries
are both possible, and both configurations at the &#x003b2;-carbon of
MeLan are considered, then over 6000 potential isomeric products can
be formed. Out of over 6000 possibilities, CylM generates only one
isomer. This remarkable level of control begs the question of how
selectivity is governed. Do the enzymes or the substrates determine
selectivity or is it a combination of both? Is selectivity under kinetic
or thermodynamic control? How does ProcM take control over cyclization
to another level by doing this not for one, but 29 different substrates?
These questions have fueled much of the recent research on cyclization
in class II lanthipeptide biosynthesis. The current understanding
regarding regioselectivity and stereoselectivity of cyclization will
be discussed in <xref rid="sec4.3.2" ref-type="other">sections <xref rid="sec4.3.2" ref-type="other">4.3.2</xref></xref> and <xref rid="sec4.3.3" ref-type="other">4.3.3</xref>, respectively.</p><sec id="sec4.3.1"><label>4.3.1</label><title>Structure and Phylogeny of LanM Cyclization
Domains</title><p>As described in <xref rid="sec4.2" ref-type="other">section <xref rid="sec4.2" ref-type="other">4.2</xref></xref>, the dehydratase domain in LanM proteins
differs entirely from that of class I LanB dehydratases, but the cyclase
domain is analogous to class I LanCs. The cyclase domain in CylM shares
with NisC the &#x003b1;,&#x003b1;-barrel fold that encapsulates a Zn<sup>2+</sup> ion ligated by one His and two Cys residues; in the case
of CylM these residues are Cys875, Cys911, and His912 (<xref rid="fig32" ref-type="fig">Figure <xref rid="fig32" ref-type="fig">32</xref></xref>).<sup><xref ref-type="bibr" rid="ref388">388</xref></sup> For NisC, the peptide substrate is expected to bind at an SH2-like
substructure that resembles eukaryotic peptide-binding motifs (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>), but this
feature is absent in CylM. Instead two putative substrate-binding
grooves, one in the dehydratase domain and one in the cyclase domain
near the Zn<sup>2+</sup> ion, were observed. Interestingly, an antiparallel
&#x003b2;-sheet is present in the cyclase domain (Ile666-Leu690; purple
in <xref rid="fig32" ref-type="fig">Figure <xref rid="fig32" ref-type="fig">32</xref></xref>) near
the interface with the dehydratase domain that provides a potential
binding surface that has similarities to the leader peptide binding
region observed in NisB (<xref rid="sec2.5" ref-type="other">section <xref rid="sec2.5" ref-type="other">2.5</xref></xref>). However, incubation of CylL<sub>S</sub> with CylM(1&#x02013;625)
lacking this &#x003b2;-sheet did not significantly alter dehydration
activity,<sup><xref ref-type="bibr" rid="ref388">388</xref></sup> suggesting that this putative
binding site is not critical for dehydration, but it might yet be
important for cyclization. Although it has not been confirmed that
the precursor peptides CylL<sub>L</sub> and CylL<sub>S</sub> have
a binding site on the cyclase domain, substrate affinity for the cyclase
domain is supported by several other studies on LanMs. In particular,
cyclase activity of isolated cyclization domains in the absence of
a dehydration domain has been observed for ProcM<sup><xref ref-type="bibr" rid="ref369">369</xref></sup> and BovM,<sup><xref ref-type="bibr" rid="ref390">390</xref></sup> implying that these
domains have substrate affinity. Although nonenzymatic cyclization
in these experiments cannot be ruled out (see <xref rid="sec4.3.2" ref-type="other">section <xref rid="sec4.3.2" ref-type="other">4.3.2</xref></xref>), the correct regioselectivity
of ring formation observed with the isolated ProcM cyclase domain
suggests that the cyclization is enzymatic.<sup><xref ref-type="bibr" rid="ref369">369</xref></sup> A role of the leader peptide in cyclization is also suggested by
investigations on the haloduracin &#x003b2; synthetase HalM2.<sup><xref ref-type="bibr" rid="ref238">238</xref></sup> In this study, the enzyme was shown to require
the leader peptide to catalyze the reverse of cyclization, a retro-conjugate
addition that opened up each of the four rings of haloduracin &#x003b2;
attached to its leader peptide (i.e., mHalA2, <xref rid="fig33" ref-type="fig">Figure <xref rid="fig33" ref-type="fig">33</xref></xref>). Binding interactions of LanA substrates
in both dehydration and cyclization domains were also implicated by
early yeast two-hybrid studies that suggested binding interactions
of the LctA substrate throughout the LctM protein.<sup><xref ref-type="bibr" rid="ref376">376</xref></sup> However, affinity of class II lanthipeptide precursors
for their LanM cyclase domains does not appear to be universal. NukA,
the precursor to the lanthipeptide nukacin ISK-1 (<xref rid="fig21" ref-type="fig">Figure <xref rid="fig21" ref-type="fig">21</xref></xref>), has much lower affinity
for the NukM cyclase domain (NukM<sub>C</sub>) than for its dehydratase
domain and no binding was detected between the leader peptide of NukA
and NukM<sub>C</sub>.<sup><xref ref-type="bibr" rid="ref389">389</xref></sup></p><fig id="fig32" position="float"><label>Figure 32</label><caption><p>Structure of the CylM
cyclization domain shown in the same orientation
as NisC in <xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>A. The antiparallel &#x003b2;-sheet that may constitute a substrate-binding
platform is shown in purple.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0032" id="gr32" position="float"/></fig><p>Although LanM and LanC proteins share certain structural
features
in the cyclization domain (<xref rid="fig12" ref-type="fig">Figures <xref rid="fig12" ref-type="fig">12</xref></xref>A and <xref rid="fig32" ref-type="fig">32</xref>), a phylogenetic analysis
of these enzyme classes showed that LanM cyclase domains and LanC
enzymes fall into two different clades with deep roots, suggesting
that the cyclase domain in LanMs was not obtained by horizontal gene
transfer from LanC, unless it happened very early.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The LanM sequence similarity network (<xref rid="fig24" ref-type="fig">Figure <xref rid="fig24" ref-type="fig">24</xref></xref>) shows one major cluster
and many small clusters. Much of the clustering is based on phyla.
For example, in the main cluster proteins from Firmicutes and Actinobacteria
primarily group among themselves. More interesting is the observation
that the phylogeny is reflective of the Zn<sup>2+</sup>-coordinating
ligands. Many LanMs that contain three Cys ligands for zinc instead
of two Cys ligands and one His ligand cluster together.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The prediction of a Cys-Cys-Cys ligand environment
is based on the presence of a &#x0201c;CCG&#x0201d; instead of a &#x0201c;CHG&#x0201d;
motif<sup><xref ref-type="bibr" rid="ref370">370</xref></sup> (e.g., Cys911, His912, Gly913
for CylM), hence this subcluster is referred to as the &#x0201c;CCG&#x0201d;
group (<xref rid="fig24" ref-type="fig">Figure <xref rid="fig24" ref-type="fig">24</xref></xref>).
The significance of this difference in zinc ligands as it affects
reactivity is discussed in <xref rid="sec4.3.2" ref-type="other">section <xref rid="sec4.3.2" ref-type="other">4.3.2</xref></xref>. Although the importance of the &#x0201c;CCG&#x0201d;
motif was first investigated for ProcM and is found in many LanMs
from Cyanobacteria, members of various phyla contain this &#x0201c;CCG&#x0201d;
motif and cluster within this group, including Actinobacteria, Firmicutes,
Proteobacteria, and Euryarchaeota. Euryarchaeota, albeit a minor source
of LanMs, cluster almost entirely within the &#x0201c;CCG&#x0201d; group.</p><p>The chemical mechanism of cyclization catalyzed by LanMs is thought
to mirror that of LanCs (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>). Cyclization is predicted to involve activation of
a cysteine thiol by coordination to the Zn<sup>2+</sup> ion. The zinc
dependence of lanthipeptide cyclases was first illustrated for NisC
and SpaC<sup><xref ref-type="bibr" rid="ref217">217</xref></sup> and then for LanMs in 2007
for the case of LctM,<sup><xref ref-type="bibr" rid="ref395">395</xref></sup> the synthetase
involved in lacticin 481 production (<xref rid="fig27" ref-type="fig">Figure <xref rid="fig27" ref-type="fig">27</xref></xref>). Two of the predicted zinc ligands of
LctM, Cys781 and Cys836, were demonstrated to be important for metal
binding as the zinc content was reduced in LctM-C781A and C836A mutants
and even further with a double mutant. Notably, mutation of either
Cys781 or Cys836 also resulted in reduced efficiency of cyclization
in vitro. The efficiency of dehydration was not affected suggesting
that these residues are only important for cyclization.</p><p>Additional
molecular complexities of the cyclization event have
recently come to light; in particular, cyclization to form (Me)Lan
rings was shown to be reversible. This reversibility was demonstrated
for the class II enzyme HalM2 with its fully modified substrate mHalA2
(<xref rid="fig33" ref-type="fig">Figure <xref rid="fig33" ref-type="fig">33</xref></xref>), and for
the class I cyclase NisC with its fully modified substrate peptide
mNisA (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>).<sup><xref ref-type="bibr" rid="ref238">238</xref></sup> mHalA2 was generated by in vitro
modification in D<sub>2</sub>O so that the intermediate enolate would
pick up deuterium instead of a proton to afford &#x003b1;-deuterated
(Me)Lan (<xref rid="fig34" ref-type="fig">Figure <xref rid="fig34" ref-type="fig">34</xref></xref>). Reexposure of &#x003b1;-D-labeled mHalA2 to HalM2 in H<sub>2</sub>O resulted in deuterium/protium exchange for all rings and incubation
of mHalA2 and mNisA in the presence of the requisite synthetase and
the thiol-selective electrophile <italic>N-</italic>ethylmaleimide
(NEM) resulted in alkylation of all cysteines in each peptide (<xref rid="fig34" ref-type="fig">Figure <xref rid="fig34" ref-type="fig">34</xref></xref>). Because these
studies show that the cyclization is reversible, the possibility of
thermodynamic control cannot be ruled out. A more definitive test
would be to expose synthetic products or intermediates with incorrect
rings to these enzymes to monitor possible correction of the incorrect
rings, but the difficulty with such a study is identifying which incorrect
ring system to prepare. As noted in <xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>, more than 6700 different ring topologies
are possible for mNisA, and 840 for mHalA2 (<xref rid="fig33" ref-type="fig">Figure <xref rid="fig33" ref-type="fig">33</xref></xref>).</p><fig id="fig33" position="float"><label>Figure 33</label><caption><p>Biosynthesis of haloduracin &#x003b2;. BH1491
is an uncharacterized
protease that has been suggested to remove residues &#x02212;1 through
&#x02212;6 after cleavage by HalT<sub>p</sub> at the GS motif.<sup><xref ref-type="bibr" rid="ref91">91</xref></sup> Although for clarity the process is drawn as
dehydration and then cyclization, the cyclization process commences
before dehydration is completed.<sup><xref ref-type="bibr" rid="ref364">364</xref>,<xref ref-type="bibr" rid="ref365">365</xref></sup> See <xref rid="sec4.4" ref-type="other">section <xref rid="sec4.4" ref-type="other">4.4</xref></xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0033" id="gr33" position="float"/></fig><fig id="fig34" position="float"><label>Figure 34</label><caption><p>Cyclization catalyzed by both HalM2 and NisC is reversible,
as
shown with &#x003b1;-D-labeled mHalA2 and mNisA. D/H exchange in &#x003b1;-D-labeled
mHalA2 occurs in the presence of HalM2 but could occur either by a
deprotonation/reprotonation mechanism or by a reversible cyclization
mechanism. The reversibility of cyclization was confirmed for &#x003b1;-D-labeled
mHalA2 and mNisA by trapping of the ring-opened species by conjugate
addition to NEM.<sup><xref ref-type="bibr" rid="ref238">238</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0034" id="gr34" position="float"/></fig><p>The active sites of LanC cyclases and LanM cyclase domains
contain
a conserved His residue (e.g., His212 for NisC; His725 for LctM and
His791 for HalM2) that has been proposed to function either as a base
that deprotonates the thiol to facilitate attack on the dehydro amino
acid or as an acid that protonates the enolate to complete cyclization.
It is unlikely that the His performs both functions given that conjugate
attack and protonation occur on opposite faces of the alkene based
on the stereochemistry of both DL- and LL-MeLan that demonstrates
a net anti addition. The ability to study the retro-conjugate addition
provided indirect insights into the role of the active site His in
HalM2 (His791). Specifically, exposure of modified deuterium-labeled
HalA2 to HalM2-H791A did not result in any deuterium exchange or ring
opening, implicating His791 in the deprotonation step of the retro-conjugate
addition, and hence protonation of the enolate during cyclization.
If His791 were responsible for thiol protonation/deprotonation then
deuterium exchange might have been observed. These findings are in
agreement with examples of related Zn-dependent enzymes that activate
thiols but do not contain an active site base for thiol deprotonation,<sup><xref ref-type="bibr" rid="ref225">225</xref></sup> and studies showing that the p<italic>K</italic><sub>a</sub> of a thiol can be dramatically lowered on binding to
Zn (e.g., 3 orders of magnitude).<sup><xref ref-type="bibr" rid="ref219">219</xref>,<xref ref-type="bibr" rid="ref224">224</xref></sup></p></sec><sec id="sec4.3.2"><label>4.3.2</label><title>Regio- and Chemoselectivity of Cyclization
of Class II Lanthipeptides</title><p>As described above, cyclization
of lanthipeptides typically proceeds selectively to afford a single
ring topology for each precursor peptide despite the myriad of isomeric
possibilities. Studies aimed at distinguishing the roles of the enzyme
and the substrate in this selectivity have relied on controlling the
enzyme state (inactive vs active) so that enzymatic and nonenzymatic
activity could be compared. Formation of the same products from enzymatic
and nonenzymatic cyclizations would support a model in which the substrate
controls selectivity. Two methods of controlling the enzyme state
have been introduced: (1) separating the activity of the two domains
of the LanM, which is a recent development that allows analysis of
the dehydration and cyclization events separately,<sup><xref ref-type="bibr" rid="ref369">369</xref>,<xref ref-type="bibr" rid="ref375">375</xref>,<xref ref-type="bibr" rid="ref388">388</xref>&#x02212;<xref ref-type="bibr" rid="ref390">390</xref>,<xref ref-type="bibr" rid="ref396">396</xref></sup> and (2) mutagenesis of the cyclase
domain to generate a cyclization-deficient mutant.<sup><xref ref-type="bibr" rid="ref395">395</xref></sup></p><p>Early results suggesting that the enzyme plays a
role in the chemoselectivity of cyclization came out of mutational
analysis of the LctM cyclase domain. Lacticin 481 was not produced
by mutant enzymes in which the Cys ligands to the zinc were replaced
by Ala,<sup><xref ref-type="bibr" rid="ref395">395</xref></sup> but some cyclization nevertheless
did occur, suggesting that the cyclization could be nonenzymatic.
Exposure of LctA(&#x02212;24&#x02013;20, S11A/Q20A), which contains
Cys14, Thr9, and Ser18 to LctM gave the correct A ring topology (<xref rid="fig35" ref-type="fig">Figure <xref rid="fig35" ref-type="fig">35</xref></xref>), but exposure
to LctM-C781A resulted in preference for a different ring topology
resulting from Cys14 attack on Dha18 instead of Dhb9.<sup><xref ref-type="bibr" rid="ref397">397</xref></sup> Thus, the substrate inherently prefers to form
Lan rings (i.e., cysteine thiols react faster with Dha than with Dhb
residues) and the enzyme is necessary to favor MeLan formation. A
similar result was obtained using truncated LctM containing only the
dehydratase domain (LctM&#x00394;<sub>cyc</sub>). Treating LctA with
the leader and core peptides in trans with LctM&#x00394;<sub>cyc</sub> resulted in a non-native Dha11-Cys14 cross-link.<sup><xref ref-type="bibr" rid="ref375">375</xref></sup> An analogous nonenzymatic cyclization is predicted for
the closely related nukacin synthetase truncant NukM&#x00394;<sub>cyc</sub> where a single ring formed,<sup><xref ref-type="bibr" rid="ref389">389</xref></sup> and similar
observations have been made for class I lanthipeptides (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>). These results
suggest that nonenzymatically Dha reacts faster than Dhb to form an
incorrect ring and the enzyme is required to overcome this intrinsic
reactivity and facilitate proper ring formation.</p><fig id="fig35" position="float"><label>Figure 35</label><caption><p>Modification of LctA(&#x02212;24&#x02013;20,
S11A/Q20A) by LctM and
by a cyclization-deficient mutant showed that LctM enforces the chemoselectivity
of cyclization. The major products are shown but the native ring topology
was observed as a minor product using the cyclization-deficient mutant.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0035" id="gr35" position="float"/></fig><p>The studies on LctM suggest that
the enzyme is required for cyclization.
However, LctM like most LanM enzymes, modifies only one substrate,
LctA. As discussed above, ProcM has 30 predicted substrates. It is
more difficult to imagine how one enzyme could selectively catalyze
ring formation, which rekindled the notion that some of the cyclizations
might be nonenzymatic. Intriguingly, ProcM is distinct from LanCs,
LctM, and other characterized LanMs in that all three zinc-binding
ligands are Cys.<sup><xref ref-type="bibr" rid="ref370">370</xref></sup> Based on model studies
with low molecular weight metal complexes,<sup><xref ref-type="bibr" rid="ref226">226</xref>&#x02212;<xref ref-type="bibr" rid="ref237">237</xref></sup> the replacement of a His ligand with a Cys should increase thiolate
reactivity compared to other LanC/LanM proteins. In turn, this increased
reactivity might assist ProcM in processing so many diverse substrates.</p><p>The possible involvement of nonenzymatic cyclization during ProcM
catalysis was recently studied in detail for two ProcA substrates
with different ring topologies, ProcA2.8 and ProcA3.3.<sup><xref ref-type="bibr" rid="ref246">246</xref></sup> The prochlorosin products of both peptides
contain two rings but one forms nonoverlapping rings (ProcA2.8) and
the other overlapping rings (ProcA3.3) (<xref rid="fig26" ref-type="fig">Figure <xref rid="fig26" ref-type="fig">26</xref></xref>). A new strategy for controlling enzyme
activity was developed by generating semisynthetic ProcA2.8 and 3.3
substrate analogs in which one Cys was free to react and the other
Cys was blocked with an ortho-nitrophenyl protecting group that can
be removed by photolysis. This strategy allowed investigation of nonenzymatic
cyclization after preorganization of the peptide by enzymatic installation
of another ring. Thus, two different monoprotected variants of both
ProcA2.8 and ProcA3.3 were first subjected to enzymatic cyclization
to form one ring. Then ProcM was removed, the protected thiol was
uncaged, and nonenzymatic cyclization was monitored at pH 8.0 or pH
8.5 (<xref rid="fig36" ref-type="fig">Figure <xref rid="fig36" ref-type="fig">36</xref></xref>). In
all four peptides investigated, nonenzymatic cyclization was much
slower than enzymatic cyclization, suggesting that ring formation
in prochlorosins 2.8 and 3.3 is enzymatic. One advantage of this approach
is that the individual cyclization events can be monitored one at
a time, which is not possible in the previously discussed approaches
that rely on mutagenesis and separation of the dehydration and cyclization
domains.</p><fig id="fig36" position="float"><label>Figure 36</label><caption><p>Nonenzymatic and enzymatic cyclization of ProcA substrates containing
a single ring installed by ProcM-catalyzed modification of a linear
substrate with one Cys protected. In all cases, nonenzymatic cyclization
was much slower (A and B). When B ring formation was blocked by Cys
protection of ProcA3.3, an incorrect ring topology was favored as
characterized for the enzymatic cyclization (B). LP = leader peptide.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0036" id="gr36" position="float"/></fig><p>Interestingly, the order of ProcM
dehydration and cyclization are
distinct. While both processes are ordered, dehydration occurs with
C-to-N directionality (see <xref rid="sec4.4" ref-type="other">section <xref rid="sec4.4" ref-type="other">4.4</xref></xref>) but cyclization does not appear to be directional.
Cyclization is ordered but the order depends on the substrate and
it appears the smaller rings form faster.<sup><xref ref-type="bibr" rid="ref246">246</xref></sup> Notably, in the ProcA3.3 substrate described above where B ring
formation was blocked, cyclization in the presence of ProcM afforded
primarily an incorrect, smaller ring, ultimately resulting in a derivative
with two nonoverlapping small rings (<xref rid="fig36" ref-type="fig">Figure <xref rid="fig36" ref-type="fig">36</xref></xref>B). The importance of the unique ligand
set of ProcM was shown by the formation of the same incorrect ring
topology upon exposure of the ProcA3.3 precursor peptide to ProcM-C971H,
in which the Cys-Cys-Cys ligand set was mutated to the more common
Cys-Cys-His coordination environment. The cyclization reactions catalyzed
by the mutant were also significantly slower than with wild-type ProcM,<sup><xref ref-type="bibr" rid="ref369">369</xref></sup> suggesting that ProcM uses the competitive
advantage of a zinc site with increased reactivity offered by a third
Cys ligand to control the regioselectivity of cyclization.</p><p>At
present, all studies on both class I and class II lanthipeptides
suggest that the enzyme catalyzes all cyclizations and is responsible
for facilitating the correct ring formation. However, several investigations
have demonstrated that both the enzyme and the substrate are critical
to the observed cyclization selectivity, and, for some systems, the
ring topology may be encoded in the substrate sequence itself. Phylogenetic
analysis of LanMs shows that enzymes that produce lanthipeptides with
similar structure do not necessarily cluster together,<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> suggesting that the ring topology may be defined
by the substrate sequence, not by the LanM. In support of this hypothesis,
several class II lanthipeptides have been prepared correctly using
the synthetic machinery of completely different lanthipeptides. For
example, ProcM modified the core peptide of LctA fused to the ProcA3.2
leader peptide to afford the correct ring topology of lacticin 481.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> This finding is remarkable since the LctA core
peptide and the resulting ring topology are very different from any
of the 30 ProcA substrates of ProcM. Furthermore, as discussed in <xref rid="sec4.4" ref-type="other">section <xref rid="sec4.4" ref-type="other">4.4</xref></xref>, the LctM-catalyzed
post-translational modifications that lead to lacticin 481 are a highly
coordinated set of reactions. Interestingly, the enzyme and the peptide
substrate do not even need to be from the same lanthipeptide class
to facilitate cyclization of a dehydrated peptide to a bioactive product.
The nisin maturation enzymes were used to modify two putative class
II lanthipeptide sequences from one gene cluster for which the natural
products had never before been accessed.<sup><xref ref-type="bibr" rid="ref185">185</xref></sup> The core peptides of the putative class II LanAs were fused to the
NisA leader and the hybrid peptides were expressed with the NisBC
enzymes, which resulted in antibacterial peptides after leader peptide
removal. It would be interesting to determine the structures of both
the natural products and the products formed by NisBC to find out
if they are the same. In addition to these studies that suggest the
lanthipeptide substrates have an inherent preference for the observed
regioselectivity of cyclization, investigations discussed in <xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref> provide
support for a role of the substrate in controlling the stereochemical
outcome of cyclization. Thus, lanthipeptide cyclization may have commonalities
with protein folding. The substrate peptide may already have a propensity
to form a certain ring topology and stereochemistry because of its
conformational energy landscape. Lanthipeptide cyclases could serve
like folding chaperones to steer the peptide into the desired conformation
or to let it adopt its preferred conformation and to then lock this
conformation by catalyzing covalent cross-link formation.</p><p>The
chemo- and regioselectivity of cyclization could be governed
via either thermodynamic or kinetic control based on the experiments
described above evidencing the reversibility of cyclization (<xref rid="sec4.3.1" ref-type="other">section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>). In the
thermodynamic case, intermediates would ultimately funnel predominantly
to the product with the lowest free energy and this would not be determined
by the enzyme. Under kinetic control, the transition state energies
for formation of the correct rings would be lower than those for formation
of incorrect rings. Kinetic control could be exerted entirely by the
enzyme by only allowing certain transition states to be attainable
through the active site geometry. Alternatively, kinetic control could
be entirely governed by the conformational energy landscape of the
peptide when bound to the protein, where the enzyme would only increase
the reactivity of the Cys nucleophile and dehydro amino acid (Dhx)
electrophile, but which Cys reacts with which Dhx would be determined
by the substrate sequence. The latter situation is likely the case
for ProcM. Finally, and probably the most likely scenario for most
lanthipeptide biosynthetic enzymes (see <xref rid="sec4.4" ref-type="other">section <xref rid="sec4.4" ref-type="other">4.4</xref></xref>), it could be a combination of both, where
the enzyme alters the conformational energy landscape of the substrate
through hydrophobic or electrostatic interactions with the peptide,
thereby achieving lower transition state energies leading to defined
ring topologies.</p><p>Thermodynamic control was first suggested as
an explanation for
how ProcM could form so many ring topologies selectively.<sup><xref ref-type="bibr" rid="ref246">246</xref>,<xref ref-type="bibr" rid="ref369">369</xref></sup> As in the experiments that determined the reversibility of cyclization
for NisC (<xref rid="sec2.3" ref-type="other">section <xref rid="sec2.3" ref-type="other">2.3</xref></xref>) and HalM2 (<xref rid="sec4.3.1" ref-type="other">section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>), fully modified ProcA2.8 and 3.3 substrates were produced
by ProcM in D<sub>2</sub>O, resulting in deuterium incorporation in
every ring. These mProcA peptides were then exposed to ProcM in H<sub>2</sub>O. In contrast to the observations with NisC and HalM2, D/H
exchange generally did not occur or was inefficient, and free Cys
could not be trapped with an electrophile such as NEM.<sup><xref ref-type="bibr" rid="ref246">246</xref></sup> These observations suggest that the first step
of a retro-conjugate addition reaction, deprotonation at the &#x003b1;-carbon
of Lan/MeLan, may still be possible, but that ring opening did not
occur. One likely explanation for the different observations is that
NisC and HalM2 have coevolved with their respective substrates to
make a single product whereas ProcM makes 30 different products. Thus,
NisC and HalM2 will have a certain amount of shape and charge complementarity
with their products, and therefore have the necessary affinity for
the final product and intermediates to catalyze retro-conjugate addition
reactions. On the other hand, ProcM cannot be complementary in shape
and/or electrostatics with its 30 products and their intermediates.
Hence, the fully modified core peptides likely do not have much if
any affinity for the cyclization active site. Another piece of evidence
against thermodynamic control for ProcM was obtained by exposure of
incorrectly cyclized ProcA3.3 or an incorrectly cyclized intermediate
to the enzyme, which did not result in conversion to the correct ring
topology.<sup><xref ref-type="bibr" rid="ref369">369</xref></sup> As noted above, the reversibility
observed for HalM2 and NisC does not necessarily mean that their reactions
are under thermodynamic control because it has not been demonstrated
whether HalM2 and NisC could convert incorrectly cyclized products
to the natural products.</p></sec><sec id="sec4.3.3"><label>4.3.3</label><title>Stereoselectivity in
Class II Lanthipeptide
Cyclization</title><p>As discussed in the previous section, the ring
topology in class II lanthipeptide biosynthesis is at least in part
determined by the substrate sequence but the enzyme is required to
enforce selectivity. Interestingly, a similar explanation has been
offered for stereoselectivity in which the substrate sequence is largely
responsible for the stereochemical outcome. Until very recently it
was thought that all rings in lanthipeptides had DL stereochemistry,
which results from attack of cysteine onto the <italic>Si-</italic>face of the dehydro amino acid and subsequent enolate protonation
to result in a net anti addition (note, only for Dhb are the two faces
at the &#x003b2;-carbon stereogenic and hence only for Dhb is the <italic>Si</italic>-face defined). Alternatively, LL stereochemistry would
arise from an <italic>anti</italic> addition via attack of Cys onto
the <italic>Re</italic>-face of the alkene. In 2013, unusual results
were reported for the two-component class II lanthipeptide cytolysin
consisting of CylL<sub>L</sub>&#x02033; and CylL<sub>S</sub>&#x02033;
(<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref>).<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> Cytolysin was demonstrated to contain both DL-
and LL-(Me)Lan structures by peptide hydrolysis and subsequent GC-MS
analysis. CylL<sub>S</sub>&#x02033; contains an LL-MeLan A-ring and
a DL-Lan B-ring, and CylL<sub>L</sub>&#x02033; contains an LL-MeLan
A-ring, an LL-Lan B-ring, and a DL-Lan C-ring (<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref>). For each of the LL rings, the precursor
sequence is Dhx-Dhx-Xxx-Xxx-Cys (Xxx = any amino acid except Cys)
providing the first hint that the substrate might be responsible for
the stereoselectivity. Although LL stereochemistry had not been seen
until the report on cytolysin in 2013, a careful analysis of other
lanthipeptides revealed the presence of the Dhx-Dhx-Xxx-Xxx-Cys sequence
as likely intermediates for the biosynthesis of several other compounds,
and indeed they all contain LL-(Me)Lan.<sup><xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref361">361</xref>,<xref ref-type="bibr" rid="ref394">394</xref></sup> Three other lanthipeptides,
cerecidins A1 and A7, isolated from a <italic>Bacillus cereus</italic> gene cluster,<sup><xref ref-type="bibr" rid="ref133">133</xref></sup> and lichenicidin &#x003b2;
isolated from various <italic>Bacillus licheniformis</italic> strains
contain a putative Dhx-Dhx-Xxx-Xxx-Cys motif (<xref rid="fig22" ref-type="fig">Figure <xref rid="fig22" ref-type="fig">22</xref></xref>) and are therefore predicted to have LL stereochemistry.
The dehydrated precursor peptide to prochlorosin 1.6 (<xref rid="fig25" ref-type="fig">Figure <xref rid="fig25" ref-type="fig">25</xref></xref>) also potentially contains
this motif but the sites of dehydration, and its ring topology and
stereochemistry, have not yet been determined. At present LL stereochemistry
has only been reported for class II lanthipeptides.</p><p>Given that
LL stereochemistry is only observed upon cyclization of the Dhx-Dhx-Xxx-Xxx-Cys
motif, the substrate is clearly important for determining stereoselectivity.
Furthermore, the enzymes that contain the motif in their substrates
generate both DL and LL stereochemistry in their products (e.g., see <xref rid="fig29" ref-type="fig">Figures <xref rid="fig29" ref-type="fig">29</xref></xref> and <xref rid="fig33" ref-type="fig">33</xref> for cytolysin and haloduracin). The reasons for
the observed selectivity have been the focus of both experimental
and computational investigations. First, the role of the enzyme was
explored by replacing the leader peptide of CylL<sub>S</sub> with
a different class II leader peptide and exposing this hybrid substrate
to the enzyme associated with the leader peptide. This approach was
used with leader peptides of HalA2, ProcA3.2, and LtnA2 and their
respective cognate modification enzymes HalM2, ProcM, and LtnM2, respectively.
ProcM and LtnM2 do not natively form rings with LL stereochemistry
in their physiological substrates. Nevertheless, the major product
with all three hybrid peptides that differed in their leader peptides
but contained the CylL<sub>S</sub> core peptide contained an A ring
with LL stereochemistry.<sup><xref ref-type="bibr" rid="ref393">393</xref></sup> In a follow
up experiment, dehydrated CylL<sub>S</sub> was generated and cyclized
nonenzymatically,<sup><xref ref-type="bibr" rid="ref396">396</xref></sup> again affording the
LL-Lan A-ring as the major product. Remarkably, the nonenzymatic cyclization
occurred rapidly at pH 7.5,<sup><xref ref-type="bibr" rid="ref396">396</xref></sup> whereas
other nonenzymatic cyclizations for lanthionine formation require
pH 8 or higher and are very slow.<sup><xref ref-type="bibr" rid="ref246">246</xref></sup> Thus,
the Dhx-Dhx-Xxx-Xxx-Cys sequence appears to not only preferentially
form LL stereochemistry but to also greatly facilitate the cyclization
reaction.</p><p>To better understand the substrate requirements for
LL stereoselectivity,
both CylM-catalyzed and nonenzymatic cyclizations were attempted on
substrates where the underlined Dhx in the Dhx-<underline>Dhx-</underline>Xxx-Xxx-Cys motif was mutated to Ala.<sup><xref ref-type="bibr" rid="ref396">396</xref></sup> For CylL<sub>S</sub>-T2A, which after dehydration resulted in a
Dhb-Ala-Pro-Ala-Cys sequence, nonenzymatic cyclization was extremely
sluggish but the CylM-catalyzed reaction still favored LL stereochemistry
although with reduced diastereoselectivity. To facilitate nonenzymatic
cyclization, the Dhb of the mutant was replaced with Dha (A-ring sequence:
Dha-Ala-Pro-Ala-Cys);<sup><xref ref-type="bibr" rid="ref396">396</xref></sup> nonenzymatic cyclization
of this substrate took place but with the canonical DL stereoselectivity.
These results suggest that CylM is enforcing the LL stereoselectivity
even in the absence of the Dhx-Dhx-Xxx-Xxx-Cys sequence and against
the inherent preference of the substrate. Similar findings were also
reported for the biosynthesis of geobacillin II.<sup><xref ref-type="bibr" rid="ref394">394</xref></sup> On the other hand, exposure of HalA2-T2A (A-ring sequence:
Dhb-Ala-Trp-Pro-Cys) to HalM2 resulted in preferential DL-ring formation.<sup><xref ref-type="bibr" rid="ref393">393</xref></sup> Thus, whether or not the enzyme overrides the
inherent selectivity of a mutant substrate is system-dependent.</p><p>The molecular origins of the stereoselectivity and reactivity induced
by the Dhx-Dhx-Xxx-Xxx-Cys motif have been illuminated through computational
analysis.<sup><xref ref-type="bibr" rid="ref393">393</xref></sup> The A rings for CylL<sub>S</sub> and HalA2 derive from Dhb-Dhb-Pro-Ala-Cys and Dhb-Dhb-Trp-Pro-Cys,
respectively (<xref rid="fig29" ref-type="fig">Figure <xref rid="fig29" ref-type="fig">29</xref></xref> and <xref rid="fig33" ref-type="fig">33</xref>). For both, computational analysis
showed that <italic>Re</italic>-face attack to give the LL stereochemistry
is favored. For the CylL<sub>S</sub> A ring <italic>Re</italic>-face
attack is favored over <italic>Si</italic>-face attack by 3.2 kcal
mol<sup>&#x02013;1</sup>, whereas for the HalA2 A-ring the transition
state difference is 1.9 kcal mol<sup>&#x02013;1</sup>. Interestingly,
although both favor <italic>Re</italic>-face attack, the conformations
of the lowest energy transition states differ greatly. For CylL<sub>S,</sub> the negative charge buildup on the reactive Dhb carbonyl
is stabilized by a hydrogen bonding network from Ala and Cys backbone
amide hydrogens. On the contrary, the HalA2 transition state is much
less ordered. For HalA2, the T2A mutation shown experimentally to
result in DL selectivity for the A ring even in the presence of its
synthetase (which installs LL stereochemistry for the native sequence),
was also modeled computationally. This mutation results in a minor
conformational change, but it is significant enough that <italic>Si-</italic>face attack is now favored, consistent with the substrate determining
the stereochemical outcome in this case.</p><p>Additional efforts
have been undertaken to understand how and why
LL stereochemistry is incorporated in select lanthipeptides. Notably,
many of the LL-rings are located at the N-terminus of the core peptide
such as for geobacillin II,<sup><xref ref-type="bibr" rid="ref394">394</xref></sup> haloduracin
&#x003b2;,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> CylL<sub>S</sub>&#x02033;,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> CrnA2&#x02032;,<sup><xref ref-type="bibr" rid="ref361">361</xref></sup> and the flavecins.<sup><xref ref-type="bibr" rid="ref137">137</xref></sup> The effect of ring
size on LL stereoselectivity was also explored. Precursors were designed
for CylL<sub>L</sub> that increased or decreased the ring size (i.e.,
Dhx-Dhx-Xxx-Xxx-Xxx-Cys or Dhx-Dhx-Xxx-Cys), and for both the stereoselectivity
switched to DL.<sup><xref ref-type="bibr" rid="ref396">396</xref></sup> All of these results
suggest that the Dhx-Dhx-Xxx-Xxx-Cys motif is important for the LL-stereochemical
preference and that perhaps the substrates evolved to form LL-rings
at very precise positions.</p><p>At this point, it is mostly unknown
how important the LL stereochemistry
is for the bioactivities of these peptides but it seems likely that
there is a reason why they evolved this stereochemistry, just as in
other natural products where the stereochemistry is generally critical
and altering it has drastic effects on the bioactivity. Before the
realization that these LL-rings existed, stereochemistry had not been
extensively explored in lanthipeptide biosynthesis. In a recent effort
to understand the role of stereochemistry for lanthipeptides, LL stereochemistry
was incorporated synthetically into lacticin 481, which naturally
only contains DL-rings. Three mutants were prepared each with one
of the rings changed to LL stereochemistry.<sup><xref ref-type="bibr" rid="ref398">398</xref></sup> Interestingly, all three diastereomers had retention times by HPLC
distinct from that of wild-type lacticin 481 prepared in the same
manner, suggesting that the LL diastereomers adopt quite different
conformations. Growth inhibition assays showed that all three diastereomers
did not display any antimicrobial activity. In these examples, native
DL stereochemistry was changed to LL stereochemistry. Conversely,
at present little is known whether the LL stereochemistry is important
for the activity of the molecules where it is found naturally. The
only information currently available is that changing the LL-stereochemistry
in the small subunit of cytolysin (CylL<sub>S</sub>&#x02033;) to DL
using synthetic chemistry did not affect the hemolytic activity of
cytolysin but did decrease its antimicrobial activity 10-fold.<sup><xref ref-type="bibr" rid="ref399">399</xref></sup></p><p>Although these studies predict that stereochemistry
in lanthipeptides
is generally important, an unusual example of a lack of stereochemical
control was reported in the biosynthesis of the two-component lanthipeptide
bicereucin. Bicereucin is the first example of a two-component lanthipeptide
where one of the components, bicereucin &#x003b1;, does not contain
(Me)Lan as there are no cysteines in the precursor peptide (<xref rid="fig37" ref-type="fig">Figure <xref rid="fig37" ref-type="fig">37</xref></xref>).<sup><xref ref-type="bibr" rid="ref400">400</xref></sup> The second component, bicereucin &#x003b2;, contains
a single C-terminal Lan. Oddly, unlike what has been observed for
other lanthipeptides, cyclization of this ring by BsjM is not stereoselective
in vitro, but the cross-link in bicereucin &#x003b2; is important to
the bioactivity. It is possible that the stereochemistry is not important
in this case but the independent bioactivity of the two diastereomers
has not been evaluated. The lack of selectivity may be explained by
the fact that the bicereucin lanthipeptide synthetase BsjM lacks two
of the Cys-Cys-His/Cys zinc ligands and active site His catalytic
acid conserved in other LanCs and LanM cyclase domains. In other words,
its cyclization active site appears disrupted. Recent genome mining
has shown that several LanMs lack some or all of these conserved active
site residues, and many of their substrates lack Cys suggesting coevolution
of the LanA and LanM cyclization domain.<sup><xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref368">368</xref></sup> These LanMs lacking conserved active site residues do not appear
to cluster in the SSN (<xref rid="fig24" ref-type="fig">Figure <xref rid="fig24" ref-type="fig">24</xref></xref>). For example, both BsjM and NpnM, a LanM that also
lacks the active site His acid and processes cysteine-free LanAs (see <xref rid="sec4.6.1" ref-type="other">section <xref rid="sec4.6.1" ref-type="other">4.6.1</xref></xref>), cluster
separately from each other but with LanMs featuring fully conserved
cyclization active sites. It is important to note that the class III
LanKC enzymes also lack these active site residues and yet catalyze
cyclization (see <xref rid="sec5" ref-type="other">section <xref rid="sec5" ref-type="other">5</xref></xref>). Interestingly, a bioinformatics genome mining study identified
clusters that are very similar to that of bicereucin.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> These clusters also contain two substrate peptides with
one lacking Cys, and a dehydrogenase that likely reduces Dhx to the
corresponding D-amino acid (see <xref rid="sec4.6.1" ref-type="other">section <xref rid="sec4.6.1" ref-type="other">4.6.1</xref></xref>). But instead of only a LanM they contain
both a LanM and a LanKC.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> It remains to
be determined whether these are class III two-component lanthipeptides.</p><fig id="fig37" position="float"><label>Figure 37</label><caption><p>Class
II two-component natural product bicereucin comprises a lanthipeptide
and a linear peptide. The Lan ring was produced as a mixture of stereoisomers
in the in vitro reconstitution of bicereucin biosynthesis.<sup><xref ref-type="bibr" rid="ref400">400</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0037" id="gr37" position="float"/></fig></sec></sec><sec id="sec4.4"><label>4.4</label><title>Communication between Dehydration and Cyclization
Events</title><p>Class II lanthipeptide synthetases catalyze a remarkable
number of reactions on a substrate that changes shape with each consecutive
transformation. As noted, these enzymes typically carry out their
iterative reactions with defined order.<sup><xref ref-type="bibr" rid="ref238">238</xref>,<xref ref-type="bibr" rid="ref246">246</xref>,<xref ref-type="bibr" rid="ref364">364</xref>,<xref ref-type="bibr" rid="ref375">375</xref></sup> Some operate with clear directionality (N-to-C terminus or vice
versa) whereas others follow a process that is not directional but
is still ordered; for some enzymes like ProcM, the directionality/order
is dependent on what substrate the enzyme acts on.<sup><xref ref-type="bibr" rid="ref246">246</xref></sup> Although many questions still remain, in recent years the
mechanisms by which the enzymes control the order in which they catalyze
these multiple chemical processes have slowly been coming into focus.
One very useful tool developed in recent years is the use of synthetic
isotopically labeled substrates in which a single Ser or Thr residue
is labeled at the &#x003b1;-carbon with deuterium.<sup><xref ref-type="bibr" rid="ref401">401</xref></sup> This label allows determination of the timing of dehydration
of the labeled residue since it involves loss of 19 Da whereas the
dehydration of all other Ser/Thr in the peptide involve loss of 18
Da (<xref rid="fig38" ref-type="fig">Figure <xref rid="fig38" ref-type="fig">38</xref></xref>).<sup><xref ref-type="bibr" rid="ref401">401</xref></sup> By using a series of synthetic peptides in
which the labeled Ser/Thr is at different positions, the order of
dehydration can be established even in cases where cyclization prevents
use of tandem MS approaches to follow the timing of each dehydration.
This technique has been used to study both class II and class III
dehydration, including the assignment of C-to-N directionality for
ProcM dehydration.<sup><xref ref-type="bibr" rid="ref246">246</xref>,<xref ref-type="bibr" rid="ref247">247</xref>,<xref ref-type="bibr" rid="ref375">375</xref>,<xref ref-type="bibr" rid="ref401">401</xref></sup> Another important development
in advancing our understanding has been the establishment of quantitative
methods to measure the kinetics of individual dehydration and cyclization
reactions by mass spectrometry and the use of computer programs to
evaluate various kinetic models. This approach was first used for
HalM2, the enzyme that makes the &#x003b2;-peptide of the two-component
lantibiotic haloduracin (<xref rid="fig33" ref-type="fig">Figure <xref rid="fig33" ref-type="fig">33</xref></xref>) and ProcM, the single enzyme that makes 30 different
prochlorosins (<xref rid="sec4.1" ref-type="other">section <xref rid="sec4.1" ref-type="other">4.1</xref></xref>).<sup><xref ref-type="bibr" rid="ref365">365</xref></sup> With HalM2, a series of interesting
observations was made. The enzyme had already been shown to function
with N-to-C terminal directionality.<sup><xref ref-type="bibr" rid="ref238">238</xref>,<xref ref-type="bibr" rid="ref364">364</xref></sup> The kinetic
analysis demonstrated that the enzyme alternates between dehydrating
and cyclizing its HalA2 substrate peptide.<sup><xref ref-type="bibr" rid="ref365">365</xref></sup> After a certain number of dehydrations has occurred, the first cyclization
takes place. Subsequent dehydrations do not happen until after the
first cyclization. One possible explanation for the latter observation
is that each formation of a ring brings the more C-terminally located
Ser/Thr closer to the leader peptide, and possibly to the dehydration
active site. Another important observation was that after a relatively
slow initiation process, subsequent cyclization reactions are progressively
faster as if each ring formation either improves the productive interaction
with the enzyme or facilitates the subsequent ring formation by adopting
a conformation that favors cyclization. In the former explanation,
the enzyme and final product could potentially be complementary in
shape and/or electrostatics.<sup><xref ref-type="bibr" rid="ref365">365</xref></sup> The complete
reversibility of the cyclization process with HalM2 (<xref rid="sec4.3.1" ref-type="other">section <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref>) is an
indirect demonstration that the intermediates and final cyclized product
can bind reasonably well to the cyclization active site.<sup><xref ref-type="bibr" rid="ref238">238</xref></sup></p><fig id="fig38" position="float"><label>Figure 38</label><caption><p>Residue-specific incorporation of deuterium
at the &#x003b1;-carbon
of Ser/Thr enables monitoring of the directionality of dehydration.
Dehydration of unlabeled Ser/Thr involves a loss of 18 Da (A), whereas
dehydration of &#x003b1;-deuterated Ser/Thr involves a loss of 19 Da
(B).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0038" id="gr38" position="float"/></fig><p>A final interesting observation
is that in general the rate constants
of the various dehydration and cyclization steps performed by HalM2
are quite similar, such that many intermediates are observed (no step
is strongly rate limiting) and several parallel pathways are operational.
Parallel pathways have also been observed for NisB dehydration<sup><xref ref-type="bibr" rid="ref245">245</xref></sup> and catalysis by class III synthetases.<sup><xref ref-type="bibr" rid="ref247">247</xref>,<xref ref-type="bibr" rid="ref401">401</xref></sup> This observation is not too surprising since a very tightly ordered
process in which only a specific mandatory order of events leads to
the final product seems difficult to achieve with a single iterative
enzyme. In addition, such a scenario would likely render these enzymes
much less substrate tolerant than they are. On the other hand, given
that dehydration and cyclization steps are very different chemical
reactions and that the substrate is constantly changing, the similarity
in rate constants is surprising. It suggests that perhaps the overall
rate of each reaction may not be governed by chemistry but perhaps
by a physical step. One possibility would be that the overall rates
of reaction are determined by conformational sampling, in which after
leader peptide binding, the core peptide samples the dehydration and
cyclization active sites.<sup><xref ref-type="bibr" rid="ref365">365</xref></sup> For some intermediates,
a dehydration might be the energetically best next reaction, and for
other intermediates a cyclization step may be favored, either because
of preferred binding of the intermediate in one of the active sites
(<italic>K</italic><sub>m</sub>-like effect), or because of faster
chemistry (<italic>k</italic><sub>cat</sub>-like effect). Although
the details remain to be elucidated and likely will require molecular
dynamic simulations, collectively, these findings paint a picture
of coevolution of the substrate sequence with the LanM enzyme to arrive
at the present-day well-orchestrated post-translational modification
process that results in a powerful antibiotic with nanomolar minimal
inhibitory concentrations against select bacteria.</p><p>Kinetic analysis
of ProcM provided a completely different picture.<sup><xref ref-type="bibr" rid="ref365">365</xref></sup> As noted in <xref rid="sec4.1" ref-type="other">section <xref rid="sec4.1" ref-type="other">4.1</xref></xref>, this enzyme has 30 different substrates
with highly diverse core peptides that are converted into a library
of cyclic peptides with very different ring topologies (<xref rid="fig25" ref-type="fig">Figures <xref rid="fig25" ref-type="fig">25</xref></xref> and <xref rid="fig26" ref-type="fig">26</xref>). Thus, it is difficult to imagine an active site
that could be shape and/or charge complementary with all 30 of its
products. Indeed, the kinetics of processing of the ProcA substrates
investigated thus far suggests that this is not the case. Unlike HalM2,
which alternates dehydration and cyclization steps, ProcM first dehydrates
all Ser and Thr in the core peptides of those ProcA substrates that
have been analyzed.<sup><xref ref-type="bibr" rid="ref246">246</xref>,<xref ref-type="bibr" rid="ref365">365</xref>,<xref ref-type="bibr" rid="ref369">369</xref></sup> The kinetics of dehydration are not very different from those observed
for dehydration of HalA2 by HalM2, but the cyclizations by ProcM are
significantly slower, and contrary to HalM2, ProcM slows down with
each successive cyclization reaction. This observation suggests that,
once a ring has been installed, the intermediate becomes a less good
substrate for subsequent cyclizations, presumably because, unlike
HalM2, ProcM has not evolved for optimal catalysis to form just one
product. Thus, increased substrate tolerance comes at the expense
of slower kinetics. Why the cyanobacteria that utilize this group
of ProcM-like enzymes put a larger premium on a diversity of products
over optimizing one product is at present not clear. The limited resources
available to many of these organisms living in the nutrient-poor open
ocean and the associated small genomes<sup><xref ref-type="bibr" rid="ref402">402</xref>,<xref ref-type="bibr" rid="ref403">403</xref></sup> may offer
an explanation. The advantages provided by a system that very efficiently
uses minimal genetic information for the production of a library of
compounds would likely be of more value under these circumstances.
A different question is what the functions are of these lanthipeptides
and how the diversity is maintained, preventing the system to evolve
to make one particular compound. The former question is still entirely
unclear, whereas one possible answer to the latter question is that
these molecules act together, in which case there would be evolutionary
pressure on keeping ProcM substrate tolerant.<sup><xref ref-type="bibr" rid="ref404">404</xref></sup> While on the surface the sequences of the 30 core peptides
and their associated products appear very diverse or even random,
mutagenesis experiments suggest that the ring topologies made from
these core peptides have some inherently favorable attributes that
make them particularly tolerant to further sequence diversification
within the constraints of an existing ring topology.<sup><xref ref-type="bibr" rid="ref405">405</xref></sup> Similarly, these experiments show that ProcM cannot turn
just any sequence into a well-defined cyclic product. It appears that
the sequences, diverse as they are, evolved because they are prone
to make a single product of defined topology. These results fit well
with the proposal described in <xref rid="sec4.3" ref-type="other">section <xref rid="sec4.3" ref-type="other">4.3</xref></xref> that the outcome of the cyclization process
is determined by the substrate peptide.</p><p>A third system for which
the kinetics of dehydration and cyclization
has been investigated is the lacticin 481 synthetase LctM.<sup><xref ref-type="bibr" rid="ref375">375</xref></sup> This study focused on the role of the leader
peptide in the overall kinetics and order of the various steps that
convert LctA to mLctA. The results of this study illustrate that the
leader peptide is critical for ensuring the efficient and correct
order of events and will be discussed in the next section.</p></sec><sec id="sec4.5"><label>4.5</label><title>Leader Peptide Dependence</title><p>Similar
to class I lanthipeptides, the leader peptide in the biosynthesis
of class II lanthipeptides is required for the efficient installation
of the (Me)Lan cross-links<sup><xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup> but is often not required for tailoring modifications as discussed
in <xref rid="sec4.6" ref-type="other">section <xref rid="sec4.6" ref-type="other">4.6</xref></xref>. Studies
showing that non-natural substrates can be processed by LanMs if they
are fused to the cognate leader peptide confirmed an important role
for the leader peptide in facilitating PTMs. For example, as described
in <xref rid="sec4.3.2" ref-type="other">section <xref rid="sec4.3.2" ref-type="other">4.3.2</xref></xref>, the class II synthetase ProcM can modify the LctA core fused to
the ProcA3.2 leader peptide to afford lacticin 481.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Extensive studies on the lacticin 481 synthetase LctM both
in vitro and in vivo have shown that this enzyme can modify a variety
of peptides fused to the LctA leader.<sup><xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref269">269</xref>,<xref ref-type="bibr" rid="ref304">304</xref>,<xref ref-type="bibr" rid="ref397">397</xref>,<xref ref-type="bibr" rid="ref406">406</xref>&#x02212;<xref ref-type="bibr" rid="ref408">408</xref></sup> Some examples include a truncated LctA core
lacking 7<sup><xref ref-type="bibr" rid="ref397">397</xref></sup> or 14<sup><xref ref-type="bibr" rid="ref304">304</xref></sup> C-terminal residues, core peptides of the class II lanthipeptides
nukacin ISK-1 and mutacin II,<sup><xref ref-type="bibr" rid="ref406">406</xref>,<xref ref-type="bibr" rid="ref407">407</xref></sup> and completely unrelated
peptides.<sup><xref ref-type="bibr" rid="ref81">81</xref></sup> One limitation to LctM processing
also evidenced for class I and III lanthionine synthases is that the
dehydratable residues must be a certain distance from the leader peptide,
presumably in order for those residues to access the active site.<sup><xref ref-type="bibr" rid="ref269">269</xref></sup> Although LanM proteins clearly recognize the
leader peptide, it is important to note that LanM recognition of the
core peptide is also generally predicted. For example, although an
LctA leader-NukA core fusion can be processed by LctM to afford nukacin
ISK-1 both in vivo<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> and in vitro,<sup><xref ref-type="bibr" rid="ref406">406</xref></sup> in vivo experiments have shown that NukM, the
LanM involved in nukacin ISK-1 production (<xref rid="fig21" ref-type="fig">Figure <xref rid="fig21" ref-type="fig">21</xref></xref>), does not convert a NukA leader-LctA core
fusion to lacticin 481,<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> suggesting that
NukM recognizes the core peptide of NukA.</p><p>Unlike in class I
biosynthesis where a cocrystal structure of NisA and NisB witnessed
interactions between the leader peptide and enzyme as described in <xref rid="sec2.5" ref-type="other">section <xref rid="sec2.5" ref-type="other">2.5</xref></xref>, the precise
molecular interactions involved in leader peptide binding have not
been elucidated for any class II lanthipeptide synthetases. No crystal
structures of substrate-bound LanM synthetases have been solved but
the first crystal structure of a LanM (CylM) was recently reported.<sup><xref ref-type="bibr" rid="ref388">388</xref></sup> Interestingly, the leader peptide binding domain
found in class I dehydratases is not conserved in CylM, suggesting
an alternative mechanism of leader peptide binding to the enzyme.
This hypothesis of an alternative mechanism is further substantiated
by differences in the leader peptide sequences. Class II lanthipeptide
leaders lack the conserved FNLD motif found in class I substrates
and are instead characterized by the incorporation of many negatively
charged residues as well as a conserved C-terminal ELXXBX motif (e.g.,
positions &#x02212;3 to &#x02212;8 for LctA and NukA), where B is a
hydrophobic residue (Val, Leu, or Ile). Truncants of LctA,<sup><xref ref-type="bibr" rid="ref304">304</xref></sup> NukA,<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> and ProcA2.8
precursor peptides<sup><xref ref-type="bibr" rid="ref368">368</xref></sup> containing this motif
but shortened at the N-terminus (by 8, 9, and 40 residues, respectively)
were fully processed by their respective LanM enzymes, illustrating
that unlike class I, the leader peptide recognition site is located
in the C-terminal half of the leader peptide.</p><p>The importance
of the conserved leader peptide residues for the
efficiency of PTMs has been explored in vitro for lacticin 481<sup><xref ref-type="bibr" rid="ref406">406</xref></sup> and bovicin HJ50,<sup><xref ref-type="bibr" rid="ref379">379</xref></sup> and in vivo for nukacin ISK-1<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> and
mutacin II.<sup><xref ref-type="bibr" rid="ref345">345</xref></sup> Most point mutations did
not dramatically reduce production of the natural products and the
effects of mutations were similar among the three systems. Notably,
incorporation of a charged residue at positions &#x02212;4 or &#x02212;7
reduced processing efficiency.<sup><xref ref-type="bibr" rid="ref345">345</xref>,<xref ref-type="bibr" rid="ref379">379</xref>,<xref ref-type="bibr" rid="ref406">406</xref>,<xref ref-type="bibr" rid="ref407">407</xref></sup> Incorporation of proline within
the ELXXBX motif as evaluated for lacticin 481 and nukacin ISK-1 resulted
in reduced LctM efficiency<sup><xref ref-type="bibr" rid="ref406">406</xref></sup> or little
or no lanthipeptide production,<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> respectively.
The detrimental effect of Pro incorporation suggests that the leader
peptide may adopt a helical conformation. Indeed, structural prediction
tools have predicted helical regions encompassing the ELXXBX motif
for the LctA<sup><xref ref-type="bibr" rid="ref406">406</xref></sup> and NukA leader peptides<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> and the NukA peptide adopts a partial helical
structure in trifluoroethanol as determined by CD.<sup><xref ref-type="bibr" rid="ref407">407</xref></sup> However, more definitive evidence is required as similar
predictions were made for the NisA leader peptide,<sup><xref ref-type="bibr" rid="ref257">257</xref></sup> but the cocrystal structure with NisB subsequently revealed
that the leader peptide engaged the enzyme in an extended conformation.
Interestingly, the in vitro mutagenesis studies also hint that the
binding interactions with LanM proteins during dehydration and cyclization
may differ.<sup><xref ref-type="bibr" rid="ref406">406</xref></sup> Although the point mutations
E&#x02013;8P, D&#x02013;6P, and I&#x02013;4P in LctA all result in much
reduced dehydration efficiency, the effects of these mutations on
cyclization are distinct. Cyclization of fully dehydrated mLctA goes
to completion for the D&#x02013;6P and I&#x02013;4P mutants but not
for the E&#x02013;8P mutant. The requirement of the leader peptide
for retro-conjugate addition<sup><xref ref-type="bibr" rid="ref238">238</xref></sup> and the
independent activities of separately expressed dehydration and cyclization
domains<sup><xref ref-type="bibr" rid="ref369">369</xref>,<xref ref-type="bibr" rid="ref396">396</xref></sup> also suggest potentially separate interactions
of these domains with the leader peptide.</p><p>In addition to how
the leader peptide is recognized by the enzyme,
the mechanism of how this interaction facilitates catalysis has been
under considerable investigation. One possible mechanism proposed
early on is that binding of the leader peptide to the enzyme induces
a conformational change to expose the enzyme active site and promote
post-translational modification. However, in 2007 it was reported
that LctM does not absolutely require the leader peptide for dehydration
although the efficiency was dramatically reduced<sup><xref ref-type="bibr" rid="ref409">409</xref></sup> and the same observations have since been reported for
HalM2.<sup><xref ref-type="bibr" rid="ref385">385</xref></sup> In trans supplementation of the
LctA core peptide with the LctA leader peptide partially restored
LctM processing,<sup><xref ref-type="bibr" rid="ref409">409</xref></sup> indicating that the
leader and core do not need to be fused as has also been described
for class I lanthipeptides in <xref rid="sec2.5" ref-type="other">section <xref rid="sec2.5" ref-type="other">2.5</xref></xref> and some class III enzymes in <xref rid="sec5.3" ref-type="other">section <xref rid="sec5.3" ref-type="other">5.3</xref></xref>. As the leader
peptide is not required for catalysis, a mechanism in which the leader
peptide induces a conformational change seems unlikely. Instead, this
data suggests a conformational selection model<sup><xref ref-type="bibr" rid="ref150">150</xref></sup> in which the enzyme exists in the absence of the precursor
peptide in an equilibrium of inactive and active forms, favoring the
inactive form (<xref rid="fig39" ref-type="fig">Figure <xref rid="fig39" ref-type="fig">39</xref></xref>). Binding of the leader peptide stabilizes the active form, shifting
the equilibrium to increase the concentration of active enzyme. The
core peptide brought in proximity by the leader is then able to bind
at the enzyme active site. Support for this synergistic leader and
core peptide binding model has been reported for some enzymes as discussed
below. Further support for the conformational selection model came
from the development of a constitutively active fusion (ConFusion)
enzyme where LctM is connected through its N-terminus by a short linker
to the LctA leader peptide (LctCE-GS<sub>15</sub>).<sup><xref ref-type="bibr" rid="ref408">408</xref></sup> The model predicts that since LctCE-GS<sub>15</sub> is
constantly in proximity to the leader peptide, the enzyme population
should favor the active form resulting in efficient processing. In
the event, treatment of the LctA core with LctCE-GS<sub>15</sub> gave
4-fold dehydrated LctA as the major species after 3 h whereas the
otherwise identical in trans experiment with a 1:1 ratio of LctA leader
and LctM mimicking the ConFusion stoichiometry gave 3-fold dehydrated
LctA as the major species.<sup><xref ref-type="bibr" rid="ref408">408</xref></sup></p><fig id="fig39" position="float"><label>Figure 39</label><caption><p>Conformational
selection model whereby leader peptide binding shifts
an equilibrium to an active enzyme state that promotes core peptide
binding to the enzyme and facilitates catalysis. The enzyme, leader
peptide, and core peptide are shown in blue, pink, and green, respectively.
The leader peptide in class II LanAs is predicted to form a helix
but this conformation has not been directly proven in the context
of interactions with the modifying enzymes and is not generalizable
to class I lanthipeptide biosynthesis, as the precursor NisA does
not adopt a helical conformation in binding to its modifying enzyme
NisB (<xref rid="sec2.5" ref-type="other">section <xref rid="sec2.5" ref-type="other">2.5</xref></xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0039" id="gr39" position="float"/></fig><p>Although affinity of the leader
peptide for the enzyme is clearly
important for catalysis, the core peptide can also independently bind
to the enzyme as is evident from the in trans<sup><xref ref-type="bibr" rid="ref409">409</xref></sup> and ConFusion<sup><xref ref-type="bibr" rid="ref408">408</xref></sup> experiments.
To investigate the relative roles of the leader and core peptide in
LanM binding, modification of haloduracin precursor peptide chimeras
(HalA1-A2, containing the A1 leader and A2 core, and HalA2-A1) was
explored.<sup><xref ref-type="bibr" rid="ref385">385</xref></sup> Exposure of HalA1-A2 to HalM1
and HalA2-A1 to HalM2 resulted in 5 and 2 dehydrations as the major
species, respectively, compared to 7 for wild-type HalA2 and 3 for
wild-type HalA1. Modification of these chimeras containing matched
leader peptides and synthetases supports the importance of leader
peptide binding. Alternatively, exposure of HalA1-A2 to HalM2 and
HalA2-A1 to HalM1 resulted in 6 and 1 dehydrations, respectively.
These results suggested that the mismatched leader peptides and enzymes
might have affinity for each other or, alternatively, that the core
peptides might also have affinity for their cognate enzymes. Fluorescence
polarization assays have confirmed both hypotheses.<sup><xref ref-type="bibr" rid="ref385">385</xref></sup> The HalA1 leader proved a competent partner for HalM2,
binding with a <italic>K</italic><sub>d</sub> of 4.1 &#x003bc;M, comparable
to that of the HalA2 leader and HalM2 (<italic>K</italic><sub>d</sub> = 3.7 &#x003bc;M). The HalA2 core peptide has low affinity for HalM2
with a <italic>K</italic><sub>d</sub> &#x0003e; 500 &#x003bc;M but interestingly,
a HalM2 ConFusion enzyme has much higher affinity for the core peptide
(<italic>K</italic><sub>d</sub> = 85 &#x003bc;M). This result demonstrates
for the first time synergistic binding of the leader and core peptides
and supports a mechanistic model in which binding of the leader peptide
not only favors an active enzyme conformation but facilitates core
peptide binding to enable catalysis. Notably, the dissociation constants
reflect a much lower binding affinity for HalM2 and its substrate
than has been demonstrated for two other characterized class II LanMs.
As determined by surface plasmon resonance studies, the nukacin ISK-1
synthetase NukM and its substrate NukA bind with a <italic>K</italic><sub>d</sub> of 60 nM<sup><xref ref-type="bibr" rid="ref353">353</xref>,<xref ref-type="bibr" rid="ref389">389</xref></sup> and the bovicin HJ50
synthetase BovM and its substrate BovA bind with a <italic>K</italic><sub>d</sub> of 16.4 nM.<sup><xref ref-type="bibr" rid="ref379">379</xref></sup> The reasons
for these large differences in affinity are not yet clear.</p><p>The
chimeric haloduracin precursor peptides described above were
never fully processed suggesting that the native leader peptide may
be required for proper positioning of the core peptide.<sup><xref ref-type="bibr" rid="ref385">385</xref></sup> Indeed, kinetic investigation into the processing
of LctA by LctM has revealed a role for the LctA leader peptide in
spatial positioning.<sup><xref ref-type="bibr" rid="ref375">375</xref></sup> To evaluate the
kinetic importance of the covalent linkage of leader and core peptides,
several systems were explored using LctA mutants incorporating deuterium
at dehydratable Ser and Thr residues to monitor the directionality
of dehydration (<xref rid="fig38" ref-type="fig">Figure <xref rid="fig38" ref-type="fig">38</xref></xref>). Wild-type LctM was shown to process deuterated LctA-T24S
with N-to-C directionality; Thr9 and Ser11 were dehydrated first followed
by Ser18 and Ser24. Notably, exposure of deuterated LctA to LctM lacking
the cyclase domain (LctM&#x00394;cyc) resulted in much slower processing
but the same directionality. Surprisingly, very different results
were obtained when the same kinetics experiments were conducted with
in trans provided LctA leader and core peptides for LctM and LctM&#x00394;cyc,
or for the LctM ConFusion enzyme with the core peptide. The rate of
both dehydration and cyclization was reduced in all three cases. Intriguingly,
the directionality of dehydration was also changed; Ser11/Thr24 was
dehydrated first, then Thr9/Ser11/Thr24, then Thr9/Thr24, and finally
Ser18. The regioselectivity of cyclization was also disrupted as analyzed
by tandem MS. Specifically, a non-native Dha11-Cys14 ring formed,
likely due to a nonenzymatic cyclization event that becomes competitive
in these less efficient systems. Thus, the leader peptide not only
increases the efficiency of catalysis through allostery, but is also
important for the correct order of dehydration presumably by proper
positioning of the core peptide. In turn the correct order prevents
incorrect nonenzymatic cyclization.<sup><xref ref-type="bibr" rid="ref375">375</xref></sup></p></sec><sec id="sec4.6"><label>4.6</label><title>Tailoring Enzymes</title><p>Like the class
I lanthipeptides described in <xref rid="sec2.6" ref-type="other">section <xref rid="sec2.6" ref-type="other">2.6</xref></xref>, many class II lanthipeptides contain
PTMs in addition to the characteristic thioether cross-links and dehydro
amino acids. These additional modifications contribute to the broad
structural diversity of lanthipeptides and also often appear to increase
their bioactivities. The presumably nonenzymatic hydrolysis of N-terminal
Dha or Dhb that occurs upon leader peptide proteolysis to afford N-terminal
2-oxopropionyl and 2-oxobutyryl groups, respectively, is seen in both
class I and II lanthipeptides (e.g., Pep5 and pinensin from class
I;<sup><xref ref-type="bibr" rid="ref276">276</xref></sup> lichenicidin, lacticin 3147, and
lactocin S from class II; <xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref>, <xref rid="fig23" ref-type="fig">23</xref>, and <xref rid="fig40" ref-type="fig">40</xref>).<sup><xref ref-type="bibr" rid="ref410">410</xref></sup> In addition, disulfide formation
is observed in class II and class III, with examples in class II including
haloduracin &#x003b1; and bovicin HJ50 (<xref rid="fig21" ref-type="fig">Figure <xref rid="fig21" ref-type="fig">21</xref></xref>). As these gene clusters either lack a
dedicated thiol&#x02013;disulfide oxidoreductase<sup><xref ref-type="bibr" rid="ref124">124</xref></sup> or it is not required for bioactivity as shown for bovicin
HJ50,<sup><xref ref-type="bibr" rid="ref411">411</xref></sup> this tailoring modification will
not be discussed further. Other than these two modifications, tailoring
PTMs tend not to be shared between classes of lanthipeptides based
on the compounds characterized thus far. The general lack of PTM crossover
between classes could be explained by different evolutionary origins
or it may be that as more lanthipeptide gene clusters are sequenced
PTMs will emerge in class II that were already seen in other classes
and vice versa. It is only within the past few years that most of
the enzymes responsible for additional PTMs in class II have been
studied. Generally, these enzymes can be divided into two groups with
respect to their substrate selectivity, although for some the selectivity
is not fully characterized. One group is very permissive and can process
both linear and cyclic peptides. These enzymes have much potential
for bioengineering. The second group is highly selective and only
acts on cyclized peptides.</p><fig id="fig40" position="float"><label>Figure 40</label><caption><p>Examples of class II lanthipeptides containing <sc>d</sc>-Ala residues
and a 2-oxobutyryl (Obu) or 2-oxopropionyl (pyruvyl, Pyr) tailoring
modification at the N-terminus.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0040" id="gr40" position="float"/></fig><sec id="sec4.6.1"><label>4.6.1</label><title>Incorporation of D-Amino Acids</title><p>D-Amino
acids have been found in ribosomally synthesized natural
products of both eukaryotic and prokaryotic origin.<sup><xref ref-type="bibr" rid="ref367">367</xref>,<xref ref-type="bibr" rid="ref412">412</xref>&#x02212;<xref ref-type="bibr" rid="ref416">416</xref></sup> This unusual stereochemistry is thought to contribute to proteolytic
stability,<sup><xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref417">417</xref>&#x02212;<xref ref-type="bibr" rid="ref419">419</xref></sup> structural conformation,<sup><xref ref-type="bibr" rid="ref420">420</xref></sup> and bioactivity.<sup><xref ref-type="bibr" rid="ref413">413</xref>,<xref ref-type="bibr" rid="ref414">414</xref>,<xref ref-type="bibr" rid="ref421">421</xref></sup> As only L-amino acids are genetically
encoded, access to the D stereochemistry requires post-translational
modification and several unique mechanisms for this transformation
have been uncovered. For nonlanthipeptide natural products, D-amino
acids are incorporated by epimerization of the corresponding L-amino
acid, either by a deprotonation-protonation mechanism<sup><xref ref-type="bibr" rid="ref422">422</xref>,<xref ref-type="bibr" rid="ref423">423</xref></sup> or by a radical mechanism.<sup><xref ref-type="bibr" rid="ref424">424</xref></sup> When the
first lanthipeptide containing D-amino acids was identified in 1994,<sup><xref ref-type="bibr" rid="ref274">274</xref></sup> it was immediately clear that a different mechanism
must be operative. Certain serines encoded in the precursor gene for
lactocin S were not found in the natural product; instead, alanine
residues were found in their place. Incorporation of nongenetically
encoded Ala was confirmed by amino acid composition analysis, and
the D-stereochemistry of these Ala residues was shown by GC-MS analysis
with a chiral stationary phase (<xref rid="fig40" ref-type="fig">Figure <xref rid="fig40" ref-type="fig">40</xref></xref>). Based on the mechanism of (Me)Lan formation
in lanthipeptides, the conversion of <sc>l</sc>-serine to <sc>d</sc>-alanine was suggested to occur by initial LanM-catalyzed dehydration
of <sc>l</sc>-Ser to afford Dha.<sup><xref ref-type="bibr" rid="ref274">274</xref></sup> Instead
of lanthionine formation, diastereoselective hydrogenation of Dha
by a hypothetical enzyme (later generically named LanJ<sup><xref ref-type="bibr" rid="ref361">361</xref>,<xref ref-type="bibr" rid="ref421">421</xref>,<xref ref-type="bibr" rid="ref425">425</xref></sup>) could then give <sc>d</sc>-Ala.</p><p>A few years later the same observation was made during the partial
structural characterization of the two-component lanthipeptide lacticin
3147, composed of Ltn&#x003b1; and Ltn&#x003b2; and produced by <italic>L. lactis</italic> (<xref rid="fig40" ref-type="fig">Figure <xref rid="fig40" ref-type="fig">40</xref></xref>).<sup><xref ref-type="bibr" rid="ref426">426</xref></sup> Chiral GC-MS analysis of
the hydrolyzed peptides showed that Ltn&#x003b1; contains one <sc>d</sc>-Ala at residue 7<sup><xref ref-type="bibr" rid="ref426">426</xref></sup> and Ltn&#x003b2; contains
two <sc>d</sc>-Ala (later shown to be residues 9 and 12).<sup><xref ref-type="bibr" rid="ref410">410</xref></sup> Subsequent studies identified the biological
role of the <sc>d</sc>-Ala residues and the substrate specificity
of dehydrogenases that convert Dha to <sc>d</sc>-Ala.<sup><xref ref-type="bibr" rid="ref421">421</xref></sup></p><p>The hypothetical dehydrogenase for converting
Dha to <sc>d</sc>-Ala was first characterized in the lacticin 3147
gene cluster,<sup><xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref421">421</xref></sup> confirming that indeed <sc>d</sc>-Ala is incorporated by dehydration
of Ser followed by diastereoselective hydrogenation. Specifically,
it was shown that <sc>d</sc>-Ala was not formed in the absence of
the enzyme LtnJ.<sup><xref ref-type="bibr" rid="ref421">421</xref></sup> Ltn&#x003b1; and Ltn&#x003b2;
produced in vivo in a &#x00394;<italic>ltnJ</italic> strain contained
Dha residues in place of <sc>d</sc>-Ala residues. In addition, the
Ltn&#x003b1; mutant from the &#x00394;<italic>ltnJ</italic> strain featured
4-fold lower activity than wild-type Ltn&#x003b1; when applied in an
equimolar ratio with wild-type Ltn&#x003b2; to susceptible <italic>L.
lactis</italic>; the bioactivity of the Ltn&#x003b2; <sc>d</sc>-Ala
to Dha mutant could not be evaluated due to poor expression yields.
Together with experiments showing reduced activity for mutants where <sc>d</sc>-Ala was replaced with <sc>l</sc>-Ala,<sup><xref ref-type="bibr" rid="ref421">421</xref></sup> these studies showed that the incorporation of alanine
as the D stereoisomer is important to the bioactivity of lacticin
3147. Interestingly, site-directed mutagenesis to incorporate Thr
at <sc>d</sc>-Ala precursor sites in the LtnA1 and LtnA2 precursor
peptides resulted in products that had undergone dehydration of Thr
to afford Dhb but not hydrogenation to afford D-Abu;<sup><xref ref-type="bibr" rid="ref421">421</xref></sup> these results suggested that LtnJ can reduce Dha but not
Dhb.</p><p>LtnJ belongs to the family of zinc-dependent alcohol dehydrogenases.
Genome mining for orthologs of LtnJ uncovered three other putative
dehydrogenases;<sup><xref ref-type="bibr" rid="ref421">421</xref></sup> SacJ, which is located
in the <italic>Staphylococcus aureus</italic> C55 operon for the biosynthesis
of staphylococcin C55,<sup><xref ref-type="bibr" rid="ref427">427</xref></sup> a lanthipeptide
predicted to be very similar in structure to lacticin 3147; PenN from <italic>Pediococcus pentosaceus</italic> FBB61, which is required to access
bioactive pediocin A;<sup><xref ref-type="bibr" rid="ref428">428</xref></sup> and NpnJ (originally
named NstJ),<sup><xref ref-type="bibr" rid="ref421">421</xref></sup> which is from a cyanobacterium <italic>Nostoc punctiforme</italic> PCC73102 cluster that contains a LanM
but does not produce lanthipeptides as the precursor peptides (NpnA)
do not contain cysteines.<sup><xref ref-type="bibr" rid="ref368">368</xref></sup> LtnJ, NpnJ,
PenN, and SacJ share many conserved residues including three or four
conserved Cys residues predicted to bind zinc (NpnJ has three of the
conserved Cys, LtnJ, SacJ, and PenN have all four).<sup><xref ref-type="bibr" rid="ref429">429</xref></sup> These four enzymes have been classified as LanJ<sub>A</sub>-type dehydrogenases based on their zinc and NADPH-dependence.<sup><xref ref-type="bibr" rid="ref425">425</xref></sup> The dehydrogenase activity for PenN and SacJ
was demonstrated in vivo with the lacticin 3147 substrate, confirming
their function and suggesting that these enzymes do not require a
leader peptide as a non-native substrate was accepted.<sup><xref ref-type="bibr" rid="ref429">429</xref></sup> Specifically, supplementing the &#x00394;<italic>ltnJ</italic> strain described above with <italic>penN</italic> restored <sc>d</sc>-Ala formation in both Ltn&#x003b1; and Ltn&#x003b2;, whereas supplementation
with <italic>sacJ</italic> restored <sc>d</sc>-Ala formation in Ltn&#x003b1;
but not in Ltn&#x003b2;. No effect was observed with <italic>npnJ</italic>, likely due to poor expression (vide infra). The activity of <italic>penN</italic> is particularly intriguing; although <italic>penN</italic> has proven necessary for accessing bioactive pediocin A<sup><xref ref-type="bibr" rid="ref428">428</xref></sup> and PenN reduced Dha in LtnA1 and LtnA2, surprisingly
the gene cluster containing PenN does not contain a LanM or LanB.
To our knowledge, the structure and the encoding gene of pediocin
A remain unknown, thus whether or not pediocin A incorporates D-amino
acids has not been established.</p><p>The important residues in LtnJ
were identified by in vivo expression
studies<sup><xref ref-type="bibr" rid="ref429">429</xref></sup> using the &#x00394;<italic>ltnJ</italic> strain supplemented with <italic>ltnJ</italic> mutants where 15
residues conserved among LtnJ, SacJ, PenN, and NpnJ were individually
replaced. Leu54, Gly99, Thr166, Ala189, and Leu317 were found to be
critical for LtnJ activity but Asn63, Ser89, Gly127, Ala157, Leu185,
Thr213, and Gly308 were not, as wild-type lacticin 3147 was obtained
without significant change in bioactivity. Gly272 and Asp335 were
important for efficient reduction in LtnA2. The most surprising effect
was observed with the LtnJ-K359A mutant; lacticin 3147 of the correct
mass was still produced but the bioactivity was 1.5 fold lower than
for the &#x00394;<italic>ltnJ</italic> strain and &#x0003e;20-fold lower
than
for wild-type lacticin 3147. Remarkably, the bioactivity is reduced
because a single mutation to Lys359 results in an enzyme that is no
longer stereoselective. For a completely diastereoselective hydrogenation,
the ratio of <sc>d</sc>-Ala to <sc>l</sc>-Ala should be 1:2 for both
Ltn&#x003b1; and Ltn&#x003b2; (<xref rid="fig40" ref-type="fig">Figure <xref rid="fig40" ref-type="fig">40</xref></xref>), but mutating Lys359 resulted in ratios of 1:4.4
and 1:6.6, respectively. These studies offer intriguing insights into
how the chirality is transferred from the enzyme to the substrate.
Although the precise roles of the important LtnJ residues have not
been assigned and would be greatly facilitated by an X-ray structure,
one possible function of Lys359 is to stabilize negative charge buildup
on the carbonyl group resulting from initial hydride conjugate addition
to the Dha.</p><p>Introduction of many PTMs in lanthipeptide biosynthesis
is highly
dependent on the substrate sequence, including the stereochemical
outcome of cyclizations as discussed in <xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>. In contrast, a high degree of flexibility
has been reported for LanJ<sub>A</sub> enzymes with no apparent loss
of stereoselectivity. For example, LtnJ has been used to incorporate <sc>d</sc>-Ala into nisin, once again suggesting that LtnJ does not require
a leader peptide.<sup><xref ref-type="bibr" rid="ref430">430</xref>,<xref ref-type="bibr" rid="ref431">431</xref></sup> These studies used an in vivo
expression system in <italic>L. lactis</italic> of LtnJ, NisA, and
NisBCT, which suggests that LtnJ can act on cyclic peptides given
the coupled activity predicted for NisBC (<xref rid="sec2.4" ref-type="other">section <xref rid="sec2.4" ref-type="other">2.4</xref></xref>). Additionally, LtnJ was shown to modify
a mutant of NisA lacking all cysteines, showing that LtnJ can act
on both linear and cyclized substrates. A variety of flanking hydrophobic
residues were well accepted by LtnJ. However, flanking charged residues
including Lys and Glu as well as an adjacent Dhx were not tolerated.
Finally, with this system it was once again shown that LtnJ can reduce
Dha but not Dhb. The substrate scope of LanJ<sub>A</sub> is also substantiated
by the fact that there are no remaining Dha in Ltn&#x003b1;, Ltn&#x003b2;,
and lactocin S (<xref rid="fig40" ref-type="fig">Figure <xref rid="fig40" ref-type="fig">40</xref></xref>) and that all of the <sc>d</sc>-Ala are flanked by hydrophobic
residues. It is also intriguing that the three Dha that react to form
Lan in Ltn&#x003b1; and Ltn&#x003b2; are adjacent to polar, charged, or
Dhx residues; it seems likely that LtnM completes its function first,
but it is interesting that the Dha residues involved in ring formation
are predicted to be poor substrates for LtnJ.</p><p>The broad substrate
scope of LanJ<sub>A</sub> enzymes has also
been illustrated for the activity of NpnJ in what was the first in
vitro reconstitution of a LanJ enzyme.<sup><xref ref-type="bibr" rid="ref425">425</xref></sup> In prior in vivo studies, NpnJ was not functional,<sup><xref ref-type="bibr" rid="ref429">429</xref></sup> but use of an MBP-tag provided soluble, active NpnJ. As
for LtnJ, the leader peptide was not required for activity and only
Dha could be hydrogenated, not Dhb. A variety of flanking residues
were tolerated although C-terminal charged residues greatly reduced
efficiency, and Trp and Pro were also poorly tolerated. NpnJ was also
shown to act on non-native substrates, including dehydrated LctA in
vitro and mLtnA1 and mLtnA2 in <italic>E. coli</italic>. These experiments
provided in vitro support for the substrate scope predicted from in
vivo studies on LanJ<sub>A</sub>s and also inspired a straightforward
method for analyzing <sc>d</sc>-Ala incorporation. Traditionally,
this analysis is carried out either by GC-MS of the hydrolyzed peptide
or by LC-MS analysis of the hydrolyzed peptides modified by Marfey&#x02019;s
reagent. However, these methods are complicated when the hydrogenation
does not go to full conversion or when the peptides also contain many
gene-encoded <sc>l</sc>-Ala residues. By carrying out the reduction
of the peptides in vitro in D<sub>2</sub>O with NpnJ and NADP<sup>2</sup>H generated in situ from NADP<sup>+</sup> by phosphite dehydrogenase,
two <sup>2</sup>H atoms are incorporated into every <sc>d</sc>-Ala.
Subsequent treatment with Marfey&#x02019;s reagent results in <sc>d</sc>-Ala and <sc>l</sc>-Ala-bearing molecules with distinct LC retention
times and distinct masses, thus facilitating analysis.<sup><xref ref-type="bibr" rid="ref425">425</xref></sup></p><p>More recently, a new class of LanJs was
characterized. This enzyme
class, termed LanJ<sub>B</sub>,<sup><xref ref-type="bibr" rid="ref425">425</xref></sup> are
flavin-dependent oxidoreductases. Notably, although the LanJ involved
in lactocin S biosynthesis has not been characterized it is also predicted
to be a LanJ<sub>B</sub> based on sequence homology<sup><xref ref-type="bibr" rid="ref425">425</xref></sup> (the protein of unknown function was originally annotated
as LasN).<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> CrnJ, involved in the biosynthesis
of carnolysin, was the first of two recently explored LanJ<sub>B</sub>s.<sup><xref ref-type="bibr" rid="ref361">361</xref></sup> Carnolysin is a two-component lanthipeptide
composed of CrnA1&#x02032; and CrnA2&#x02032; and interestingly it contains
both unusual ring stereochemistry (LL-Lan and LL-MeLan, see <xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>) and D-amino
acids. Another unusual feature is that both <sc>d</sc>-Ala and <sc>d</sc>-Abu are incorporated, resulting from hydrogenation of Dha
and Dhb, respectively. CrnA1&#x02032; contains four <sc>d</sc>-Ala
and CrnA2&#x02032; contains one <sc>d</sc>-Ala and one <sc>d</sc>-Abu.
Coexpression in <italic>E. coli</italic> of the precursor peptides
CrnA1 or CrnA2 with CrnM in the presence or absence of CrnJ showed
that CrnJ is responsible for both Dha and Dhb hydrogenation.<sup><xref ref-type="bibr" rid="ref361">361</xref></sup></p><p>The second of two LanJ<sub>B</sub>s explored
was BsjJ<sub>B</sub>,<sup><xref ref-type="bibr" rid="ref400">400</xref></sup> the enzyme responsible
for hydrogenation
in the recently discovered two-component lanthipeptide bicereucin
(<xref rid="fig37" ref-type="fig">Figure <xref rid="fig37" ref-type="fig">37</xref></xref>). In addition
to the D-amino acids, another unusual feature of bicereucin is that
only one component is a lanthipeptide and its lanthionine cross-link
is formed as a mixture of stereoisomers (see <xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>). The activity of BsjJ<sub>B</sub> was reconstituted both in a heterologous coexpression system
in <italic>E. coli</italic> and in vitro using dehydrated BsjA1 as
the substrate in the presence of FMN and NADH. As observed for CrnJ,
BsjJ<sub>B</sub> reduces both Dha and Dhb. Specifically, Bsj&#x003b1;
contains four <sc>d</sc>-Ala while Bsj&#x003b2; contains one <sc>d</sc>-Abu and three <sc>d</sc>-Ala (<xref rid="fig37" ref-type="fig">Figure <xref rid="fig37" ref-type="fig">37</xref></xref>). At this point it is unclear why the LanJ<sub>B</sub> class of enzymes can hydrogenate both Dha and Dhb whereas
the LanJ<sub>A</sub> class can only reduce Dha.</p><p>Although the
sequence specificity of LanJ<sub>B</sub> enzymes has
not been as extensively explored by mutagenesis as for LanJ<sub>A</sub> enzymes, some trends can be gleaned from the structures of carnolysin
and bicereucin. LanJ<sub>A</sub> and LanJ<sub>B</sub> enzymes feature
similarities in their requirements for flanking residues, which are
commonly hydrophobic and no hydrogenation occurs adjacent to Pro.
In addition, Dhx flanked by thioether cross-links are not hydrogenated
likely due to steric hindrance or possibly the presence of a D-stereocenter
in (Me)Lan. Spatial positioning of the Dhx residues may be more important
for the LanJ<sub>B</sub> class than for the LanJ<sub>A</sub> class,
which reduces Dha at many different positions. For instance, BsjJ<sub>B</sub> does not act on Dhb33 near the C-terminus of Bsj&#x003b1;.
Second, when ring formation is blocked in Bsj&#x003b2; by mutating Cys40
(see <xref rid="fig37" ref-type="fig">Figure <xref rid="fig37" ref-type="fig">37</xref></xref> for
numbering) neither Dha35 nor Dhb39 were reduced; however, another
possible explanation is that these residues are not hydrogenated due
to flanking polar/charged residues.</p><p>Now that it has been demonstrated
that there are two independent
enzyme families that convert dehydro amino acids to the corresponding
D-amino acids, we propose that for clarity and consistency the gene/protein
designation of LanJ proteins always indicate whether they are members
of the Zn<sup>2+</sup>-dependent dehydrogenase family (i.e., LtnJ<sub>A</sub>, SacJ<sub>A</sub>, PenJ<sub>A</sub>, and NpnJ<sub>A</sub>) or the flavin dependent dehydrogenase family (LasJ<sub>B</sub>,
CrnJ<sub>B</sub>, and BsjJ<sub>B</sub>).</p></sec><sec id="sec4.6.2"><label>4.6.2</label><title>Lysinoalanine
Formation and Aspartate &#x003b2;-Hydroxylation</title><p>Cinnamycin
(formerly also named Ro 09-0198 and lanthiopeptin),<sup><xref ref-type="bibr" rid="ref432">432</xref>&#x02212;<xref ref-type="bibr" rid="ref435">435</xref></sup> cinnamycin B,<sup><xref ref-type="bibr" rid="ref436">436</xref></sup> duramycin (formerly
also named leucopeptin),<sup><xref ref-type="bibr" rid="ref437">437</xref></sup> and duramycins
B and C<sup><xref ref-type="bibr" rid="ref438">438</xref>,<xref ref-type="bibr" rid="ref439">439</xref></sup> form a small group of globular class II
lanthipeptides that share high sequence identity and a fully conserved
set of PTMs as determined by extensive NMR analysis.<sup><xref ref-type="bibr" rid="ref433">433</xref>,<xref ref-type="bibr" rid="ref440">440</xref>&#x02212;<xref ref-type="bibr" rid="ref443">443</xref></sup> Each lanthipeptide comprises 19 amino acids (<xref rid="fig41" ref-type="fig">Figure <xref rid="fig41" ref-type="fig">41</xref></xref>); duramycin and duramycin B differ from
cinnamycin by a single residue, and cinnamycin B and duramycin C differ
by five and six residues, respectively. These peptides are an unusual
example, analogous to the prochlorosin natural products, in which
Lan and (Me)Lan are formed by both C-to-N directional cyclization,
and by N-to-C directional cyclization wherein the nucleophilic Cys
is N-terminal to the reactive Dhx. These duramycin-type lanthipeptides
contain three DL-(Me)Lan, an <italic>erythro</italic>-3-hydroxy-<sc>l</sc>-aspartic acid at position 15, and a lysinoalanine (Lal) cross-link
that forms between Ser6 and Lys19 with LL-stereoselectivity.<sup><xref ref-type="bibr" rid="ref441">441</xref></sup> Although Lal formation and &#x003b2;-Asp hydroxylation
are otherwise unknown for lanthipeptides, a mammalian Asp &#x003b2;-hydroxylase
has been characterized and is an &#x003b1;-ketoglutarate/iron(II)-dependent
hydroxylase.<sup><xref ref-type="bibr" rid="ref444">444</xref></sup> Additionally, nonenzymatically
generated Lal is prevalent in aging and interestingly forms in a manner
reminiscent of lanthipeptide biosynthesis by Lys attack on Dha.<sup><xref ref-type="bibr" rid="ref445">445</xref></sup></p><fig id="fig41" position="float"><label>Figure 41</label><caption><p>(A) Cinnamycin and duramycin peptides share
identical post-translational
modifications including Lal formation and Asp hydroxylation, for which
the structures are shown in (B).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0041" id="gr41" position="float"/></fig><p>In these molecules, the well-defined pocket set up by the
four
cyclization events recognizes the target phosphatidyl ethanolamine
(PE) with high affinity and selectivity. As a result, various derivatives
of duramycin have been used to image PE in cells and inside organisms,<sup><xref ref-type="bibr" rid="ref26">26</xref>&#x02212;<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref446">446</xref>,<xref ref-type="bibr" rid="ref447">447</xref></sup> the compound has been shown
to inhibit viral entry,<sup><xref ref-type="bibr" rid="ref448">448</xref></sup> and duramycin
has been used to effect chloride secretion in lung epithelial cells<sup><xref ref-type="bibr" rid="ref11">11</xref>&#x02212;<xref ref-type="bibr" rid="ref15">15</xref></sup> and calcium release in cancer cells.<sup><xref ref-type="bibr" rid="ref449">449</xref></sup></p><p>In groundbreaking studies on cinnamycin biosynthesis, its
biosynthetic
gene cluster was cloned from <italic>Streptomyces cinnamoneus cinnamoneus</italic> DSM 40005 and heterologously expressed in <italic>Streptomyces lividans</italic>.<sup><xref ref-type="bibr" rid="ref328">328</xref></sup> Subsequent genetic experiments identified
four out of 21 predicted open reading frames (orfs) as critical to
cinnamycin production: genes encoding the precursor peptide CinA,
the lanthionine synthetase CinM, an &#x003b1;-ketoglutarate/iron(II)-dependent
hydroxylase homologue CinX, and Cinorf7, for which no homologues with
assigned function had been found. The respective roles of <italic>cinM</italic>, <italic>cinX</italic>, and <italic>cinorf7</italic> were determined by evaluating each orf individually.<sup><xref ref-type="bibr" rid="ref450">450</xref></sup> CinM and CinX functions were reconstituted
in vitro and as a coexpression system in <italic>E. coli</italic>.
As predicted by sequence homology, CinX was confirmed to be an &#x003b1;-ketoglutarate
(&#x003b1;-KG)/iron(II)-dependent hydroxylase responsible for Asp15
hydroxylation. CinX could process both linear CinA and CinM-modified
CinA and also did not require the leader peptide,<sup><xref ref-type="bibr" rid="ref450">450</xref></sup> as is common for tailoring enzymes.</p><p>CinM was shown
to dehydrate all Ser/Thr in the CinA core peptide,
including the Ser involved in Lal formation (Ser6), thus suggesting
that Lal formation results from Lys attack on Dha (<xref rid="fig41" ref-type="fig">Figure <xref rid="fig41" ref-type="fig">41</xref></xref>).<sup><xref ref-type="bibr" rid="ref450">450</xref></sup> However, CinM does not catalyze Lys attack, serving only to catalyze
Cys conjugate addition that results in the three (Me)Lan. Instead,
Cinorf7 was found to promote Lal formation when coexpressed with CinAMX
in <italic>E. coli.</italic> Unfortunately, the activity of Cinorf7,
a small protein of just 13 kDa, could not been reconstituted in vitro;
alternatively, exposure of CinM and CinX-modified CinA to pH 9.5 in
vitro resulted in nonenzymatic cyclization to afford Lal. The stereoselectivity
of this cyclization was not confirmed due to complicating epimerization
of Lal groups upon the peptide hydrolysis necessary for chiral GC-MS
analysis. However, the substrate-controlled stereoselectivity observed
in (Me)Lan formation (<xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>) suggests that nonenzymatic Lys attack to form Lal
may give the native LL-cross-link, especially given the very compact
and well-ordered structure of the final product, which may not allow
formation of the DL-Lal isomer.<sup><xref ref-type="bibr" rid="ref443">443</xref></sup></p><p>Very recently, the biosynthetic gene cluster of duramycin was also
reported.<sup><xref ref-type="bibr" rid="ref451">451</xref></sup> The overall gene organization
and the biochemical activities of the enzymes DurM and DurX were very
similar to those reported for the cinnamycin orthologs. A Cinorf7
homologue was required for lysinoalanine formation and was designated
the name DurN (with LanN instead of Lanorf7 as a general designation
for orthologous lysinoalanine synthases). The mechanistic details
of lysinoalanine formation await further investigation but the reported
findings suggest that it will be a unique mechanism despite the deceptive
similarities to (Me)Lan formation.</p></sec><sec id="sec4.6.3"><label>4.6.3</label><title>Sulfoxide
Formation</title><p>Another unusual
tailoring modification in class II lanthipeptides is the installation
of a single sulfoxide by oxidation of a MeLan thioether. This modification
has only been found in the 19-amino acid globular lanthipeptide actagardine
(also known as gardimycin)<sup><xref ref-type="bibr" rid="ref452">452</xref></sup> and Ala(0)-actagardine,
which differs from actagardine by a single additional Ala residue
at the N-terminus (<xref rid="fig42" ref-type="fig">Figure <xref rid="fig42" ref-type="fig">42</xref></xref>).<sup><xref ref-type="bibr" rid="ref453">453</xref></sup> The structure of actagardine
was determined by a combination of Edman sequencing, MS, and NMR analysis,<sup><xref ref-type="bibr" rid="ref454">454</xref>&#x02212;<xref ref-type="bibr" rid="ref456">456</xref></sup> revealing that oxidation occurs site-selectivity in the D-ring.<sup><xref ref-type="bibr" rid="ref454">454</xref></sup> The genetic origin of sulfoxide formation was
uncovered through a comparison of the gene clusters of actagardine
and another lanthipeptide michiganin A,<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> which is similar in structure to actagardine but lacks the sulfoxide.<sup><xref ref-type="bibr" rid="ref457">457</xref></sup> Annotation of the actagardine gene cluster
from <italic>Actinoplanes garbadinensis</italic> ATCC 31049 revealed
the unique presence of a gene encoding a luciferase-like flavin-dependent
monoxygenase termed <italic>garO</italic>. A &#x00394;<italic>garO</italic> mutant of <italic>A. garbadinensis</italic> ATCC 31049 produced
only deoxyactagardine and Ala(0)-deoxyactagardine. The actagardine
gene cluster also encodes GarA, the lanthipeptide precursor peptide,
and GarM, the lanthipeptide synthetase.</p><fig id="fig42" position="float"><label>Figure 42</label><caption><p>Structures of actagardine
and Ala(0)-actagardine.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0042" id="gr42" position="float"/></fig><p>Actagardine has been heterologously produced in <italic>S.
lividans</italic>(<xref ref-type="bibr" rid="ref86">86</xref>) and in <italic>E. coli</italic>.<sup><xref ref-type="bibr" rid="ref458">458</xref></sup> Similar to the gene deletion studies,
coexpressing
only GarA and GarM in <italic>E. coli</italic> gave deoxyactagardine,
whereas coexpression with GarO resulted in actagardine. The activity
of GarO was reconstituted in vitro with FMN and NADH as cofactors
and shown to not require the leader peptide.<sup><xref ref-type="bibr" rid="ref458">458</xref></sup> As with other luciferase-like flavin-dependent monooxygenases,<sup><xref ref-type="bibr" rid="ref459">459</xref>,<xref ref-type="bibr" rid="ref460">460</xref></sup> the proposed mechanism involves oxidation of FMN to a hydroperoxide
species that serves as the oxygen donor to the substrate, followed
by reduction of the oxidized FMN by NADH. The molecular explanation
for regioselective oxidation of the D-ring remains to be determined
but in vitro results suggest that the selectivity is under catalyst
control. Multiple oxidations were sometimes observed in vitro, likely
resulting from precedented nonenzymatic oxidation by a hydrogen peroxide
side product rather than direct transfer of oxygen from FMN.<sup><xref ref-type="bibr" rid="ref461">461</xref></sup> The stereochemistry of the sulfoxide in actagardine
is currently not known.</p></sec></sec><sec id="sec4.7"><label>4.7</label><title>Immunity
Against Class II Lanthipeptides</title><p>Many class II lanthipeptide
gene clusters also encode LanEFG transporters
that were discussed in <xref rid="sec2.7" ref-type="other">section <xref rid="sec2.7" ref-type="other">2.7</xref></xref> for class I lanthipeptides, and some encode LanI-like
proteins.<sup><xref ref-type="bibr" rid="ref317">317</xref>,<xref ref-type="bibr" rid="ref462">462</xref>,<xref ref-type="bibr" rid="ref463">463</xref></sup> In some cases, a different type of immunity protein cooperates with
LanEFG secretion systems such as the NukH protein involved in self-resistance
of the nukacin ISK-1 producer.<sup><xref ref-type="bibr" rid="ref464">464</xref>&#x02212;<xref ref-type="bibr" rid="ref466">466</xref></sup></p><p>A unique immunity mechanism
is found in the producer of cinnamycin, <italic>Streptomyces cinnamoneus</italic> DSM 40646.<sup><xref ref-type="bibr" rid="ref467">467</xref></sup> Cinnamycin and similar
compounds (<xref rid="sec4.6.2" ref-type="other">section <xref rid="sec4.6.2" ref-type="other">4.6.2</xref></xref>) exert their antimicrobial activity by binding to phosphatidyl
ethanolamine (PE),<sup><xref ref-type="bibr" rid="ref170">170</xref>,<xref ref-type="bibr" rid="ref468">468</xref>,<xref ref-type="bibr" rid="ref469">469</xref></sup> a target that is a major membrane lipid in streptomycetes. To protect
the producing strain, the <italic>cinorf10</italic> gene encodes a
PE monomethyltransferase.<sup><xref ref-type="bibr" rid="ref467">467</xref></sup> Transcription
of <italic>cinorf10</italic> is initiated upon production of a low
concentration of cinnamycin, leading to PE methylation in the producer
prior to high-level production of cinnamycin. Based on the structure
of cinnamycin bound to PE,<sup><xref ref-type="bibr" rid="ref468">468</xref>,<xref ref-type="bibr" rid="ref469">469</xref></sup> monomethylated PE
is unlikely to be accommodated in the binding pocket. Immunity to
cinnamycin or the closely related duramycin was conferred by expressing <italic>cinorf10</italic> in a previously sensitive <italic>Streptomyces
lividans</italic> strain, which was shown to result in accumulation
of monomethylated PE.<sup><xref ref-type="bibr" rid="ref467">467</xref></sup> Interestingly,
this immunity mechanism does not appear to be universal among the
producers of the cinnamycin-group of lanthipeptides because a homologue
of <italic>cinorf10</italic> was not found in the genome of <italic>Streptomyces cinnamoneus</italic> ATCC 12686 (previously also known
as <italic>Streptoverticillium cinnamoneum</italic> forma azacoluta),<sup><xref ref-type="bibr" rid="ref451">451</xref></sup> a producer of duramycin.<sup><xref ref-type="bibr" rid="ref470">470</xref></sup> How the organism then defends itself against the duramycin
it produces is currently not known.</p></sec></sec><sec id="sec5"><label>5</label><title>Class III
and IV Lanthipeptide Biosynthesis</title><sec id="sec5.1"><label>5.1</label><title>Discovery
of Class III and IV Pathways</title><p>The two most recently discovered
classes of lanthipeptides have a
common mechanism of dehydration that is distinct from class I and
II, but they differ in their cyclization strategies. Because their
shared dehydration reactions are much better understood than the cyclization
processes, these classes will be discussed together in this review.
Class III lanthipeptides were first established when Willey and co-workers
reported that the small morphogenetic peptide SapB was a lanthipeptide.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> SapB was known to be important for formation
of the aerial mycelium at the start of the sporulation process of <italic>Streptomyces coelicolor.</italic>(<xref ref-type="bibr" rid="ref471">471</xref>) Its
structure had been unknown, but genetic studies had identified the
locus for rapid aerial mycelium (<italic>ram</italic>) formation.<sup><xref ref-type="bibr" rid="ref472">472</xref>,<xref ref-type="bibr" rid="ref473">473</xref></sup> This gene cluster had no similarities with known lanthipeptide gene
clusters, but it did encode a 42-amino acid peptide (RamS) as well
as a protein RamC with homology to Ser/Thr protein kinases.<sup><xref ref-type="bibr" rid="ref474">474</xref></sup> A similar cluster (aerial mycelium formation, <italic>amf</italic>) was found in <italic>Streptomyces griseus</italic> and
encodes the AmfS peptide.<sup><xref ref-type="bibr" rid="ref475">475</xref>,<xref ref-type="bibr" rid="ref476">476</xref></sup> A sequence analysis
of RamC suggested that the protein, in addition to a Ser/Thr protein
kinase domain, contained a C-terminal domain with homology to the
C-terminal cyclization domain of the class II lanthipeptide synthetases
CinM and MrsM that are involved in the biosynthesis of cinnamycin
and mersacidin, respectively.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Even though
RamC lacks the catalytic residues and Zn<sup>2+</sup>-binding residues
that are conserved in the cyclase domains of LanM and in LanC proteins
(<xref rid="sec4.3.1" ref-type="other">sections <xref rid="sec4.3.1" ref-type="other">4.3.1</xref></xref> and <xref rid="sec2.3" ref-type="other">2.3</xref>, respectively), the authors showed
that the mass of SapB was consistent with the C-terminal 21 residues
of RamS after four dehydrations.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Chemical
derivatization studies followed by mass spectrometry, Edman degradation,
and amino acid analyses provided strong evidence for the structure
shown in <xref rid="fig43" ref-type="fig">Figure <xref rid="fig43" ref-type="fig">43</xref></xref>. A decade later, analysis of the available Actinobacteria genomes
showed that the <italic>ram/amf-</italic>like gene clusters are the
most common lanthipeptide gene cluster family in this phylum.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Another morphogenetic peptide, SapT, is also
involved in aerial mycelium formation in <italic>Streptomyces tendae</italic> and was also shown to be a lanthipeptide.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Whereas SapB was too hydrophobic to obtain an NMR structure because
of aggregation, SapT was amenable to NMR structure elucidation (<xref rid="fig44" ref-type="fig">Figure <xref rid="fig44" ref-type="fig">44</xref></xref>A).<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Although the gene cluster encoding SapT has not yet been
reported, a BLAST search performed for this review with its putative
precursor core peptide sequence returns a 50-amino acid peptide in <italic>Streptomyces reticuli</italic> (GenBank accession number CUW32634.1)
with a potential core peptide that differs in just two residues (<xref rid="fig44" ref-type="fig">Figure <xref rid="fig44" ref-type="fig">44</xref></xref>B). Interestingly,
immediately adjacent to the putative substrate gene is a <italic>lanB</italic> gene. The contig does not provide additional information, but another
56-amino acid peptide from <italic>Streptomyces albulus</italic> CCRC11814
(GenBank accession number EPY92828.1) differs in nine residues from
SapT in its putative core region and is predicted to contain the same
4-ring topology of SapT but also to have a fifth ring at its C-terminus
(<xref rid="fig44" ref-type="fig">Figure <xref rid="fig44" ref-type="fig">44</xref></xref>B). Similarly,
this gene is flanked by a <italic>lanB</italic> gene, but the cluster
also clearly contains genes for a LanC and a standalone LanB C_terminal
domain protein (Pfam 14028; homologous to LanB glutamate elimination
domain, <xref rid="sec2.2" ref-type="other">section <xref rid="sec2.2" ref-type="other">2.2</xref></xref>), with the function of the latter unclear. Thus, it is very likely
that these gene clusters encode class I lanthipeptides and that SapT
also belongs in this class and not class III as previously assigned
based on bioactivity.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p><fig id="fig43" position="float"><label>Figure 43</label><caption><p>Biosynthesis of SapB.
For clarity the process is drawn as first
complete dehydration and then cyclization, but the order of the PTMs
for SapB is not actually known.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0043" id="gr43" position="float"/></fig><fig id="fig44" position="float"><label>Figure 44</label><caption><p>SapT (A) is predicted to be a class I lanthipeptide based on sequence
alignment (B) with putative LanAs from <italic>S. reticuli</italic> and <italic>S. albulus</italic> that cluster with genes encoding
putative LanB enzymes. Asterisks indicate fully conserved identical
residues whereas colons indicate conserved similar residues.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0044" id="gr44" position="float"/></fig><p>A few years after the recognition
that SapB was a lanthipeptide
and that there was a third biosynthetic pathway to this family of
RiPPs, two studies in 2010 provided key new information on this pathway.
The first study reported the structure of the labyrinthopeptins and
the associated gene cluster.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Structure
elucidation of a series of congeners of these compounds had proven
unusually challenging, hence their name, and only when a crystal structure
of one of them was obtained did it become clear why: the compound
contains two entirely unprecedented and unanticipated cross-links
in which new carbon&#x02013;carbon bonds are made between the &#x003b1;-carbon
of what used to be a Ser and the &#x003b2;-carbon of what used to be
another Ser (<xref rid="fig1" ref-type="fig">Figures <xref rid="fig1" ref-type="fig">1</xref></xref> and <xref rid="fig45" ref-type="fig">45</xref>A).<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> This
new type of cross-link was termed labionin. The presumed mechanism
of its formation involves initial attack of a Cys thiol onto a Dha.
Instead of protonation of the resulting enolate to form a lanthionine,
another conjugate addition is thought to take place in which the enolate
attacks a different Dha to form a second enolate, which upon protonation
forms the labionin (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> The gene cluster that encodes
for labyrinthopeptins showed the presence of a protein that has clear
homology with RamC comprising a kinase domain and a C-terminal cyclase
domain. In vitro studies confirmed that this protein carries out both
dehydration and labionin formation.<sup><xref ref-type="bibr" rid="ref477">477</xref></sup> These
studies also observed phosphorylated intermediates that demonstrated
that the Ser/Thr kinase domain indeed carries out the presumed reaction
and resulted in the designation LanKC for this class of proteins (for
lanthipeptide kinase and cyclase). As noted above, the C-terminal
domain of RamC/LanKC shows sequence homology with LanC enzymes and
the C-termini of LanM proteins but lacks the catalytic residues and
zinc-binding ligands of the latter two protein families (<xref rid="fig46" ref-type="fig">Figure <xref rid="fig46" ref-type="fig">46</xref></xref>).<sup><xref ref-type="bibr" rid="ref477">477</xref></sup></p><fig id="fig45" position="float"><label>Figure 45</label><caption><p>(A) X-ray crystal structure of labyrinthopeptin
A2 (CCDC number
721326). The color coding uses standard atom-type colors (red, oxygen;
blue, nitrogen; yellow, sulfur). For Lab, the carbons originating
from Cys are shown in light blue and those originating from Ser are
in magenta. (B) Biosynthesis of labyrinthopeptin A2. For clarity the
process is drawn as complete dehydration and then cyclization, but
the order of the PTMs can be more complicated; e.g. see text and <xref rid="fig49" ref-type="fig">Figure <xref rid="fig49" ref-type="fig">49</xref></xref> for curvopeptin.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0045" id="gr45" position="float"/></fig><fig id="fig46" position="float"><label>Figure 46</label><caption><p>Class III and class IV lanthipeptide
synthetases are distinguished
by their cyclase domains. LanL (class IV) contains zinc-binding ligands
conserved in class I and II but these ligands are absent in the class
III LanKC.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0046" id="gr46" position="float"/></fig><p>A second independent
study reported in 2010 provided additional
insights into RamC/LanKC catalysis.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> Genome
mining of Actinobacteria uncovered examples of proteins with a C-terminal
LanC-like domain (this time including the zinc ligands and catalytic
residues), a central Ser/Thr kinase domain, and an N-terminal domain
that resembled type III effector proteins of Gram-negative pathogens
including Salmonella, Pseudomonas, and Shigella (<xref rid="fig46" ref-type="fig">Figure <xref rid="fig46" ref-type="fig">46</xref></xref>). These effector proteins
recognize a phosphorylated Thr on the activation loop of mitogen activated
protein kinases (MAPK) and eliminate the phosphate to inactivate these
proteins that are a key part of the immune response.<sup><xref ref-type="bibr" rid="ref478">478</xref>&#x02212;<xref ref-type="bibr" rid="ref481">481</xref></sup> In vitro studies with the putative lanthipeptide biosynthetic protein
discovered in <italic>Streptomyces venezuelae</italic> showed that
it indeed catalyzed three independent reactions (phosphorylation,
phosphate elimination, and cyclization) on its substrate peptide (VenA)
as discussed in the next section.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> Homologous
phospholyase domains that presumably also catalyze phosphate elimination
were also detected at the N-termini of the RamC/LanKC family (<xref rid="fig46" ref-type="fig">Figure <xref rid="fig46" ref-type="fig">46</xref></xref>).<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> However, the clear differences in the cyclization
domains required separation of the enzymes into two classes of lanthipeptide
synthetases (class III and IV); the enzymes with the zinc-binding
ligands were given the generic name LanL (<xref rid="fig46" ref-type="fig">Figure <xref rid="fig46" ref-type="fig">46</xref></xref>).<sup><xref ref-type="bibr" rid="ref128">128</xref></sup></p><p>Interestingly,
the biological activities of class III lanthipeptides
are very diverse and many do not display antimicrobial activities
against the organisms tested. As a result, following the lead of the
prototypical labyrinthopeptin, class III peptides have been designated
with the suffix&#x02013;peptin,<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref132">132</xref></sup> rather than the often
used suffix -cin or -cidin, which implies a toxic activity. Based
on the currently available genomes, class III lanthipeptide gene clusters
significantly outnumber class IV clusters.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> To date, all class IV lanthipeptides are close analogs of the original
prototype from <italic>S. venezuelae</italic> and they have been generically
called venezuelins (<xref rid="fig47" ref-type="fig">Figure <xref rid="fig47" ref-type="fig">47</xref></xref>).<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Whereas the original venezuelin
was not produced under a variety of growth conditions, sequence variants
with the same ring topology are produced by <italic>Streptomyces collinus</italic> T&#x000fc; 365 (streptocollin),<sup><xref ref-type="bibr" rid="ref134">134</xref></sup><italic>S. katrae</italic> ISP5550, <italic>S. lavendulae</italic> subsp.
lavendulae NRRL B-2508, and <italic>Streptomyces</italic> sp. strain
NRRL B-2375.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Despite several attempts
to determine the biological activity of the venezuelins, thus far
their function(s) are not clear.<sup><xref ref-type="bibr" rid="ref128">128</xref>,<xref ref-type="bibr" rid="ref134">134</xref></sup></p><fig id="fig47" position="float"><label>Figure 47</label><caption><p>Biosynthesis
of venezuelin. For clarity the process is drawn as
completion of dehydration before cyclization, but the order of the
PTMs for venezuelin is not currently known.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0047" id="gr47" position="float"/></fig></sec><sec id="sec5.2"><label>5.2</label><title>Mechanism of Phosphorylation, Phosphate Elimination,
and Cyclization</title><p>Class III and IV lanthipeptide synthetases
consist of three different domains, each presumably with its own active
site. Hence, the mechanism and timing of each consecutive reaction
is more complicated than in the case of class II LanM enzymes for
which phosphorylation and phosphate elimination take place in one
active site and are usually tightly coupled (<xref rid="sec4.2" ref-type="other">section <xref rid="sec4.2" ref-type="other">4.2</xref></xref>). Although X-ray structures are available
for orthologs of each of the three individual domains,<sup><xref ref-type="bibr" rid="ref177">177</xref>,<xref ref-type="bibr" rid="ref480">480</xref>,<xref ref-type="bibr" rid="ref482">482</xref>,<xref ref-type="bibr" rid="ref483">483</xref></sup> thus far LanKC and LanL proteins have not yielded crystal structures,
possibly because some of the proteins that have been characterized
in vitro have needed fusions with solubilizing proteins such as SUMO<sup><xref ref-type="bibr" rid="ref132">132</xref></sup> or coexpression with folding chaperones<sup><xref ref-type="bibr" rid="ref484">484</xref></sup> to achieve reasonable quantities of soluble
protein. The three proteins and their substrates that are the best
behaved and did not need additional measures to obtain soluble enzyme,
LabKC,<sup><xref ref-type="bibr" rid="ref271">271</xref>,<xref ref-type="bibr" rid="ref477">477</xref></sup> CurKC,<sup><xref ref-type="bibr" rid="ref131">131</xref>,<xref ref-type="bibr" rid="ref247">247</xref></sup> and VenL,<sup><xref ref-type="bibr" rid="ref128">128</xref>,<xref ref-type="bibr" rid="ref485">485</xref></sup> have been investigated in more detail with respect to the three
activities catalyzed by these trifunctional enzymes. Notably, CurKC
is encoded in the genome of the thermophile <italic>Thermomonospora
curvata</italic>,<sup><xref ref-type="bibr" rid="ref131">131</xref></sup> which may provide
improved thermostability of both the final product and the biosynthetic
enzymes as seen for the class II lanthipeptide geobacilin II.<sup><xref ref-type="bibr" rid="ref394">394</xref>,<xref ref-type="bibr" rid="ref486">486</xref></sup></p><sec id="sec5.2.1"><label>5.2.1</label><title>Dehydration via Phosphorylation</title><p>Although
RamC was the first discovered class III lanthipeptide synthetase,
the extreme insolubility of its substrate RamS precluded any in vitro
studies. LabKC, the enzyme responsible for the biosynthesis of the
labyrinthopeptins, could be studied in vitro and was shown to convert
synthetic LabA2 into mLabA2 (<xref rid="fig45" ref-type="fig">Figure <xref rid="fig45" ref-type="fig">45</xref></xref>B), confirming that the enzyme catalyzes both dehydration
and cyclization, despite the absence of zinc-ligands.<sup><xref ref-type="bibr" rid="ref477">477</xref></sup> Metal analysis of the AciKC ortholog involved
in catenulipeptin biosynthesis (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>) corroborated that the protein did not
bind zinc nor any other metal.<sup><xref ref-type="bibr" rid="ref130">130</xref></sup> The in
vitro reconstitution of LabKC demonstrated another unusual feature,
the requirement of guanosine triphosphate (GTP) or deoxy-GTP for dehydration
instead of ATP that is utilized by class II LanM enzymes.<sup><xref ref-type="bibr" rid="ref477">477</xref></sup> Subsequent studies on a series of LanKC enzymes
showed that the nucleotide specificity is not uniform: EryKC involved
in erythreapeptin biosynthesis is ATP dependent,<sup><xref ref-type="bibr" rid="ref132">132</xref></sup> AciKC that generates catenulipeptin accepts ATP, GTP, CTP,
or TTP as a cosubstrate,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup> and StaKC<sup><xref ref-type="bibr" rid="ref484">484</xref></sup> and CurKC<sup><xref ref-type="bibr" rid="ref131">131</xref></sup> responsible
for stackepeptin and curvopeptin biosynthesis, respectively, can utilize
all NTPs/dNTPs but prefer purine nucleoside triphosphates as the phosphoryl
donor for the central kinase domain (for structures of these class
III lanthipeptides, see <xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>).</p><fig id="fig48" position="float"><label>Figure 48</label><caption><p>Structures of class III lanthipeptides. Labyrinthopeptin
A3 differs
from labyrinthopeptin A1 by a single additional Asp residue at the
N-terminus thought to derive from incomplete leader removal (<xref rid="sec5.4" ref-type="other">section <xref rid="sec5.4" ref-type="other">5.4</xref></xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0048" id="gr48" position="float"/></fig><p>The order of dehydration has been investigated
for two enzymes,
LabKC and CurKC, using the Ser/Thr deuterium-labeling strategy described
in <xref rid="sec4.4" ref-type="other">section <xref rid="sec4.4" ref-type="other">4.4</xref></xref> but
that was originally developed for studies on LabKC (<xref rid="fig38" ref-type="fig">Figure <xref rid="fig38" ref-type="fig">38</xref></xref>).<sup><xref ref-type="bibr" rid="ref401">401</xref></sup> Both enzymes are distributive, and unlike class II lanthipeptide
synthetases, phosphorylated intermediates are detected with wild-type
substrates. LabKC and CurKC catalyze dehydration with net C-to-N terminal
directionality.<sup><xref ref-type="bibr" rid="ref247">247</xref>,<xref ref-type="bibr" rid="ref401">401</xref></sup> Although both enzymes clearly
display overall directionality, the differentiation between two consecutively
dehydrated residues is not always complete and hence several parallel
pathways are operational,<sup><xref ref-type="bibr" rid="ref247">247</xref>,<xref ref-type="bibr" rid="ref401">401</xref></sup> similar to what is
observed for class I and class II dehydration.<sup><xref ref-type="bibr" rid="ref245">245</xref>,<xref ref-type="bibr" rid="ref364">364</xref>,<xref ref-type="bibr" rid="ref365">365</xref>,<xref ref-type="bibr" rid="ref375">375</xref></sup> Thus, it may be that the model of conformational sampling discussed
in <xref rid="sec4.4" ref-type="other">section <xref rid="sec4.4" ref-type="other">4.4</xref></xref> is
a general feature of dehydration in all three enzyme classes; the
order and directionality for class IV LanL enzymes has thus far not
been investigated.</p><p>As noted above, the dehydration reaction
involves two separate
active sites with phosphorylation taking place in the central kinase
domain and phosphate elimination in the N-terminal pSer/pThr lyase
domain. The timing of these two processes has been most extensively
investigated for CurKC. Surprisingly, phosphorylation and elimination
are not always consecutive reactions. During processing of CurA by
CurKC, an initially phosphorylated Ser1 remains phosphorylated as
the enzyme dehydrates Ser12 and Ser15, leading to bisphosphorylated
intermediates (<xref rid="fig49" ref-type="fig">Figure <xref rid="fig49" ref-type="fig">49</xref></xref>).<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> Only after
Ser12 and Ser15 have been converted into Dha is the phosphate at pSer1
eliminated, and it appears that only then is cyclization initiated.
Interestingly, when Ser1 was mutated to Ala, Ser2 was phosphorylated
first.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> Thus, it appears that leader
peptide binding juxtaposes the core peptide in such a way with respect
to the kinase active site that a residue at its N-terminus is the
preferred substrate for the first phosphorylation. However, in the
ensuing competition between the lyase and kinase domain to either
eliminate the phosphate from pSer1 or phosphorylate a second time
at Ser12/15, the kinase wins out possibly because pSer1 is a particularly
unfavorable substrate for the lyase domain. After Dha12/15 are both
installed, a new competition is set up between elimination at pSer1
and phosphorylation at Ser4, which apparently now favors the lyase
reaction. Interestingly, it is proposed that immediately after introduction
of the Dha1, the cyclase domain catalyzes Lan formation between Cys19
and Dha12.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> Thus, it appears that the
phosphate at Ser1 prevented cyclization. Once the Lan is introduced,
Ser4 and subsequently Ser2 become improved substrates of the kinase.
For all lanthipeptide synthetases, such models can likely only be
tested with cocrystal structures of enzymes bound to intermediates
and/or by kinetic studies with (semi)synthetic intermediates of defined
structures. Given the size of the substrates and the complexity of
the overall process, both of these approaches are highly challenging.</p><fig id="fig49" position="float"><label>Figure 49</label><caption><p>CurKC
catalyzes phosphorylation, phosphate elimination, and cyclization
of CurA in a distributive fashion and unusual order. Only the main
pathway is shown, with minor parallel pathways also observed.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> Pi = phosphate; LP = leader peptide.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0049" id="gr49" position="float"/></fig><p>The phosphate elimination activity
in the N-terminal lyase site
follows a very similar mechanism as in the homologous type III effector
proteins of the OspF family that catalyze phosphate elimination from
a very specific pThr in MAP kinases.<sup><xref ref-type="bibr" rid="ref478">478</xref>&#x02212;<xref ref-type="bibr" rid="ref481">481</xref></sup> It is interesting that these
effector proteins are found in Gram-negative pathogens,<sup><xref ref-type="bibr" rid="ref487">487</xref></sup> whereas the LanKC and LanL enzymes are phylogenetically
more diverse and are found in Actinobacteria, Firmicutes, and Proteobacteria.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> As expected from the structure of the effector
proteins and from the fact that elimination takes place in a separate
active site from phosphorylation, unlike for class II LanM enzymes
phosphate elimination for class III/IV does not require the presence
of an NDP as shown for LabKC.<sup><xref ref-type="bibr" rid="ref401">401</xref></sup> At present
no structures are available for class III and IV lanthipeptide synthetases
nor for their three individual domains. However, mutagenesis studies
on VenL illustrate that several of the conserved catalytic residues
in OspF proteins are also important for catalysis by class III/IV
lanthipeptide synthetases (vide infra).</p><p>A truncated form of
VenL containing only the lyase and kinase domains,
termed VenL-&#x00394;cyc, was able to fully dehydrate the VenA substrate,
illustrating that cyclization is not required for full dehydration.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> However, this finding does not rule out a mechanism
whereby full length VenL processes VenA by alternating dehydration
and cyclization events, as has been observed for several lanthipeptide
synthetases. Expression and purification of the individual kinase
and lyase domains of VenL and incubation of these proteins with VenA
resulted in incomplete conversion, indicating that the domains can
operate separately, albeit less efficiently than when present in one
polypeptide.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> Whether the decreased efficiency
signifies some level of communication between the kinase and lyase
domains, for instance by sharing a leader peptide binding site, or
whether it simply results from less well-folded proteins, is currently
not known. Indeed, many questions remain that in principle can be
investigated such as whether or not the leader peptide is required
for all three activities of LanL/LanKC proteins.</p><p>In SpvC, a
type III effector protein from <italic>Salmonella</italic>, Lys136
is responsible for deprotonation at the &#x003b1;-carbon of
the pThr targeted for phosphate elimination (<xref rid="fig50" ref-type="fig">Figure <xref rid="fig50" ref-type="fig">50</xref></xref>),<sup><xref ref-type="bibr" rid="ref480">480</xref></sup> and accordingly
mutation of the corresponding Lys80 in VenL resulted in phosphorylated
VenA products, indicating interference with the elimination step.<sup><xref ref-type="bibr" rid="ref485">485</xref></sup> His106 in SpvC is thought to act as the catalytic
acid that protonates the bridging oxygen in the phosphate leaving
group, and indeed mutation of the corresponding His53 in VenL interfered
with phosphate elimination. A third critical residue in SpvC, Lys104,
is thought to decrease the p<italic>K</italic><sub>a</sub> of the
&#x003b1;-proton of the pThr residue by electrostatic activation of
its carbonyl group.<sup><xref ref-type="bibr" rid="ref481">481</xref></sup> The corresponding
residue in VenL, Lys51, was also shown to be important for phosphate
elimination. However, two other residues that are fully conserved
in OspF, LanL, and RamC/LanKC family members,<sup><xref ref-type="bibr" rid="ref485">485</xref></sup> Thr106 and Tyr108 in VenL (Thr156 and Tyr158 in SpvC),
were not critical for VenL catalyzed dehydration of its VenA substrate.<sup><xref ref-type="bibr" rid="ref485">485</xref></sup> Also different are the interactions with the
nonbridging phosphate oxygens. In SpvC, three Arg residues (Arg213,
Arg220, and Arg148) stabilize the negatively charged phosphate group.
A homology model predicts that in VenL these roles may be fulfilled
by residues that are not conserved in the OspF family but are in the
LanL/LanKC families: Arg156 and Lys103. A possible model for the elimination
reaction in VenL is shown in <xref rid="fig51" ref-type="fig">Figure <xref rid="fig51" ref-type="fig">51</xref></xref>.<sup><xref ref-type="bibr" rid="ref485">485</xref></sup></p><fig id="fig50" position="float"><label>Figure 50</label><caption><p>(A) Structure of SpvC
type III effector protein K136A mutant (purple)
bound to a model pThr-bearing substrate (brown). (B) Close-up view
of the SpvC active site. PDB ID 2Z8P.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0050" id="gr50" position="float"/></fig><fig id="fig51" position="float"><label>Figure 51</label><caption><p>Proposed mechanism of VenL-catalyzed phosphate elimination to afford
Dhx.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0051" id="gr51" position="float"/></fig></sec><sec id="sec5.2.2"><label>5.2.2</label><title>Cyclization</title><p>The most intriguing
aspect of class III lanthipeptides is that they can contain either
lanthionine or labionin residues. Comparison of the core peptide sequences
of RamS (leading to SapB) and LabA2 (leading to labyrinthopeptin A2)
demonstrates very similar SX<sub>2</sub>SX<sub>3</sub>C motifs but
one leads to lanthionine and one to labionin (<xref rid="fig52" ref-type="fig">Figure <xref rid="fig52" ref-type="fig">52</xref></xref>). Phylogenetic analysis of class III enzymes
that make Lan or Lab did not provide any clear indications that could
be predictive of the outcome.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Even more
interestingly, some LanKC enzymes such as EryKC<sup><xref ref-type="bibr" rid="ref132">132</xref></sup> and StaKC<sup><xref ref-type="bibr" rid="ref484">484</xref></sup> can form both Lan
and Lab in the same product (e.g., <xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref> for the product of EryKC). Although the
molecular mechanism of how the enzymes achieve the remarkable tandem
cross-linking reaction resulting in labionin is still mostly unclear,
several insightful observations have been reported. It is notable
that whereas some of the enzymes appear to have strong preference
to turn a given substrate sequence into either Lab or Lan, the selectivity
is not complete since small amounts of Lab have been detected by GC-MS
after acid hydrolysis of SapB<sup><xref ref-type="bibr" rid="ref132">132</xref></sup> and curvopeptin,<sup><xref ref-type="bibr" rid="ref131">131</xref></sup> two Lan-containing class III lanthipeptides
(<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>). In addition
to GC-MS analysis, which can detect small amounts of minor products,
Lan and Lab have been distinguished by taking advantage of the reactivity
of a Dha that will remain upon formation of Lan but not Lab (<xref rid="fig52" ref-type="fig">Figure <xref rid="fig52" ref-type="fig">52</xref></xref>). This noncyclized
Dha will react selectively with either a thiol nucleophile or NaBH<sub>4</sub>.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref484">484</xref></sup></p><fig id="fig52" position="float"><label>Figure 52</label><caption><p>Class III lanthipeptides labyrinthopeptin A2
and SapB contain different
PTMs (Lab and Lan, respectively) despite high similarity of their
precursor sequences.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0052" id="gr52" position="float"/></fig><p>A Lab introduces two cross-links when incorporated into a
peptide.
Of these, the carbacyclic ring is N-terminal and the thioether ring
is C-terminal. A common nomenclature labels these two rings as A and
A&#x02032;, respectively, if they are the first Lab, B and B&#x02032;
if they are the second Lab, etc. (e.g., <xref rid="fig52" ref-type="fig">Figure <xref rid="fig52" ref-type="fig">52</xref></xref> for labyrinthopeptin A2). Whereas the majority
of Lab structures in the currently characterized class III lanthipeptides
are formed from a SX<sub>2</sub>SX<sub>3</sub>C motif, other sequences
have also been shown to result in Lab formation. Labyrinthopeptins
A1 and A3 contain a C-terminal labionin formed from an SX<sub>2</sub>SX<sub>5</sub>C sequence that has a larger thioether ring made up
of seven residues (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>),<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> and the C-terminal labionin
in catenulipeptin contains a smaller thioether ring formed from an
SX<sub>2</sub>SX<sub>2</sub>C sequence (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>).<sup><xref ref-type="bibr" rid="ref130">130</xref></sup> Variations
in the ring size are not limited to the C-terminal ring; the N-terminal
Lab residue in NAI-112 incorporates a six-residue thioether ring generated
from an SX<sub>2</sub>SX<sub>4</sub>C motif (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>).<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Indeed, in
vivo and in vitro engineering studies have also demonstrated the ability
of LabKC to generate thioether rings with expanded or contracted rings.<sup><xref ref-type="bibr" rid="ref488">488</xref></sup> Conversely, the carbacyclic ring in (Me)Lab
appears more restricted since all such rings reported thus far in
natural products consist of four residues, and attempts to increase
or decrease this size by engineering were not successful.<sup><xref ref-type="bibr" rid="ref488">488</xref></sup> Similarly, it has been challenging to change
a Lab into a Lan,<sup><xref ref-type="bibr" rid="ref488">488</xref></sup> suggesting that the
conformation of the substrate peptide and the active site geometry
of the enzymes appear to be quite specific for one product or the
other for a given precursor peptide. An intriguing group of LanKCs
were recently found by genome mining that have putative precursor
peptides that do not contain the canonical labionin motif but that
do contain a conserved CXSX<sub>2</sub>S motif. Whether this motif
also encodes a labionin structure formed in the opposite direction
(Dha residues localized C-terminal to the Cys) remains to be determined.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> The discussion below focuses on two Lab-forming
class III enzymes (LabKC and AciKC), one Lan-forming class III enzyme
(CurKC), and one Lan-forming class IV enzyme (VenL) that have been
investigated in more detail with respect to the cyclization process.</p><p>Similarly to the directionality of phosphorylation and elimination
discussed in <xref rid="sec5.2.1" ref-type="other">section <xref rid="sec5.2.1" ref-type="other">5.2.1</xref></xref>, the cyclization appears to take place with C-to-N directionality
based on mutagenesis studies. Mutation of serines that prevent formation
of C-terminal rings, whether Lab in catenulipeptin,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup> Lan in curvopeptin,<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> or either
Lab or Lan in stackepeptin,<sup><xref ref-type="bibr" rid="ref484">484</xref></sup> negatively
affected ring formation involving N-terminal residues. The timing
of cyclization has also been determined by tandem MS analysis of intermediates
formed during the biosynthesis of curvopeptin by CurKC, with the results
again pointing at C-to-N directionality of cyclization.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> Formation of the C-terminal Lan in curvopeptin
appears to take place only after dehydration of Ser1, Ser12, and Ser15
(<xref rid="fig49" ref-type="fig">Figure <xref rid="fig49" ref-type="fig">49</xref></xref>). This
means that the dehydro amino acids required for labionin installation
are available, but yet the enzyme preferentially forms a Lan. The
N-terminal Lan is proposed to be generated only after completion of
dehydration, including introduction of Dha2, and it has been suggested
that this order of events may facilitate proper positioning of the
intermediate peptide for formation of the Lan A-ring in curvopeptin.<sup><xref ref-type="bibr" rid="ref247">247</xref></sup> A strict requirement of the leader peptide
for the cyclization reaction has been determined for AciKC,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup> and hence leader peptide binding and the resulting
juxtaposition with respect to the cyclase active site may also be
important for the observed order and specificity of cyclization. Whether
the leader peptide utilizes a single binding site or whether all three
domains have their own individual binding sites is currently unknown.
Sequence comparison does not locate a winged helix-turn-helix domain
like that found in LanB in either LanKC or LanL. Another intriguing
and currently unresolved question is what the functional significance
is of a clade of class IV enzymes that have a zinc site with a Cys-Cys-Cys
ligand set.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> As discussed in <xref rid="sec4.3" ref-type="other">section <xref rid="sec4.3" ref-type="other">4.3</xref></xref>, this ligand
environment in LanM enzymes is associated with higher reactivity and
substrate tolerance.</p><p>The stereochemistry of the venezuelin family
of class IV lanthipeptides
has been determined to be the canonical DL,<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> but for class III lanthipeptides stereochemistry has not yet been
explored in much detail. The stereochemistry of the founding member
of labionin-containing peptides, labyrinthopeptin A2, was firmly established
by X-ray crystallography.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> However, the
stereochemistry of the MeLab present in NAI-112 (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>) is currently unknown.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Similarly, the stereochemistry of Lab in many
other family members is inferred and has not been experimentally demonstrated.
Given the unexpected findings of noncanonical stereochemistry in class
II lanthipeptides that turned out to be sequence-dependent,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> it could be that the stereochemistry of labionin
formed from sequences other than the SX<sub>2</sub>SX<sub>3</sub>C
motif in labyrinthopeptin A2 is also different. A GC-MS method has
been developed that can detect labionins,<sup><xref ref-type="bibr" rid="ref489">489</xref></sup> but the use of this method to confirm the stereochemistry of other
labionin-containing lanthipeptides has not yet been reported. Unambiguous
determination of stereochemistry would require synthesis of all four
diastereomers of Lab, as was done for Lan and MeLan,<sup><xref ref-type="bibr" rid="ref490">490</xref></sup> or alternatively use of the diastereomers of &#x003b1;-methyl-2,4-diaminoglutaric
acid, the product formed upon application of a desulfurization protocol
with NiCl<sub>2</sub>/NaBH<sub>4</sub> to labionin-containing peptides.<sup><xref ref-type="bibr" rid="ref489">489</xref></sup></p><p>Similarly, the stereochemistry of lanthionines
formed in class
III lanthipeptides has not been reported. We note that the L stereochemistry
at carbon 2 of labionin requires protonation of the enolate from the
opposite face of the canonical protonation at carbon 2 in DL-Lan (as
seen in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).
Although the stereochemical nomenclature is <italic>S</italic> in
both cases, the actual stereochemistry is different because of the
change in Cahn-Ingold-Prelog priorities upon sulfur substitution at
the &#x003b2;-carbon of Lan compared to carbon substitution in Lab.
If protonation occurs from the same face during formation of both
Lab and Lan, then SapB and other lanthionine-containing class III
lanthipeptides would form LL-Lan. Conversely, it is possible that
the enzyme presents different faces of the enolate to the active site
acid for protonation during Lab or Lan formation. This would be analogous
to the different faces of protonation induced by a Dhx-Dhx-Xxx-Xxx-Cys
motif discussed for class II lanthipeptide synthetases in <xref rid="sec4.3.3" ref-type="other">section <xref rid="sec4.3.3" ref-type="other">4.3.3</xref></xref>.</p></sec></sec><sec id="sec5.3"><label>5.3</label><title>Substrate Recognition</title><p>The features
of the substrate peptides that are important for biosynthesis of class
III and IV lanthipeptides have been most extensively investigated
for labyrinthopeptin A2.<sup><xref ref-type="bibr" rid="ref271">271</xref>,<xref ref-type="bibr" rid="ref488">488</xref></sup> Truncation experiments
on the LabA2 precursor peptide showed that the LabKC enzyme requires
its leader peptide. Addition of the leader peptide in trans did not
result in any activity.<sup><xref ref-type="bibr" rid="ref271">271</xref></sup> Systematic truncation
of residues at the N- or C-terminus of the leader peptide as well
as site-specific mutagenesis showed that the first three amino acids
of the leader peptide are dispensable, but that a subsequent I-L-E-L-Q
motif is very important. Substitution of individual amino acids suggested
that the second and fourth residues in this five-amino acid motif
(both Leu) may be most important, whereas the Glu and Gln could be
replaced with Ala without losing processing by LabKC. Truncations
and replacement of residues at the C-terminus of the leader peptide
showed that residues located C-terminal to the above-mentioned motif
are not important for catalysis but are critical to position Ser/Thr
residues that are destined for dehydration at a sufficient distance
from the leader peptide binding region. If a Ser/Thr is too close
to the binding site, it is not dehydrated.<sup><xref ref-type="bibr" rid="ref271">271</xref></sup> This observation is very similar to that in class I and class II
lanthipeptide synthetases,<sup><xref ref-type="bibr" rid="ref194">194</xref>,<xref ref-type="bibr" rid="ref251">251</xref>,<xref ref-type="bibr" rid="ref269">269</xref></sup> and in those proteins likely reflects the distance from the leader
peptide binding site on the protein to the phosphorylation/glutamylation
active sites. Interestingly, when the RamS leader peptide was fused
to the N-terminus of a truncated LabA2 core peptide, LabKC catalyzed
dehydration of both Ser residues albeit more slowly than with the
wild type leader peptide.<sup><xref ref-type="bibr" rid="ref271">271</xref></sup> Indeed, the
leader peptide of RamS contains an LFDLQ motif at its N-terminus that
is similar to the ILELQ motif of LabA2, and this motif is widely found
in class III precursor peptides (<xref rid="fig53" ref-type="fig">Figure <xref rid="fig53" ref-type="fig">53</xref></xref>). Hence, leader peptide recognition may
be a conserved feature. Whether cyclization of the RamS-LabA2 hybrid
also led to labionin formation (as in labyrinthopeptin), or resulted
in lanthionine generation (as in SapB), was not reported and constitutes
an interesting question.</p><fig id="fig53" position="float"><label>Figure 53</label><caption><p>Alignment of class III lanthipeptide precursors.
Lanthipeptides
used: labyrinthopeptins A1-A3 (LabA1-A3), SapB (RamS), curvopeptin
(CurA), griseopeptin (<italic>Streptomyces griseus</italic> AmfS),
avermipeptin (<italic>Streptomyces avermitilis</italic> AmfS), erythreapeptin
(EryS), flavipeptin (FlaA), catenulipeptin (AciA), stackepeptin (StaA),
and NAI-112 (LabA). Fully conserved identical residues in the leader
region are shown in dark orange and conserved similar residues are
shown in green. Ser/Thr residues that undergo dehydration are shown
in purple, and Cys residues are shown in blue.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cr-2016-00591e_0053" id="gr53" position="float"/></fig><p>Although LabKC did not show any activity in the absence of
the
leader peptide or when the leader peptide was presented in trans,
the StaKC enzyme involved in stackepeptin biosynthesis did show a
low level basal activity on its core peptide, and the activity was
enhanced by addition of the leader peptide in trans.<sup><xref ref-type="bibr" rid="ref484">484</xref></sup> Thus, it may be that the leader peptide also functions
as an allosteric activator as in many other RiPP biosynthetic enzymes.<sup><xref ref-type="bibr" rid="ref150">150</xref></sup> Like the substrates for class I and II lanthipeptides,<sup><xref ref-type="bibr" rid="ref257">257</xref></sup> and those for cyanobactins<sup><xref ref-type="bibr" rid="ref491">491</xref></sup> and microcin B17<sup><xref ref-type="bibr" rid="ref492">492</xref></sup> (two other
RiPP families), the LabA2 leader peptide has a propensity to form
an &#x003b1;-helical secondary structure.<sup><xref ref-type="bibr" rid="ref271">271</xref></sup> However, for class I lanthipeptides, cyanobactins, and microcin
B17-like RiPPs, it has been shown that, despite their propensity to
form helices, the leader peptides bind to a conserved domain in an
extended conformation.<sup><xref ref-type="bibr" rid="ref194">194</xref>,<xref ref-type="bibr" rid="ref259">259</xref>,<xref ref-type="bibr" rid="ref263">263</xref></sup></p></sec><sec id="sec5.4"><label>5.4</label><title>Leader Peptide Removal</title><p>The removal
of the leader peptide of class III and IV lanthipeptides is quite
different from that of class I/II compounds. First, most clusters
lack a gene encoding a dedicated protease. Second, for many family
members, a series of congeners have been observed that contain differing
numbers of amino acids originating from the leader peptide at their
N-termini. This observation was first made for the labyrinthopeptins;
the A1 and A3 congeners differ only in that A3 contains an additional
Asp at its N-terminus (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>).<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Subsequently, similar
observations have been made for erythreapeptin (five congeners with
different numbers of remaining leader peptide residues), avermipeptin
(seven congeners), griseopeptin (two congeners), curvopeptin (five
congeners), stackepeptin (two congeners), and even SapB (two congeners).<sup><xref ref-type="bibr" rid="ref131">131</xref>,<xref ref-type="bibr" rid="ref132">132</xref>,<xref ref-type="bibr" rid="ref484">484</xref></sup> Similar observations have been
made for the class IV compounds venezuelin<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> and streptocollin<sup><xref ref-type="bibr" rid="ref134">134</xref></sup> for which two variants
of each were observed. Thus, it appears that the class III and IV
lanthipeptides are generated by stepwise trimming of the leader peptides
by currently unidentified amino peptidases. It is possible that for
some or all members, an N-terminal segment of the leader peptide is
first removed in one step by a specific endopeptidase. Indeed, this
scenario has been experimentally demonstrated for flavipeptin from <italic>Kribbella flavida.</italic> Its biosynthetic gene cluster contains
a prolyl oligopeptidase (POP) designated FlaP (note that it is not
a member of the LanP Ser proteases of the subtilisin family) that
is predicted to be cytoplasmic.<sup><xref ref-type="bibr" rid="ref493">493</xref></sup> In vitro
reconstitution of FlaP activity showed that the enzyme is specific
for cyclized FlaA. The enzyme cleaves mFlaA after Pro&#x02212;12 but
did not act on linear FlaA or the leader peptide, and very slowly
processed dehydrated FlaA. Hence, the rings are important for substrate
recognition. POPs were shown to be encoded in a small subset of class
III gene clusters,<sup><xref ref-type="bibr" rid="ref493">493</xref></sup> but quite a few class
III LanA substrates have Pro in their leader peptides, and hence cleavage
by a POP and subsequent trimming by aminopeptidases could be a more
general pathway. A POP has also been shown to be involved in the biosynthesis
of the RiPP class of amanitins produced by mushrooms.<sup><xref ref-type="bibr" rid="ref494">494</xref></sup> Rather than the POP encoded in the flavipeptin
biosynthetic gene cluster, a different type of protease appears to
be encoded in the cluster responsible for the biosynthesis of NAI-112
(<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>).<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Thus far, the activity of this protein has not
been reported.</p></sec><sec id="sec5.5"><label>5.5</label><title>Tailoring Reactions: Disulfide
Bond Formation
and Glycosylation</title><p>Class III and IV lanthipeptides are not
as richly decorated with PTMs resulting from tailoring reactions as
class I and II lanthipeptides. Only two types of modification have
been reported thus far. The prototype class III lanthipeptide labyrinthopeptin
A2 contains a disulfide linkage made by Cys9 and Cys18 that spans
the C-terminal labionin (<xref rid="fig45" ref-type="fig">Figure <xref rid="fig45" ref-type="fig">45</xref></xref>), and labyrinthopeptin A1/A3 contain a similarly positioned
disulfide formed from Cys9 and Cys20 (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>).<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Like other
disulfide containing class II lanthipeptides such as haloduracin &#x003b1;
and bovicin HJ50,<sup><xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref411">411</xref></sup> the gene cluster encoding the
labyrinthopeptins does not appear to contain a disulfide isomerase
that is required for disulfide formation.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> A second tailoring PTM was discovered in NAI-112 produced by <italic>Actinoplanes</italic> DSM 24059. This compound, which also contains
the first example of a MeLab, is unusual in that it is the first example
of a glycosylated lanthipeptide (<xref rid="fig48" ref-type="fig">Figure <xref rid="fig48" ref-type="fig">48</xref></xref>).<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Furthermore,
the glycosylation is unusual as a 6-deoxyhexose is attached to the
indole nitrogen of Trp. At present the identity of the 6-deoxyhexose
is not known. Interestingly, a putative glycosyltransferase is encoded
within the gene cluster just downstream of the <italic>lanA</italic> gene.</p></sec></sec><sec id="sec6"><label>6</label><title>Concluding Remarks and Outlook</title><p>As discussed in this review, lanthipeptide biosynthesis is very
widely distributed, and based on the number of lanthipeptide gene
clusters, this family is currently the most abundant of all RiPPs.
The origin of this widespread occurrence may lie in the ease by which
lanthipeptides are fashioned from a linear peptide. Both the dehydration
of Ser/Thr and the conjugate addition of thiol nucleophiles to dehydro
amino acids are chemically relatively straightforward reactions to
turn a linear peptide into a polycyclic, conformationally constrained
peptide. Cyclization offers important evolutionary advantages of higher
stability<sup><xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref176">176</xref>,<xref ref-type="bibr" rid="ref178">178</xref>,<xref ref-type="bibr" rid="ref495">495</xref>,<xref ref-type="bibr" rid="ref496">496</xref></sup> and improved target recognition.<sup><xref ref-type="bibr" rid="ref468">468</xref>,<xref ref-type="bibr" rid="ref497">497</xref></sup> The notion
that at least four different routes to lanthipeptides have evolved
may be a further demonstration of both the ease of evolution of these
pathways, and the privileged nature of the thioether cross-link to
access biological activity space.</p><p>At least three very different
solutions have evolved for the dehydration
step. Glutamylation in class I lanthipeptides is entirely novel and
the evolutionary origins are at present still enigmatic. Classes II&#x02013;IV
all involve Ser/Thr activation via phosphorylation by a kinase-like
protein followed by phosphate elimination, but different solutions
have evolved for the latter step. For class II lanthipeptides, the
elimination activity evolved out of the kinase active site, whereas
for class III and IV a separate standalone elimination domain was
recruited. It is possible that there are other dehydration mechanisms
that remain to be discovered for which the associated biosynthetic
gene clusters have not yet been recognized as lanthipeptide gene clusters.
Indeed, most genome mining efforts in the lanthipeptides field have
used knowledge of existing biosynthetic strategies as queries, which
would only return members of known classes. Even when limiting genome
mining efforts to the four known classes of lanthipeptides, the amount
of diversity and biosynthetic novelty remaining to be discovered is
staggering. For instance, an analysis of 830 actinobacterial genomes
illustrated that known lanthipeptides from this phylum cover only
a very small fraction of biosynthetic space.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Many gene cluster families that are quite common in these genomes
at present do not have a member with a characterized structure of
the final product, and many clusters contain putative biosynthetic
enzymes for which the function currently is unclear, such as radical-SAM
proteins and methyltransferases.<sup><xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> It is also
noteworthy that the utilization of the lanthipeptide biosynthetic
enzymes, or domains thereof, is also observed in other classes of
RiPPs, such as thiopeptides<sup><xref ref-type="bibr" rid="ref202">202</xref></sup> and proteusins,<sup><xref ref-type="bibr" rid="ref367">367</xref></sup> and RiPPs that are formed from precursor peptides
lacking Cys,<sup><xref ref-type="bibr" rid="ref368">368</xref></sup> and they are even found
in gene clusters for natural products that are not RiPPs such as NRPS
and PKS clusters.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup></p><p>Despite the variety
of ways by which dehydration is achieved, remarkable
similarities have started to emerge with respect to the role of the
leader peptide and the determination of ring topology. In three of
the four classes, a low basal level of dehydration activity has been
observed in the absence of a leader peptide, and addition of the leader
peptide in trans has increased this activity. These observations are
consistent with a model in which the leader peptide functions as an
allosteric activator.<sup><xref ref-type="bibr" rid="ref150">150</xref></sup> Another similarity
is the existence of multiple parallel modification pathways in an
overall ordered process, suggesting that the energy differences governing
site selectivity can be small for residues that are close in space.
A third commonality is the observation that dehydration and cyclization
are often coupled, such that a later dehydration may require a prior
cyclization. This is not observed for all systems, however, since
in all classes there are some dehydratases or dehydration domains
that can complete dehydration of all targeted sites even when no cyclization
has occurred (e.g., NisB,<sup><xref ref-type="bibr" rid="ref243">243</xref></sup> ProcM,<sup><xref ref-type="bibr" rid="ref246">246</xref>,<xref ref-type="bibr" rid="ref365">365</xref></sup> NukM,<sup><xref ref-type="bibr" rid="ref498">498</xref></sup> and CurKC<sup><xref ref-type="bibr" rid="ref131">131</xref></sup>).</p><p>Although the classification scheme for lanthipeptides
highlights
their differences with regards to the dehydration reaction, the cyclization
processes also have distinct features despite being catalyzed by enzymes
or domains with clear sequence similarities. Phylogenetic analyses
of the LanC enzymes with the cyclization domains of class II&#x02013;IV
lanthipeptide synthetases show that they have evolved separately with
perhaps a common ancient ancestor.<sup><xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref404">404</xref></sup></p><p>Phylogenetic analysis also supports coevolution
of the biosynthetic
enzymes and their substrates. This has been seen in the tRNA and leader
peptide specificity of class I dehydratases, and in the observation
of clusters containing substrates that lack Cys and synthetases that
have lost the conserved catalytic residues for cyclization.<sup><xref ref-type="bibr" rid="ref196">196</xref>,<xref ref-type="bibr" rid="ref368">368</xref></sup> With respect to the regio- and stereoselectivity of cyclization,
several studies have demonstrated that the final outcome may be at
least in part determined by the substrate. The enzyme is still required
for efficient catalysis, as indicated by comparisons with nonenzymatic
processes, but the ultimate ring topology and stereochemistry is in
some of the cases that have been investigated determined by the substrate
sequence. As such, similarities exist with protein folding in that
lanthipeptide cyclases could serve like folding chaperones to let
the substrate adopt its preferred conformation on the enzyme and to
then lock this conformation by catalyzing covalent cross-link formation.</p><p>Even though the enzymology of lanthipeptide biosynthesis is much
better understood than a decade ago,<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> many
questions remain and new questions have been raised by the discovery
of two new pathways and the mechanistic, crystallographic, and bioinformatics
studies that have been conducted on the previously known pathways.
Further advancement of our understanding will likely require studies
on the dynamic interactions of the enzymes and their substrates and
investigation of the makeup of the lanthipeptide synthetase complexes.
While challenging to study, the lanthipeptide biosynthetic enzymes
offer so much promise with respect to bioengineering and synthetic
biology applications that continuing investigations are warranted.</p></sec></body><back><notes notes-type="" id="notes-1"><title>Author Contributions</title><p><sup>&#x02225;</sup> L.M.R.
and J.R.C. contributed equally.</p></notes><notes notes-type="COI-statement" id="NOTES-d90e5926-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><bio id="BIO-d90e5906-autogenerated" rid="ath1"><p>Lindsay
M. Repka received her B.A. in Chemistry from Barnard College
in 2008. She completed her Ph.D. in Chemistry in 2013 under the direction
of Prof. Sarah E. Reisman at the California Institute of Technology.
Lindsay is currently a postdoctoral researcher in the group of Prof.
Wilfred A. van der Donk at the University of Illinois. Her research
focuses on investigating the mechanistic details of lanthipeptide
biosynthetic enzymes. In 2017, she will begin her independent career
as an Assistant Professor of Chemistry at Middlebury College.</p></bio><bio id="BIO-d90e5909-autogenerated" rid="ath2"><p>Jonathan R. Chekan received his B.S. degree in
Microbiology from
the Pennsylvania State University in 2011. Under Prof. Satish K. Nair,
he obtained his Ph.D. in Biochemistry from the University of Illinois
in 2016. He is currently a postdoctoral researcher under Prof. Bradley
S. Moore at the Scripps Institution of Oceanography. His research
has primarily focused on structural and biochemical studies of enzymes
involved in the biosynthesis of RiPP natural products.</p></bio><bio id="BIO-d90e5912-autogenerated" rid="ath3"><p>Satish K. Nair obtained his Sc.B. (with Honors) in Chemistry
from
Brown University in 1989. He obtained his Ph.D. in Chemistry (1994)
with Prof. David W. Christianson at the University of Pennsylvania.
Following postdoctoral studies with Prof. Stephen K. Burley at the
Rockefeller University, he began his independent career at the University
of Illinois in 2001, where he currently holds the I.C. Gunsalus chair
in the Department of Biochemistry. His research focus aims to utilize
physical chemical methods, especially X-ray crystallography, to study
the function of biosynthetic enzymes and bacterial receptor signaling.</p></bio><bio id="BIO-d90e5915-autogenerated" rid="ath4"><p>Wilfred A. van der Donk obtained his B.S.
and M.S. at Leiden University
in The Netherlands under the direction of Jan Reedijk and Willem Driessen.
In 1989 he moved to Rice University where he completed his Ph.D. in
organic chemistry with Kevin Burgess. After postdoctoral studies with
JoAnne Stubbe at MIT, he started his independent career in 1997 at
the University of Illinois, where he currently holds the Richard E.
Heckert chair in the Department of Chemistry. Since 2008, he is an
Investigator of the Howard Hughes Medical Institute.</p></bio><ack><title>Acknowledgments</title><p>The authors thank Dr. Brian San Francisco in
the laboratory
of Professor John A. Gerlt (UIUC) and Dr. Mark Walker (van der Donk
group) for help with constructing the SSN figures. The authors also
thank Dr. Mark Walker for performing profile HMM alignments for this
review. This work was supported by grants from the National Institutes
of Health (R37 GM 058822 to W.A.v.d.D., R01 GM 079038 to S.K.N., and
F32 GM108275 to L.M.R.).</p></ack><glossary id="dl1"><def-list><title>Abbreviations</title><def-item><term>&#x003b1;-KG</term><def><p>&#x003b1;-ketoglutarate</p></def></def-item><def-item><term>&#x00394;cyc</term><def><p>lacking the cyclase domain</p></def></def-item><def-item><term>ABC</term><def><p>ATP-binding cassette</p></def></def-item><def-item><term>Abu</term><def><p>&#x003b1;-aminobutyric
acid</p></def></def-item><def-item><term>ADP</term><def><p>adenosine
diphosphate</p></def></def-item><def-item><term>amf</term><def><p>aerial mycelium formation</p></def></def-item><def-item><term>AMP</term><def><p>adenosine monophosphate</p></def></def-item><def-item><term>AMS</term><def><p>ABC-transporter maturation and secretion</p></def></def-item><def-item><term>ATCC</term><def><p>American Type Culture
Collection</p></def></def-item><def-item><term>ATP</term><def><p>adenosine
triphosphate</p></def></def-item><def-item><term>AviCys</term><def><p><italic>S</italic>-[(<italic>Z</italic>)-2-aminovinyl]-<sc>d</sc>-cysteine</p></def></def-item><def-item><term>BLAST</term><def><p>Basic Local Alignment Search Tool</p></def></def-item><def-item><term>CD</term><def><p>circular dichroism</p></def></def-item><def-item><term>CTP</term><def><p>cytidine triphosphate</p></def></def-item><def-item><term>ConFusion</term><def><p>constitutively active fusion</p></def></def-item><def-item><term>Dha</term><def><p>2,3-didehydroalanine</p></def></def-item><def-item><term>Dhb</term><def><p>(<italic>Z</italic>)-2,3-didehydrobutyrine</p></def></def-item><def-item><term>Dhx</term><def><p>dehydro amino acid</p></def></def-item><def-item><term>dNTP</term><def><p>deoxynucleoside triphosphate</p></def></def-item><def-item><term>DSM</term><def><p>Deutsche Sammlung von Mikroorganismen</p></def></def-item><def-item><term>EFI-EST</term><def><p>Enzyme Function Initiative-Enzyme
Similarity Tool</p></def></def-item><def-item><term>FADH<sub>2</sub></term><def><p>flavin adenine dinucleotide</p></def></def-item><def-item><term>FMN</term><def><p>flavin mononucleotide</p></def></def-item><def-item><term>GC</term><def><p>gas chromatography</p></def></def-item><def-item><term>GluRS</term><def><p>glutamyl-tRNA synthetase</p></def></def-item><def-item><term>GSH</term><def><p>glutathione</p></def></def-item><def-item><term>GTP</term><def><p>guanosine triphosphate</p></def></def-item><def-item><term>HFCD</term><def><p>homo-oligomeric
flavin-containing
Cys decarboxylase</p></def></def-item><def-item><term>HMM</term><def><p>hidden Markov model</p></def></def-item><def-item><term>HPLC</term><def><p>high performance liquid chromatography</p></def></def-item><def-item><term>KA</term><def><p>kinase-activation</p></def></def-item><def-item><term><italic>k</italic><sub>cat</sub></term><def><p>catalytic
rate constant</p></def></def-item><def-item><term><italic>K</italic><sub>d</sub></term><def><p>dissociation
constant</p></def></def-item><def-item><term><italic>K</italic><sub>m</sub></term><def><p>Michaelis
constant</p></def></def-item><def-item><term>Lac</term><def><p>lactyl</p></def></def-item><def-item><term>Lab</term><def><p>labionin</p></def></def-item><def-item><term>Lal</term><def><p>lysinoalanine</p></def></def-item><def-item><term>Lan</term><def><p>lanthionine</p></def></def-item><def-item><term>LanA</term><def><p>generic designation
for precursor
peptides in lanthipeptide biosynthesis</p></def></def-item><def-item><term>LanB</term><def><p>generic designation for lanthipeptide
dehydratases</p></def></def-item><def-item><term>LanC</term><def><p>generic designation for lanthipeptide
cyclases</p></def></def-item><def-item><term>LanCL</term><def><p>LanC-like
protein</p></def></def-item><def-item><term>LanD</term><def><p>generic
designation for lanthipeptide
oxidative decarboxylases belonging to the HFCD family</p></def></def-item><def-item><term>LanE</term><def><p>generic designation
for component
of the ABC transport complex involved in lanthipeptide self-immunity</p></def></def-item><def-item><term>LanF</term><def><p>generic designation
for component
of the ABC transport complex involved in lanthipeptide self-immunity</p></def></def-item><def-item><term>LanG</term><def><p>generic designation
for component
of the ABC transport complex involved in lanthipeptide self-immunity</p></def></def-item><def-item><term>LanI</term><def><p>generic designation
for lanthipeptide
immunity proteins</p></def></def-item><def-item><term>LanJ</term><def><p>generic designation for lanthipeptide
dehydrogenases</p></def></def-item><def-item><term>LanJ<sub>A</sub></term><def><p>generic designation
for zinc and NADPH-dependent lanthipeptide dehydrogenases</p></def></def-item><def-item><term>LanJ<sub>B</sub></term><def><p>generic
designation
for flavin-dependent lanthipeptide dehydrogenases</p></def></def-item><def-item><term>LanK</term><def><p>generic designation for lanthipeptide
regulatory histidine kinases</p></def></def-item><def-item><term>LanKC</term><def><p>generic designation of class III
bifunctional enzymes catalyzing both dehydration and cyclization reactions</p></def></def-item><def-item><term>LanL</term><def><p>generic designation
of class IV
bifunctional enzymes catalyzing both dehydration and cyclization reactions</p></def></def-item><def-item><term>LanM</term><def><p>generic designation
of class II
bifunctional enzymes catalyzing both dehydration and cyclization reactions</p></def></def-item><def-item><term>LanO</term><def><p>generic designation
for lanthipeptide
oxidoreductases that convert Pyr to Lac</p></def></def-item><def-item><term>LanP</term><def><p>generic designation of proteases
that remove lanthipeptide leader peptides</p></def></def-item><def-item><term>LanR</term><def><p>generic designation for lanthipeptide
response regulator protein</p></def></def-item><def-item><term>LanT</term><def><p>generic designation of ABC transporters
that excrete lanthipeptides after biosynthesis</p></def></def-item><def-item><term>LanT<sub>p</sub></term><def><p>generic designation
of bifunctional ABC transporters that excrete lanthipeptides after
biosynthesis and remove the leader peptide</p></def></def-item><def-item><term>LC</term><def><p>liquid chromatography</p></def></def-item><def-item><term>LP</term><def><p>leader peptide</p></def></def-item><def-item><term>MAPK</term><def><p>mitogen activated protein
kinase</p></def></def-item><def-item><term>MBP</term><def><p>maltose
binding protein</p></def></def-item><def-item><term>MeLan</term><def><p>methyllanthionine</p></def></def-item><def-item><term>MeLab</term><def><p>methyllabionin</p></def></def-item><def-item><term>MFS</term><def><p>major facilitator superfamily</p></def></def-item><def-item><term>mLanA</term><def><p>generic designation for modified
precursor peptides in lanthipeptide biosynthesis</p></def></def-item><def-item><term>MS</term><def><p>mass spectrometry</p></def></def-item><def-item><term>N11P</term><def><p>Nif11 nitrogen-fixing protein</p></def></def-item><def-item><term>NADH</term><def><p>nicotinamide adenine
dinucleotide</p></def></def-item><def-item><term>NADPH</term><def><p>nicotinamide adenine dinucleotide
phosphate</p></def></def-item><def-item><term>NBD</term><def><p>nucleotide
binding domain</p></def></def-item><def-item><term>NDP</term><def><p>nucleoside diphosphate</p></def></def-item><def-item><term>NEM</term><def><p><italic>N</italic>-ethylmaleimide</p></def></def-item><def-item><term>NHLP</term><def><p>nitrile hydratase-like leader peptide</p></def></def-item><def-item><term>NMR</term><def><p>nuclear magnetic resonance</p></def></def-item><def-item><term>NRPS</term><def><p>nonribosomal peptide
synthetase</p></def></def-item><def-item><term>NSR</term><def><p>nisin
resistance protein</p></def></def-item><def-item><term>NTP</term><def><p>nucleoside triphosphate</p></def></def-item><def-item><term>NukM<sub>C</sub></term><def><p>NukM cyclase domain</p></def></def-item><def-item><term>Obu</term><def><p>2-oxobutyryl</p></def></def-item><def-item><term>orf</term><def><p>open reading frame</p></def></def-item><def-item><term>Pfam</term><def><p>protein family</p></def></def-item><def-item><term>PE</term><def><p>phosphatidyl ethanolamine</p></def></def-item><def-item><term>Pi</term><def><p>phosphate</p></def></def-item><def-item><term>PI3K</term><def><p>phosphoinositide 3-kinase</p></def></def-item><def-item><term>PKS</term><def><p>polyketide synthase</p></def></def-item><def-item><term>POP</term><def><p>prolyl oligopeptidase</p></def></def-item><def-item><term>pSer</term><def><p>phosphoSer</p></def></def-item><def-item><term>pThr</term><def><p>phosphoThr</p></def></def-item><def-item><term>PSI-BLAST</term><def><p>Position-Specific
Iterated
BLAST</p></def></def-item><def-item><term>PTM</term><def><p>post-translational
modification</p></def></def-item><def-item><term>Pyr</term><def><p>2-oxopropionyl (pyruvyl)</p></def></def-item><def-item><term><italic>ram</italic></term><def><p>rapid aerial mycelium</p></def></def-item><def-item><term>RiPPs</term><def><p>ribosomally synthesized and post-translationally
modified peptides</p></def></def-item><def-item><term>RNase</term><def><p>ribonuclease</p></def></def-item><def-item><term>RRE</term><def><p>RiPP Recognition Element</p></def></def-item><def-item><term>S<italic>a</italic>NSR</term><def><p><italic>Streptococcus
agalactiae</italic> nisin resistance protein</p></def></def-item><def-item><term>SAM</term><def><p>S-adenosyl methionine</p></def></def-item><def-item><term>SDR</term><def><p>short chain dehydrogenase/reductase</p></def></def-item><def-item><term>SDS-PAGE</term><def><p>sodium dodecyl
sulfate-polyacrylamide
gel electrophoresis</p></def></def-item><def-item><term>Sec</term><def><p>secretory pathway</p></def></def-item><def-item><term>SH2</term><def><p>Src homology 2</p></def></def-item><def-item><term>SSN</term><def><p>sequence similarity network</p></def></def-item><def-item><term>SUMO</term><def><p>small ubiquitin-related modifier</p></def></def-item><def-item><term>TMD</term><def><p>transmembrane domain</p></def></def-item><def-item><term>TTP</term><def><p>thymidine triphosphate</p></def></def-item><def-item><term>UniProtKB</term><def><p>UniProt Knowledgebase</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Arnison</surname><given-names>P. G.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Bowers</surname><given-names>A. A.</given-names></name>; <name><surname>Bugni</surname><given-names>T. S.</given-names></name>; <name><surname>Bulaj</surname><given-names>G.</given-names></name>; <name><surname>Camarero</surname><given-names>J. A.</given-names></name>; <name><surname>Campopiano</surname><given-names>D. J.</given-names></name>; <name><surname>Challis</surname><given-names>G. L.</given-names></name>; <name><surname>Clardy</surname><given-names>J.</given-names></name>; et al. <article-title>Ribosomally
synthesized
and post-translationally modified peptide natural products: overview
and recommendations for a universal nomenclature</article-title>. <source>Nat. Prod. Rep.</source>
<year>2013</year>, <volume>30</volume> (<issue>1</issue>), <fpage>108</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1039/C2NP20085F</pub-id>.<pub-id pub-id-type="pmid">23165928</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Schnell</surname><given-names>N.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>; <name><surname>Schneider</surname><given-names>U.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>; <name><surname>Zahner</surname><given-names>H.</given-names></name>; <name><surname>Kellner</surname><given-names>R.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>
<article-title>Prepeptide sequence
of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings</article-title>. <source>Nature</source>
<year>1988</year>, <volume>333</volume> (<issue>6170</issue>), <fpage>276</fpage>&#x02013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1038/333276a0</pub-id>.<pub-id pub-id-type="pmid">2835685</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Mayer</surname><given-names>H.</given-names></name>; <name><surname>Bauer</surname><given-names>H.</given-names></name>; <name><surname>Breuss</surname><given-names>J.</given-names></name>; <name><surname>Ziegler</surname><given-names>S.</given-names></name>; <name><surname>Prohaska</surname><given-names>R.</given-names></name>
<article-title>Characterization
of rat LANCL1, a novel member of the lanthionine synthetase C-like
protein family, highly expressed in testis and brain</article-title>. <source>Gene</source>
<year>2001</year>, <volume>269</volume> (<issue>1&#x02013;2</issue>), <fpage>73</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1119(01)00463-2</pub-id>.<pub-id pub-id-type="pmid">11376939</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Park</surname><given-names>S.</given-names></name>; <name><surname>James</surname><given-names>C. D.</given-names></name>
<article-title>Lanthionine synthetase components
C-like 2 increases
cellular sensitivity to adriamycin by decreasing the expression of
P-glycoprotein through a transcription-mediated mechanism</article-title>. <source>Cancer Res.</source>
<year>2003</year>, <volume>63</volume> (<issue>3</issue>), <fpage>723</fpage>&#x02013;<lpage>727</lpage>.<pub-id pub-id-type="pmid">12566319</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Mohr</surname><given-names>K. I.</given-names></name>; <name><surname>Volz</surname><given-names>C.</given-names></name>; <name><surname>Jansen</surname><given-names>R.</given-names></name>; <name><surname>Wray</surname><given-names>V.</given-names></name>; <name><surname>Hoffmann</surname><given-names>J.</given-names></name>; <name><surname>Bernecker</surname><given-names>S.</given-names></name>; <name><surname>Wink</surname><given-names>J.</given-names></name>; <name><surname>Gerth</surname><given-names>K.</given-names></name>; <name><surname>Stadler</surname><given-names>M.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Pinensins: the first antifungal lantibiotics</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2015</year>, <volume>54</volume> (<issue>38</issue>), <fpage>11254</fpage>&#x02013;<lpage>11258</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201500927</pub-id>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Kodani</surname><given-names>S.</given-names></name>; <name><surname>Hudson</surname><given-names>M. E.</given-names></name>; <name><surname>Durrant</surname><given-names>M. C.</given-names></name>; <name><surname>Buttner</surname><given-names>M. J.</given-names></name>; <name><surname>Nodwell</surname><given-names>J. R.</given-names></name>; <name><surname>Willey</surname><given-names>J. M.</given-names></name>
<article-title>The SapB morphogen
is a lantibiotic-like peptide derived
from the product of the developmental gene <italic>ramS</italic> in <italic>Streptomyces coelicolor</italic></article-title>. <source>Proc. Natl.
Acad. Sci. U. S. A.</source>
<year>2004</year>, <volume>101</volume> (<issue>31</issue>), <fpage>11448</fpage>&#x02013;<lpage>11453</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0404220101</pub-id>.<pub-id pub-id-type="pmid">15277670</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Kodani</surname><given-names>S.</given-names></name>; <name><surname>Lodato</surname><given-names>M. A.</given-names></name>; <name><surname>Durrant</surname><given-names>M. C.</given-names></name>; <name><surname>Picart</surname><given-names>F.</given-names></name>; <name><surname>Willey</surname><given-names>J. M.</given-names></name>
<article-title>SapT, a
lanthionine-containing peptide involved in aerial hyphae formation
in the streptomycetes</article-title>. <source>Mol. Microbiol.</source>
<year>2005</year>, <volume>58</volume>, <fpage>1368</fpage>&#x02013;<lpage>1380</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04921.x</pub-id>.<pub-id pub-id-type="pmid">16313622</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>F&#x000e9;rir</surname><given-names>G.</given-names></name>; <name><surname>Petrova</surname><given-names>M. I.</given-names></name>; <name><surname>Andrei</surname><given-names>G.</given-names></name>; <name><surname>Huskens</surname><given-names>D.</given-names></name>; <name><surname>Hoorelbeke</surname><given-names>B.</given-names></name>; <name><surname>Snoeck</surname><given-names>R.</given-names></name>; <name><surname>Vanderleyden</surname><given-names>J.</given-names></name>; <name><surname>Balzarini</surname><given-names>J.</given-names></name>; <name><surname>Bartoschek</surname><given-names>S.</given-names></name>; <name><surname>Br&#x000f6;nstrup</surname><given-names>M.</given-names></name>; et al. <article-title>The lantibiotic peptide
labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity
with potential for microbicidal applications</article-title>. <source>PLoS One</source>
<year>2013</year>, <volume>8</volume> (<issue>5</issue>), <fpage>e64010</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0064010</pub-id>.<pub-id pub-id-type="pmid">23724015</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Iorio</surname><given-names>M.</given-names></name>; <name><surname>Sasso</surname><given-names>O.</given-names></name>; <name><surname>Maffioli</surname><given-names>S. I.</given-names></name>; <name><surname>Bertorelli</surname><given-names>R.</given-names></name>; <name><surname>Monciardini</surname><given-names>P.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Bonezzi</surname><given-names>F.</given-names></name>; <name><surname>Summa</surname><given-names>M.</given-names></name>; <name><surname>Brunati</surname><given-names>C.</given-names></name>; <name><surname>Bordoni</surname><given-names>R.</given-names></name>; et al. <article-title>A glycosylated, labionin-containing
lanthipeptide with marked antinociceptive activity</article-title>. <source>ACS Chem. Biol.</source>
<year>2014</year>, <volume>9</volume> (<issue>2</issue>), <fpage>398</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1021/cb400692w</pub-id>.<pub-id pub-id-type="pmid">24191663</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Meindl</surname><given-names>K.</given-names></name>; <name><surname>Schmiederer</surname><given-names>T.</given-names></name>; <name><surname>Schneider</surname><given-names>K.</given-names></name>; <name><surname>Reicke</surname><given-names>A.</given-names></name>; <name><surname>Butz</surname><given-names>D.</given-names></name>; <name><surname>Keller</surname><given-names>S.</given-names></name>; <name><surname>Guhring</surname><given-names>H.</given-names></name>; <name><surname>Vertesy</surname><given-names>L.</given-names></name>; <name><surname>Wink</surname><given-names>J.</given-names></name>; <name><surname>Hoffmann</surname><given-names>H.</given-names></name>; et al. <article-title>Labyrinthopeptins: a new class of carbacyclic
lantibiotics</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2010</year>, <volume>49</volume> (<issue>6</issue>), <fpage>1151</fpage>&#x02013;<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200905773</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Grasemann</surname><given-names>H.</given-names></name>; <name><surname>Stehling</surname><given-names>F.</given-names></name>; <name><surname>Brunar</surname><given-names>H.</given-names></name>; <name><surname>Widmann</surname><given-names>R.</given-names></name>; <name><surname>Laliberte</surname><given-names>T. W.</given-names></name>; <name><surname>Molina</surname><given-names>L.</given-names></name>; <name><surname>Doring</surname><given-names>G.</given-names></name>; <name><surname>Ratjen</surname><given-names>F.</given-names></name>
<article-title>Inhalation of Moli1901
in patients with cystic fibrosis</article-title>. <source>Chest</source>
<year>2007</year>, <volume>131</volume> (<issue>5</issue>), <fpage>1461</fpage>&#x02013;<lpage>1466</lpage>. <pub-id pub-id-type="doi">10.1378/chest.06-2085</pub-id>.<pub-id pub-id-type="pmid">17494794</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>McNulty</surname><given-names>M. J.</given-names></name>; <name><surname>Hutabarat</surname><given-names>R. H.</given-names></name>; <name><surname>Findlay</surname><given-names>J. W.</given-names></name>; <name><surname>Devereux</surname><given-names>K.</given-names></name>; <name><surname>Knick</surname><given-names>V. C.</given-names></name>; <name><surname>Harvey</surname><given-names>R. J.</given-names></name>; <name><surname>Molina</surname><given-names>L.</given-names></name>
<article-title>Pharmacokinetics and tissue distribution
of the nonadecapeptide Moli1901 in rats and mice</article-title>. <source>Xenobiotica</source>
<year>2003</year>, <volume>33</volume> (<issue>2</issue>), <fpage>197</fpage>&#x02013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1080/0049825021000022320</pub-id>.<pub-id pub-id-type="pmid">12623761</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Steiner</surname><given-names>I.</given-names></name>; <name><surname>Errhalt</surname><given-names>P.</given-names></name>; <name><surname>Kubesch</surname><given-names>K.</given-names></name>; <name><surname>Hubner</surname><given-names>M.</given-names></name>; <name><surname>Holy</surname><given-names>M.</given-names></name>; <name><surname>Bauer</surname><given-names>M.</given-names></name>; <name><surname>Muller</surname><given-names>M.</given-names></name>; <name><surname>Hinterberger</surname><given-names>S.</given-names></name>; <name><surname>Widmann</surname><given-names>R.</given-names></name>; <name><surname>Mascher</surname><given-names>D.</given-names></name>; et al. <article-title>Pulmonary pharmacokinetics
and safety of nebulized duramycin in healthy male volunteers</article-title>. <source>Naunyn-Schmiedeberg's Arch. Pharmacol.</source>
<year>2008</year>, <volume>378</volume> (<issue>3</issue>), <fpage>323</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1007/s00210-008-0293-8</pub-id>.<pub-id pub-id-type="pmid">18500510</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Jones</surname><given-names>A. M.</given-names></name>; <name><surname>Helm</surname><given-names>J. M.</given-names></name>
<article-title>Emerging treatments in cystic fibrosis</article-title>. <source>Drugs</source>
<year>2009</year>, <volume>69</volume> (<issue>14</issue>), <fpage>1903</fpage>&#x02013;<lpage>1910</lpage>. <pub-id pub-id-type="doi">10.2165/11318500-000000000-00000</pub-id>.<pub-id pub-id-type="pmid">19747007</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Oliynyk</surname><given-names>I.</given-names></name>; <name><surname>Varelogianni</surname><given-names>G.</given-names></name>; <name><surname>Roomans</surname><given-names>G. M.</given-names></name>; <name><surname>Johannesson</surname><given-names>M.</given-names></name>
<article-title>Effect of
duramycin on chloride transport and intracellular calcium concentration
in cystic fibrosis and non-cystic fibrosis epithelia</article-title>. <source>APMIS</source>
<year>2010</year>, <volume>118</volume> (<issue>12</issue>), <fpage>982</fpage>&#x02013;<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0463.2010.02680.x</pub-id>.<pub-id pub-id-type="pmid">21091780</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Jab&#x000e9;s</surname><given-names>D.</given-names></name>; <name><surname>Brunati</surname><given-names>C.</given-names></name>; <name><surname>Candiani</surname><given-names>G.</given-names></name>; <name><surname>Riva</surname><given-names>S.</given-names></name>; <name><surname>Roman&#x000f3;</surname><given-names>G.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>
<article-title>Efficacy of the new
lantibiotic NAI-107 in experimental
infections induced by multidrug-resistant Gram-positive pathogens</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2011</year>, <volume>55</volume> (<issue>4</issue>), <fpage>1671</fpage>&#x02013;<lpage>1676</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01288-10</pub-id>.<pub-id pub-id-type="pmid">21220527</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Crowther</surname><given-names>G. S.</given-names></name>; <name><surname>Baines</surname><given-names>S. D.</given-names></name>; <name><surname>Todhunter</surname><given-names>S. L.</given-names></name>; <name><surname>Freeman</surname><given-names>J.</given-names></name>; <name><surname>Chilton</surname><given-names>C. H.</given-names></name>; <name><surname>Wilcox</surname><given-names>M. H.</given-names></name>
<article-title>Evaluation of NVB302
versus vancomycin activity in
an in vitro human gut model of <italic>Clostridium difficile</italic> infection</article-title>. <source>J. Antimicrob. Chemother.</source>
<year>2013</year>, <volume>68</volume> (<issue>1</issue>), <fpage>168</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dks359</pub-id>.<pub-id pub-id-type="pmid">22966180</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Lepak</surname><given-names>A. J.</given-names></name>; <name><surname>Marchillo</surname><given-names>K.</given-names></name>; <name><surname>Craig</surname><given-names>W. A.</given-names></name>; <name><surname>Andes</surname><given-names>D. R.</given-names></name>
<article-title>In vivo pharmacokinetics
and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine
thigh infection model</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2015</year>, <volume>59</volume> (<issue>2</issue>), <fpage>1258</fpage>&#x02013;<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.04444-14</pub-id>.<pub-id pub-id-type="pmid">25512404</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Boakes</surname><given-names>S.</given-names></name>; <name><surname>Weiss</surname><given-names>W. J.</given-names></name>; <name><surname>Vinson</surname><given-names>M.</given-names></name>; <name><surname>Wadman</surname><given-names>S.</given-names></name>; <name><surname>Dawson</surname><given-names>M. J.</given-names></name>
<article-title>Antibacterial
activity of the novel semisynthetic lantibiotic NVB333 in vitro and
in experimental infection models</article-title>. <source>J. Antibiot.</source>
<year>2016</year>, <volume>69</volume> (<issue>12</issue>), <fpage>850</fpage>&#x02013;<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2016.47</pub-id>.<pub-id pub-id-type="pmid">27189121</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Thomsen</surname><given-names>T.
T.</given-names></name>; <name><surname>Mojsoska</surname><given-names>B.</given-names></name>; <name><surname>Cruz</surname><given-names>J. C.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>; <name><surname>Jenssen</surname><given-names>H.</given-names></name>; <name><surname>Lobner-Olesen</surname><given-names>A.</given-names></name>; <name><surname>Rewitz</surname><given-names>K.</given-names></name>
<article-title>The lantibiotic NAI-107 efficiently
rescues <italic>Drosophila melanogaster</italic> from infection with
methicillin-resistant <italic>Staphylococcus aureus</italic> USA300</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2016</year>, <volume>60</volume> (<issue>9</issue>), <fpage>5427</fpage>&#x02013;<lpage>5436</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.02965-15</pub-id>.<pub-id pub-id-type="pmid">27381394</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Maffioli</surname><given-names>S. I.</given-names></name>; <name><surname>Cruz</surname><given-names>J. C.</given-names></name>; <name><surname>Monciardini</surname><given-names>P.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>
<article-title>Advancing
cell wall inhibitors towards clinical applications</article-title>. <source>J. Ind. Microbiol. Biotechnol.</source>
<year>2016</year>, <volume>43</volume> (<issue>2&#x02013;3</issue>), <fpage>177</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1007/s10295-015-1703-9</pub-id>.<pub-id pub-id-type="pmid">26515981</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Ghobrial</surname><given-names>O. G.</given-names></name>; <name><surname>Derendorf</surname><given-names>H.</given-names></name>; <name><surname>Hillman</surname><given-names>J. D.</given-names></name>
<article-title>Pharmacodynamic activity of the lantibiotic
MU1140</article-title>. <source>Int. J. Antimicrob. Agents</source>
<year>2009</year>, <volume>33</volume> (<issue>1</issue>), <fpage>70</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2008.07.028</pub-id>.<pub-id pub-id-type="pmid">18835136</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Ghobrial</surname><given-names>O. G.</given-names></name>; <name><surname>Derendorf</surname><given-names>H.</given-names></name>; <name><surname>Hillman</surname><given-names>J. D.</given-names></name>
<article-title>Development and validation of a LC-MS
quantification method for the lantibiotic MU1140 in rat plasma</article-title>. <source>J. Pharm. Biomed. Anal.</source>
<year>2009</year>, <volume>49</volume> (<issue>4</issue>), <fpage>970</fpage>&#x02013;<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2008.12.022</pub-id>.<pub-id pub-id-type="pmid">19269770</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Ghobrial</surname><given-names>O.</given-names></name>; <name><surname>Derendorf</surname><given-names>H.</given-names></name>; <name><surname>Hillman</surname><given-names>J. D.</given-names></name>
<article-title>Human serum binding and its effect
on the pharmacodynamics of the lantibiotic MU1140</article-title>. <source>Eur. J. Pharm. Sci.</source>
<year>2010</year>, <volume>41</volume> (<issue>5</issue>), <fpage>658</fpage>&#x02013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2010.09.005</pub-id>.<pub-id pub-id-type="pmid">20869439</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Ghobrial</surname><given-names>O.</given-names></name>; <name><surname>Derendorf</surname><given-names>H.</given-names></name>; <name><surname>Hillman</surname><given-names>J. D.</given-names></name>
<article-title>Pharmacokinetic and pharmacodynamic
evaluation of the lantibiotic MU1140</article-title>. <source>J. Pharm.
Sci.</source>
<year>2010</year>, <volume>99</volume> (<issue>5</issue>), <fpage>2521</fpage>&#x02013;<lpage>2528</lpage>. <pub-id pub-id-type="doi">10.1002/jps.22015</pub-id>.<pub-id pub-id-type="pmid">20039385</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Johnson</surname><given-names>S. E.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Moulder</surname><given-names>J. E.</given-names></name>; <name><surname>Zhao</surname><given-names>M.</given-names></name>
<article-title>Whole-body imaging
of high-dose ionizing irradiation-induced tissue injuries using 99mTc-duramycin</article-title>. <source>J. Nucl. Med.</source>
<year>2013</year>, <volume>54</volume> (<issue>8</issue>), <fpage>1397</fpage>&#x02013;<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.112.112490</pub-id>.<pub-id pub-id-type="pmid">23804327</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Yao</surname><given-names>S.</given-names></name>; <name><surname>Hu</surname><given-names>K.</given-names></name>; <name><surname>Tang</surname><given-names>G.</given-names></name>; <name><surname>Liang</surname><given-names>X.</given-names></name>; <name><surname>Du</surname><given-names>K.</given-names></name>; <name><surname>Nie</surname><given-names>D.</given-names></name>; <name><surname>Jiang</surname><given-names>S.</given-names></name>; <name><surname>Zang</surname><given-names>L.</given-names></name>
<article-title>Positron emission tomography imaging
of cell death with [(18)F]FPDuramycin</article-title>. <source>Apoptosis</source>
<year>2014</year>, <volume>19</volume> (<issue>5</issue>), <fpage>841</fpage>&#x02013;<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1007/s10495-013-0964-x</pub-id>.<pub-id pub-id-type="pmid">24464510</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Audi</surname><given-names>S. H.</given-names></name>; <name><surname>Jacobs</surname><given-names>E. R.</given-names></name>; <name><surname>Zhao</surname><given-names>M.</given-names></name>; <name><surname>Roerig</surname><given-names>D. L.</given-names></name>; <name><surname>Haworth</surname><given-names>S. T.</given-names></name>; <name><surname>Clough</surname><given-names>A. V.</given-names></name>
<article-title>In vivo detection of hyperoxia-induced pulmonary endothelial
cell death using (99m)Tc-duramycin</article-title>. <source>Nucl. Med.
Biol.</source>
<year>2015</year>, <volume>42</volume> (<issue>1</issue>), <fpage>46</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2014.08.010</pub-id>.<pub-id pub-id-type="pmid">25218023</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>F.</given-names></name>; <name><surname>Fang</surname><given-names>W.</given-names></name>; <name><surname>Johnson</surname><given-names>S. E.</given-names></name>; <name><surname>Audi</surname><given-names>S.</given-names></name>; <name><surname>Zimmer</surname><given-names>M.</given-names></name>; <name><surname>Holly</surname><given-names>T. A.</given-names></name>; <name><surname>Lee</surname><given-names>D. C.</given-names></name>; <name><surname>Zhu</surname><given-names>B.</given-names></name>; <name><surname>Zhu</surname><given-names>H.</given-names></name>; et al. <article-title>The feasibility
of imaging myocardial ischemic/reperfusion
injury using (99m)Tc-labeled duramycin in a porcine model</article-title>. <source>Nucl. Med. Biol.</source>
<year>2015</year>, <volume>42</volume> (<issue>2</issue>), <fpage>198</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2014.09.002</pub-id>.<pub-id pub-id-type="pmid">25451214</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Elvas</surname><given-names>F.</given-names></name>; <name><surname>Vangestel</surname><given-names>C.</given-names></name>; <name><surname>Rapic</surname><given-names>S.</given-names></name>; <name><surname>Verhaeghe</surname><given-names>J.</given-names></name>; <name><surname>Gray</surname><given-names>B.</given-names></name>; <name><surname>Pak</surname><given-names>K.</given-names></name>; <name><surname>Stroobants</surname><given-names>S.</given-names></name>; <name><surname>Staelens</surname><given-names>S.</given-names></name>; <name><surname>Wyffels</surname><given-names>L.</given-names></name>
<article-title>Characterization of
[(99m)Tc]duramycin
as a SPECT imaging agent for early assessment of tumor apoptosis</article-title>. <source>Mol. Imaging Biol.</source>
<year>2015</year>, <volume>17</volume> (<issue>6</issue>), <fpage>838</fpage>&#x02013;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-015-0852-6</pub-id>.<pub-id pub-id-type="pmid">25896815</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Elvas</surname><given-names>F.</given-names></name>; <name><surname>Vangestel</surname><given-names>C.</given-names></name>; <name><surname>Pak</surname><given-names>K.</given-names></name>; <name><surname>Vermeulen</surname><given-names>P.</given-names></name>; <name><surname>Gray</surname><given-names>B.</given-names></name>; <name><surname>Stroobants</surname><given-names>S.</given-names></name>; <name><surname>Staelens</surname><given-names>S.</given-names></name>; <name><surname>Wyffels</surname><given-names>L.</given-names></name>
<article-title>Early prediction
of tumor response to treatment: preclinical validation of 99mTc-duramycin</article-title>. <source>J. Nucl. Med.</source>
<year>2016</year>, <volume>57</volume> (<issue>5</issue>), <fpage>805</fpage>&#x02013;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.115.168344</pub-id>.<pub-id pub-id-type="pmid">26837335</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><person-group person-group-type="allauthors"><name><surname>Luo</surname><given-names>R.</given-names></name>; <name><surname>Niu</surname><given-names>L.</given-names></name>; <name><surname>Qiu</surname><given-names>F.</given-names></name>; <name><surname>Fang</surname><given-names>W.</given-names></name>; <name><surname>Fu</surname><given-names>T.</given-names></name>; <name><surname>Zhao</surname><given-names>M.</given-names></name>; <name><surname>Zhang</surname><given-names>Y. J.</given-names></name>; <name><surname>Hua</surname><given-names>Z. C.</given-names></name>; <name><surname>Li</surname><given-names>X. F.</given-names></name>; <name><surname>Wang</surname><given-names>F.</given-names></name></person-group><article-title>Monitoring apoptosis
of breast cancer xenograft after paclitaxel treatment with 99mTc-Labeled
duramycin SPECT/CT</article-title>. <source>Mol. Imaging</source><year>2016</year>, <volume>15</volume>, DOI: <pub-id pub-id-type="doi">10.1177/1536012115624918</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Medhora</surname><given-names>M.</given-names></name>; <name><surname>Haworth</surname><given-names>S.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Narayanan</surname><given-names>J.</given-names></name>; <name><surname>Gao</surname><given-names>F.</given-names></name>; <name><surname>Zhao</surname><given-names>M.</given-names></name>; <name><surname>Audi</surname><given-names>S.</given-names></name>; <name><surname>Jacobs</surname><given-names>E. R.</given-names></name>; <name><surname>Fish</surname><given-names>B. L.</given-names></name>; <name><surname>Clough</surname><given-names>A. V.</given-names></name>
<article-title>Biomarkers for radiation pneumonitis using noninvasive
molecular imaging</article-title>. <source>J. Nucl. Med.</source>
<year>2016</year>, <volume>57</volume> (<issue>8</issue>), <fpage>1296</fpage>&#x02013;<lpage>1301</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.115.160291</pub-id>.<pub-id pub-id-type="pmid">27033892</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Larsen</surname><given-names>B. T.</given-names></name>; <name><surname>Lerman</surname><given-names>L. O.</given-names></name>; <name><surname>Gray</surname><given-names>B. D.</given-names></name>; <name><surname>Barber</surname><given-names>C.</given-names></name>; <name><surname>Hedayat</surname><given-names>A. F.</given-names></name>; <name><surname>Zhao</surname><given-names>M.</given-names></name>; <name><surname>Furenlid</surname><given-names>L. R.</given-names></name>; <name><surname>Pak</surname><given-names>K. Y.</given-names></name>; <name><surname>Woolfenden</surname><given-names>J. M.</given-names></name>
<article-title>Detection
of atherosclerotic plaques in ApoE-deficient
mice using (99m)Tc-duramycin</article-title>. <source>Nucl. Med. Biol.</source>
<year>2016</year>, <volume>43</volume> (<issue>8</issue>), <fpage>496</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2016.05.007</pub-id>.<pub-id pub-id-type="pmid">27236285</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Doroghazi</surname><given-names>J. R.</given-names></name>; <name><surname>Zhao</surname><given-names>X.</given-names></name>; <name><surname>Walker</surname><given-names>M. C.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Expanded natural product diversity revealed by analysis
of lanthipeptide-like gene clusters in Actinobacteria</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2015</year>, <volume>81</volume> (<issue>13</issue>), <fpage>4339</fpage>&#x02013;<lpage>4350</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00635-15</pub-id>.<pub-id pub-id-type="pmid">25888176</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>Vel&#x000e1;squez</surname><given-names>J. E.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Evolution
of lanthipeptide synthetases</article-title>. <source>Proc. Natl. Acad.
Sci. U. S. A.</source>
<year>2012</year>, <volume>109</volume> (<issue>45</issue>), <fpage>18361</fpage>&#x02013;<lpage>18366</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1210393109</pub-id>.<pub-id pub-id-type="pmid">23071302</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Marsh</surname><given-names>A. J.</given-names></name>; <name><surname>O&#x02019;Sullivan</surname><given-names>O.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>
<article-title>In silico
analysis highlights the frequency and diversity of type 1 lantibiotic
gene clusters in genome sequenced bacteria</article-title>. <source>BMC Genomics</source>
<year>2010</year>, <volume>11</volume>, <fpage>679</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-11-679</pub-id>.<pub-id pub-id-type="pmid">21118552</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>The sequence
of the enterococcal cytolysin imparts
unusual lanthionine stereochemistry</article-title>. <source>Nat. Chem.
Biol.</source>
<year>2013</year>, <volume>9</volume> (<issue>3</issue>), <fpage>157</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1162</pub-id>.<pub-id pub-id-type="pmid">23314913</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Jung</surname><given-names>G.</given-names></name>
<article-title>Lantibiotics-Ribosomally
synthesized biologically active polypeptides containing sulfide bridges
and &#x003b1;,&#x003b2;-dehydroamino acids</article-title>. <source>Angew.
Chem., Int. Ed. Engl.</source>
<year>1991</year>, <volume>30</volume>, <fpage>1051</fpage>&#x02013;<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1002/anie.199110513</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>
<article-title>Comparison of lantibiotic gene clusters
and encoded proteins</article-title>. <source>Antonie van Leeuwenhoek</source>
<year>1996</year>, <volume>69</volume> (<issue>2</issue>), <fpage>171</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1007/BF00399422</pub-id>.<pub-id pub-id-type="pmid">8775977</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>
<article-title>Lantibiotics: biosynthesis
and biological activities
of uniquely modified peptides from gram-positive bacteria</article-title>. <source>Annu. Rev. Microbiol.</source>
<year>1998</year>, <volume>52</volume>, <fpage>41</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.52.1.41</pub-id>.<pub-id pub-id-type="pmid">9891793</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>van
Kraaij</surname><given-names>C.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Lantibiotics:
biosynthesis, mode of action and applications</article-title>. <source>Nat. Prod. Rep.</source>
<year>1999</year>, <volume>16</volume> (<issue>5</issue>), <fpage>575</fpage>&#x02013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1039/a804531c</pub-id>.<pub-id pub-id-type="pmid">10584332</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>McAuliffe</surname><given-names>O.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>
<article-title>Lantibiotics: structure, biosynthesis
and mode of action</article-title>. <source>FEMS Microbiol. Rev.</source>
<year>2001</year>, <volume>25</volume> (<issue>3</issue>), <fpage>285</fpage>&#x02013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6976.2001.tb00579.x</pub-id>.<pub-id pub-id-type="pmid">11348686</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Chatterjee</surname><given-names>C.</given-names></name>; <name><surname>Paul</surname><given-names>M.</given-names></name>; <name><surname>Xie</surname><given-names>L.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Biosynthesis
and mode of action of lantibiotics</article-title>. <source>Chem. Rev.</source>
<year>2005</year>, <volume>105</volume>, <fpage>633</fpage>&#x02013;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1021/cr030105v</pub-id>.<pub-id pub-id-type="pmid">15700960</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Bacterial
lantibiotics: strategies
to improve therapeutic potential</article-title>. <source>Curr. Protein
Pept. Sci.</source>
<year>2005</year>, <volume>6</volume> (<issue>1</issue>), <fpage>61</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.2174/1389203053027584</pub-id>.<pub-id pub-id-type="pmid">15638769</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Chandrapati</surname><given-names>S.</given-names></name>; <name><surname>O&#x02019;Sullivan</surname><given-names>D.
J.</given-names></name>
<article-title>Nisin independent induction
of the nisA promoter in <italic>Lactococcus lactis</italic> during
growth in lactose or galactose</article-title>. <source>FEMS Microbiol.
Lett.</source>
<year>1999</year>, <volume>170</volume> (<issue>1</issue>), <fpage>191</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1999.tb13374.x</pub-id>.<pub-id pub-id-type="pmid">9919668</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Jack</surname><given-names>R.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Heidrich</surname><given-names>C.</given-names></name>; <name><surname>Sahl</surname><given-names>H.-G.</given-names></name>
<article-title>The genetics of
lantibiotic biosynthesis</article-title>. <source>BioEssays</source>
<year>1995</year>, <volume>17</volume>, <fpage>793</fpage>&#x02013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1002/bies.950170909</pub-id>.<pub-id pub-id-type="pmid">8763832</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Chandrapati</surname><given-names>S.</given-names></name>; <name><surname>O&#x02019;Sullivan</surname><given-names>D. J.</given-names></name>
<article-title>Characterization
of the promoter regions involved in
galactose- and nisin-mediated induction of the nisA gene in <italic>Lactococcus lactis</italic> ATCC 11454</article-title>. <source>Mol.
Microbiol.</source>
<year>2002</year>, <volume>46</volume> (<issue>2</issue>), <fpage>467</fpage>&#x02013;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03163.x</pub-id>.<pub-id pub-id-type="pmid">12406222</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>O&#x02019;Sullivan</surname><given-names>D. J.</given-names></name>
<article-title>Heterologous
expression of the <italic>Lactococcus
lactis</italic> bacteriocin, nisin, in a dairy Enterococcus strain</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2002</year>, <volume>68</volume> (<issue>7</issue>), <fpage>3392</fpage>&#x02013;<lpage>3400</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.68.7.3392-3400.2002</pub-id>.<pub-id pub-id-type="pmid">12089020</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Skaugen</surname><given-names>M.</given-names></name>; <name><surname>Andersen</surname><given-names>E. L.</given-names></name>; <name><surname>Christie</surname><given-names>V. H.</given-names></name>; <name><surname>Nes</surname><given-names>I. F.</given-names></name>
<article-title>Identification,
characterization, and expression of a second, bicistronic, operon
involved in the production of lactocin S in <italic>Lactobacillus
sakei</italic> L45</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2002</year>, <volume>68</volume> (<issue>2</issue>), <fpage>720</fpage>&#x02013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.68.2.720-727.2002</pub-id>.<pub-id pub-id-type="pmid">11823212</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Stein</surname><given-names>T.</given-names></name>; <name><surname>Heinzmann</surname><given-names>S.</given-names></name>; <name><surname>Kiesau</surname><given-names>P.</given-names></name>; <name><surname>Himmel</surname><given-names>B.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>
<article-title>The spa-box
for transcriptional activation of subtilin biosynthesis and immunity
in <italic>Bacillus subtilis</italic></article-title>. <source>Mol.
Microbiol.</source>
<year>2003</year>, <volume>47</volume> (<issue>6</issue>), <fpage>1627</fpage>&#x02013;<lpage>1636</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03374.x</pub-id>.<pub-id pub-id-type="pmid">12622817</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Schmitz</surname><given-names>S.</given-names></name>; <name><surname>Hoffmann</surname><given-names>A.</given-names></name>; <name><surname>Szekat</surname><given-names>C.</given-names></name>; <name><surname>Rudd</surname><given-names>B.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>
<article-title>The lantibiotic
mersacidin is an autoinducing peptide</article-title>. <source>Appl.
Environ. Microbiol.</source>
<year>2006</year>, <volume>72</volume> (<issue>11</issue>), <fpage>7270</fpage>&#x02013;<lpage>7277</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00723-06</pub-id>.<pub-id pub-id-type="pmid">16980420</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>O&#x02019;Sullivan</surname><given-names>D. J.</given-names></name>
<article-title>Identification
of a nisI promoter within the nisABCTIP
operon that may enable establishment of nisin immunity prior to induction
of the operon via signal transduction</article-title>. <source>J. Bacteriol.</source>
<year>2006</year>, <volume>188</volume> (<issue>24</issue>), <fpage>8496</fpage>&#x02013;<lpage>8503</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00946-06</pub-id>.<pub-id pub-id-type="pmid">17012392</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Willey</surname><given-names>J. M.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Lantibiotics: peptides of diverse structure and function</article-title>. <source>Annu. Rev. Microbiol.</source>
<year>2007</year>, <volume>61</volume>, <fpage>477</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.61.080706.093501</pub-id>.<pub-id pub-id-type="pmid">17506681</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Lubelski</surname><given-names>J.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Khusainov</surname><given-names>R.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Biosynthesis,
immunity, regulation, mode of action and engineering of the model
lantibiotic nisin</article-title>. <source>Cell. Mol. Life Sci.</source>
<year>2008</year>, <volume>65</volume>, <fpage>455</fpage>&#x02013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-007-7171-2</pub-id>.<pub-id pub-id-type="pmid">17965835</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Lantibiotics: mode
of action, biosynthesis and bioengineering</article-title>. <source>Curr. Pharm. Biotechnol.</source>
<year>2009</year>, <volume>10</volume> (<issue>1</issue>), <fpage>2</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.2174/138920109787048616</pub-id>.<pub-id pub-id-type="pmid">19149587</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Foulston</surname><given-names>L.</given-names></name>; <name><surname>Bibb</surname><given-names>M.</given-names></name>
<article-title>Feed-forward regulation
of microbisporicin biosynthesis in <italic>Microbispora corallina</italic></article-title>. <source>J. Bacteriol.</source>
<year>2011</year>, <volume>193</volume> (<issue>12</issue>), <fpage>3064</fpage>&#x02013;<lpage>3071</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00250-11</pub-id>.<pub-id pub-id-type="pmid">21478362</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Ni</surname><given-names>J.</given-names></name>; <name><surname>Teng</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>G.</given-names></name>; <name><surname>Qiao</surname><given-names>C.</given-names></name>; <name><surname>Huan</surname><given-names>L.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>
<article-title>Autoregulation of lantibiotic
bovicin HJ50 biosynthesis by the BovK-BovR
two-component signal transduction system in <italic>Streptococcus
bovis</italic> HJ50</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2011</year>, <volume>77</volume> (<issue>2</issue>), <fpage>407</fpage>&#x02013;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01278-10</pub-id>.<pub-id pub-id-type="pmid">21075878</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Lee</surname><given-names>J. H.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>O&#x02019;Sullivan</surname><given-names>D. J.</given-names></name>
<article-title>Transcription analysis of a lantibiotic
gene cluster from <italic>Bifidobacterium longum</italic> DJO10A</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2011</year>, <volume>77</volume> (<issue>17</issue>), <fpage>5879</fpage>&#x02013;<lpage>5887</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00571-11</pub-id>.<pub-id pub-id-type="pmid">21742926</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Gaskell</surname><given-names>A. A.</given-names></name>; <name><surname>Giovinazzo</surname><given-names>J. A.</given-names></name>; <name><surname>Fonte</surname><given-names>V.</given-names></name>; <name><surname>Willey</surname><given-names>J. M.</given-names></name>
<article-title>Multi-tier regulation
of the streptomycete morphogenetic peptide SapB</article-title>. <source>Mol. Microbiol.</source>
<year>2012</year>, <volume>84</volume> (<issue>3</issue>), <fpage>501</fpage>&#x02013;<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2012.08041.x</pub-id>.<pub-id pub-id-type="pmid">22486809</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Sherwood</surname><given-names>E. J.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>
<article-title>The antibiotic planosporicin
coordinates its own production
in the actinomycete</article-title>. <source>Proc. Natl. Acad. Sci.
U. S. A.</source>
<year>2013</year>, <volume>110</volume> (<issue>27</issue>), <fpage>E2500</fpage>&#x02013;<lpage>2509</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1305392110</pub-id>.<pub-id pub-id-type="pmid">23776227</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Fern&#x000e1;ndez-Mart&#x000ed;nez</surname><given-names>L. T.</given-names></name>; <name><surname>Gomez-Escribano</surname><given-names>J. P.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>
<article-title>A relA-dependent regulatory cascade
for auto-induction of microbisporicin production in <italic>Microbispora
corallina</italic></article-title>. <source>Mol. Microbiol.</source>
<year>2015</year>, <volume>97</volume> (<issue>3</issue>), <fpage>502</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.13046</pub-id>.<pub-id pub-id-type="pmid">25939852</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name><surname>Breukink</surname><given-names>E.</given-names></name>; <name><surname>de Kruijff</surname><given-names>B.</given-names></name>
<article-title>Lipid II as
a target for antibiotics</article-title>. <source>Nat. Rev. Drug Discovery</source>
<year>2006</year>, <volume>5</volume> (<issue>4</issue>), <fpage>321</fpage>&#x02013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2004</pub-id>.<pub-id pub-id-type="pmid">16531990</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name><surname>Schneider</surname><given-names>T.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Lipid II
and other bactoprenol-bound cell wall precursors
as drug targets</article-title>. <source>Curr. Opin. Investig. Drugs</source>
<year>2010</year>, <volume>11</volume> (<issue>2</issue>), <fpage>157</fpage>&#x02013;<lpage>164</lpage>.</mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name><surname>Zhao</surname><given-names>M.</given-names></name>
<article-title>Lantibiotics
as probes for phosphatidylethanolamine</article-title>. <source>Amino
Acids</source>
<year>2011</year>, <volume>41</volume> (<issue>5</issue>), <fpage>1071</fpage>&#x02013;<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-009-0386-9</pub-id>.<pub-id pub-id-type="pmid">21573677</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name><surname>Islam</surname><given-names>M. R.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Zendo</surname><given-names>T.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Antimicrobial
mechanism
of lantibiotics</article-title>. <source>Biochem. Soc. Trans.</source>
<year>2012</year>, <volume>40</volume> (<issue>6</issue>), <fpage>1528</fpage>&#x02013;<lpage>1533</lpage>. <pub-id pub-id-type="doi">10.1042/BST20120190</pub-id>.<pub-id pub-id-type="pmid">23176511</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name><surname>Barbour</surname><given-names>A.</given-names></name>; <name><surname>Tagg</surname><given-names>J.</given-names></name>; <name><surname>Abou-Zied</surname><given-names>O. K.</given-names></name>; <name><surname>Philip</surname><given-names>K.</given-names></name>
<article-title>New insights into the
mode of action of the lantibiotic salivaricin B</article-title>. <source>Sci. Rep.</source>
<year>2016</year>, <volume>6</volume>, <fpage>31749</fpage><pub-id pub-id-type="doi">10.1038/srep31749</pub-id>.<pub-id pub-id-type="pmid">27526944</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Rollema</surname><given-names>H. S.</given-names></name>; <name><surname>Yap</surname><given-names>W. M.</given-names></name>; <name><surname>Boot</surname><given-names>H. J.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>
<article-title>Engineering dehydrated
amino acid residues in the antimicrobial
peptide nisin</article-title>. <source>J. Biol. Chem.</source>
<year>1992</year>, <volume>267</volume> (<issue>34</issue>), <fpage>24340</fpage>&#x02013;<lpage>24346</lpage>.<pub-id pub-id-type="pmid">1447185</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name><surname>Liu</surname><given-names>W.</given-names></name>; <name><surname>Hansen</surname><given-names>J. N.</given-names></name>
<article-title>Enhancement of the
chemical and antimicrobial properties
of subtilin by site-directed mutagenesis</article-title>. <source>J.
Biol. Chem.</source>
<year>1992</year>, <volume>267</volume> (<issue>35</issue>), <fpage>25078</fpage>&#x02013;<lpage>25085</lpage>.<pub-id pub-id-type="pmid">1460009</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name><surname>Rollema</surname><given-names>H. S.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Both</surname><given-names>P.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>
<article-title>Improvement
of solubility and stability of the antimicrobial peptide nisin by
protein engineering</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1995</year>, <volume>61</volume> (<issue>8</issue>), <fpage>2873</fpage>&#x02013;<lpage>2878</lpage>.<pub-id pub-id-type="pmid">7487019</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Szekat</surname><given-names>C.</given-names></name>; <name><surname>Josten</surname><given-names>M.</given-names></name>; <name><surname>Heidrich</surname><given-names>C.</given-names></name>; <name><surname>Kempter</surname><given-names>C.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Engineering
of a novel thioether
bridge and role of modified residues in the lantibiotic Pep5</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1996</year>, <volume>62</volume> (<issue>2</issue>), <fpage>385</fpage>&#x02013;<lpage>392</lpage>.<pub-id pub-id-type="pmid">8593044</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Ottenw&#x000e4;lder</surname><given-names>B.</given-names></name>; <name><surname>Dodd</surname><given-names>H. M.</given-names></name>; <name><surname>Horn</surname><given-names>N.</given-names></name>; <name><surname>Metzger</surname><given-names>J.</given-names></name>; <name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Gnau</surname><given-names>V.</given-names></name>; <name><surname>Bongers</surname><given-names>R.</given-names></name>; <name><surname>van den Bogaard</surname><given-names>P.</given-names></name>; et al. <article-title>Protein engineering of lantibiotics</article-title>. <source>Antonie
van Leeuwenhoek</source>
<year>1996</year>, <volume>69</volume> (<issue>2</issue>), <fpage>161</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1007/BF00399421</pub-id>.<pub-id pub-id-type="pmid">8775976</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name><surname>Szekat</surname><given-names>C.</given-names></name>; <name><surname>Jack</surname><given-names>R. W.</given-names></name>; <name><surname>Skutlarek</surname><given-names>D.</given-names></name>; <name><surname>Farber</surname><given-names>H.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>
<article-title>Construction
of an expression system for site-directed mutagenesis of the lantibiotic
mersacidin</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2003</year>, <volume>69</volume> (<issue>7</issue>), <fpage>3777</fpage>&#x02013;<lpage>3783</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.69.7.3777-3783.2003</pub-id>.<pub-id pub-id-type="pmid">12839744</pub-id></mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>de Boef</surname><given-names>E.</given-names></name>; <name><surname>Leenhouts</surname><given-names>K. J.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Lantibiotic structures
as guidelines for the design of peptides that can be modified by lantibiotic
enzymes</article-title>. <source>Biochemistry</source>
<year>2005</year>, <volume>44</volume> (<issue>24</issue>), <fpage>8873</fpage>&#x02013;<lpage>8882</lpage>. <pub-id pub-id-type="doi">10.1021/bi050081h</pub-id>.<pub-id pub-id-type="pmid">15952794</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Asaduzzaman</surname><given-names>S. M.</given-names></name>; <name><surname>Aso</surname><given-names>Y.</given-names></name>; <name><surname>Okuda</surname><given-names>K.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Lantibiotics: insight
and foresight for new paradigm</article-title>. <source>J. Biosci. Bioeng.</source>
<year>2006</year>, <volume>102</volume> (<issue>3</issue>), <fpage>139</fpage>&#x02013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1263/jbb.102.139</pub-id>.<pub-id pub-id-type="pmid">17046525</pub-id></mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Deegan</surname><given-names>L. H.</given-names></name>; <name><surname>Lawton</surname><given-names>E. M.</given-names></name>; <name><surname>Draper</surname><given-names>L. A.</given-names></name>; <name><surname>O&#x02019;Connor</surname><given-names>P. M.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Complete alanine scanning of the
two-component lantibiotic lacticin 3147: generating a blueprint for
rational drug design</article-title>. <source>Mol. Microbiol.</source>
<year>2006</year>, <volume>62</volume> (<issue>3</issue>), <fpage>735</fpage>&#x02013;<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05398.x</pub-id>.<pub-id pub-id-type="pmid">17076667</pub-id></mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Aso</surname><given-names>Y.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Lantibiotic engineering:
molecular characterization and exploitation of lantibiotic-synthesizing
enzymes for peptide engineering</article-title>. <source>J. Mol. Microbiol.
Biotechnol.</source>
<year>2007</year>, <volume>13</volume> (<issue>4</issue>), <fpage>235</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1159/000104749</pub-id>.<pub-id pub-id-type="pmid">17827974</pub-id></mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Wierenga</surname><given-names>J.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J. M.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>Dissection and modulation of the
four distinct activities of nisin by mutagenesis of rings A and B
and by C-terminal truncation</article-title>. <source>Appl. Environ.
Microbiol.</source>
<year>2007</year>, <volume>73</volume> (<issue>18</issue>), <fpage>5809</fpage>&#x02013;<lpage>5816</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01104-07</pub-id>.<pub-id pub-id-type="pmid">17660303</pub-id></mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Wierenga</surname><given-names>J.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J. M.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>Production of dehydroamino acid-containing
peptides by <italic>Lactococcus lactis</italic></article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2007</year>, <volume>73</volume> (<issue>6</issue>), <fpage>1792</fpage>&#x02013;<lpage>1796</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02350-06</pub-id>.<pub-id pub-id-type="pmid">17261515</pub-id></mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>NisC, the cyclase
of the lantibiotic nisin, can catalyze
cyclization of designed nonlantibiotic peptides</article-title>. <source>Biochemistry</source>
<year>2007</year>, <volume>46</volume>, <fpage>13179</fpage>&#x02013;<lpage>13189</lpage>. <pub-id pub-id-type="doi">10.1021/bi700106z</pub-id>.<pub-id pub-id-type="pmid">17929939</pub-id></mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name><surname>Levengood</surname><given-names>M. R.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Use of lantibiotic synthetases for the preparation
of bioactive constrained peptides</article-title>. <source>Bioorg. Med.
Chem. Lett.</source>
<year>2008</year>, <volume>18</volume>, <fpage>3025</fpage>&#x02013;<lpage>3028</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2008.01.062</pub-id>.<pub-id pub-id-type="pmid">18294843</pub-id></mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name><surname>Appleyard</surname><given-names>A. N.</given-names></name>; <name><surname>Choi</surname><given-names>S.</given-names></name>; <name><surname>Read</surname><given-names>D. M.</given-names></name>; <name><surname>Lightfoot</surname><given-names>A.</given-names></name>; <name><surname>Boakes</surname><given-names>S.</given-names></name>; <name><surname>Hoffmann</surname><given-names>A.</given-names></name>; <name><surname>Chopra</surname><given-names>I.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Rudd</surname><given-names>B. A.</given-names></name>; <name><surname>Dawson</surname><given-names>M. J.</given-names></name>; et al. <article-title>Dissecting structural
and functional diversity of the lantibiotic mersacidin</article-title>. <source>Chem. Biol.</source>
<year>2009</year>, <volume>16</volume> (<issue>5</issue>), <fpage>490</fpage>&#x02013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2009.03.011</pub-id>.<pub-id pub-id-type="pmid">19477413</pub-id></mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name><surname>Cort&#x000e9;s</surname><given-names>J.</given-names></name>; <name><surname>Appleyard</surname><given-names>A. N.</given-names></name>; <name><surname>Dawson</surname><given-names>M. J.</given-names></name>
<article-title>Whole-cell generation of lantibiotic
variants</article-title>. <source>Methods Enzymol.</source>
<year>2009</year>, <volume>458</volume>, <fpage>559</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/S0076-6879(09)04822-8</pub-id>.<pub-id pub-id-type="pmid">19374998</pub-id></mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name><surname>Islam</surname><given-names>M. R.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Nishie</surname><given-names>M.</given-names></name>; <name><surname>Jikuya</surname><given-names>H.</given-names></name>; <name><surname>Zendo</surname><given-names>T.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Evaluation of essential
and variable residues of nukacin ISK-1 by NNK scanning</article-title>. <source>Mol. Microbiol.</source>
<year>2009</year>, <volume>72</volume> (<issue>6</issue>), <fpage>1438</fpage>&#x02013;<lpage>1447</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06733.x</pub-id>.<pub-id pub-id-type="pmid">19432794</pub-id></mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name><surname>Levengood</surname><given-names>M. R.</given-names></name>; <name><surname>Knerr</surname><given-names>P. J.</given-names></name>; <name><surname>Oman</surname><given-names>T. J.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>In vitro
mutasynthesis of lantibiotic analogues containing nonproteinogenic
amino acids</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2009</year>, <volume>131</volume> (<issue>34</issue>), <fpage>12024</fpage>&#x02013;<lpage>12025</lpage>. <pub-id pub-id-type="doi">10.1021/ja903239s</pub-id>.<pub-id pub-id-type="pmid">19655738</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name><surname>Boakes</surname><given-names>S.</given-names></name>; <name><surname>Cort&#x000e9;s</surname><given-names>J.</given-names></name>; <name><surname>Appleyard</surname><given-names>A. N.</given-names></name>; <name><surname>Rudd</surname><given-names>B. A.</given-names></name>; <name><surname>Dawson</surname><given-names>M. J.</given-names></name>
<article-title>Organization
of the genes encoding the biosynthesis of actagardine and engineering
of a variant generation system</article-title>. <source>Mol. Microbiol.</source>
<year>2009</year>, <volume>72</volume> (<issue>5</issue>), <fpage>1126</fpage>&#x02013;<lpage>1136</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2009.06708.x</pub-id>.<pub-id pub-id-type="pmid">19400806</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal" id="cit87"><name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Arkema-Meter</surname><given-names>A.</given-names></name>; <name><surname>Baudoin</surname><given-names>I.</given-names></name>; <name><surname>Post</surname><given-names>E.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Nelemans</surname><given-names>S. A.</given-names></name>; <name><surname>Akanbi</surname><given-names>M. H.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>To protect peptide
pharmaceuticals against peptidases</article-title>. <source>J. Pharmacol.
Toxicol. Methods</source>
<year>2010</year>, <volume>61</volume> (<issue>2</issue>), <fpage>210</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.vascn.2010.02.010</pub-id>.<pub-id pub-id-type="pmid">20176117</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal" id="cit88"><name><surname>Field</surname><given-names>D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>The dawning
of a
&#x02019;Golden era&#x02019; in lantibiotic bioengineering</article-title>. <source>Mol. Microbiol.</source>
<year>2010</year>, <volume>78</volume>, <fpage>1077</fpage>&#x02013;<lpage>1087</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07406.x</pub-id>.<pub-id pub-id-type="pmid">21091497</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>
<article-title>Microbial
engineering of dehydro-amino
acids and lanthionines in non-lantibiotic peptides</article-title>. <source>Antonie van Leeuwenhoek</source>
<year>2010</year>, <volume>97</volume> (<issue>4</issue>), <fpage>319</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1007/s10482-010-9418-4</pub-id>.<pub-id pub-id-type="pmid">20140513</pub-id></mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name><surname>Ross</surname><given-names>A. C.</given-names></name>; <name><surname>Vederas</surname><given-names>J. C.</given-names></name>
<article-title>Fundamental functionality:
recent developments in understanding
the structure-activity relationships of lantibiotic peptides</article-title>. <source>J. Antibiot.</source>
<year>2011</year>, <volume>64</volume> (<issue>1</issue>), <fpage>27</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2010.136</pub-id>.<pub-id pub-id-type="pmid">21081951</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal" id="cit91"><name><surname>Caetano</surname><given-names>T.</given-names></name>; <name><surname>Krawczyk</surname><given-names>J. M.</given-names></name>; <name><surname>Mosker</surname><given-names>E.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>; <name><surname>Mendo</surname><given-names>S.</given-names></name>
<article-title>Heterologous expression, biosynthesis, and mutagenesis of type II
lantibiotics from <italic>Bacillus licheniformis</italic> in <italic>Escherichia coli</italic></article-title>. <source>Chem. Biol.</source>
<year>2011</year>, <volume>18</volume> (<issue>1</issue>), <fpage>90</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2010.11.010</pub-id>.<pub-id pub-id-type="pmid">21276942</pub-id></mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Garg</surname><given-names>N.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Production
of lantipeptides in <italic>Escherichia coli</italic></article-title>. <source>J. Am. Chem. Soc.</source>
<year>2011</year>, <volume>133</volume> (<issue>8</issue>), <fpage>2338</fpage>&#x02013;<lpage>2341</lpage>. <pub-id pub-id-type="doi">10.1021/ja109044r</pub-id>.<pub-id pub-id-type="pmid">21114289</pub-id></mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Harada</surname><given-names>Y.</given-names></name>; <name><surname>Okuda</surname><given-names>K.</given-names></name>; <name><surname>Zendo</surname><given-names>T.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Engineering
unusual amino acids into
peptides using lantibiotic synthetase</article-title>. <source>Methods
Mol. Biol.</source>
<year>2011</year>, <volume>705</volume>, <fpage>225</fpage>&#x02013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61737-967-3_13</pub-id>.<pub-id pub-id-type="pmid">21125389</pub-id></mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal" id="cit94"><name><surname>Knerr</surname><given-names>P. J.</given-names></name>; <name><surname>Oman</surname><given-names>T. J.</given-names></name>; <name><surname>Garcia de Gonzalo</surname><given-names>C.</given-names></name>; <name><surname>Lupoli</surname><given-names>T. J.</given-names></name>; <name><surname>Walker</surname><given-names>S.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Non-proteinogenic amino acids in lacticin 481 analogues
result in more potent inhibition of peptidoglycan transglycosylation</article-title>. <source>ACS Chem. Biol.</source>
<year>2012</year>, <volume>7</volume>, <fpage>1791</fpage>&#x02013;<lpage>1795</lpage>. <pub-id pub-id-type="doi">10.1021/cb300372b</pub-id>.<pub-id pub-id-type="pmid">22920239</pub-id></mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name><surname>Suda</surname><given-names>S.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Lacticin 3147-biosynthesis,
molecular analysis, immunity, bioengineering and applications</article-title>. <source>Curr. Protein Pept. Sci.</source>
<year>2012</year>, <volume>13</volume> (<issue>3</issue>), <fpage>193</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.2174/138920312800785021</pub-id>.<pub-id pub-id-type="pmid">21827422</pub-id></mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal" id="cit96"><name><surname>Oldach</surname><given-names>F.</given-names></name>; <name><surname>Al Toma</surname><given-names>R.</given-names></name>; <name><surname>Kuthning</surname><given-names>A.</given-names></name>; <name><surname>Caetano</surname><given-names>T.</given-names></name>; <name><surname>Mendo</surname><given-names>S.</given-names></name>; <name><surname>Budisa</surname><given-names>N.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Congeneric
lantibiotics from ribosomal
in vivo peptide synthesis with noncanonical amino acids</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2012</year>, <volume>51</volume>, <fpage>415</fpage>&#x02013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201106154</pub-id>.</mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal" id="cit97"><name><surname>Boakes</surname><given-names>S.</given-names></name>; <name><surname>Ayala</surname><given-names>T.</given-names></name>; <name><surname>Herman</surname><given-names>M.</given-names></name>; <name><surname>Appleyard</surname><given-names>A. N.</given-names></name>; <name><surname>Dawson</surname><given-names>M. J.</given-names></name>; <name><surname>Cort&#x000e9;s</surname><given-names>J.</given-names></name>
<article-title>Generation of an actagardine A variant
library through saturation mutagenesis</article-title>. <source>Appl.
Microbiol. Biotechnol.</source>
<year>2012</year>, <volume>15</volume>, <fpage>1509</fpage>&#x02013;<lpage>1517</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-012-4041-0</pub-id>.</mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal" id="cit98"><name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>; <name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Buivydas</surname><given-names>A.</given-names></name>; <name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Increasing
the success rate of lantibiotic drug discovery by synthetic biology</article-title>. <source>Expert Opin. Drug Discovery</source>
<year>2012</year>, <volume>7</volume> (<issue>8</issue>), <fpage>695</fpage>&#x02013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1517/17460441.2012.693476</pub-id>.</mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal" id="cit99"><name><surname>Field</surname><given-names>D.</given-names></name>; <name><surname>Begley</surname><given-names>M.</given-names></name>; <name><surname>O&#x02019;Connor</surname><given-names>P. M.</given-names></name>; <name><surname>Daly</surname><given-names>K. M.</given-names></name>; <name><surname>Hugenholtz</surname><given-names>F.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Bioengineered nisin
A derivatives with enhanced activity against both Gram positive and
Gram negative pathogens</article-title>. <source>PLoS One</source>
<year>2012</year>, <volume>7</volume> (<issue>10</issue>), <fpage>e46884</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0046884</pub-id>.<pub-id pub-id-type="pmid">23056510</pub-id></mixed-citation></ref><ref id="ref100"><mixed-citation publication-type="journal" id="cit100"><name><surname>Molloy</surname><given-names>E. M.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>
<article-title>&#x02019;Bac&#x02019;
to the future: bioengineering lantibiotics for designer purposes</article-title>. <source>Biochem. Soc. Trans.</source>
<year>2012</year>, <volume>40</volume> (<issue>6</issue>), <fpage>1492</fpage>&#x02013;<lpage>1497</lpage>. <pub-id pub-id-type="doi">10.1042/BST20120193</pub-id>.<pub-id pub-id-type="pmid">23176504</pub-id></mixed-citation></ref><ref id="ref101"><mixed-citation publication-type="journal" id="cit101"><name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Wilson-Stanford</surname><given-names>S.</given-names></name>; <name><surname>Cromwell</surname><given-names>W.</given-names></name>; <name><surname>Hillman</surname><given-names>J. D.</given-names></name>; <name><surname>Guerrero</surname><given-names>A.</given-names></name>; <name><surname>Allen</surname><given-names>C. A.</given-names></name>; <name><surname>Sorg</surname><given-names>J. A.</given-names></name>; <name><surname>Smith</surname><given-names>L.</given-names></name>
<article-title>Site-directed
mutations in the lanthipeptide mutacin 1140</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2013</year>, <volume>79</volume> (<issue>13</issue>), <fpage>4015</fpage>&#x02013;<lpage>4023</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00704-13</pub-id>.<pub-id pub-id-type="pmid">23603688</pub-id></mixed-citation></ref><ref id="ref102"><mixed-citation publication-type="journal" id="cit102"><name><surname>Molloy</surname><given-names>E. M.</given-names></name>; <name><surname>Field</surname><given-names>D.</given-names></name>; <name><surname>PM</surname><given-names>O. C.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Saturation mutagenesis
of lysine
12 leads to the identification of derivatives of nisin A with enhanced
antimicrobial activity</article-title>. <source>PLoS One</source>
<year>2013</year>, <volume>8</volume> (<issue>3</issue>), <fpage>e58530</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0058530</pub-id>.<pub-id pub-id-type="pmid">23505531</pub-id></mixed-citation></ref><ref id="ref103"><mixed-citation publication-type="journal" id="cit103"><name><surname>Caetano</surname><given-names>T.</given-names></name>; <name><surname>Barbosa</surname><given-names>J.</given-names></name>; <name><surname>Moesker</surname><given-names>E.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>; <name><surname>Mendo</surname><given-names>S.</given-names></name>
<article-title>Bioengineering of lanthipeptides
in <italic>Escherichia coli</italic>: assessing the specificity of
lichenicidin and haloduracin biosynthetic
machinery</article-title>. <source>Res. Microbiol.</source>
<year>2014</year>, <volume>165</volume> (<issue>7</issue>), <fpage>600</fpage>&#x02013;<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1016/j.resmic.2014.07.006</pub-id>.<pub-id pub-id-type="pmid">25058408</pub-id></mixed-citation></ref><ref id="ref104"><mixed-citation publication-type="journal" id="cit104"><name><surname>Kuthning</surname><given-names>A.</given-names></name>; <name><surname>M&#x000f6;sker</surname><given-names>E.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Engineering
the heterologous expression of lanthipeptides in <italic>Escherichia
coli</italic> by multigene assembly</article-title>. <source>Appl. Microbiol.
Biotechnol.</source>
<year>2015</year>, <volume>99</volume> (<issue>15</issue>), <fpage>6351</fpage>&#x02013;<lpage>6361</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-015-6557-6</pub-id>.<pub-id pub-id-type="pmid">25846334</pub-id></mixed-citation></ref><ref id="ref105"><mixed-citation publication-type="journal" id="cit105"><name><surname>Escano</surname><given-names>J.</given-names></name>; <name><surname>Smith</surname><given-names>L.</given-names></name>
<article-title>Multipronged approach for engineering
novel peptide analogues of existing lantibiotics</article-title>. <source>Expert Opin. Drug Discovery</source>
<year>2015</year>, <volume>10</volume> (<issue>8</issue>), <fpage>857</fpage>&#x02013;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1517/17460441.2015.1049527</pub-id>.</mixed-citation></ref><ref id="ref106"><mixed-citation publication-type="journal" id="cit106"><name><surname>Kong</surname><given-names>W.</given-names></name>; <name><surname>Kapuganti</surname><given-names>V. S.</given-names></name>; <name><surname>Lu</surname><given-names>T.</given-names></name>
<article-title>A gene network engineering
platform for lactic acid bacteria</article-title>. <source>Nucleic Acids
Res.</source>
<year>2016</year>, <volume>44</volume> (<issue>4</issue>), <fpage>e37</fpage><pub-id pub-id-type="doi">10.1093/nar/gkv1093</pub-id>.<pub-id pub-id-type="pmid">26503255</pub-id></mixed-citation></ref><ref id="ref107"><mixed-citation publication-type="journal" id="cit107"><name><surname>Kong</surname><given-names>W.</given-names></name>; <name><surname>Lu</surname><given-names>T.</given-names></name>
<article-title>Cloning and optimization
of a nisin
biosynthesis pathway for bacteriocin harvest</article-title>. <source>ACS Synth. Biol.</source>
<year>2014</year>, <volume>3</volume> (<issue>7</issue>), <fpage>439</fpage>&#x02013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1021/sb500225r</pub-id>.<pub-id pub-id-type="pmid">24847677</pub-id></mixed-citation></ref><ref id="ref108"><mixed-citation publication-type="journal" id="cit108"><name><surname>Kuthning</surname><given-names>A.</given-names></name>; <name><surname>Durkin</surname><given-names>P.</given-names></name>; <name><surname>Oehm</surname><given-names>S.</given-names></name>; <name><surname>Hoesl</surname><given-names>M. G.</given-names></name>; <name><surname>Budisa</surname><given-names>N.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Towards biocontained cell factories:
an evolutionarily adapted <italic>Escherichia coli</italic> strain
produces a new-to-nature bioactive lantibiotic containing thienopyrrole-alanine</article-title>. <source>Sci. Rep.</source>
<year>2016</year>, <volume>6</volume>, <fpage>33447</fpage><pub-id pub-id-type="doi">10.1038/srep33447</pub-id>.<pub-id pub-id-type="pmid">27634138</pub-id></mixed-citation></ref><ref id="ref109"><mixed-citation publication-type="journal" id="cit109"><person-group person-group-type="allauthors"><name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>; <name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name></person-group><article-title>Employing the promiscuity of lantibiotic
biosynthetic machineries
to produce novel antimicrobials</article-title>. <source>FEMS Microbiol.
Rev.</source><year>2016</year>, DOI: <pub-id pub-id-type="doi">10.1093/femsre/fuw034</pub-id>.</mixed-citation></ref><ref id="ref110"><mixed-citation publication-type="journal" id="cit110"><name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Shao</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>de Vries</surname><given-names>M. P.</given-names></name>; <name><surname>Broos</surname><given-names>J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Incorporation of
tryptophan analogues into the lantibiotic nisin</article-title>. <source>Amino Acids</source>
<year>2016</year>, <volume>48</volume> (<issue>5</issue>), <fpage>1309</fpage>&#x02013;<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-016-2186-3</pub-id>.<pub-id pub-id-type="pmid">26872656</pub-id></mixed-citation></ref><ref id="ref111"><mixed-citation publication-type="journal" id="cit111"><name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Potentiating the activity of nisin against <italic>Escherichia coli</italic></article-title>. <source>Front. Cell Dev.
Biol.</source>
<year>2016</year>, <volume>4</volume>, <fpage>7</fpage><pub-id pub-id-type="doi">10.3389/fcell.2016.00007</pub-id>.<pub-id pub-id-type="pmid">26904542</pub-id></mixed-citation></ref><ref id="ref112"><mixed-citation publication-type="journal" id="cit112"><name><surname>Doroghazi</surname><given-names>J. R.</given-names></name>; <name><surname>Albright</surname><given-names>J. C.</given-names></name>; <name><surname>Goering</surname><given-names>A. W.</given-names></name>; <name><surname>Ju</surname><given-names>K. S.</given-names></name>; <name><surname>Haines</surname><given-names>R. R.</given-names></name>; <name><surname>Tchalukov</surname><given-names>K. A.</given-names></name>; <name><surname>Labeda</surname><given-names>D. P.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>; <name><surname>Metcalf</surname><given-names>W. W.</given-names></name>
<article-title>A roadmap for natural
product discovery based on large-scale
genomics and metabolomics</article-title>. <source>Nat. Chem. Biol.</source>
<year>2014</year>, <volume>10</volume> (<issue>11</issue>), <fpage>963</fpage>&#x02013;<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1659</pub-id>.<pub-id pub-id-type="pmid">25262415</pub-id></mixed-citation></ref><ref id="ref113"><mixed-citation publication-type="journal" id="cit113"><name><surname>Cimermancic</surname><given-names>P.</given-names></name>; <name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Claesen</surname><given-names>J.</given-names></name>; <name><surname>Kurita</surname><given-names>K.</given-names></name>; <name><surname>Wieland
Brown</surname><given-names>L. C.</given-names></name>; <name><surname>Mavrommatis</surname><given-names>K.</given-names></name>; <name><surname>Pati</surname><given-names>A.</given-names></name>; <name><surname>Godfrey</surname><given-names>P. A.</given-names></name>; <name><surname>Koehrsen</surname><given-names>M.</given-names></name>; <name><surname>Clardy</surname><given-names>J.</given-names></name>; et al. <article-title>Insights into secondary
metabolism from a global analysis of prokaryotic biosynthetic gene
clusters</article-title>. <source>Cell</source>
<year>2014</year>, <volume>158</volume> (<issue>2</issue>), <fpage>412</fpage>&#x02013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.06.034</pub-id>.<pub-id pub-id-type="pmid">25036635</pub-id></mixed-citation></ref><ref id="ref114"><mixed-citation publication-type="journal" id="cit114"><name><surname>Walsh</surname><given-names>C. J.</given-names></name>; <name><surname>Guinane</surname><given-names>C. M.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>O&#x02019;Toole</surname><given-names>P. W.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>
<article-title>In silico identification
of bacteriocin
gene clusters in the gastrointestinal tract, based on the Human Microbiome
Project&#x02019;s reference genome database</article-title>. <source>BMC Microbiol.</source>
<year>2015</year>, <volume>15</volume>, <fpage>183</fpage><pub-id pub-id-type="doi">10.1186/s12866-015-0515-4</pub-id>.<pub-id pub-id-type="pmid">26377179</pub-id></mixed-citation></ref><ref id="ref115"><mixed-citation publication-type="journal" id="cit115"><name><surname>Skinnider</surname><given-names>M. A.</given-names></name>; <name><surname>Johnston</surname><given-names>C. W.</given-names></name>; <name><surname>Edgar</surname><given-names>R. E.</given-names></name>; <name><surname>Dejong</surname><given-names>C. A.</given-names></name>; <name><surname>Merwin</surname><given-names>N. J.</given-names></name>; <name><surname>Rees</surname><given-names>P. N.</given-names></name>; <name><surname>Magarvey</surname><given-names>N. A.</given-names></name>
<article-title>Genomic
charting
of ribosomally synthesized natural product chemical space facilitates
targeted mining</article-title>. <source>Proc. Natl. Acad. Sci. U. S.
A.</source>
<year>2016</year>, <volume>113</volume> (<issue>42</issue>), <fpage>E6343</fpage>&#x02013;<lpage>E6351</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1609014113</pub-id>.<pub-id pub-id-type="pmid">27698135</pub-id></mixed-citation></ref><ref id="ref116"><mixed-citation publication-type="journal" id="cit116"><name><surname>Vel&#x000e1;squez</surname><given-names>J. E.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Genome mining for ribosomally synthesized
natural products</article-title>. <source>Curr. Opin. Chem. Biol.</source>
<year>2011</year>, <volume>15</volume> (<issue>1</issue>), <fpage>11</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2010.10.027</pub-id>.<pub-id pub-id-type="pmid">21095156</pub-id></mixed-citation></ref><ref id="ref117"><mixed-citation publication-type="journal" id="cit117"><name><surname>de Jong</surname><given-names>A.</given-names></name>; <name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>Kok</surname><given-names>J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>BAGEL2:
mining for bacteriocins in genomic data</article-title>. <source>Nucleic
Acids Res.</source>
<year>2010</year>, <volume>38</volume>, <fpage>W647</fpage>&#x02013;<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq365</pub-id>.<pub-id pub-id-type="pmid">20462861</pub-id></mixed-citation></ref><ref id="ref118"><mixed-citation publication-type="journal" id="cit118"><name><surname>Medema</surname><given-names>M. H.</given-names></name>; <name><surname>Blin</surname><given-names>K.</given-names></name>; <name><surname>Cimermancic</surname><given-names>P.</given-names></name>; <name><surname>de Jager</surname><given-names>V.</given-names></name>; <name><surname>Zakrzewski</surname><given-names>P.</given-names></name>; <name><surname>Fischbach</surname><given-names>M. A.</given-names></name>; <name><surname>Weber</surname><given-names>T.</given-names></name>; <name><surname>Takano</surname><given-names>E.</given-names></name>; <name><surname>Breitling</surname><given-names>R.</given-names></name>
<article-title>antiSMASH:
rapid identification, annotation and analysis of secondary metabolite
biosynthesis gene clusters in bacterial and fungal genome sequences</article-title>. <source>Nucleic Acids Res.</source>
<year>2011</year>, <volume>39</volume>, <fpage>W339</fpage><pub-id pub-id-type="doi">10.1093/nar/gkr466</pub-id>.<pub-id pub-id-type="pmid">21672958</pub-id></mixed-citation></ref><ref id="ref119"><mixed-citation publication-type="journal" id="cit119"><name><surname>Kersten</surname><given-names>R. D.</given-names></name>; <name><surname>Yang</surname><given-names>Y.-L.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Cimermancic</surname><given-names>P.</given-names></name>; <name><surname>Nam</surname><given-names>S.-J.</given-names></name>; <name><surname>Fenical</surname><given-names>W.</given-names></name>; <name><surname>Fischbach</surname><given-names>M. A.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>; <name><surname>Dorrestein</surname><given-names>P. C.</given-names></name>
<article-title>A mass spectrometry&#x02013;guided
genome mining approach for natural product peptidogenomics</article-title>. <source>Nat. Chem. Biol.</source>
<year>2011</year>, <volume>7</volume>, <fpage>794</fpage>&#x02013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.684</pub-id>.<pub-id pub-id-type="pmid">21983601</pub-id></mixed-citation></ref><ref id="ref120"><mixed-citation publication-type="journal" id="cit120"><name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>de Jong</surname><given-names>A.</given-names></name>; <name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>; <name><surname>Kok</surname><given-names>J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>BAGEL3: Automated identification of genes encoding
bacteriocins and (non-)bactericidal posttranslationally modified peptides</article-title>. <source>Nucleic Acids Res.</source>
<year>2013</year>, <volume>41</volume>, <fpage>W448</fpage>&#x02013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt391</pub-id>.<pub-id pub-id-type="pmid">23677608</pub-id></mixed-citation></ref><ref id="ref121"><mixed-citation publication-type="journal" id="cit121"><name><surname>Mohimani</surname><given-names>H.</given-names></name>; <name><surname>Kersten</surname><given-names>R. D.</given-names></name>; <name><surname>Liu</surname><given-names>W. T.</given-names></name>; <name><surname>Wang</surname><given-names>M.</given-names></name>; <name><surname>Purvine</surname><given-names>S. O.</given-names></name>; <name><surname>Wu</surname><given-names>S.</given-names></name>; <name><surname>Brewer</surname><given-names>H. M.</given-names></name>; <name><surname>Pasa-Tolic</surname><given-names>L.</given-names></name>; <name><surname>Bandeira</surname><given-names>N.</given-names></name>; <name><surname>Moore</surname><given-names>B. S.</given-names></name>; et al. <article-title>Automated genome mining
of ribosomal peptide natural products</article-title>. <source>ACS Chem.
Biol.</source>
<year>2014</year>, <volume>9</volume> (<issue>7</issue>), <fpage>1545</fpage>&#x02013;<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1021/cb500199h</pub-id>.<pub-id pub-id-type="pmid">24802639</pub-id></mixed-citation></ref><ref id="ref122"><mixed-citation publication-type="journal" id="cit122"><name><surname>Singh</surname><given-names>M.</given-names></name>; <name><surname>Sareen</surname><given-names>D.</given-names></name>
<article-title>Novel LanT associated lantibiotic
clusters identified by genome database mining</article-title>. <source>PLoS One</source>
<year>2014</year>, <volume>9</volume> (<issue>3</issue>), <fpage>e91352</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0091352</pub-id>.<pub-id pub-id-type="pmid">24621781</pub-id></mixed-citation></ref><ref id="ref123"><mixed-citation publication-type="journal" id="cit123"><name><surname>Weber</surname><given-names>T.</given-names></name>; <name><surname>Blin</surname><given-names>K.</given-names></name>; <name><surname>Duddela</surname><given-names>S.</given-names></name>; <name><surname>Krug</surname><given-names>D.</given-names></name>; <name><surname>Kim</surname><given-names>H. U.</given-names></name>; <name><surname>Bruccoleri</surname><given-names>R.</given-names></name>; <name><surname>Lee</surname><given-names>S. Y.</given-names></name>; <name><surname>Fischbach</surname><given-names>M. A.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>; <name><surname>Wohlleben</surname><given-names>W.</given-names></name>; et al. <article-title>antiSMASH 3.0-a comprehensive
resource for the genome mining of biosynthetic gene clusters</article-title>. <source>Nucleic Acids Res.</source>
<year>2015</year>, <volume>43</volume> (<issue>W1</issue>), <fpage>W237</fpage>&#x02013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv437</pub-id>.<pub-id pub-id-type="pmid">25948579</pub-id></mixed-citation></ref><ref id="ref124"><mixed-citation publication-type="journal" id="cit124"><name><surname>McClerren</surname><given-names>A. L.</given-names></name>; <name><surname>Cooper</surname><given-names>L. E.</given-names></name>; <name><surname>Quan</surname><given-names>C.</given-names></name>; <name><surname>Thomas</surname><given-names>P. M.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Discovery
and in vitro biosynthesis
of haloduracin, a two-component lantibiotic</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2006</year>, <volume>103</volume> (<issue>46</issue>), <fpage>17243</fpage>&#x02013;<lpage>17248</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0606088103</pub-id>.<pub-id pub-id-type="pmid">17085596</pub-id></mixed-citation></ref><ref id="ref125"><mixed-citation publication-type="journal" id="cit125"><name><surname>Lawton</surname><given-names>E. M.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Identification
of a novel two-peptide lantibiotic, Haloduracin, produced by the alkaliphile <italic>Bacillus halodurans</italic> C-125</article-title>. <source>FEMS Microbiol.
Lett.</source>
<year>2007</year>, <volume>267</volume>, <fpage>64</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2006.00539.x</pub-id>.<pub-id pub-id-type="pmid">17233677</pub-id></mixed-citation></ref><ref id="ref126"><mixed-citation publication-type="journal" id="cit126"><name><surname>Begley</surname><given-names>M.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Identification
of a novel two-peptide lantibiotic, lichenicidin, following rational
genome mining for LanM proteins</article-title>. <source>Appl. Environ.
Microbiol.</source>
<year>2009</year>, <volume>75</volume> (<issue>17</issue>), <fpage>5451</fpage>&#x02013;<lpage>5460</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00730-09</pub-id>.<pub-id pub-id-type="pmid">19561184</pub-id></mixed-citation></ref><ref id="ref127"><mixed-citation publication-type="journal" id="cit127"><name><surname>Dischinger</surname><given-names>J.</given-names></name>; <name><surname>Josten</surname><given-names>M.</given-names></name>; <name><surname>Szekat</surname><given-names>C.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>
<article-title>Production of the novel two-peptide lantibiotic lichenicidin
by <italic>Bacillus licheniformis</italic> DSM 13</article-title>. <source>PLoS One</source>
<year>2009</year>, <volume>4</volume> (<issue>8</issue>), <fpage>e6788</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0006788</pub-id>.<pub-id pub-id-type="pmid">19707558</pub-id></mixed-citation></ref><ref id="ref128"><mixed-citation publication-type="journal" id="cit128"><name><surname>Goto</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Claesen</surname><given-names>J.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Discovery of unique lanthionine synthetases
reveals new mechanistic and evolutionary insights</article-title>. <source>PLoS Biol.</source>
<year>2010</year>, <volume>8</volume> (<issue>3</issue>), <fpage>e1000339</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.1000339</pub-id>.<pub-id pub-id-type="pmid">20351769</pub-id></mixed-citation></ref><ref id="ref129"><mixed-citation publication-type="journal" id="cit129"><name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Sher</surname><given-names>D.</given-names></name>; <name><surname>Kelly</surname><given-names>L.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>K.</given-names></name>; <name><surname>Knerr</surname><given-names>P. J.</given-names></name>; <name><surname>Joewono</surname><given-names>I.</given-names></name>; <name><surname>Rusch</surname><given-names>D.</given-names></name>; <name><surname>Chisholm</surname><given-names>S. W.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Catalytic promiscuity in the biosynthesis
of cyclic
peptide secondary metabolites in planktonic marine cyanobacteria</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2010</year>, <volume>107</volume> (<issue>23</issue>), <fpage>10430</fpage>&#x02013;<lpage>10435</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0913677107</pub-id>.<pub-id pub-id-type="pmid">20479271</pub-id></mixed-citation></ref><ref id="ref130"><mixed-citation publication-type="journal" id="cit130"><name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Biosynthesis
of the class III lantipeptide
catenulipeptin</article-title>. <source>ACS Chem. Biol.</source>
<year>2012</year>, <volume>7</volume>, <fpage>1529</fpage>&#x02013;<lpage>1535</lpage>. <pub-id pub-id-type="doi">10.1021/cb3002446</pub-id>.<pub-id pub-id-type="pmid">22725258</pub-id></mixed-citation></ref><ref id="ref131"><mixed-citation publication-type="journal" id="cit131"><name><surname>Krawczyk</surname><given-names>B.</given-names></name>; <name><surname>V&#x000f6;ller</surname><given-names>G. H.</given-names></name>; <name><surname>V&#x000f6;ller</surname><given-names>J.</given-names></name>; <name><surname>Ensle</surname><given-names>P.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Curvopeptin:
a new lanthionine-containing
class III lantibiotic and its co-substrate promiscuous synthetase</article-title>. <source>ChemBioChem</source>
<year>2012</year>, <volume>13</volume> (<issue>14</issue>), <fpage>2065</fpage>&#x02013;<lpage>2071</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201200417</pub-id>.<pub-id pub-id-type="pmid">22907786</pub-id></mixed-citation></ref><ref id="ref132"><mixed-citation publication-type="journal" id="cit132"><name><surname>V&#x000f6;ller</surname><given-names>G. H.</given-names></name>; <name><surname>Krawczyk</surname><given-names>J. M.</given-names></name>; <name><surname>Pesic</surname><given-names>A.</given-names></name>; <name><surname>Krawczyk</surname><given-names>B.</given-names></name>; <name><surname>Nachtigall</surname><given-names>J.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Characterization
of new class III
lantibiotics-erythreapeptin, avermipeptin and griseopeptin from <italic>Saccharopolyspora erythraea</italic>, <italic>Streptomyces avermitilis</italic> and <italic>Streptomyces griseus</italic> demonstrates stepwise
N-terminal leader processing</article-title>. <source>ChemBioChem</source>
<year>2012</year>, <volume>13</volume>, <fpage>1174</fpage>&#x02013;<lpage>1183</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201200118</pub-id>.<pub-id pub-id-type="pmid">22556031</pub-id></mixed-citation></ref><ref id="ref133"><mixed-citation publication-type="journal" id="cit133"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Teng</surname><given-names>K.</given-names></name>; <name><surname>Sun</surname><given-names>S.</given-names></name>; <name><surname>Sun</surname><given-names>Z.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>
<article-title>Cerecidins, novel lantibiotics from <italic>Bacillus
cereus</italic> with potent antimicrobial activity</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2014</year>, <volume>80</volume> (<issue>8</issue>), <fpage>2633</fpage>&#x02013;<lpage>2643</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.03751-13</pub-id>.<pub-id pub-id-type="pmid">24532070</pub-id></mixed-citation></ref><ref id="ref134"><mixed-citation publication-type="journal" id="cit134"><name><surname>Iftime</surname><given-names>D.</given-names></name>; <name><surname>Jasyk</surname><given-names>M.</given-names></name>; <name><surname>Kulik</surname><given-names>A.</given-names></name>; <name><surname>Imhoff</surname><given-names>J. F.</given-names></name>; <name><surname>Stegmann</surname><given-names>E.</given-names></name>; <name><surname>Wohlleben</surname><given-names>W.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>; <name><surname>Weber</surname><given-names>T.</given-names></name>
<article-title>Streptocollin, a type IV lanthipeptide
produced by <italic>Streptomyces
collinus</italic> T&#x000fc; 365</article-title>. <source>ChemBioChem</source>
<year>2015</year>, <volume>16</volume> (<issue>18</issue>), <fpage>2615</fpage>&#x02013;<lpage>2623</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201500377</pub-id>.<pub-id pub-id-type="pmid">26437689</pub-id></mixed-citation></ref><ref id="ref135"><mixed-citation publication-type="journal" id="cit135"><name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Ma</surname><given-names>H.</given-names></name>; <name><surname>Ge</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Teng</surname><given-names>K.</given-names></name>; <name><surname>Sun</surname><given-names>Z.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>
<article-title>Bovicin HJ50-like lantibiotics,
a novel subgroup of lantibiotics featured by an indispensable disulfide
bridge</article-title>. <source>PLoS One</source>
<year>2014</year>, <volume>9</volume> (<issue>5</issue>), <fpage>e97121</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0097121</pub-id>.<pub-id pub-id-type="pmid">24821187</pub-id></mixed-citation></ref><ref id="ref136"><mixed-citation publication-type="journal" id="cit136"><name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>Kloosterman</surname><given-names>T. G.</given-names></name>; <name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>; <name><surname>Deng</surname><given-names>J.</given-names></name>; <name><surname>Plat</surname><given-names>A.</given-names></name>; <name><surname>Baudu</surname><given-names>B.</given-names></name>; <name><surname>Hendriks</surname><given-names>D.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Discovery,
production and modification
of five novel lantibiotics using the promiscuous nisin modification
machinery</article-title>. <source>ACS Synth. Biol.</source>
<year>2016</year>, <volume>5</volume>, <fpage>1146</fpage>&#x02013;<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.6b00033</pub-id>.<pub-id pub-id-type="pmid">27294279</pub-id></mixed-citation></ref><ref id="ref137"><mixed-citation publication-type="journal" id="cit137"><name><surname>Zhao</surname><given-names>X.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Structural
characterization and bioactivity
analysis of the two-component lantibiotic Flv system from a ruminant
bacterium</article-title>. <source>Cell Chem. Biol.</source>
<year>2016</year>, <volume>23</volume> (<issue>2</issue>), <fpage>246</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2015.11.014</pub-id>.<pub-id pub-id-type="pmid">27028884</pub-id></mixed-citation></ref><ref id="ref138"><mixed-citation publication-type="journal" id="cit138"><name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Ma</surname><given-names>H.</given-names></name>; <name><surname>Sun</surname><given-names>S.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>
<article-title>Semi-in vitro biosynthesis of cryptic
lanthipeptide
CLA 124 from <italic>Streptomyces clavuligerus</italic></article-title>. <source>Wei Sheng Wu Xue Bao</source>
<year>2015</year>, <volume>55</volume> (<issue>11</issue>), <fpage>1402</fpage>&#x02013;<lpage>1408</lpage>.<pub-id pub-id-type="pmid">26915221</pub-id></mixed-citation></ref><ref id="ref139"><mixed-citation publication-type="journal" id="cit139"><name><surname>Basi-Chipalu</surname><given-names>S.</given-names></name>; <name><surname>Dischinger</surname><given-names>J.</given-names></name>; <name><surname>Josten</surname><given-names>M.</given-names></name>; <name><surname>Szekat</surname><given-names>C.</given-names></name>; <name><surname>Zweynert</surname><given-names>A.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>
<article-title>Pseudomycoicidin, a
class II lantibiotic from <italic>Bacillus pseudomycoides</italic></article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2015</year>, <volume>81</volume> (<issue>10</issue>), <fpage>3419</fpage>&#x02013;<lpage>3429</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00299-15</pub-id>.<pub-id pub-id-type="pmid">25769830</pub-id></mixed-citation></ref><ref id="ref140"><mixed-citation publication-type="journal" id="cit140"><name><surname>McIntosh</surname><given-names>J. A.</given-names></name>; <name><surname>Donia</surname><given-names>M. S.</given-names></name>; <name><surname>Schmidt</surname><given-names>E. W.</given-names></name>
<article-title>Ribosomal
peptide
natural products: bridging the ribosomal and nonribosomal worlds</article-title>. <source>Nat. Prod. Rep.</source>
<year>2009</year>, <volume>26</volume>, <fpage>537</fpage>&#x02013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1039/b714132g</pub-id>.<pub-id pub-id-type="pmid">19642421</pub-id></mixed-citation></ref><ref id="ref141"><mixed-citation publication-type="journal" id="cit141"><name><surname>Ortega</surname><given-names>M. A.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>New insights into the biosynthetic
logic of ribosomally synthesized and post-translationally modified
peptide natural products</article-title>. <source>Cell Chem. Biol.</source>
<year>2016</year>, <volume>23</volume> (<issue>1</issue>), <fpage>31</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2015.11.012</pub-id>.<pub-id pub-id-type="pmid">26933734</pub-id></mixed-citation></ref><ref id="ref142"><mixed-citation publication-type="journal" id="cit142"><name><surname>Dunbar</surname><given-names>K. L.</given-names></name>; <name><surname>Mitchell</surname><given-names>D. A.</given-names></name>
<article-title>Revealing nature&#x02019;s synthetic
potential through the study of ribosomal natural product biosynthesis</article-title>. <source>ACS Chem. Biol.</source>
<year>2013</year>, <volume>8</volume> (<issue>3</issue>), <fpage>473</fpage>&#x02013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1021/cb3005325</pub-id>.<pub-id pub-id-type="pmid">23286465</pub-id></mixed-citation></ref><ref id="ref143"><mixed-citation publication-type="journal" id="cit143"><name><surname>Walsh</surname><given-names>C. T.</given-names></name>
<article-title>Blurring the lines between ribosomal
and nonribosomal
peptide scaffolds</article-title>. <source>ACS Chem. Biol.</source>
<year>2014</year>, <volume>9</volume> (<issue>8</issue>), <fpage>1653</fpage>&#x02013;<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1021/cb5003587</pub-id>.<pub-id pub-id-type="pmid">24883916</pub-id></mixed-citation></ref><ref id="ref144"><mixed-citation publication-type="journal" id="cit144"><name><surname>Oman</surname><given-names>T. J.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Follow
the leader: the use of leader
peptides to guide natural product biosynthesis</article-title>. <source>Nat. Chem. Biol.</source>
<year>2010</year>, <volume>6</volume>, <fpage>9</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.286</pub-id>.<pub-id pub-id-type="pmid">20016494</pub-id></mixed-citation></ref><ref id="ref145"><mixed-citation publication-type="journal" id="cit145"><name><surname>Crone</surname><given-names>W. J. K.</given-names></name>; <name><surname>Leeper</surname><given-names>F. J.</given-names></name>; <name><surname>Truman</surname><given-names>A. W.</given-names></name>
<article-title>Identification and
characterisation of the gene cluster for the anti-MRSA antibiotic
bottromycin:expanding the biosynthetic diversity of ribosomal peptides</article-title>. <source>Chem. Sci.</source>
<year>2012</year>, <volume>3</volume>, <fpage>3516</fpage>&#x02013;<lpage>3521</lpage>. <pub-id pub-id-type="doi">10.1039/c2sc21190d</pub-id>.</mixed-citation></ref><ref id="ref146"><mixed-citation publication-type="journal" id="cit146"><name><surname>Gomez-Escribano</surname><given-names>J. P.</given-names></name>; <name><surname>Song</surname><given-names>L.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>; <name><surname>Challis</surname><given-names>G. L.</given-names></name>
<article-title>Posttranslational
&#x003b2;-methylation and macrolactamidination in the biosynthesis of
the bottromycin complex of ribosomal peptide antibiotics</article-title>. <source>Chem. Sci.</source>
<year>2012</year>, <volume>3</volume>, <fpage>3522</fpage>&#x02013;<lpage>3525</lpage>. <pub-id pub-id-type="doi">10.1039/c2sc21183a</pub-id>.</mixed-citation></ref><ref id="ref147"><mixed-citation publication-type="journal" id="cit147"><name><surname>Hou</surname><given-names>Y.</given-names></name>; <name><surname>Tianero</surname><given-names>M. D.</given-names></name>; <name><surname>Kwan</surname><given-names>J. C.</given-names></name>; <name><surname>Wyche</surname><given-names>T. P.</given-names></name>; <name><surname>Michel</surname><given-names>C. R.</given-names></name>; <name><surname>Ellis</surname><given-names>G. A.</given-names></name>; <name><surname>Vazquez-Rivera</surname><given-names>E.</given-names></name>; <name><surname>Braun</surname><given-names>D. R.</given-names></name>; <name><surname>Rose</surname><given-names>W. E.</given-names></name>; <name><surname>Schmidt</surname><given-names>E. W.</given-names></name>; et al. <article-title>Structure and biosynthesis of the antibiotic
bottromycin D</article-title>. <source>Org. Lett.</source>
<year>2012</year>, <volume>14</volume>, <fpage>5050</fpage>&#x02013;<lpage>5053</lpage>. <pub-id pub-id-type="doi">10.1021/ol3022758</pub-id>.<pub-id pub-id-type="pmid">22984777</pub-id></mixed-citation></ref><ref id="ref148"><mixed-citation publication-type="journal" id="cit148"><name><surname>Huo</surname><given-names>L.</given-names></name>; <name><surname>Rachid</surname><given-names>S.</given-names></name>; <name><surname>Stadler</surname><given-names>M.</given-names></name>; <name><surname>Wenzel</surname><given-names>S. C.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name>
<article-title>Synthetic
biotechnology to study and engineer ribosomal bottromycin biosynthesis</article-title>. <source>Chem. Biol.</source>
<year>2012</year>, <volume>19</volume>, <fpage>1278</fpage>&#x02013;<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2012.08.013</pub-id>.<pub-id pub-id-type="pmid">23021914</pub-id></mixed-citation></ref><ref id="ref149"><mixed-citation publication-type="journal" id="cit149"><name><surname>Sardar</surname><given-names>D.</given-names></name>; <name><surname>Pierce</surname><given-names>E.</given-names></name>; <name><surname>McIntosh</surname><given-names>J. A.</given-names></name>; <name><surname>Schmidt</surname><given-names>E. W.</given-names></name>
<article-title>Recognition
sequences and substrate evolution in cyanobactin biosynthesis</article-title>. <source>ACS Synth. Biol.</source>
<year>2015</year>, <volume>4</volume> (<issue>2</issue>), <fpage>167</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1021/sb500019b</pub-id>.<pub-id pub-id-type="pmid">24625112</pub-id></mixed-citation></ref><ref id="ref150"><mixed-citation publication-type="journal" id="cit150"><name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Ribosomally
synthesized and post-translationally
modified peptide natural products: new insights into the role of leader
and core peptides during biosynthesis</article-title>. <source>Chem.
- Eur. J.</source>
<year>2013</year>, <volume>19</volume>, <fpage>7662</fpage>&#x02013;<lpage>7677</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201300401</pub-id>.<pub-id pub-id-type="pmid">23666908</pub-id></mixed-citation></ref><ref id="ref151"><mixed-citation publication-type="journal" id="cit151"><name><surname>Plat</surname><given-names>A.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>Mechanistic
aspects of lanthipeptide leaders</article-title>. <source>Curr. Protein
Pept. Sci.</source>
<year>2013</year>, <volume>14</volume>, <fpage>85</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.2174/1389203711314020001</pub-id>.<pub-id pub-id-type="pmid">23441895</pub-id></mixed-citation></ref><ref id="ref152"><mixed-citation publication-type="book" id="cit152"><person-group person-group-type="allauthors"><name><surname>de Vos</surname><given-names>W. M.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Sahl</surname><given-names>H.-G.</given-names></name></person-group> In <source>Nisin and Novel Lantibiotics</source>; <person-group person-group-type="editor"><name><surname>Jung</surname><given-names>G.</given-names></name>, <name><surname>Sahl</surname><given-names>H.-G.</given-names></name></person-group>, Eds.; <publisher-name>ESCOM</publisher-name>: <publisher-loc>Leiden</publisher-loc>, <year>1991</year>; pp <fpage>457</fpage>&#x02013;<lpage>464</lpage>.</mixed-citation></ref><ref id="ref153"><mixed-citation publication-type="journal" id="cit153"><name><surname>Pag</surname><given-names>U.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Multiple activities in lantibiotics--models for the
design of novel antibiotics?</article-title>. <source>Curr. Pharm. Des.</source>
<year>2002</year>, <volume>8</volume> (<issue>9</issue>), <fpage>815</fpage>&#x02013;<lpage>833</lpage>. <pub-id pub-id-type="doi">10.2174/1381612023395439</pub-id>.<pub-id pub-id-type="pmid">11945173</pub-id></mixed-citation></ref><ref id="ref154"><mixed-citation publication-type="journal" id="cit154"><name><surname>Rogers</surname><given-names>L. A.</given-names></name>
<article-title>The inhibiting
effect of <italic>Streptococcus lactis</italic> on <italic>Lactobacillus
bulgaricus</italic></article-title>. <source>J. Bacteriol.</source>
<year>1928</year>, <volume>16</volume>, <fpage>321</fpage>&#x02013;<lpage>325</lpage>.<pub-id pub-id-type="pmid">16559344</pub-id></mixed-citation></ref><ref id="ref155"><mixed-citation publication-type="journal" id="cit155"><name><surname>Gross</surname><given-names>E.</given-names></name>; <name><surname>Morell</surname><given-names>J. L.</given-names></name>
<article-title>The presence of
dehydroalanine in
the antibiotic nisin and its relationship to activity</article-title>. <source>J. Am. Chem. Soc.</source>
<year>1967</year>, <volume>89</volume> (<issue>11</issue>), <fpage>2791</fpage>&#x02013;<lpage>2792</lpage>. <pub-id pub-id-type="doi">10.1021/ja00987a084</pub-id>.<pub-id pub-id-type="pmid">6043807</pub-id></mixed-citation></ref><ref id="ref156"><mixed-citation publication-type="journal" id="cit156"><name><surname>Gross</surname><given-names>E.</given-names></name>; <name><surname>Morell</surname><given-names>J. L.</given-names></name>; <name><surname>Craig</surname><given-names>L. C.</given-names></name>
<article-title>Dehydroalanyllysine:
identical COOH-terminal structures in the peptide antibiotics nisin
and subtilin</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>1969</year>, <volume>62</volume> (<issue>3</issue>), <fpage>952</fpage>&#x02013;<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.62.3.952</pub-id>.<pub-id pub-id-type="pmid">5257015</pub-id></mixed-citation></ref><ref id="ref157"><mixed-citation publication-type="journal" id="cit157"><name><surname>Gross</surname><given-names>E.</given-names></name>; <name><surname>Morell</surname><given-names>J. L.</given-names></name>
<article-title>The structure of nisin</article-title>. <source>J. Am.
Chem. Soc.</source>
<year>1971</year>, <volume>93</volume>, <fpage>4634</fpage>&#x02013;<lpage>4635</lpage>. <pub-id pub-id-type="doi">10.1021/ja00747a073</pub-id>.<pub-id pub-id-type="pmid">5131162</pub-id></mixed-citation></ref><ref id="ref158"><mixed-citation publication-type="journal" id="cit158"><name><surname>Ingram</surname><given-names>L.</given-names></name>
<article-title>A ribosomal
mechanism for synthesis of peptides related
to nisin</article-title>. <source>Biochim. Biophys. Acta, Nucleic Acids
Protein Synth.</source>
<year>1970</year>, <volume>224</volume> (<issue>1</issue>), <fpage>263</fpage>&#x02013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2787(70)90642-8</pub-id>.</mixed-citation></ref><ref id="ref159"><mixed-citation publication-type="journal" id="cit159"><name><surname>Banerjee</surname><given-names>S.</given-names></name>; <name><surname>Hansen</surname><given-names>J. N.</given-names></name>
<article-title>Structure and expression of a gene
encoding the precursor of subtilin, a small protein antibiotic</article-title>. <source>J. Biol. Chem.</source>
<year>1988</year>, <volume>262</volume>, <fpage>9508</fpage>&#x02013;<lpage>9514</lpage>.</mixed-citation></ref><ref id="ref160"><mixed-citation publication-type="journal" id="cit160"><name><surname>Buchman</surname><given-names>G. W.</given-names></name>; <name><surname>Banerjee</surname><given-names>S.</given-names></name>; <name><surname>Hansen</surname><given-names>J. N.</given-names></name>
<article-title>Structure, expression,
and evolution of a gene encoding the precursor of nisin, a small protein
antibiotic</article-title>. <source>J. Biol. Chem.</source>
<year>1988</year>, <volume>263</volume> (<issue>31</issue>), <fpage>16260</fpage>&#x02013;<lpage>16266</lpage>.<pub-id pub-id-type="pmid">3141403</pub-id></mixed-citation></ref><ref id="ref161"><mixed-citation publication-type="journal" id="cit161"><name><surname>Kaletta</surname><given-names>C.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>
<article-title>Nisin, a peptide
antibiotic: cloning
and sequencing of the nisA gene and posttranslational processing of
its peptide product</article-title>. <source>J. Bacteriol.</source>
<year>1989</year>, <volume>171</volume> (<issue>3</issue>), <fpage>1597</fpage>&#x02013;<lpage>1601</lpage>. <pub-id pub-id-type="doi">10.1128/jb.171.3.1597-1601.1989</pub-id>.<pub-id pub-id-type="pmid">2493449</pub-id></mixed-citation></ref><ref id="ref162"><mixed-citation publication-type="journal" id="cit162"><name><surname>Dodd</surname><given-names>H. M.</given-names></name>; <name><surname>Horn</surname><given-names>N.</given-names></name>; <name><surname>Gasson</surname><given-names>M. J.</given-names></name>
<article-title>Analysis of the
genetic determinant for production of the peptide antibiotic nisin</article-title>. <source>J. Gen. Microbiol.</source>
<year>1990</year>, <volume>136</volume> (<issue>3</issue>), <fpage>555</fpage>&#x02013;<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-136-3-555</pub-id>.<pub-id pub-id-type="pmid">2118169</pub-id></mixed-citation></ref><ref id="ref163"><mixed-citation publication-type="journal" id="cit163"><name><surname>Schnell</surname><given-names>N.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>; <name><surname>Horner</surname><given-names>T.</given-names></name>; <name><surname>Kellner</surname><given-names>R.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>
<article-title>Structural gene isolation
and prepeptide sequence of gallidermin, a new lanthionine containing
antibiotic</article-title>. <source>FEMS Microbiol. Lett.</source>
<year>1989</year>, <volume>58</volume> (<issue>2&#x02013;3</issue>), <fpage>263</fpage>&#x02013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1989.tb03056.x</pub-id>.</mixed-citation></ref><ref id="ref164"><mixed-citation publication-type="journal" id="cit164"><name><surname>Morell</surname><given-names>J. L.</given-names></name>; <name><surname>Gross</surname><given-names>E.</given-names></name>
<article-title>Configuration of the beta-carbon
atoms of the beta-methyllanthionine residues in nisin</article-title>. <source>J. Am. Chem. Soc.</source>
<year>1973</year>, <volume>95</volume> (<issue>19</issue>), <fpage>6480</fpage>&#x02013;<lpage>6481</lpage>. <pub-id pub-id-type="doi">10.1021/ja00800a069</pub-id>.<pub-id pub-id-type="pmid">4582097</pub-id></mixed-citation></ref><ref id="ref165"><mixed-citation publication-type="journal" id="cit165"><name><surname>Chan</surname><given-names>W. C.</given-names></name>; <name><surname>Bycroft</surname><given-names>B. W.</given-names></name>; <name><surname>Leyland</surname><given-names>M. L.</given-names></name>; <name><surname>Lian</surname><given-names>L. Y.</given-names></name>; <name><surname>Yang</surname><given-names>J. C.</given-names></name>; <name><surname>Roberts</surname><given-names>G. C.</given-names></name>
<article-title>Sequence-specific
resonance assignment
and conformational analysis of subtilin by 2D NMR</article-title>. <source>FEBS Lett.</source>
<year>1992</year>, <volume>300</volume> (<issue>1</issue>), <fpage>56</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(92)80163-B</pub-id>.<pub-id pub-id-type="pmid">1547888</pub-id></mixed-citation></ref><ref id="ref166"><mixed-citation publication-type="journal" id="cit166"><name><surname>Br&#x000f6;tz</surname><given-names>H.</given-names></name>; <name><surname>Josten</surname><given-names>M.</given-names></name>; <name><surname>Wiedemann</surname><given-names>I.</given-names></name>; <name><surname>Schneider</surname><given-names>U.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Sahl</surname><given-names>H.-G.</given-names></name>
<article-title>Role of
lipid-bound peptidoglycan precursors in the formation of pores by
nisin, epidermin and other lantibiotics</article-title>. <source>Mol.
Microbiol.</source>
<year>1998</year>, <volume>30</volume> (<issue>2</issue>), <fpage>317</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.1998.01065.x</pub-id>.<pub-id pub-id-type="pmid">9791177</pub-id></mixed-citation></ref><ref id="ref167"><mixed-citation publication-type="journal" id="cit167"><name><surname>Breukink</surname><given-names>E.</given-names></name>; <name><surname>Wiedemann</surname><given-names>I.</given-names></name>; <name><surname>van Kraaij</surname><given-names>C.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>de Kruijff</surname><given-names>B.</given-names></name>
<article-title>Use of the
cell wall precursor lipid II by a pore-forming peptide antibiotic</article-title>. <source>Science</source>
<year>1999</year>, <volume>286</volume> (<issue>5448</issue>), <fpage>2361</fpage>&#x02013;<lpage>2364</lpage>. <pub-id pub-id-type="doi">10.1126/science.286.5448.2361</pub-id>.<pub-id pub-id-type="pmid">10600751</pub-id></mixed-citation></ref><ref id="ref168"><mixed-citation publication-type="journal" id="cit168"><name><surname>Hasper</surname><given-names>H. E.</given-names></name>; <name><surname>Kramer</surname><given-names>N. E.</given-names></name>; <name><surname>Smith</surname><given-names>J. L.</given-names></name>; <name><surname>Hillman</surname><given-names>J. D.</given-names></name>; <name><surname>Zachariah</surname><given-names>C.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>de Kruijff</surname><given-names>B.</given-names></name>; <name><surname>Breukink</surname><given-names>E.</given-names></name>
<article-title>An alternative bactericidal mechanism of action for
lantibiotic peptides that target lipid II</article-title>. <source>Science</source>
<year>2006</year>, <volume>313</volume> (<issue>5793</issue>), <fpage>1636</fpage>&#x02013;<lpage>1637</lpage>. <pub-id pub-id-type="doi">10.1126/science.1129818</pub-id>.<pub-id pub-id-type="pmid">16973881</pub-id></mixed-citation></ref><ref id="ref169"><mixed-citation publication-type="journal" id="cit169"><name><surname>Wakamatsu</surname><given-names>K.</given-names></name>; <name><surname>Choung</surname><given-names>S. Y.</given-names></name>; <name><surname>Kobayashi</surname><given-names>T.</given-names></name>; <name><surname>Inoue</surname><given-names>K.</given-names></name>; <name><surname>Higashijima</surname><given-names>T.</given-names></name>; <name><surname>Miyazawa</surname><given-names>T.</given-names></name>
<article-title>Complex formation of
peptide antibiotic Ro09&#x02013;0198 with lysophosphatidylethanolamine:
1H NMR analyses in dimethyl sulfoxide solution</article-title>. <source>Biochemistry</source>
<year>1990</year>, <volume>29</volume> (<issue>1</issue>), <fpage>113</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1021/bi00453a013</pub-id>.<pub-id pub-id-type="pmid">2157477</pub-id></mixed-citation></ref><ref id="ref170"><mixed-citation publication-type="journal" id="cit170"><name><surname>M&#x000e4;rki</surname><given-names>F.</given-names></name>; <name><surname>Hanni</surname><given-names>E.</given-names></name>; <name><surname>Fredenhagen</surname><given-names>A.</given-names></name>; <name><surname>van Oostrum</surname><given-names>J.</given-names></name>
<article-title>Mode of action of the lanthionine-containing peptide
antibiotics duramycin, duramycin B and C, and cinnamycin as indirect
inhibitors of phospholipase A2</article-title>. <source>Biochem. Pharmacol.</source>
<year>1991</year>, <volume>42</volume> (<issue>10</issue>), <fpage>2027</fpage>&#x02013;<lpage>2035</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(91)90604-4</pub-id>.<pub-id pub-id-type="pmid">1741778</pub-id></mixed-citation></ref><ref id="ref171"><mixed-citation publication-type="journal" id="cit171"><name><surname>Vel&#x000e1;squez</surname><given-names>J. E.</given-names></name>; <name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Biosynthesis
of the antimicrobial peptide epilancin 15X and its unusual N-terminal
lactate moiety</article-title>. <source>Chem. Biol.</source>
<year>2011</year>, <volume>18</volume>, <fpage>857</fpage>&#x02013;<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2011.05.007</pub-id>.<pub-id pub-id-type="pmid">21802007</pub-id></mixed-citation></ref><ref id="ref172"><mixed-citation publication-type="journal" id="cit172"><name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Stevanovic</surname><given-names>S.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<article-title>Purification
and characterization of EpiD, a flavoprotein involved in the biosynthesis
of the lantibiotic epidermin</article-title>. <source>J. Bacteriol.</source>
<year>1992</year>, <volume>174</volume> (<issue>16</issue>), <fpage>5354</fpage>&#x02013;<lpage>5361</lpage>. <pub-id pub-id-type="doi">10.1128/jb.174.16.5354-5361.1992</pub-id>.<pub-id pub-id-type="pmid">1644762</pub-id></mixed-citation></ref><ref id="ref173"><mixed-citation publication-type="journal" id="cit173"><name><surname>Allgaier</surname><given-names>H.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Werner</surname><given-names>R. G.</given-names></name>; <name><surname>Schneider</surname><given-names>U.</given-names></name>
<article-title>Elucidation
of the structure of epidermin, a ribosomally synthesized, tetracyclic
heterodetic polypeptide antibiotic</article-title>. <source>Angew. Chem.,
Int. Ed. Engl.</source>
<year>1985</year>, <volume>24</volume>, <fpage>1051</fpage>&#x02013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1002/anie.198510511</pub-id>.</mixed-citation></ref><ref id="ref174"><mixed-citation publication-type="journal" id="cit174"><name><surname>Ekkelenkamp</surname><given-names>M. B.</given-names></name>; <name><surname>Hanssen</surname><given-names>M.</given-names></name>; <name><surname>Danny Hsu</surname><given-names>S. T.</given-names></name>; <name><surname>de Jong</surname><given-names>A.</given-names></name>; <name><surname>Milatovic</surname><given-names>D.</given-names></name>; <name><surname>Verhoef</surname><given-names>J.</given-names></name>; <name><surname>van Nuland</surname><given-names>N. A.</given-names></name>
<article-title>Isolation
and structural characterization of epilancin 15X, a novel lantibiotic
from a clinical strain of <italic>Staphylococcus epidermidis</italic></article-title>. <source>FEBS Lett.</source>
<year>2005</year>, <volume>579</volume> (<issue>9</issue>), <fpage>1917</fpage>&#x02013;<lpage>1922</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2005.01.083</pub-id>.<pub-id pub-id-type="pmid">15792796</pub-id></mixed-citation></ref><ref id="ref175"><mixed-citation publication-type="journal" id="cit175"><name><surname>Castiglione</surname><given-names>F.</given-names></name>; <name><surname>Lazzarini</surname><given-names>A.</given-names></name>; <name><surname>Carrano</surname><given-names>L.</given-names></name>; <name><surname>Corti</surname><given-names>E.</given-names></name>; <name><surname>Ciciliato</surname><given-names>I.</given-names></name>; <name><surname>Gastaldo</surname><given-names>L.</given-names></name>; <name><surname>Candiani</surname><given-names>P.</given-names></name>; <name><surname>Losi</surname><given-names>D.</given-names></name>; <name><surname>Marinelli</surname><given-names>F.</given-names></name>; <name><surname>Selva</surname><given-names>E.</given-names></name>; et al. <article-title>Determining the structure
and mode of action of microbisporicin, a potent lantibiotic active
against multiresistant pathogens</article-title>. <source>Chem. Biol.</source>
<year>2008</year>, <volume>15</volume> (<issue>1</issue>), <fpage>22</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2007.11.009</pub-id>.<pub-id pub-id-type="pmid">18215770</pub-id></mixed-citation></ref><ref id="ref176"><mixed-citation publication-type="journal" id="cit176"><name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>de Boef</surname><given-names>E.</given-names></name>; <name><surname>Fekken</surname><given-names>S.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>Post-translational
modification of therapeutic peptides by NisB, the dehydratase of the
lantibiotic nisin</article-title>. <source>Biochemistry</source>
<year>2005</year>, <volume>44</volume> (<issue>38</issue>), <fpage>12827</fpage>&#x02013;<lpage>12834</lpage>. <pub-id pub-id-type="doi">10.1021/bi050805p</pub-id>.<pub-id pub-id-type="pmid">16171398</pub-id></mixed-citation></ref><ref id="ref177"><mixed-citation publication-type="journal" id="cit177"><name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Yu</surname><given-names>J. P.</given-names></name>; <name><surname>Brunzelle</surname><given-names>J. S.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>
<article-title>Structure and mechanism of the lantibiotic
cyclase involved in nisin biosynthesis</article-title>. <source>Science</source>
<year>2006</year>, <volume>311</volume> (<issue>5766</issue>), <fpage>1464</fpage>&#x02013;<lpage>1467</lpage>. <pub-id pub-id-type="doi">10.1126/science.1121422</pub-id>.<pub-id pub-id-type="pmid">16527981</pub-id></mixed-citation></ref><ref id="ref178"><mixed-citation publication-type="journal" id="cit178"><name><surname>van der Meer</surname><given-names>J. R.</given-names></name>; <name><surname>Polman</surname><given-names>J.</given-names></name>; <name><surname>Beerthuyzen</surname><given-names>M. M.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>
<article-title>Characterization
of the <italic>Lactococcus lactis</italic> nisin A operon genes <italic>nisP</italic>, encoding a subtilisin-like serine protease involved
in precursor processing, and <italic>nisR</italic>, encoding a regulatory
protein involved in nisin biosynthesis</article-title>. <source>J. Bacteriol.</source>
<year>1993</year>, <volume>175</volume> (<issue>9</issue>), <fpage>2578</fpage>&#x02013;<lpage>2588</lpage>. <pub-id pub-id-type="doi">10.1128/jb.175.9.2578-2588.1993</pub-id>.<pub-id pub-id-type="pmid">8478324</pub-id></mixed-citation></ref><ref id="ref179"><mixed-citation publication-type="journal" id="cit179"><name><surname>Koponen</surname><given-names>O.</given-names></name>; <name><surname>Takala</surname><given-names>T. M.</given-names></name>; <name><surname>Saarela</surname><given-names>U.</given-names></name>; <name><surname>Qiao</surname><given-names>M.</given-names></name>; <name><surname>Saris</surname><given-names>P. E. J.</given-names></name>
<article-title>Distribution
of the NisI immunity protein and enhancement
of nisin activity by the lipid-free NisI</article-title>. <source>FEMS
Microbiol. Lett.</source>
<year>2004</year>, <volume>231</volume> (<issue>1</issue>), <fpage>85</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1097(03)00934-0</pub-id>.<pub-id pub-id-type="pmid">14769471</pub-id></mixed-citation></ref><ref id="ref180"><mixed-citation publication-type="journal" id="cit180"><name><surname>Stein</surname><given-names>T.</given-names></name>; <name><surname>Heinzmann</surname><given-names>S.</given-names></name>; <name><surname>Solovieva</surname><given-names>I.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>
<article-title>Function of <italic>Lactococcus lactis</italic> nisin
immunity genes <italic>nisI</italic> and <italic>nisFEG</italic> after
coordinated expression in the surrogate host <italic>Bacillus subtilis</italic></article-title>. <source>J. Biol. Chem.</source>
<year>2002</year>, <volume>278</volume> (<issue>1</issue>), <fpage>89</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M207237200</pub-id>.<pub-id pub-id-type="pmid">12379654</pub-id></mixed-citation></ref><ref id="ref181"><mixed-citation publication-type="journal" id="cit181"><name><surname>Schnell</surname><given-names>N.</given-names></name>; <name><surname>Engelke</surname><given-names>G.</given-names></name>; <name><surname>Augustin</surname><given-names>J.</given-names></name>; <name><surname>Rosenstein</surname><given-names>R.</given-names></name>; <name><surname>Ungermann</surname><given-names>V.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>; <name><surname>Entian</surname><given-names>K.-D.</given-names></name>
<article-title>Analysis of genes
involved in the biosynthesis of the lantibiotic epidermin</article-title>. <source>Eur. J. Biochem.</source>
<year>1992</year>, <volume>204</volume> (<issue>1</issue>), <fpage>57</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1992.tb16605.x</pub-id>.<pub-id pub-id-type="pmid">1740156</pub-id></mixed-citation></ref><ref id="ref182"><mixed-citation publication-type="journal" id="cit182"><name><surname>Engelke</surname><given-names>G.</given-names></name>; <name><surname>Gutowski-Eckel</surname><given-names>Z.</given-names></name>; <name><surname>Hammelmann</surname><given-names>M.</given-names></name>; <name><surname>Entian</surname><given-names>K.-D.</given-names></name>
<article-title>Biosynthesis of the lantibiotic nisin:
genomic organization
and membrane localization of the NisB protein</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1992</year>, <volume>58</volume> (<issue>11</issue>), <fpage>3730</fpage>&#x02013;<lpage>3743</lpage>.<pub-id pub-id-type="pmid">1482192</pub-id></mixed-citation></ref><ref id="ref183"><mixed-citation publication-type="journal" id="cit183"><name><surname>Klein</surname><given-names>C.</given-names></name>; <name><surname>Kaletta</surname><given-names>C.</given-names></name>; <name><surname>Schnell</surname><given-names>N.</given-names></name>; <name><surname>Entian</surname><given-names>K.-D.</given-names></name>
<article-title>Analysis
of genes involved in biosynthesis of the lantibiotic subtilin</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1992</year>, <volume>58</volume> (<issue>1</issue>), <fpage>132</fpage>&#x02013;<lpage>142</lpage>.<pub-id pub-id-type="pmid">1539969</pub-id></mixed-citation></ref><ref id="ref184"><mixed-citation publication-type="journal" id="cit184"><name><surname>Chung</surname><given-names>Y. J.</given-names></name>; <name><surname>Steen</surname><given-names>M. T.</given-names></name>; <name><surname>Hansen</surname><given-names>J. N.</given-names></name>
<article-title>The subtilin
gene
of <italic>Bacillus subtilis</italic> ATCC 6633 is encoded in an operon
that contains a homolog of the hemolysin B transport protein</article-title>. <source>J. Bacteriol.</source>
<year>1992</year>, <volume>174</volume> (<issue>4</issue>), <fpage>1417</fpage>&#x02013;<lpage>1422</lpage>. <pub-id pub-id-type="doi">10.1128/jb.174.4.1417-1422.1992</pub-id>.<pub-id pub-id-type="pmid">1735728</pub-id></mixed-citation></ref><ref id="ref185"><mixed-citation publication-type="journal" id="cit185"><name><surname>Majchrzykiewicz</surname><given-names>J. A.</given-names></name>; <name><surname>Lubelski</surname><given-names>J.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Bijlsma</surname><given-names>J. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>
<article-title>Production
of a class
II two-component lantibiotic of <italic>Streptococcus pneumoniae</italic> using the class I nisin synthetic machinery and leader sequence</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2010</year>, <volume>54</volume> (<issue>4</issue>), <fpage>1498</fpage>&#x02013;<lpage>1505</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00883-09</pub-id>.<pub-id pub-id-type="pmid">20100873</pub-id></mixed-citation></ref><ref id="ref186"><mixed-citation publication-type="journal" id="cit186"><name><surname>Chakicherla</surname><given-names>A.</given-names></name>; <name><surname>Hansen</surname><given-names>J. N.</given-names></name>
<article-title>Role of the leader
and structural
regions of prelantibiotic peptides as assessed by expressing nisin-subtilin
chimeras in <italic>Bacillus subtilis</italic> 168, and characterization
of their physical, chemical, and antimicrobial properties</article-title>. <source>J. Biol. Chem.</source>
<year>1995</year>, <volume>270</volume> (<issue>40</issue>), <fpage>23533</fpage>&#x02013;<lpage>23539</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.40.23533</pub-id>.<pub-id pub-id-type="pmid">7559517</pub-id></mixed-citation></ref><ref id="ref187"><mixed-citation publication-type="journal" id="cit187"><name><surname>Sen</surname><given-names>A. K.</given-names></name>; <name><surname>Narbad</surname><given-names>A.</given-names></name>; <name><surname>Horn</surname><given-names>N.</given-names></name>; <name><surname>Dodd</surname><given-names>H. M.</given-names></name>; <name><surname>Parr</surname><given-names>A. J.</given-names></name>; <name><surname>Colquhoun</surname><given-names>I.</given-names></name>; <name><surname>Gasson</surname><given-names>M. J.</given-names></name>
<article-title>Post-translational
modification of nisin. The involvement of NisB in the dehydration
process</article-title>. <source>Eur. J. Biochem.</source>
<year>1999</year>, <volume>261</volume> (<issue>2</issue>), <fpage>524</fpage>&#x02013;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1327.1999.00303.x</pub-id>.<pub-id pub-id-type="pmid">10215865</pub-id></mixed-citation></ref><ref id="ref188"><mixed-citation publication-type="journal" id="cit188"><name><surname>Koponen</surname><given-names>O.</given-names></name>; <name><surname>Tolonen</surname><given-names>M.</given-names></name>; <name><surname>Qiao</surname><given-names>M.</given-names></name>; <name><surname>Wahlstrom</surname><given-names>G.</given-names></name>; <name><surname>Helin</surname><given-names>J.</given-names></name>; <name><surname>Saris</surname><given-names>P. E. J.</given-names></name>
<article-title>NisB is required
for the dehydration
and NisC for the lanthionine formation in the post-translational modification
of nisin</article-title>. <source>Microbiology</source>
<year>2002</year>, <volume>148</volume> (<issue>11</issue>), <fpage>3561</fpage>&#x02013;<lpage>3568</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-148-11-3561</pub-id>.<pub-id pub-id-type="pmid">12427947</pub-id></mixed-citation></ref><ref id="ref189"><mixed-citation publication-type="journal" id="cit189"><name><surname>van den Berg van Saparoea</surname><given-names>H. B.</given-names></name>; <name><surname>Bakkes</surname><given-names>P. J.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name>
<article-title>Distinct contributions of the nisin
biosynthesis enzymes
NisB and NisC and transporter NisT to prenisin production by <italic>Lactococcus lactis</italic></article-title>. <source>Appl. Environ.
Microbiol.</source>
<year>2008</year>, <volume>74</volume> (<issue>17</issue>), <fpage>5541</fpage>&#x02013;<lpage>5548</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00342-08</pub-id>.<pub-id pub-id-type="pmid">18621866</pub-id></mixed-citation></ref><ref id="ref190"><mixed-citation publication-type="journal" id="cit190"><name><surname>Xie</surname><given-names>L.</given-names></name>; <name><surname>Chatterjee</surname><given-names>C.</given-names></name>; <name><surname>Balsara</surname><given-names>R.</given-names></name>; <name><surname>Okeley</surname><given-names>N. M.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Heterologous expression and purification of SpaB involved
in subtilin biosynthesis</article-title>. <source>Biochem. Biophys.
Res. Commun.</source>
<year>2002</year>, <volume>295</volume> (<issue>4</issue>), <fpage>952</fpage>&#x02013;<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-291X(02)00783-0</pub-id>.<pub-id pub-id-type="pmid">12127987</pub-id></mixed-citation></ref><ref id="ref191"><mixed-citation publication-type="journal" id="cit191"><name><surname>Mavaro</surname><given-names>A.</given-names></name>; <name><surname>Abts</surname><given-names>A.</given-names></name>; <name><surname>Bakkes</surname><given-names>P. J.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name>; <name><surname>Smits</surname><given-names>S. H.</given-names></name>; <name><surname>Schmitt</surname><given-names>L.</given-names></name>
<article-title>Substrate recognition
and specificity of the NisB protein, the lantibiotic dehydratase involved
in nisin biosynthesis</article-title>. <source>J. Biol. Chem.</source>
<year>2011</year>, <volume>286</volume> (<issue>35</issue>), <fpage>30552</fpage>&#x02013;<lpage>30560</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.263210</pub-id>.<pub-id pub-id-type="pmid">21757717</pub-id></mixed-citation></ref><ref id="ref192"><mixed-citation publication-type="journal" id="cit192"><name><surname>Garg</surname><given-names>N.</given-names></name>; <name><surname>Salazar-Ocampo</surname><given-names>L. M.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>In vitro
activity of the nisin dehydratase NisB</article-title>. <source>Proc.
Natl. Acad. Sci. U. S. A.</source>
<year>2013</year>, <volume>110</volume> (<issue>18</issue>), <fpage>7258</fpage>&#x02013;<lpage>7263</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1222488110</pub-id>.<pub-id pub-id-type="pmid">23589847</pub-id></mixed-citation></ref><ref id="ref193"><mixed-citation publication-type="journal" id="cit193"><name><surname>Edde</surname><given-names>B.</given-names></name>; <name><surname>Rossier</surname><given-names>J.</given-names></name>; <name><surname>Le Caer</surname><given-names>J. P.</given-names></name>; <name><surname>Desbruyeres</surname><given-names>E.</given-names></name>; <name><surname>Gros</surname><given-names>F.</given-names></name>; <name><surname>Denoulet</surname><given-names>P.</given-names></name>
<article-title>Posttranslational glutamylation
of
alpha-tubulin</article-title>. <source>Science</source>
<year>1990</year>, <volume>247</volume> (<issue>4938</issue>), <fpage>83</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1126/science.1967194</pub-id>.<pub-id pub-id-type="pmid">1967194</pub-id></mixed-citation></ref><ref id="ref194"><mixed-citation publication-type="journal" id="cit194"><name><surname>Ortega</surname><given-names>M. A.</given-names></name>; <name><surname>Hao</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Walker</surname><given-names>M. C.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>
<article-title>Structure and mechanism
of the tRNA-dependent
lantibiotic dehydratase NisB</article-title>. <source>Nature</source>
<year>2014</year>, <volume>517</volume> (<issue>7535</issue>), <fpage>509</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1038/nature13888</pub-id>.<pub-id pub-id-type="pmid">25363770</pub-id></mixed-citation></ref><ref id="ref195"><mixed-citation publication-type="journal" id="cit195"><name><surname>Ozaki</surname><given-names>T.</given-names></name>; <name><surname>Kurokawa</surname><given-names>Y.</given-names></name>; <name><surname>Hayashi</surname><given-names>S.</given-names></name>; <name><surname>Oku</surname><given-names>N.</given-names></name>; <name><surname>Asamizu</surname><given-names>S.</given-names></name>; <name><surname>Igarashi</surname><given-names>Y.</given-names></name>; <name><surname>Onaka</surname><given-names>H.</given-names></name>
<article-title>Insights into the biosynthesis
of dehydroalanines in goadsporin</article-title>. <source>ChemBioChem</source>
<year>2016</year>, <volume>17</volume> (<issue>3</issue>), <fpage>218</fpage>&#x02013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201500541</pub-id>.<pub-id pub-id-type="pmid">26630235</pub-id></mixed-citation></ref><ref id="ref196"><mixed-citation publication-type="journal" id="cit196"><name><surname>Ortega</surname><given-names>M. A.</given-names></name>; <name><surname>Hao</surname><given-names>Y.</given-names></name>; <name><surname>Walker</surname><given-names>M. C.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Structure
and tRNA specificity of MibB, a lantibiotic dehydratase from Actinobacteria
involved in NAI-107 biosynthesis</article-title>. <source>Cell Chem.
Biol.</source>
<year>2016</year>, <volume>23</volume> (<issue>3</issue>), <fpage>370</fpage>&#x02013;<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2015.11.017</pub-id>.<pub-id pub-id-type="pmid">26877024</pub-id></mixed-citation></ref><ref id="ref197"><mixed-citation publication-type="journal" id="cit197"><name><surname>Westbrook</surname><given-names>J.</given-names></name>; <name><surname>Feng</surname><given-names>Z.</given-names></name>; <name><surname>Jain</surname><given-names>S.</given-names></name>; <name><surname>Bhat</surname><given-names>T. N.</given-names></name>; <name><surname>Thanki</surname><given-names>N.</given-names></name>; <name><surname>Ravichandran</surname><given-names>V.</given-names></name>; <name><surname>Gilliland</surname><given-names>G. L.</given-names></name>; <name><surname>Bluhm</surname><given-names>W.</given-names></name>; <name><surname>Weissig</surname><given-names>H.</given-names></name>; <name><surname>Greer</surname><given-names>D. S.</given-names></name>; et al. <article-title>The
Protein Data Bank: unifying the archive</article-title>. <source>Nucleic
Acids Res.</source>
<year>2002</year>, <volume>30</volume> (<issue>1</issue>), <fpage>245</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.1.245</pub-id>.<pub-id pub-id-type="pmid">11752306</pub-id></mixed-citation></ref><ref id="ref198"><mixed-citation publication-type="journal" id="cit198"><name><surname>Khusainov</surname><given-names>R.</given-names></name>; <name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>Lubelski</surname><given-names>J.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Identification of essential amino acid residues in
the nisin dehydratase NisB</article-title>. <source>Front. Microbiol.</source>
<year>2015</year>, <volume>6</volume>, <fpage>102</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00102</pub-id>.<pub-id pub-id-type="pmid">25767464</pub-id></mixed-citation></ref><ref id="ref199"><mixed-citation publication-type="journal" id="cit199"><name><surname>Igarashi</surname><given-names>Y.</given-names></name>; <name><surname>Kan</surname><given-names>Y.</given-names></name>; <name><surname>Fujii</surname><given-names>K.</given-names></name>; <name><surname>Fujita</surname><given-names>T.</given-names></name>; <name><surname>Harada</surname><given-names>K.</given-names></name>; <name><surname>Naoki</surname><given-names>H.</given-names></name>; <name><surname>Tabata</surname><given-names>H.</given-names></name>; <name><surname>Onaka</surname><given-names>H.</given-names></name>; <name><surname>Furumai</surname><given-names>T.</given-names></name>
<article-title>Goadsporin, a chemical substance
which promotes secondary
metabolism and morphogenesis in streptomycetes. II. Structure determination</article-title>. <source>J. Antibiot.</source>
<year>2001</year>, <volume>54</volume> (<issue>12</issue>), <fpage>1045</fpage>&#x02013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.54.1045</pub-id>.<pub-id pub-id-type="pmid">11858659</pub-id></mixed-citation></ref><ref id="ref200"><mixed-citation publication-type="journal" id="cit200"><name><surname>Onaka</surname><given-names>H.</given-names></name>; <name><surname>Nakaho</surname><given-names>M.</given-names></name>; <name><surname>Hayashi</surname><given-names>K.</given-names></name>; <name><surname>Igarashi</surname><given-names>Y.</given-names></name>; <name><surname>Furumai</surname><given-names>T.</given-names></name>
<article-title>Cloning and characterization of the
goadsporin biosynthetic
gene cluster from <italic>Streptomyces</italic> sp. TP-A0584</article-title>. <source>Microbiology</source>
<year>2005</year>, <volume>151</volume> (<issue>12</issue>), <fpage>3923</fpage>&#x02013;<lpage>3933</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.28420-0</pub-id>.<pub-id pub-id-type="pmid">16339937</pub-id></mixed-citation></ref><ref id="ref201"><mixed-citation publication-type="journal" id="cit201"><person-group person-group-type="allauthors"><name><surname>Burkhart</surname><given-names>B. J.</given-names></name>; <name><surname>Schwalen</surname><given-names>C.</given-names></name>; <name><surname>Mann</surname><given-names>G.</given-names></name>; <name><surname>Naismith</surname><given-names>J. H.</given-names></name>; <name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group><article-title>YcaO-dependent posttranslational
amide activation: biosynthesis, structure, and function</article-title>. <source>Chem. Rev.</source><year>2017</year>, <volume>117</volume>.</mixed-citation></ref><ref id="ref202"><mixed-citation publication-type="journal" id="cit202"><name><surname>Hudson</surname><given-names>G. A.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Tietz</surname><given-names>J. I.</given-names></name>; <name><surname>Mitchell</surname><given-names>D. A.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>In vitro biosynthesis of the core
scaffold of the thiopeptide
thiomuracin</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2015</year>, <volume>137</volume> (<issue>51</issue>), <fpage>16012</fpage>&#x02013;<lpage>16015</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b10194</pub-id>.<pub-id pub-id-type="pmid">26675417</pub-id></mixed-citation></ref><ref id="ref203"><mixed-citation publication-type="journal" id="cit203"><name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Hudson</surname><given-names>G. A.</given-names></name>; <name><surname>Mahanta</surname><given-names>N.</given-names></name>; <name><surname>Tietz</surname><given-names>J. I.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>; <name><surname>Mitchell</surname><given-names>D. A.</given-names></name>
<article-title>Biosynthetic timing and substrate
specificity for the thiopeptide thiomuracin</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2016</year>, <volume>138</volume>, <fpage>15511</fpage>&#x02013;<lpage>15514</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.6b08987</pub-id>.<pub-id pub-id-type="pmid">27700071</pub-id></mixed-citation></ref><ref id="ref204"><mixed-citation publication-type="journal" id="cit204"><name><surname>Cheng</surname><given-names>F.</given-names></name>; <name><surname>Takala</surname><given-names>T. M.</given-names></name>; <name><surname>Saris</surname><given-names>P. E.</given-names></name>
<article-title>Nisin biosynthesis
in vitro</article-title>. <source>J. Mol. Microbiol. Biotechnol.</source>
<year>2007</year>, <volume>13</volume> (<issue>4</issue>), <fpage>248</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1159/000104754</pub-id>.<pub-id pub-id-type="pmid">17827976</pub-id></mixed-citation></ref><ref id="ref205"><mixed-citation publication-type="book" id="cit205"><person-group person-group-type="allauthors"><name><surname>Jung</surname><given-names>G.</given-names></name></person-group> In <source>Nisin and Novel Lantibiotics</source>; <person-group person-group-type="editor"><name><surname>Jung</surname><given-names>G.</given-names></name>, <name><surname>Sahl</surname><given-names>H. G.</given-names></name></person-group>, Eds.; <publisher-name>ESCOM</publisher-name>: <publisher-loc>Leiden, The Netherlands</publisher-loc>, <year>1991</year>; pp <fpage>1</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="ref206"><mixed-citation publication-type="journal" id="cit206"><person-group person-group-type="allauthors"><name><surname>Moutiez</surname><given-names>M.</given-names></name>; <name><surname>Belin</surname><given-names>P.</given-names></name>; <name><surname>Gondry</surname><given-names>M.</given-names></name></person-group><article-title>Aminoacyl-tRNA-utilizing enzymes
in natural product biosynthesis</article-title>. <source>Chem. Rev.</source><year>2017</year>, <volume>117</volume>, DOI: <pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00523</pub-id>.</mixed-citation></ref><ref id="ref207"><mixed-citation publication-type="journal" id="cit207"><name><surname>Gerlt</surname><given-names>J. A.</given-names></name>; <name><surname>Bouvier</surname><given-names>J. T.</given-names></name>; <name><surname>Davidson</surname><given-names>D. B.</given-names></name>; <name><surname>Imker</surname><given-names>H. J.</given-names></name>; <name><surname>Sadkhin</surname><given-names>B.</given-names></name>; <name><surname>Slater</surname><given-names>D. R.</given-names></name>; <name><surname>Whalen</surname><given-names>K. L.</given-names></name>
<article-title>Enzyme Function
Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating
protein sequence similarity networks</article-title>. <source>Biochim.
Biophys. Acta, Proteins Proteomics</source>
<year>2015</year>, <volume>1854</volume> (<issue>8</issue>), <fpage>1019</fpage>&#x02013;<lpage>1037</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbapap.2015.04.015</pub-id>.</mixed-citation></ref><ref id="ref208"><mixed-citation publication-type="journal" id="cit208"><name><surname>Shannon</surname><given-names>P.</given-names></name>; <name><surname>Markiel</surname><given-names>A.</given-names></name>; <name><surname>Ozier</surname><given-names>O.</given-names></name>; <name><surname>Baliga</surname><given-names>N. S.</given-names></name>; <name><surname>Wang</surname><given-names>J. T.</given-names></name>; <name><surname>Ramage</surname><given-names>D.</given-names></name>; <name><surname>Amin</surname><given-names>N.</given-names></name>; <name><surname>Schwikowski</surname><given-names>B.</given-names></name>; <name><surname>Ideker</surname><given-names>T.</given-names></name>
<article-title>Cytoscape: a software environment
for integrated models
of biomolecular interaction networks</article-title>. <source>Genome
Res.</source>
<year>2003</year>, <volume>13</volume> (<issue>11</issue>), <fpage>2498</fpage>&#x02013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>.<pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation></ref><ref id="ref209"><mixed-citation publication-type="journal" id="cit209"><name><surname>Toogood</surname><given-names>P. L.</given-names></name>
<article-title>Model studies
of lantibiotic biogenesis</article-title>. <source>Tetrahedron Lett.</source>
<year>1993</year>, <volume>34</volume>, <fpage>7833</fpage>&#x02013;<lpage>7836</lpage>. <pub-id pub-id-type="doi">10.1016/S0040-4039(00)61488-0</pub-id>.</mixed-citation></ref><ref id="ref210"><mixed-citation publication-type="journal" id="cit210"><name><surname>Burrage</surname><given-names>S.</given-names></name>; <name><surname>Raynham</surname><given-names>T.</given-names></name>; <name><surname>Williams</surname><given-names>G.</given-names></name>; <name><surname>Essex</surname><given-names>J. W.</given-names></name>; <name><surname>Allen</surname><given-names>C.</given-names></name>; <name><surname>Cardno</surname><given-names>M.</given-names></name>; <name><surname>Swali</surname><given-names>V.</given-names></name>; <name><surname>Bradley</surname><given-names>M.</given-names></name>
<article-title>Biomimetic
synthesis of lantibiotics</article-title>. <source>Chem. - Eur. J.</source>
<year>2000</year>, <volume>6</volume> (<issue>8</issue>), <fpage>1455</fpage>&#x02013;<lpage>1466</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1521-3765(20000417)6:8&#x0003c;1455::AID-CHEM1455&#x0003e;3.3.CO;2-D</pub-id>.<pub-id pub-id-type="pmid">10840968</pub-id></mixed-citation></ref><ref id="ref211"><mixed-citation publication-type="journal" id="cit211"><name><surname>Okeley</surname><given-names>N. M.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Facile
chemoselective synthesis of dehydroalanine-containing peptides</article-title>. <source>Org. Lett.</source>
<year>2000</year>, <volume>2</volume>, <fpage>3603</fpage>&#x02013;<lpage>3606</lpage>. <pub-id pub-id-type="doi">10.1021/ol006485d</pub-id>.<pub-id pub-id-type="pmid">11073655</pub-id></mixed-citation></ref><ref id="ref212"><mixed-citation publication-type="journal" id="cit212"><name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Gieselman</surname><given-names>M.</given-names></name>; <name><surname>Zhou</surname><given-names>H.</given-names></name>; <name><surname>Averin</surname><given-names>O.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Biomimetic studies on the mechanism of stereoselective
lanthionine formation</article-title>. <source>Org. Biomol. Chem.</source>
<year>2003</year>, <volume>1</volume>, <fpage>3304</fpage>&#x02013;<lpage>3315</lpage>. <pub-id pub-id-type="doi">10.1039/b304945k</pub-id>.<pub-id pub-id-type="pmid">14584794</pub-id></mixed-citation></ref><ref id="ref213"><mixed-citation publication-type="journal" id="cit213"><name><surname>Zhou</surname><given-names>H.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Biomimetic
stereoselective formation
of methyllanthionine</article-title>. <source>Org. Lett.</source>
<year>2002</year>, <volume>4</volume>, <fpage>1335</fpage>&#x02013;<lpage>1338</lpage>. <pub-id pub-id-type="doi">10.1021/ol025629g</pub-id>.<pub-id pub-id-type="pmid">11950356</pub-id></mixed-citation></ref><ref id="ref214"><mixed-citation publication-type="journal" id="cit214"><name><surname>Meyer</surname><given-names>C.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Heidrich</surname><given-names>C.</given-names></name>; <name><surname>Reis</surname><given-names>M.</given-names></name>; <name><surname>Suling</surname><given-names>J.</given-names></name>; <name><surname>Iglesias-Wind</surname><given-names>M. I.</given-names></name>; <name><surname>Kempter</surname><given-names>C.</given-names></name>; <name><surname>Molitor</surname><given-names>E.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Nucleotide sequence
of the lantibiotic Pep5 biosynthetic
gene cluster and functional analysis of PepP and PepC. Evidence for
a role of PepC in thioether formation</article-title>. <source>Eur.
J. Biochem.</source>
<year>1995</year>, <volume>232</volume> (<issue>2</issue>), <fpage>478</fpage>&#x02013;<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20834.x</pub-id>.<pub-id pub-id-type="pmid">7556197</pub-id></mixed-citation></ref><ref id="ref215"><mixed-citation publication-type="journal" id="cit215"><name><surname>Augustin</surname><given-names>J.</given-names></name>; <name><surname>Rosenstein</surname><given-names>R.</given-names></name>; <name><surname>Wieland</surname><given-names>B.</given-names></name>; <name><surname>Schneider</surname><given-names>U.</given-names></name>; <name><surname>Schnell</surname><given-names>N.</given-names></name>; <name><surname>Engelke</surname><given-names>G.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<article-title>Genetic analysis
of epidermin biosynthetic genes and epidermin-negative mutants of <italic>Staphylococcus epidermidis</italic></article-title>. <source>Eur. J.
Biochem.</source>
<year>1992</year>, <volume>204</volume> (<issue>3</issue>), <fpage>1149</fpage>&#x02013;<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1992.tb16740.x</pub-id>.<pub-id pub-id-type="pmid">1551392</pub-id></mixed-citation></ref><ref id="ref216"><mixed-citation publication-type="journal" id="cit216"><name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<article-title>Expression,
purification, and characterization
of EpiC, an enzyme involved in the biosynthesis of the lantibiotic
epidermin, and sequence analysis of <italic>Staphylococcus epidermidis
epiC</italic> mutants</article-title>. <source>J. Bacteriol.</source>
<year>1996</year>, <volume>178</volume>, <fpage>1335</fpage>&#x02013;<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1128/jb.178.5.1335-1340.1996</pub-id>.<pub-id pub-id-type="pmid">8631710</pub-id></mixed-citation></ref><ref id="ref217"><mixed-citation publication-type="journal" id="cit217"><name><surname>Okeley</surname><given-names>N. M.</given-names></name>; <name><surname>Paul</surname><given-names>M.</given-names></name>; <name><surname>Stasser</surname><given-names>J. P.</given-names></name>; <name><surname>Blackburn</surname><given-names>N.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>SpaC and NisC, the cyclases involved
in subtilin and
nisin biosynthesis, are zinc proteins</article-title>. <source>Biochemistry</source>
<year>2003</year>, <volume>42</volume>, <fpage>13613</fpage>&#x02013;<lpage>13624</lpage>. <pub-id pub-id-type="doi">10.1021/bi0354942</pub-id>.<pub-id pub-id-type="pmid">14622008</pub-id></mixed-citation></ref><ref id="ref218"><mixed-citation publication-type="journal" id="cit218"><name><surname>Matthews</surname><given-names>R. G.</given-names></name>; <name><surname>Goulding</surname><given-names>C. W.</given-names></name>
<article-title>Enzyme-catalyzed
methyl transfers
to thiols: the role of zinc</article-title>. <source>Curr. Opin. Chem.
Biol.</source>
<year>1997</year>, <volume>1</volume> (<issue>3</issue>), <fpage>332</fpage>&#x02013;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1016/S1367-5931(97)80070-1</pub-id>.<pub-id pub-id-type="pmid">9667865</pub-id></mixed-citation></ref><ref id="ref219"><mixed-citation publication-type="journal" id="cit219"><name><surname>Rozema</surname><given-names>D. B.</given-names></name>; <name><surname>Poulter</surname><given-names>C. D.</given-names></name>
<article-title>Yeast protein farnesyltransferase.
pKas of peptide substrates bound as zinc thiolates</article-title>. <source>Biochemistry</source>
<year>1999</year>, <volume>38</volume> (<issue>40</issue>), <fpage>13138</fpage>&#x02013;<lpage>13146</lpage>. <pub-id pub-id-type="doi">10.1021/bi990794y</pub-id>.<pub-id pub-id-type="pmid">10529185</pub-id></mixed-citation></ref><ref id="ref220"><mixed-citation publication-type="journal" id="cit220"><name><surname>Bradshaw</surname><given-names>J. M.</given-names></name>; <name><surname>Waksman</surname><given-names>G.</given-names></name>
<article-title>Molecular recognition
by SH2 domains</article-title>. <source>Adv. Protein Chem.</source>
<year>2002</year>, <volume>61</volume>, <fpage>161</fpage>&#x02013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-3233(02)61005-8</pub-id>.<pub-id pub-id-type="pmid">12461824</pub-id></mixed-citation></ref><ref id="ref221"><mixed-citation publication-type="journal" id="cit221"><name><surname>Zhang</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Zhu</surname><given-names>G.</given-names></name>; <name><surname>Cang</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Bartlam</surname><given-names>M.</given-names></name>; <name><surname>Hensley</surname><given-names>K.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>; et al. <article-title>Structure of human lanthionine
synthetase C-like protein
1 and its interaction with Eps8 and glutathione</article-title>. <source>Genes Dev.</source>
<year>2009</year>, <volume>23</volume> (<issue>12</issue>), <fpage>1387</fpage>&#x02013;<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1789209</pub-id>.<pub-id pub-id-type="pmid">19528316</pub-id></mixed-citation></ref><ref id="ref222"><mixed-citation publication-type="journal" id="cit222"><name><surname>Helfrich</surname><given-names>M.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>; <name><surname>Stein</surname><given-names>T.</given-names></name>
<article-title>Structure-function
relationships of the lanthionine cyclase SpaC involved in biosynthesis
of the <italic>Bacillus subtilis</italic> peptide antibiotic subtilin</article-title>. <source>Biochemistry</source>
<year>2007</year>, <volume>46</volume> (<issue>11</issue>), <fpage>3224</fpage>&#x02013;<lpage>3233</lpage>. <pub-id pub-id-type="doi">10.1021/bi062124f</pub-id>.<pub-id pub-id-type="pmid">17305367</pub-id></mixed-citation></ref><ref id="ref223"><mixed-citation publication-type="journal" id="cit223"><name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Identification
of essential catalytic
residues of the cyclase NisC involved in the biosynthesis of nisin</article-title>. <source>J. Biol. Chem.</source>
<year>2007</year>, <volume>282</volume>, <fpage>21169</fpage>&#x02013;<lpage>21175</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M701802200</pub-id>.<pub-id pub-id-type="pmid">17513866</pub-id></mixed-citation></ref><ref id="ref224"><mixed-citation publication-type="journal" id="cit224"><name><surname>Hightower</surname><given-names>K. E.</given-names></name>; <name><surname>Huang</surname><given-names>C. C.</given-names></name>; <name><surname>Casey</surname><given-names>P. J.</given-names></name>; <name><surname>Fierke</surname><given-names>C. A.</given-names></name>
<article-title>H-Ras peptide
and protein substrates bind protein farnesyltransferase as an ionized
thiolate</article-title>. <source>Biochemistry</source>
<year>1998</year>, <volume>37</volume> (<issue>44</issue>), <fpage>15555</fpage>&#x02013;<lpage>15562</lpage>. <pub-id pub-id-type="doi">10.1021/bi981525v</pub-id>.<pub-id pub-id-type="pmid">9799520</pub-id></mixed-citation></ref><ref id="ref225"><mixed-citation publication-type="journal" id="cit225"><name><surname>Hightower</surname><given-names>K. E.</given-names></name>; <name><surname>Fierke</surname><given-names>C. A.</given-names></name>
<article-title>Zinc-catalyzed sulfur
alkylation:
insights from protein farnesyltransferase</article-title>. <source>Curr.
Opin. Chem. Biol.</source>
<year>1999</year>, <volume>3</volume> (<issue>2</issue>), <fpage>176</fpage>&#x02013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/S1367-5931(99)80030-1</pub-id>.<pub-id pub-id-type="pmid">10226042</pub-id></mixed-citation></ref><ref id="ref226"><mixed-citation publication-type="journal" id="cit226"><name><surname>Wilker</surname><given-names>J. J.</given-names></name>; <name><surname>Lippard</surname><given-names>S. J.</given-names></name>
<article-title>Alkyl transfer to metal thiolates:
kinetics, active species identification, and relevance to the DNA
methyl phosphotriester repair center of <italic>Escherichia coli</italic> Ada</article-title>. <source>Inorg. Chem.</source>
<year>1997</year>, <volume>36</volume> (<issue>6</issue>), <fpage>969</fpage>&#x02013;<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1021/ic961082o</pub-id>.<pub-id pub-id-type="pmid">11669658</pub-id></mixed-citation></ref><ref id="ref227"><mixed-citation publication-type="journal" id="cit227"><name><surname>Warthen</surname><given-names>C. R.</given-names></name>; <name><surname>Hammes</surname><given-names>B. S.</given-names></name>; <name><surname>Carrano</surname><given-names>C. J.</given-names></name>; <name><surname>Crans</surname><given-names>D. C.</given-names></name>
<article-title>Methylation
of neutral pseudotetrahedral zinc thiolate complexes: model reactions
for alkyl group transfer to sulfur by zinc-containing enzymes</article-title>. <source>JBIC, J. Biol. Inorg. Chem.</source>
<year>2001</year>, <volume>6</volume> (<issue>1</issue>), <fpage>82</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1007/s007750000171</pub-id>.<pub-id pub-id-type="pmid">11191225</pub-id></mixed-citation></ref><ref id="ref228"><mixed-citation publication-type="journal" id="cit228"><name><surname>Brand</surname><given-names>U.</given-names></name>; <name><surname>Rombach</surname><given-names>M.</given-names></name>; <name><surname>Seebacher</surname><given-names>J.</given-names></name>; <name><surname>Vahrenkamp</surname><given-names>H.</given-names></name>
<article-title>Functional modeling of cobalamine-independent methionine
synthase with pyrazolylborate-zinc-thiolate complexes</article-title>. <source>Inorg. Chem.</source>
<year>2001</year>, <volume>40</volume> (<issue>24</issue>), <fpage>6151</fpage>&#x02013;<lpage>6157</lpage>. <pub-id pub-id-type="doi">10.1021/ic0105112</pub-id>.<pub-id pub-id-type="pmid">11703113</pub-id></mixed-citation></ref><ref id="ref229"><mixed-citation publication-type="journal" id="cit229"><name><surname>Chiou</surname><given-names>S. J.</given-names></name>; <name><surname>Riordan</surname><given-names>C. G.</given-names></name>; <name><surname>Rheingold</surname><given-names>A. L.</given-names></name>
<article-title>Synthetic
modeling of zinc thiolates: Quantitative assessment of hydrogen bonding
in modulating sulfur alkylation rates</article-title>. <source>Proc.
Natl. Acad. Sci. U. S. A.</source>
<year>2003</year>, <volume>100</volume> (<issue>7</issue>), <fpage>3695</fpage>&#x02013;<lpage>3700</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0637221100</pub-id>.<pub-id pub-id-type="pmid">12649324</pub-id></mixed-citation></ref><ref id="ref230"><mixed-citation publication-type="journal" id="cit230"><name><surname>Wilker</surname><given-names>J. J.</given-names></name>; <name><surname>Lippard</surname><given-names>S. J.</given-names></name>
<article-title>Modeling the DNA
methylphosphotriester
repair site in <italic>Escherichia coli</italic> Ada. Why zinc and
four cysteines?</article-title>. <source>J. Am. Chem. Soc.</source>
<year>1995</year>, <volume>117</volume> (<issue>33</issue>), <fpage>8682</fpage>&#x02013;<lpage>8683</lpage>. <pub-id pub-id-type="doi">10.1021/ja00138a031</pub-id>.</mixed-citation></ref><ref id="ref231"><mixed-citation publication-type="journal" id="cit231"><name><surname>Chiou</surname><given-names>S.-J.</given-names></name>; <name><surname>Innocent</surname><given-names>J.</given-names></name>; <name><surname>Riordan</surname><given-names>C. G.</given-names></name>; <name><surname>Lam</surname><given-names>K.-C.</given-names></name>; <name><surname>Liable-Sands</surname><given-names>L.</given-names></name>; <name><surname>Rheingold</surname><given-names>A. L.</given-names></name>
<article-title>Synthetic models for the zinc sites
in the methionine synthases</article-title>. <source>Inorg. Chem.</source>
<year>2000</year>, <volume>39</volume> (<issue>19</issue>), <fpage>4347</fpage>&#x02013;<lpage>4353</lpage>. <pub-id pub-id-type="doi">10.1021/ic000505q</pub-id>.<pub-id pub-id-type="pmid">11196931</pub-id></mixed-citation></ref><ref id="ref232"><mixed-citation publication-type="journal" id="cit232"><name><surname>Parkin</surname><given-names>G.</given-names></name>
<article-title>Synthetic analogues relevant to the
structure and function
of zinc enzymes</article-title>. <source>Chem. Rev.</source>
<year>2004</year>, <volume>104</volume> (<issue>2</issue>), <fpage>699</fpage>&#x02013;<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1021/cr0206263</pub-id>.<pub-id pub-id-type="pmid">14871139</pub-id></mixed-citation></ref><ref id="ref233"><mixed-citation publication-type="journal" id="cit233"><name><surname>Morlok</surname><given-names>M. M.</given-names></name>; <name><surname>Janak</surname><given-names>K. E.</given-names></name>; <name><surname>Zhu</surname><given-names>G.</given-names></name>; <name><surname>Quarless</surname><given-names>D. A.</given-names></name>; <name><surname>Parkin</surname><given-names>G.</given-names></name>
<article-title>Intramolecular N-H&#x000b7;&#x000b7;&#x000b7;S
hydrogen bonding
in the zinc thiolate complex [Tm(Ph)]ZnSCH<sub>2</sub>C(O)NHPh: a
mechanistic investigation of thiolate alkylation as probed by kinetics
studies and by kinetic isotope effects</article-title>. <source>J. Am.
Chem. Soc.</source>
<year>2005</year>, <volume>127</volume> (<issue>40</issue>), <fpage>14039</fpage>&#x02013;<lpage>14050</lpage>. <pub-id pub-id-type="doi">10.1021/ja0536670</pub-id>.<pub-id pub-id-type="pmid">16201826</pub-id></mixed-citation></ref><ref id="ref234"><mixed-citation publication-type="journal" id="cit234"><name><surname>Ibrahim</surname><given-names>M. M.</given-names></name>; <name><surname>Seebacher</surname><given-names>J.</given-names></name>; <name><surname>Steinfeld</surname><given-names>G.</given-names></name>; <name><surname>Vahrenkamp</surname><given-names>H.</given-names></name>
<article-title>Tris(thioimidazolyl)borate-zinc-thiolate
complexes
for the modeling of biological thiolate alkylations</article-title>. <source>Inorg. Chem.</source>
<year>2005</year>, <volume>44</volume> (<issue>23</issue>), <fpage>8531</fpage>&#x02013;<lpage>8538</lpage>. <pub-id pub-id-type="doi">10.1021/ic0508270</pub-id>.<pub-id pub-id-type="pmid">16270993</pub-id></mixed-citation></ref><ref id="ref235"><mixed-citation publication-type="journal" id="cit235"><name><surname>Ji</surname><given-names>M.</given-names></name>; <name><surname>Benkmil</surname><given-names>B.</given-names></name>; <name><surname>Vahrenkamp</surname><given-names>H.</given-names></name>
<article-title>Zinc-thiolate
complexes of the bis(pyrazolyl)
(thioimidazolyl)hydroborate tripods for the modeling of thiolate alkylating
enzymes</article-title>. <source>Inorg. Chem.</source>
<year>2005</year>, <volume>44</volume> (<issue>10</issue>), <fpage>3518</fpage>&#x02013;<lpage>3523</lpage>. <pub-id pub-id-type="doi">10.1021/ic0484147</pub-id>.<pub-id pub-id-type="pmid">15877434</pub-id></mixed-citation></ref><ref id="ref236"><mixed-citation publication-type="journal" id="cit236"><name><surname>Melnick</surname><given-names>J. G.</given-names></name>; <name><surname>Zhu</surname><given-names>G.</given-names></name>; <name><surname>Buccella</surname><given-names>D.</given-names></name>; <name><surname>Parkin</surname><given-names>G.</given-names></name>
<article-title>Thiolate exchange
in [TmR]ZnSR&#x02019; complexes and relevance to the mechanisms of
thiolate alkylation reactions involving zinc enzymes and proteins</article-title>. <source>J. Inorg. Biochem.</source>
<year>2006</year>, <volume>100</volume> (<issue>5&#x02013;6</issue>), <fpage>1147</fpage>&#x02013;<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2005.12.023</pub-id>.<pub-id pub-id-type="pmid">16516971</pub-id></mixed-citation></ref><ref id="ref237"><mixed-citation publication-type="journal" id="cit237"><name><surname>Rombach</surname><given-names>M.</given-names></name>; <name><surname>Seebacher</surname><given-names>J.</given-names></name>; <name><surname>Ji</surname><given-names>M.</given-names></name>; <name><surname>Zhang</surname><given-names>G.</given-names></name>; <name><surname>He</surname><given-names>G.</given-names></name>; <name><surname>Ibrahim</surname><given-names>M. M.</given-names></name>; <name><surname>Benkmil</surname><given-names>B.</given-names></name>; <name><surname>Vahrenkamp</surname><given-names>H.</given-names></name>
<article-title>Thiolate alkylation
in tripod zinc complexes: a comparative kinetic study</article-title>. <source>Inorg. Chem.</source>
<year>2006</year>, <volume>45</volume> (<issue>11</issue>), <fpage>4571</fpage>&#x02013;<lpage>4575</lpage>. <pub-id pub-id-type="doi">10.1021/ic060301v</pub-id>.<pub-id pub-id-type="pmid">16711708</pub-id></mixed-citation></ref><ref id="ref238"><mixed-citation publication-type="journal" id="cit238"><name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Michael-type
cyclizations in lantibiotic
biosynthesis are reversible</article-title>. <source>ACS Chem. Biol.</source>
<year>2015</year>, <volume>10</volume> (<issue>5</issue>), <fpage>1234</fpage>&#x02013;<lpage>1238</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.5b00007</pub-id>.<pub-id pub-id-type="pmid">25723375</pub-id></mixed-citation></ref><ref id="ref239"><mixed-citation publication-type="journal" id="cit239"><name><surname>Stein</surname><given-names>T.</given-names></name>; <name><surname>Borchert</surname><given-names>S.</given-names></name>; <name><surname>Conrad</surname><given-names>B.</given-names></name>; <name><surname>Feesche</surname><given-names>J.</given-names></name>; <name><surname>Hofemeister</surname><given-names>B.</given-names></name>; <name><surname>Hofemeister</surname><given-names>J.</given-names></name>; <name><surname>Entian</surname><given-names>K.-D.</given-names></name>
<article-title>Two different lantibiotic-like
peptides originate from the ericin gene cluster of <italic>Bacillus
subtilis</italic> A1/3</article-title>. <source>J. Bacteriol.</source>
<year>2002</year>, <volume>184</volume> (<issue>6</issue>), <fpage>1703</fpage>&#x02013;<lpage>1711</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.6.1703-1711.2002</pub-id>.<pub-id pub-id-type="pmid">11872722</pub-id></mixed-citation></ref><ref id="ref240"><mixed-citation publication-type="journal" id="cit240"><name><surname>Siegers</surname><given-names>K.</given-names></name>; <name><surname>Heinzmann</surname><given-names>S.</given-names></name>; <name><surname>Entian</surname><given-names>K.-D.</given-names></name>
<article-title>Biosynthesis of
lantibiotic nisin. Posttranslational modification of its prepeptide
occurs at a multimeric membrane-associated lanthionine synthetase
complex</article-title>. <source>J. Biol. Chem.</source>
<year>1996</year>, <volume>271</volume>, <fpage>12294</fpage>&#x02013;<lpage>12301</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.21.12294</pub-id>.<pub-id pub-id-type="pmid">8647829</pub-id></mixed-citation></ref><ref id="ref241"><mixed-citation publication-type="journal" id="cit241"><name><surname>Kiesau</surname><given-names>P.</given-names></name>; <name><surname>Eikmanns</surname><given-names>U.</given-names></name>; <name><surname>Gutowski-Eckel</surname><given-names>Z.</given-names></name>; <name><surname>Weber</surname><given-names>S.</given-names></name>; <name><surname>Hammelmann</surname><given-names>M.</given-names></name>; <name><surname>Entian</surname><given-names>K.-D.</given-names></name>
<article-title>Evidence for a multimeric
subtilin synthetase complex</article-title>. <source>J. Bacteriol.</source>
<year>1997</year>, <volume>179</volume> (<issue>5</issue>), <fpage>1475</fpage>&#x02013;<lpage>1481</lpage>. <pub-id pub-id-type="doi">10.1128/jb.179.5.1475-1481.1997</pub-id>.<pub-id pub-id-type="pmid">9045802</pub-id></mixed-citation></ref><ref id="ref242"><mixed-citation publication-type="journal" id="cit242"><name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Wierenga</surname><given-names>J.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>Sec-mediated transport
of post-translationally dehydrated peptides in <italic>Lactococcus
lactis</italic></article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2006</year>, <volume>72</volume>, <fpage>7626</fpage>&#x02013;<lpage>7633</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01802-06</pub-id>.<pub-id pub-id-type="pmid">17041158</pub-id></mixed-citation></ref><ref id="ref243"><mixed-citation publication-type="journal" id="cit243"><name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>De Boef</surname><given-names>E.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Fekken</surname><given-names>S.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Driessen</surname><given-names>A. J.</given-names></name>; <name><surname>Leenhouts</surname><given-names>K.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>NisT, the transporter of the lantibiotic
nisin, can transport fully modified, dehydrated and unmodified prenisin
and fusions of the leader peptide with non-lantibiotic peptides</article-title>. <source>J. Biol. Chem.</source>
<year>2004</year>, <volume>279</volume>, <fpage>22176</fpage>&#x02013;<lpage>22182</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M312789200</pub-id>.<pub-id pub-id-type="pmid">15044440</pub-id></mixed-citation></ref><ref id="ref244"><mixed-citation publication-type="journal" id="cit244"><name><surname>Lubelski</surname><given-names>J.</given-names></name>; <name><surname>Khusainov</surname><given-names>R.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Directionality and
coordination of dehydration and ring formation during biosynthesis
of the lantibiotic nisin</article-title>. <source>J. Biol. Chem.</source>
<year>2009</year>, <volume>284</volume> (<issue>38</issue>), <fpage>25962</fpage>&#x02013;<lpage>25972</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.026690</pub-id>.<pub-id pub-id-type="pmid">19620240</pub-id></mixed-citation></ref><ref id="ref245"><mixed-citation publication-type="journal" id="cit245"><name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Ortega</surname><given-names>M.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Melby</surname><given-names>J. O.</given-names></name>; <name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>Mitchell</surname><given-names>D. A.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Structural investigation of ribosomally synthesized
natural products by hypothetical structure enumeration and evaluation
using tandem MS</article-title>. <source>Proc. Natl. Acad. Sci. U. S.
A.</source>
<year>2014</year>, <volume>111</volume> (<issue>33</issue>), <fpage>12031</fpage>&#x02013;<lpage>12036</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1406418111</pub-id>.<pub-id pub-id-type="pmid">25092299</pub-id></mixed-citation></ref><ref id="ref246"><mixed-citation publication-type="journal" id="cit246"><name><surname>Mukherjee</surname><given-names>S.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Mechanistic studies on the substrate-tolerant
lanthipeptide synthetase ProcM</article-title>. <source>J. Am. Chem.
Soc.</source>
<year>2014</year>, <volume>136</volume> (<issue>29</issue>), <fpage>10450</fpage>&#x02013;<lpage>10459</lpage>. <pub-id pub-id-type="doi">10.1021/ja504692v</pub-id>.<pub-id pub-id-type="pmid">24972336</pub-id></mixed-citation></ref><ref id="ref247"><mixed-citation publication-type="journal" id="cit247"><name><surname>Jungmann</surname><given-names>N. A.</given-names></name>; <name><surname>Krawczyk</surname><given-names>B.</given-names></name>; <name><surname>Tietzmann</surname><given-names>M.</given-names></name>; <name><surname>Ensle</surname><given-names>P.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Dissecting
reactions of nonlinear
precursor peptide processing of the class III lanthipeptide curvopeptin</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2014</year>, <volume>136</volume> (<issue>43</issue>), <fpage>15222</fpage>&#x02013;<lpage>15228</lpage>. <pub-id pub-id-type="doi">10.1021/ja5062054</pub-id>.<pub-id pub-id-type="pmid">25291240</pub-id></mixed-citation></ref><ref id="ref248"><mixed-citation publication-type="journal" id="cit248"><name><surname>van der Meer</surname><given-names>J. R.</given-names></name>; <name><surname>Rollema</surname><given-names>H. S.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>Beerthuyzen</surname><given-names>M. M.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>
<article-title>Influence of amino
acid substitutions
in the nisin leader peptide on biosynthesis and secretion of nisin
by <italic>Lactococcus lactis</italic></article-title>. <source>J. Biol.
Chem.</source>
<year>1994</year>, <volume>269</volume> (<issue>5</issue>), <fpage>3555</fpage>&#x02013;<lpage>3562</lpage>.<pub-id pub-id-type="pmid">8106398</pub-id></mixed-citation></ref><ref id="ref249"><mixed-citation publication-type="journal" id="cit249"><name><surname>van
den Hooven</surname><given-names>H. W.</given-names></name>; <name><surname>Rollema</surname><given-names>H. S.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>Hilbers</surname><given-names>C. W.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Structural features of the final intermediate in the
biosynthesis of the lantibiotic nisin. Influence of the leader peptide</article-title>. <source>Biochemistry</source>
<year>1997</year>, <volume>36</volume> (<issue>46</issue>), <fpage>14137</fpage>&#x02013;<lpage>14145</lpage>. <pub-id pub-id-type="doi">10.1021/bi9713106</pub-id>.<pub-id pub-id-type="pmid">9369486</pub-id></mixed-citation></ref><ref id="ref250"><mixed-citation publication-type="journal" id="cit250"><name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Rollema</surname><given-names>H. S.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>
<article-title>Biosynthesis
and secretion of a precursor of nisin Z by <italic>Lactococcus lactis</italic>, directed by the leader peptide of the homologous lantibiotic subtilin
from <italic>Bacillus subtilis</italic></article-title>. <source>FEBS
Lett.</source>
<year>1993</year>, <volume>330</volume> (<issue>1</issue>), <fpage>23</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(93)80911-D</pub-id>.<pub-id pub-id-type="pmid">8370453</pub-id></mixed-citation></ref><ref id="ref251"><mixed-citation publication-type="journal" id="cit251"><name><surname>Plat</surname><given-names>A.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>Requirements of the engineered leader peptide of nisin
for inducing modification, export, and cleavage</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2011</year>, <volume>77</volume> (<issue>2</issue>), <fpage>604</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01503-10</pub-id>.<pub-id pub-id-type="pmid">21097596</pub-id></mixed-citation></ref><ref id="ref252"><mixed-citation publication-type="journal" id="cit252"><name><surname>Khusainov</surname><given-names>R.</given-names></name>; <name><surname>Heils</surname><given-names>R.</given-names></name>; <name><surname>Lubelski</surname><given-names>J.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Determining sites of interaction
between prenisin and
its modification enzymes NisB and NisC</article-title>. <source>Mol.
Microbiol.</source>
<year>2011</year>, <volume>82</volume>, <fpage>706</fpage>&#x02013;<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07846.x</pub-id>.<pub-id pub-id-type="pmid">22011325</pub-id></mixed-citation></ref><ref id="ref253"><mixed-citation publication-type="journal" id="cit253"><name><surname>Abts</surname><given-names>A.</given-names></name>; <name><surname>Montalb&#x000e1;n-Lopez</surname><given-names>M.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Smits</surname><given-names>S. H.</given-names></name>; <name><surname>Schmitt</surname><given-names>L.</given-names></name>
<article-title>NisC binds the FxLx motif of the
nisin leader peptide</article-title>. <source>Biochemistry</source>
<year>2013</year>, <volume>52</volume> (<issue>32</issue>), <fpage>5387</fpage>&#x02013;<lpage>5395</lpage>. <pub-id pub-id-type="doi">10.1021/bi4008116</pub-id>.<pub-id pub-id-type="pmid">23869662</pub-id></mixed-citation></ref><ref id="ref254"><mixed-citation publication-type="journal" id="cit254"><name><surname>Khusainov</surname><given-names>R.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Identification of
distinct nisin leader peptide regions that determine interactions
with the modification enzymes NisB and NisC</article-title>. <source>FEBS Open Bio.</source>
<year>2013</year>, <volume>3</volume>, <fpage>237</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.fob.2013.05.001</pub-id>.</mixed-citation></ref><ref id="ref255"><mixed-citation publication-type="journal" id="cit255"><name><surname>Khusainov</surname><given-names>R.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>When the leader gets loose: in vivo
biosynthesis of a leaderless prenisin is stimulated by a trans-acting
leader peptide</article-title>. <source>ChemBioChem</source>
<year>2012</year>, <volume>13</volume>, <fpage>2433</fpage>&#x02013;<lpage>2438</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201200437</pub-id>.<pub-id pub-id-type="pmid">23070977</pub-id></mixed-citation></ref><ref id="ref256"><mixed-citation publication-type="journal" id="cit256"><name><surname>Khusainov</surname><given-names>R.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>The presence of
modifiable residues
in the core peptide part of precursor nisin is not crucial for precursor
nisin interactions with NisB- and NisC</article-title>. <source>PLoS
One</source>
<year>2013</year>, <volume>8</volume> (<issue>9</issue>), <fpage>e74890</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0074890</pub-id>.<pub-id pub-id-type="pmid">24040355</pub-id></mixed-citation></ref><ref id="ref257"><mixed-citation publication-type="book" id="cit257"><person-group person-group-type="allauthors"><name><surname>Beck-Sickinger</surname><given-names>A. G.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name></person-group> In <source>Nisin
and Novel Lantibiotics</source>; <person-group person-group-type="editor"><name><surname>Jung</surname><given-names>G.</given-names></name>, <name><surname>Sahl</surname><given-names>H.-G.</given-names></name></person-group>, Eds.; <publisher-name>ESCOM</publisher-name>: <publisher-loc>Leiden</publisher-loc>, <year>1991</year>; pp <fpage>218</fpage>&#x02013;<lpage>230</lpage>.</mixed-citation></ref><ref id="ref258"><mixed-citation publication-type="journal" id="cit258"><name><surname>Koehnke</surname><given-names>J.</given-names></name>; <name><surname>Bent</surname><given-names>A. F.</given-names></name>; <name><surname>Zollman</surname><given-names>D.</given-names></name>; <name><surname>Smith</surname><given-names>K.</given-names></name>; <name><surname>Houssen</surname><given-names>W. E.</given-names></name>; <name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Mann</surname><given-names>G.</given-names></name>; <name><surname>Lebl</surname><given-names>T.</given-names></name>; <name><surname>Scharff</surname><given-names>R.</given-names></name>; <name><surname>Shirran</surname><given-names>S.</given-names></name>; et al. <article-title>The cyanobactin heterocyclase
enzyme: a processive adenylase that operates with a defined order
of reaction</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2013</year>, <volume>52</volume> (<issue>52</issue>), <fpage>13991</fpage>&#x02013;<lpage>13996</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201306302</pub-id>.</mixed-citation></ref><ref id="ref259"><mixed-citation publication-type="journal" id="cit259"><name><surname>Koehnke</surname><given-names>J.</given-names></name>; <name><surname>Mann</surname><given-names>G.</given-names></name>; <name><surname>Bent</surname><given-names>A. F.</given-names></name>; <name><surname>Ludewig</surname><given-names>H.</given-names></name>; <name><surname>Shirran</surname><given-names>S.</given-names></name>; <name><surname>Botting</surname><given-names>C.</given-names></name>; <name><surname>Lebl</surname><given-names>T.</given-names></name>; <name><surname>Houssen</surname><given-names>W. E.</given-names></name>; <name><surname>Jaspars</surname><given-names>M.</given-names></name>; <name><surname>Naismith</surname><given-names>J. H.</given-names></name>
<article-title>Structural analysis of leader peptide
binding enables leader-free cyanobactin processing</article-title>. <source>Nat. Chem. Biol.</source>
<year>2015</year>, <volume>11</volume> (<issue>8</issue>), <fpage>558</fpage>&#x02013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1841</pub-id>.<pub-id pub-id-type="pmid">26098679</pub-id></mixed-citation></ref><ref id="ref260"><mixed-citation publication-type="journal" id="cit260"><name><surname>Tsai</surname><given-names>T. Y.</given-names></name>; <name><surname>Yang</surname><given-names>C. Y.</given-names></name>; <name><surname>Shih</surname><given-names>H. L.</given-names></name>; <name><surname>Wang</surname><given-names>A. H.</given-names></name>; <name><surname>Chou</surname><given-names>S. H.</given-names></name>
<article-title><italic>Xanthomonas campestris</italic> PqqD in the
pyrroloquinoline quinone biosynthesis operon adopts a novel saddle-like
fold that possibly serves as a PQQ carrier</article-title>. <source>Proteins: Struct., Funct., Genet.</source>
<year>2009</year>, <volume>76</volume> (<issue>4</issue>), <fpage>1042</fpage>&#x02013;<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1002/prot.22461</pub-id>.<pub-id pub-id-type="pmid">19475705</pub-id></mixed-citation></ref><ref id="ref261"><mixed-citation publication-type="journal" id="cit261"><name><surname>Latham</surname><given-names>J. A.</given-names></name>; <name><surname>Iavarone</surname><given-names>A. T.</given-names></name>; <name><surname>Barr</surname><given-names>I.</given-names></name>; <name><surname>Juthani</surname><given-names>P. V.</given-names></name>; <name><surname>Klinman</surname><given-names>J. P.</given-names></name>
<article-title>PqqD is a novel peptide chaperone
that forms a ternary
complex with the radical S-adenosylmethionine protein PqqE in the
pyrroloquinoline quinone biosynthetic pathway</article-title>. <source>J. Biol. Chem.</source>
<year>2015</year>, <volume>290</volume> (<issue>20</issue>), <fpage>12908</fpage>&#x02013;<lpage>12918</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.646521</pub-id>.<pub-id pub-id-type="pmid">25817994</pub-id></mixed-citation></ref><ref id="ref262"><mixed-citation publication-type="journal" id="cit262"><name><surname>Ghodge</surname><given-names>S. V.</given-names></name>; <name><surname>Biernat</surname><given-names>K. A.</given-names></name>; <name><surname>Bassett</surname><given-names>S. J.</given-names></name>; <name><surname>Redinbo</surname><given-names>M. R.</given-names></name>; <name><surname>Bowers</surname><given-names>A. A.</given-names></name>
<article-title>Post-translational Claisen condensation
and decarboxylation
en route to the bicyclic core of pantocin A</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2016</year>, <volume>138</volume> (<issue>17</issue>), <fpage>5487</fpage>&#x02013;<lpage>5490</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b13529</pub-id>.<pub-id pub-id-type="pmid">27088303</pub-id></mixed-citation></ref><ref id="ref263"><mixed-citation publication-type="journal" id="cit263"><name><surname>Burkhart</surname><given-names>B. J.</given-names></name>; <name><surname>Hudson</surname><given-names>G. A.</given-names></name>; <name><surname>Dunbar</surname><given-names>K. L.</given-names></name>; <name><surname>Mitchell</surname><given-names>D. A.</given-names></name>
<article-title>A prevalent
peptide-binding domain guides ribosomal natural product biosynthesis</article-title>. <source>Nat. Chem. Biol.</source>
<year>2015</year>, <volume>11</volume> (<issue>8</issue>), <fpage>564</fpage>&#x02013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1856</pub-id>.<pub-id pub-id-type="pmid">26167873</pub-id></mixed-citation></ref><ref id="ref264"><mixed-citation publication-type="journal" id="cit264"><name><surname>Fuchs</surname><given-names>S. W.</given-names></name>; <name><surname>Lackner</surname><given-names>G.</given-names></name>; <name><surname>Morinaka</surname><given-names>B. I.</given-names></name>; <name><surname>Morishita</surname><given-names>Y.</given-names></name>; <name><surname>Asai</surname><given-names>T.</given-names></name>; <name><surname>Riniker</surname><given-names>S.</given-names></name>; <name><surname>Piel</surname><given-names>J.</given-names></name>
<article-title>A lanthipeptide-like
N-terminal leader region guides peptide epimerization by radical SAM
epimerases: implications for RiPP evolution</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2016</year>, <volume>55</volume> (<issue>40</issue>), <fpage>12330</fpage>&#x02013;<lpage>12333</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201602863</pub-id>.</mixed-citation></ref><ref id="ref265"><mixed-citation publication-type="journal" id="cit265"><name><surname>Wieckowski</surname><given-names>B. M.</given-names></name>; <name><surname>Hegemann</surname><given-names>J. D.</given-names></name>; <name><surname>Mielcarek</surname><given-names>A.</given-names></name>; <name><surname>Boss</surname><given-names>L.</given-names></name>; <name><surname>Burghaus</surname><given-names>O.</given-names></name>; <name><surname>Marahiel</surname><given-names>M. A.</given-names></name>
<article-title>The PqqD homologous
domain of the radical SAM enzyme ThnB is required for thioether bond
formation during thurincin H maturation</article-title>. <source>FEBS
Lett.</source>
<year>2015</year>, <volume>589</volume> (<issue>15</issue>), <fpage>1802</fpage>&#x02013;<lpage>1806</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2015.05.032</pub-id>.<pub-id pub-id-type="pmid">26026269</pub-id></mixed-citation></ref><ref id="ref266"><mixed-citation publication-type="journal" id="cit266"><name><surname>Escano</surname><given-names>J.</given-names></name>; <name><surname>Stauffer</surname><given-names>B.</given-names></name>; <name><surname>Brennan</surname><given-names>J.</given-names></name>; <name><surname>Bullock</surname><given-names>M.</given-names></name>; <name><surname>Smith</surname><given-names>L.</given-names></name>
<article-title>The leader peptide of mutacin 1140 has distinct structural components
compared to related class I lantibiotics</article-title>. <source>MicrobiologyOpen</source>
<year>2014</year>, <volume>3</volume> (<issue>6</issue>), <fpage>961</fpage>&#x02013;<lpage>972</lpage>. <pub-id pub-id-type="doi">10.1002/mbo3.222</pub-id>.<pub-id pub-id-type="pmid">25400246</pub-id></mixed-citation></ref><ref id="ref267"><mixed-citation publication-type="journal" id="cit267"><name><surname>Lubelski</surname><given-names>J.</given-names></name>; <name><surname>Overkamp</surname><given-names>W.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Influence of shifting
positions of Ser, Thr, and Cys
residues in prenisin on the efficiency of modification reactions and
on the antimicrobial activities of the modified prepeptides</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2008</year>, <volume>74</volume> (<issue>15</issue>), <fpage>4680</fpage>&#x02013;<lpage>4685</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00112-08</pub-id>.<pub-id pub-id-type="pmid">18539792</pub-id></mixed-citation></ref><ref id="ref268"><mixed-citation publication-type="journal" id="cit268"><name><surname>Escano</surname><given-names>J.</given-names></name>; <name><surname>Stauffer</surname><given-names>B.</given-names></name>; <name><surname>Brennan</surname><given-names>J.</given-names></name>; <name><surname>Bullock</surname><given-names>M.</given-names></name>; <name><surname>Smith</surname><given-names>L.</given-names></name>
<article-title>Biosynthesis and transport of the
lantibiotic mutacin 1140 produced
by <italic>Streptococcus mutans</italic></article-title>. <source>J.
Bacteriol.</source>
<year>2015</year>, <volume>197</volume> (<issue>7</issue>), <fpage>1173</fpage>&#x02013;<lpage>1184</lpage>. <pub-id pub-id-type="doi">10.1128/JB.02531-14</pub-id>.<pub-id pub-id-type="pmid">25605307</pub-id></mixed-citation></ref><ref id="ref269"><mixed-citation publication-type="journal" id="cit269"><name><surname>Chatterjee</surname><given-names>C.</given-names></name>; <name><surname>Patton</surname><given-names>G. C.</given-names></name>; <name><surname>Cooper</surname><given-names>L.</given-names></name>; <name><surname>Paul</surname><given-names>M.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Engineering dehydro amino acids and thioethers into
peptides using lacticin 481 synthetase</article-title>. <source>Chem.
Biol.</source>
<year>2006</year>, <volume>13</volume>, <fpage>1109</fpage>&#x02013;<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2006.08.015</pub-id>.<pub-id pub-id-type="pmid">17052615</pub-id></mixed-citation></ref><ref id="ref270"><mixed-citation publication-type="journal" id="cit270"><name><surname>Bindman</surname><given-names>N. A.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>A general method for fluorescent
labeling of the N-termini of lanthipeptides and its application to
visualize their cellular localization</article-title>. <source>J. Am.
Chem. Soc.</source>
<year>2013</year>, <volume>135</volume> (<issue>28</issue>), <fpage>10362</fpage>&#x02013;<lpage>10371</lpage>. <pub-id pub-id-type="doi">10.1021/ja4010706</pub-id>.<pub-id pub-id-type="pmid">23789944</pub-id></mixed-citation></ref><ref id="ref271"><mixed-citation publication-type="journal" id="cit271"><name><surname>M&#x000fc;ller</surname><given-names>W. M.</given-names></name>; <name><surname>Ensle</surname><given-names>P.</given-names></name>; <name><surname>Krawczyk</surname><given-names>B.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Leader
peptide-directed processing of labyrinthopeptin A2 precursor peptide
by the modifying enzyme LabKC</article-title>. <source>Biochemistry</source>
<year>2011</year>, <volume>50</volume> (<issue>39</issue>), <fpage>8362</fpage>&#x02013;<lpage>8373</lpage>. <pub-id pub-id-type="doi">10.1021/bi200526q</pub-id>.<pub-id pub-id-type="pmid">21905643</pub-id></mixed-citation></ref><ref id="ref272"><mixed-citation publication-type="journal" id="cit272"><name><surname>Heidrich</surname><given-names>C.</given-names></name>; <name><surname>Pag</surname><given-names>U.</given-names></name>; <name><surname>Josten</surname><given-names>M.</given-names></name>; <name><surname>Metzger</surname><given-names>J.</given-names></name>; <name><surname>Jack</surname><given-names>R. W.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Isolation,
characterization, and heterologous expression of the novel lantibiotic
epicidin 280 and analysis of its biosynthetic gene cluster</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1998</year>, <volume>64</volume> (<issue>9</issue>), <fpage>3140</fpage>&#x02013;<lpage>3146</lpage>.<pub-id pub-id-type="pmid">9726851</pub-id></mixed-citation></ref><ref id="ref273"><mixed-citation publication-type="journal" id="cit273"><name><surname>van de Kamp</surname><given-names>M.</given-names></name>; <name><surname>van den Hooven</surname><given-names>H. W.</given-names></name>; <name><surname>Konings</surname><given-names>R. N. H.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Sahl</surname><given-names>H.-G.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>de Vos</surname><given-names>W.</given-names></name>; <name><surname>Hilbers</surname><given-names>C. W.</given-names></name>; <name><surname>van de
Ven</surname><given-names>F. J.</given-names></name>
<article-title>Elucidation of the primary structure
of the lantibiotic epilancin K7 from <italic>Staphylococcus epidermis</italic> K7. Cloning and characterization of the epilancin-K7-encoding gene
and NMR analysis of mature epilancin K7</article-title>. <source>Eur.
J. Biochem.</source>
<year>1995</year>, <volume>230</volume> (<issue>2</issue>), <fpage>587</fpage>&#x02013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20600.x</pub-id>.<pub-id pub-id-type="pmid">7607233</pub-id></mixed-citation></ref><ref id="ref274"><mixed-citation publication-type="journal" id="cit274"><name><surname>Skaugen</surname><given-names>M.</given-names></name>; <name><surname>Nissenmeyer</surname><given-names>J.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Stevanovic</surname><given-names>S.</given-names></name>; <name><surname>Sletten</surname><given-names>K.</given-names></name>; <name><surname>Abildgaard</surname><given-names>C. I. M.</given-names></name>; <name><surname>Nes</surname><given-names>I. F.</given-names></name>
<article-title>In vivo conversion
of L-serine to D-alanine in a ribosomally synthesized polypeptide</article-title>. <source>J. Biol. Chem.</source>
<year>1994</year>, <volume>269</volume> (<issue>44</issue>), <fpage>27183</fpage>&#x02013;<lpage>27185</lpage>.<pub-id pub-id-type="pmid">7961627</pub-id></mixed-citation></ref><ref id="ref275"><mixed-citation publication-type="journal" id="cit275"><name><surname>Mortvedt</surname><given-names>C. I.</given-names></name>; <name><surname>Nissen-Meyer</surname><given-names>J.</given-names></name>; <name><surname>Sletten</surname><given-names>K.</given-names></name>; <name><surname>Nes</surname><given-names>I. F.</given-names></name>
<article-title>Purification
and amino acid sequence of lactocin S, a bacteriocin produced by <italic>Lactobacillus sake</italic> L45</article-title>. <source>Appl. Environ.
Microbiol.</source>
<year>1991</year>, <volume>57</volume> (<issue>6</issue>), <fpage>1829</fpage>&#x02013;<lpage>1834</lpage>.<pub-id pub-id-type="pmid">1872611</pub-id></mixed-citation></ref><ref id="ref276"><mixed-citation publication-type="journal" id="cit276"><name><surname>Kellner</surname><given-names>R.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Josten</surname><given-names>M.</given-names></name>; <name><surname>Kaletta</surname><given-names>C.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Pep5: structure elucidation of a
large lantibiotic</article-title>. <source>Angew. Chem.</source>
<year>1989</year>, <volume>101</volume> (<issue>5</issue>), <fpage>618</fpage>&#x02013;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1002/ange.19891010514</pub-id>.</mixed-citation></ref><ref id="ref277"><mixed-citation publication-type="journal" id="cit277"><name><surname>van de Kamp</surname><given-names>M.</given-names></name>; <name><surname>van den Hooven</surname><given-names>H. W.</given-names></name>; <name><surname>Konings</surname><given-names>R. N.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>; <name><surname>Hilbers</surname><given-names>C. W.</given-names></name>; <name><surname>van de Ven</surname><given-names>F. J.</given-names></name>
<article-title>Elucidation of the primary structure
of the lantibiotic epilancin K7 from <italic>Staphylococcus epidermidis</italic> K7. Cloning and characterisation of the epilancin-K7-encoding gene
and NMR analysis of mature epilancin K7</article-title>. <source>Eur.
J. Biochem.</source>
<year>1995</year>, <volume>230</volume> (<issue>2</issue>), <fpage>587</fpage>&#x02013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20600.x</pub-id>.<pub-id pub-id-type="pmid">7607233</pub-id></mixed-citation></ref><ref id="ref278"><mixed-citation publication-type="journal" id="cit278"><name><surname>Ortega</surname><given-names>M. A.</given-names></name>; <name><surname>Vel&#x000e1;squez</surname><given-names>J. E.</given-names></name>; <name><surname>Garg</surname><given-names>N.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Joyce</surname><given-names>R. E.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Substrate
specificity of the lanthipeptide peptidase ElxP and the oxidoreductase
ElxO</article-title>. <source>ACS Chem. Biol.</source>
<year>2014</year>, <volume>9</volume> (<issue>8</issue>), <fpage>1718</fpage>&#x02013;<lpage>1725</lpage>. <pub-id pub-id-type="doi">10.1021/cb5002526</pub-id>.<pub-id pub-id-type="pmid">24866416</pub-id></mixed-citation></ref><ref id="ref279"><mixed-citation publication-type="journal" id="cit279"><name><surname>Kavanagh</surname><given-names>K. L.</given-names></name>; <name><surname>J&#x000f6;rnvall</surname><given-names>H.</given-names></name>; <name><surname>Persson</surname><given-names>B.</given-names></name>; <name><surname>Oppermann</surname><given-names>U.</given-names></name>
<article-title>Medium- and
short-chain dehydrogenase/reductase gene and protein families: the
SDR superfamily: functional and structural diversity within a family
of metabolic and regulatory enzymes</article-title>. <source>Cell. Mol.
Life Sci.</source>
<year>2008</year>, <volume>65</volume> (<issue>24</issue>), <fpage>3895</fpage>&#x02013;<lpage>3906</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-008-8588-y</pub-id>.<pub-id pub-id-type="pmid">19011750</pub-id></mixed-citation></ref><ref id="ref280"><mixed-citation publication-type="journal" id="cit280"><name><surname>Huang</surname><given-names>E.</given-names></name>; <name><surname>Yousef</surname><given-names>A. E.</given-names></name>
<article-title>Biosynthesis of paenibacillin, a
lantibiotic with N-terminal acetylation, by <italic>Paenibacillus
polymyxa</italic></article-title>. <source>Microbiol. Res.</source>
<year>2015</year>, <volume>181</volume>, <fpage>15</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2015.08.001</pub-id>.<pub-id pub-id-type="pmid">26640048</pub-id></mixed-citation></ref><ref id="ref281"><mixed-citation publication-type="journal" id="cit281"><name><surname>He</surname><given-names>Z.</given-names></name>; <name><surname>Yuan</surname><given-names>C.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Yousef</surname><given-names>A. E.</given-names></name>
<article-title>N-Terminal acetylation
in paenibacillin, a novel lantibiotic</article-title>. <source>FEBS
Lett.</source>
<year>2008</year>, <volume>582</volume> (<issue>18</issue>), <fpage>2787</fpage>&#x02013;<lpage>2792</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2008.07.008</pub-id>.<pub-id pub-id-type="pmid">18625234</pub-id></mixed-citation></ref><ref id="ref282"><mixed-citation publication-type="journal" id="cit282"><name><surname>Moore</surname><given-names>D.</given-names></name>; <name><surname>Hamilton</surname><given-names>C. M.</given-names></name>; <name><surname>Maneewannakul</surname><given-names>K.</given-names></name>; <name><surname>Mintz</surname><given-names>Y.</given-names></name>; <name><surname>Frost</surname><given-names>L. S.</given-names></name>; <name><surname>Ippen-Ihler</surname><given-names>K.</given-names></name>
<article-title>The <italic>Escherichia coli</italic> K-12 F plasmid gene traX is required for
acetylation of F pilin</article-title>. <source>J. Bacteriol.</source>
<year>1993</year>, <volume>175</volume> (<issue>5</issue>), <fpage>1375</fpage>&#x02013;<lpage>1383</lpage>. <pub-id pub-id-type="doi">10.1128/jb.175.5.1375-1383.1993</pub-id>.<pub-id pub-id-type="pmid">8444800</pub-id></mixed-citation></ref><ref id="ref283"><mixed-citation publication-type="journal" id="cit283"><name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<article-title>In vivo reaction of affinity-tag-labelled
epidermin precursor peptide with flavoenzyme EpiD</article-title>. <source>FEMS Microbiol. Lett.</source>
<year>1997</year>, <volume>153</volume> (<issue>1</issue>), <fpage>25</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1997.tb10459.x</pub-id>.<pub-id pub-id-type="pmid">9252569</pub-id></mixed-citation></ref><ref id="ref284"><mixed-citation publication-type="journal" id="cit284"><name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Kempter</surname><given-names>C.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<article-title>Oxidative
decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination
of substrate specificity using peptide libraries and neutral loss
mass spectrometry</article-title>. <source>J. Biol. Chem.</source>
<year>1995</year>, <volume>270</volume> (<issue>19</issue>), <fpage>11282</fpage>&#x02013;<lpage>11289</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.19.11282</pub-id>.<pub-id pub-id-type="pmid">7744764</pub-id></mixed-citation></ref><ref id="ref285"><mixed-citation publication-type="journal" id="cit285"><name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Kempter</surname><given-names>C.</given-names></name>; <name><surname>Gnau</surname><given-names>V.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<article-title>Mass spectroscopic
analysis of a novel enzymatic reaction.
Oxidative decarboxylation of the lantibiotic precursor peptide EpiA
catalyzed by the flavoprotein EpiD</article-title>. <source>J. Biol.
Chem.</source>
<year>1994</year>, <volume>269</volume> (<issue>8</issue>), <fpage>5653</fpage>&#x02013;<lpage>5659</lpage>.<pub-id pub-id-type="pmid">8119901</pub-id></mixed-citation></ref><ref id="ref286"><mixed-citation publication-type="journal" id="cit286"><name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Uebele</surname><given-names>M.</given-names></name>; <name><surname>Schmid</surname><given-names>D.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Blaesse</surname><given-names>M.</given-names></name>; <name><surname>Steinbacher</surname><given-names>S.</given-names></name>
<article-title>Molecular characterization of lantibiotic-synthesizing
enzyme EpiD reveals a function for bacterial Dfp proteins in coenzyme
A biosynthesis</article-title>. <source>J. Biol. Chem.</source>
<year>2000</year>, <volume>275</volume> (<issue>41</issue>), <fpage>31838</fpage>&#x02013;<lpage>31846</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M004273200</pub-id>.<pub-id pub-id-type="pmid">10922366</pub-id></mixed-citation></ref><ref id="ref287"><mixed-citation publication-type="journal" id="cit287"><name><surname>Blaesse</surname><given-names>M.</given-names></name>; <name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Huber</surname><given-names>R.</given-names></name>; <name><surname>Steinbacher</surname><given-names>S.</given-names></name>
<article-title>Crystal structure
of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide
substrate</article-title>. <source>EMBO J.</source>
<year>2000</year>, <volume>19</volume> (<issue>23</issue>), <fpage>6299</fpage>&#x02013;<lpage>6310</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/19.23.6299</pub-id>.<pub-id pub-id-type="pmid">11101502</pub-id></mixed-citation></ref><ref id="ref288"><mixed-citation publication-type="journal" id="cit288"><name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>G&#x000f6;tz</surname><given-names>F.</given-names></name>
<article-title>The enethiolate
anion reaction products
of EpiD. pKa value of the enethiol side chain is lower than that of
the thiol side chain of peptides</article-title>. <source>J. Biol. Chem.</source>
<year>1997</year>, <volume>272</volume> (<issue>8</issue>), <fpage>4759</fpage>&#x02013;<lpage>4762</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.8.4759</pub-id>.<pub-id pub-id-type="pmid">9030529</pub-id></mixed-citation></ref><ref id="ref289"><mixed-citation publication-type="journal" id="cit289"><name><surname>Majer</surname><given-names>F.</given-names></name>; <name><surname>Schmid</surname><given-names>D. G.</given-names></name>; <name><surname>Altena</surname><given-names>K.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Kupke</surname><given-names>T.</given-names></name>
<article-title>The flavoprotein
MrsD catalyzes the oxidative decarboxylation reaction
involved in formation of the peptidoglycan biosynthesis inhibitor
mersacidin</article-title>. <source>J. Bacteriol.</source>
<year>2002</year>, <volume>184</volume> (<issue>5</issue>), <fpage>1234</fpage>&#x02013;<lpage>1243</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.5.1234-1243.2002</pub-id>.<pub-id pub-id-type="pmid">11844751</pub-id></mixed-citation></ref><ref id="ref290"><mixed-citation publication-type="journal" id="cit290"><name><surname>Blaesse</surname><given-names>M.</given-names></name>; <name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Huber</surname><given-names>R.</given-names></name>; <name><surname>Steinbacher</surname><given-names>S.</given-names></name>
<article-title>Structure
of MrsD, an FAD-binding protein of the HFCD family</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<year>2003</year>, <volume>59</volume> (<issue>8</issue>), <fpage>1414</fpage>&#x02013;<lpage>1421</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444903011831</pub-id>.<pub-id pub-id-type="pmid">12876343</pub-id></mixed-citation></ref><ref id="ref291"><mixed-citation publication-type="journal" id="cit291"><person-group person-group-type="allauthors"><name><surname>Ortega</surname><given-names>M. A.</given-names></name>; <name><surname>Cogan</surname><given-names>D. P.</given-names></name>; <name><surname>Mukherjee</surname><given-names>S.</given-names></name>; <name><surname>Garg</surname><given-names>N.</given-names></name>; <name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Thibodeaux</surname><given-names>G. N.</given-names></name>; <name><surname>Maffioli</surname><given-names>S.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Escano</surname><given-names>J.</given-names></name></person-group><etal/><article-title>Two flavoenzymes catalyze
the post-translational generation of 5-chlorotryptophan and 2-aminovinyl-cysteine
during NAI-107 biosynthesis</article-title>. <source>ACS Chem. Biol.</source><year>2017</year>, DOI: <pub-id pub-id-type="doi">10.1021/acschembio.6b01031</pub-id>.</mixed-citation></ref><ref id="ref292"><mixed-citation publication-type="journal" id="cit292"><name><surname>Steinbacher</surname><given-names>S.</given-names></name>; <name><surname>Hernandez-Acosta</surname><given-names>P.</given-names></name>; <name><surname>Bieseler</surname><given-names>B.</given-names></name>; <name><surname>Blaesse</surname><given-names>M.</given-names></name>; <name><surname>Huber</surname><given-names>R.</given-names></name>; <name><surname>Culianez-Macia</surname><given-names>F. A.</given-names></name>; <name><surname>Kupke</surname><given-names>T.</given-names></name>
<article-title>Crystal structure of
the plant PPC decarboxylase AtHAL3a complexed with an ene-thiol reaction
intermediate</article-title>. <source>J. Mol. Biol.</source>
<year>2003</year>, <volume>327</volume> (<issue>1</issue>), <fpage>193</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-2836(03)00092-5</pub-id>.<pub-id pub-id-type="pmid">12614618</pub-id></mixed-citation></ref><ref id="ref293"><mixed-citation publication-type="journal" id="cit293"><name><surname>Strauss</surname><given-names>E.</given-names></name>; <name><surname>Begley</surname><given-names>T. P.</given-names></name>
<article-title>Stereochemical studies
on phosphopantothenoylcysteine
decarboxylase from <italic>Escherichia coli</italic></article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<year>2003</year>, <volume>13</volume> (<issue>3</issue>), <fpage>339</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-894X(02)01018-1</pub-id>.<pub-id pub-id-type="pmid">12565925</pub-id></mixed-citation></ref><ref id="ref294"><mixed-citation publication-type="journal" id="cit294"><name><surname>Strauss</surname><given-names>E.</given-names></name>; <name><surname>Begley</surname><given-names>T. P.</given-names></name>
<article-title>Mechanistic studies
on phosphopantothenoylcysteine
decarboxylase</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2001</year>, <volume>123</volume> (<issue>26</issue>), <fpage>6449</fpage>&#x02013;<lpage>6450</lpage>. <pub-id pub-id-type="doi">10.1021/ja016020y</pub-id>.<pub-id pub-id-type="pmid">11427085</pub-id></mixed-citation></ref><ref id="ref295"><mixed-citation publication-type="journal" id="cit295"><name><surname>Hernandez-Acosta</surname><given-names>P.</given-names></name>; <name><surname>Schmid</surname><given-names>D. G.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Culianez-Macia</surname><given-names>F. A.</given-names></name>; <name><surname>Kupke</surname><given-names>T.</given-names></name>
<article-title>Molecular characterization of the <italic>Arabidopsis thaliana</italic> flavoprotein AtHAL3a reveals the general reaction mechanism of 4&#x02032;-phosphopantothenoylcysteine
decarboxylases</article-title>. <source>J. Biol. Chem.</source>
<year>2002</year>, <volume>277</volume> (<issue>23</issue>), <fpage>20490</fpage>&#x02013;<lpage>20498</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M201557200</pub-id>.<pub-id pub-id-type="pmid">11923307</pub-id></mixed-citation></ref><ref id="ref296"><mixed-citation publication-type="journal" id="cit296"><name><surname>Strauss</surname><given-names>E.</given-names></name>; <name><surname>Zhai</surname><given-names>H.</given-names></name>; <name><surname>Brand</surname><given-names>L. A.</given-names></name>; <name><surname>McLafferty</surname><given-names>F. W.</given-names></name>; <name><surname>Begley</surname><given-names>T. P.</given-names></name>
<article-title>Mechanistic studies on phosphopantothenoylcysteine
decarboxylase: trapping of an enethiolate intermediate with a mechanism-based
inactivating agent</article-title>. <source>Biochemistry</source>
<year>2004</year>, <volume>43</volume> (<issue>49</issue>), <fpage>15520</fpage>&#x02013;<lpage>15533</lpage>. <pub-id pub-id-type="doi">10.1021/bi048340a</pub-id>.<pub-id pub-id-type="pmid">15581364</pub-id></mixed-citation></ref><ref id="ref297"><mixed-citation publication-type="journal" id="cit297"><name><surname>Claesen</surname><given-names>J.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>
<article-title>Genome mining and
genetic analysis
of cypemycin biosynthesis reveal an unusual class of posttranslationally
modified peptides</article-title>. <source>Proc. Natl. Acad. Sci. U.
S. A.</source>
<year>2010</year>, <volume>107</volume> (<issue>37</issue>), <fpage>16297</fpage>&#x02013;<lpage>16302</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1008608107</pub-id>.<pub-id pub-id-type="pmid">20805503</pub-id></mixed-citation></ref><ref id="ref298"><mixed-citation publication-type="journal" id="cit298"><name><surname>Claesen</surname><given-names>J.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>
<article-title>Biosynthesis and regulation of grisemycin,
a new member of the linaridin family of ribosomally synthesized peptides
produced by <italic>Streptomyces griseus</italic> IFO 13350</article-title>. <source>J. Bacteriol.</source>
<year>2011</year>, <volume>193</volume> (<issue>10</issue>), <fpage>2510</fpage>&#x02013;<lpage>2516</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00171-11</pub-id>.<pub-id pub-id-type="pmid">21421760</pub-id></mixed-citation></ref><ref id="ref299"><mixed-citation publication-type="journal" id="cit299"><name><surname>Hayakawa</surname><given-names>Y.</given-names></name>; <name><surname>Sasaki</surname><given-names>K.</given-names></name>; <name><surname>Nagai</surname><given-names>K.</given-names></name>; <name><surname>Shin-ya</surname><given-names>K.</given-names></name>; <name><surname>Furihata</surname><given-names>K.</given-names></name>
<article-title>Structure of thioviridamide, a novel
apoptosis inducer
from <italic>Streptomyces olivoviridis</italic></article-title>. <source>J. Antibiot.</source>
<year>2006</year>, <volume>59</volume> (<issue>1</issue>), <fpage>6</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2006.2</pub-id>.<pub-id pub-id-type="pmid">16568713</pub-id></mixed-citation></ref><ref id="ref300"><mixed-citation publication-type="journal" id="cit300"><name><surname>Izawa</surname><given-names>M.</given-names></name>; <name><surname>Kawasaki</surname><given-names>T.</given-names></name>; <name><surname>Hayakawa</surname><given-names>Y.</given-names></name>
<article-title>Cloning and heterologous
expression of the thioviridamide biosynthesis gene cluster from <italic>Streptomyces olivoviridis</italic></article-title>. <source>Appl. Environ.
Microbiol.</source>
<year>2013</year>, <volume>79</volume> (<issue>22</issue>), <fpage>7110</fpage>&#x02013;<lpage>7113</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01978-13</pub-id>.<pub-id pub-id-type="pmid">23995943</pub-id></mixed-citation></ref><ref id="ref301"><mixed-citation publication-type="journal" id="cit301"><name><surname>Foulston</surname><given-names>L. C.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>
<article-title>Microbisporicin gene cluster reveals
unusual features of lantibiotic biosynthesis in actinomycetes</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2010</year>, <volume>107</volume> (<issue>30</issue>), <fpage>13461</fpage>&#x02013;<lpage>13466</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1008285107</pub-id>.<pub-id pub-id-type="pmid">20628010</pub-id></mixed-citation></ref><ref id="ref302"><mixed-citation publication-type="journal" id="cit302"><name><surname>van Pe&#x000e9;</surname><given-names>K. H.</given-names></name>; <name><surname>Patallo</surname><given-names>E. P.</given-names></name>
<article-title>Flavin-dependent
halogenases involved
in secondary metabolism in bacteria</article-title>. <source>Appl. Microbiol.
Biotechnol.</source>
<year>2006</year>, <volume>70</volume> (<issue>6</issue>), <fpage>631</fpage>&#x02013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-005-0232-2</pub-id>.<pub-id pub-id-type="pmid">16544142</pub-id></mixed-citation></ref><ref id="ref303"><mixed-citation publication-type="journal" id="cit303"><name><surname>Cruz</surname><given-names>J. C.</given-names></name>; <name><surname>Iorio</surname><given-names>M.</given-names></name>; <name><surname>Monciardini</surname><given-names>P.</given-names></name>; <name><surname>Simone</surname><given-names>M.</given-names></name>; <name><surname>Brunati</surname><given-names>C.</given-names></name>; <name><surname>Gaspari</surname><given-names>E.</given-names></name>; <name><surname>Maffioli</surname><given-names>S. I.</given-names></name>; <name><surname>Wellington</surname><given-names>E.</given-names></name>; <name><surname>Sosio</surname><given-names>M.</given-names></name>; <name><surname>Donadio</surname><given-names>S.</given-names></name>
<article-title>Brominated variant
of the lantibiotic NAI-107 with enhanced antibacterial potency</article-title>. <source>J. Nat. Prod.</source>
<year>2015</year>, <volume>78</volume> (<issue>11</issue>), <fpage>2642</fpage>&#x02013;<lpage>2647</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b00576</pub-id>.<pub-id pub-id-type="pmid">26512731</pub-id></mixed-citation></ref><ref id="ref304"><mixed-citation publication-type="journal" id="cit304"><name><surname>Xie</surname><given-names>L.</given-names></name>; <name><surname>Miller</surname><given-names>L. M.</given-names></name>; <name><surname>Chatterjee</surname><given-names>C.</given-names></name>; <name><surname>Averin</surname><given-names>O.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Lacticin
481: in vitro reconstitution of lantibiotic
synthetase activity</article-title>. <source>Science</source>
<year>2004</year>, <volume>303</volume> (<issue>5658</issue>), <fpage>679</fpage>&#x02013;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1126/science.1092600</pub-id>.<pub-id pub-id-type="pmid">14752162</pub-id></mixed-citation></ref><ref id="ref305"><mixed-citation publication-type="journal" id="cit305"><name><surname>Br&#x000f6;tz</surname><given-names>H.</given-names></name>; <name><surname>Bierbaum</surname><given-names>G.</given-names></name>; <name><surname>Leopold</surname><given-names>K.</given-names></name>; <name><surname>Reynolds</surname><given-names>P. E.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>The lantibiotic mersacidin inhibits
peptidoglycan synthesis
by targeting lipid II</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>1998</year>, <volume>42</volume> (<issue>1</issue>), <fpage>154</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="pmid">9449277</pub-id></mixed-citation></ref><ref id="ref306"><mixed-citation publication-type="journal" id="cit306"><name><surname>Islam</surname><given-names>M.
R.</given-names></name>; <name><surname>Nishie</surname><given-names>M.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Zendo</surname><given-names>T.</given-names></name>; <name><surname>Keller</surname><given-names>S.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Kohda</surname><given-names>D.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Ring A of nukacin ISK-1:
a lipid II-binding motif for
type-A(II) lantibiotic</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2012</year>, <volume>134</volume> (<issue>8</issue>), <fpage>3687</fpage>&#x02013;<lpage>3690</lpage>. <pub-id pub-id-type="doi">10.1021/ja300007h</pub-id>.<pub-id pub-id-type="pmid">22329487</pub-id></mixed-citation></ref><ref id="ref307"><mixed-citation publication-type="journal" id="cit307"><name><surname>Wiedemann</surname><given-names>I.</given-names></name>; <name><surname>Bottiger</surname><given-names>T.</given-names></name>; <name><surname>Bonelli</surname><given-names>R. R.</given-names></name>; <name><surname>Wiese</surname><given-names>A.</given-names></name>; <name><surname>Hagge</surname><given-names>S. O.</given-names></name>; <name><surname>Gutsmann</surname><given-names>T.</given-names></name>; <name><surname>Seydel</surname><given-names>U.</given-names></name>; <name><surname>Deegan</surname><given-names>L.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>P.</given-names></name>; et al. <article-title>The mode of action of
the lantibiotic lacticin 3147--a complex mechanism involving specific
interaction of two peptides and the cell wall precursor lipid II</article-title>. <source>Mol. Microbiol.</source>
<year>2006</year>, <volume>61</volume> (<issue>2</issue>), <fpage>285</fpage>&#x02013;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05223.x</pub-id>.<pub-id pub-id-type="pmid">16771847</pub-id></mixed-citation></ref><ref id="ref308"><mixed-citation publication-type="journal" id="cit308"><name><surname>Breukink</surname><given-names>E.</given-names></name>
<article-title>A lesson in efficient killing from
two-component lantibiotics</article-title>. <source>Mol. Microbiol.</source>
<year>2006</year>, <volume>61</volume> (<issue>2</issue>), <fpage>271</fpage>&#x02013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05239.x</pub-id>.<pub-id pub-id-type="pmid">16771845</pub-id></mixed-citation></ref><ref id="ref309"><mixed-citation publication-type="journal" id="cit309"><name><surname>Oman</surname><given-names>T. J.</given-names></name>; <name><surname>Lupoli</surname><given-names>T. J.</given-names></name>; <name><surname>Wang</surname><given-names>T.-S. A.</given-names></name>; <name><surname>Kahne</surname><given-names>D.</given-names></name>; <name><surname>Walker</surname><given-names>S.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Haloduracin &#x003b1; binds the peptidoglycan
precursor lipid II with 2:1 stoichiometry</article-title>. <source>J.
Am. Chem. Soc.</source>
<year>2011</year>, <volume>133</volume>, <fpage>17544</fpage>&#x02013;<lpage>17547</lpage>. <pub-id pub-id-type="doi">10.1021/ja206281k</pub-id>.<pub-id pub-id-type="pmid">22003874</pub-id></mixed-citation></ref><ref id="ref310"><mixed-citation publication-type="journal" id="cit310"><name><surname>Siegers</surname><given-names>K.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>
<article-title>Genes involved in immunity to the
lantibiotic nisin produced by <italic>Lactococcus lactis</italic> 6F3</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1995</year>, <volume>61</volume> (<issue>3</issue>), <fpage>1082</fpage>&#x02013;<lpage>1089</lpage>.<pub-id pub-id-type="pmid">7793910</pub-id></mixed-citation></ref><ref id="ref311"><mixed-citation publication-type="journal" id="cit311"><name><surname>Immonen</surname><given-names>T.</given-names></name>; <name><surname>Saris</surname><given-names>P. E.</given-names></name>
<article-title>Characterization
of the nisFEG operon
of the nisin Z producing <italic>Lactococcus lactis</italic> subsp. <italic>lactis</italic> N8 strain</article-title>. <source>DNA Sequence</source>
<year>1998</year>, <volume>9</volume> (<issue>5&#x02013;6</issue>), <fpage>263</fpage>&#x02013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.3109/10425179809008466</pub-id>.<pub-id pub-id-type="pmid">10524754</pub-id></mixed-citation></ref><ref id="ref312"><mixed-citation publication-type="journal" id="cit312"><name><surname>Kuipers</surname><given-names>O. P.</given-names></name>; <name><surname>Beerthuyzen</surname><given-names>M. M.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>de Vos</surname><given-names>W. M.</given-names></name>
<article-title>Characterization
of the nisin gene cluster nisABTCIPR of <italic>Lactococcus lactis</italic>. Requirement of expression of the <italic>nisA</italic> and <italic>nisI</italic> genes for development of immunity</article-title>. <source>Eur. J. Biochem.</source>
<year>1993</year>, <volume>216</volume> (<issue>1</issue>), <fpage>281</fpage>&#x02013;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1993.tb18143.x</pub-id>.<pub-id pub-id-type="pmid">7689965</pub-id></mixed-citation></ref><ref id="ref313"><mixed-citation publication-type="journal" id="cit313"><name><surname>Halami</surname><given-names>P. M.</given-names></name>; <name><surname>Stein</surname><given-names>T.</given-names></name>; <name><surname>Chandrashekar</surname><given-names>A.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>
<article-title>Maturation and processing of SpaI, the lipoprotein
involved in subtilin immunity in <italic>Bacillus subtilis</italic> ATCC 6633</article-title>. <source>Microbiol. Res.</source>
<year>2010</year>, <volume>165</volume> (<issue>3</issue>), <fpage>183</fpage>&#x02013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2009.02.001</pub-id>.<pub-id pub-id-type="pmid">19540743</pub-id></mixed-citation></ref><ref id="ref314"><mixed-citation publication-type="journal" id="cit314"><name><surname>Reis</surname><given-names>M.</given-names></name>; <name><surname>Eschbach-Bludau</surname><given-names>M.</given-names></name>; <name><surname>Iglesias-Wind</surname><given-names>M. I.</given-names></name>; <name><surname>Kupke</surname><given-names>T.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Producer immunity
towards the lantibiotic
Pep5: identification of the immunity gene pepI and localization and
functional analysis of its gene product</article-title>. <source>Appl.
Environ. Microbiol.</source>
<year>1994</year>, <volume>60</volume> (<issue>8</issue>), <fpage>2876</fpage>&#x02013;<lpage>2883</lpage>.<pub-id pub-id-type="pmid">8085827</pub-id></mixed-citation></ref><ref id="ref315"><mixed-citation publication-type="journal" id="cit315"><name><surname>Qiao</surname><given-names>M.</given-names></name>; <name><surname>Immonen</surname><given-names>T.</given-names></name>; <name><surname>Koponen</surname><given-names>O.</given-names></name>; <name><surname>Saris</surname><given-names>P. E. J.</given-names></name>
<article-title>The
cellular location and effect on nisin immunity of the NisI protein
from <italic>Lactococcus lactis</italic> N8 expressed in <italic>Escherichia
coli</italic> and <italic>L. lactis</italic></article-title>. <source>FEMS Microbiol. Lett.</source>
<year>1995</year>, <volume>131</volume> (<issue>1</issue>), <fpage>75</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1995.tb07757.x</pub-id>.<pub-id pub-id-type="pmid">7557313</pub-id></mixed-citation></ref><ref id="ref316"><mixed-citation publication-type="journal" id="cit316"><name><surname>Saris</surname><given-names>P. E.</given-names></name>; <name><surname>Immonen</surname><given-names>T.</given-names></name>; <name><surname>Reis</surname><given-names>M.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>
<article-title>Immunity
to lantibiotics</article-title>. <source>Antonie van Leeuwenhoek</source>
<year>1996</year>, <volume>69</volume> (<issue>2</issue>), <fpage>151</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1007/BF00399420</pub-id>.<pub-id pub-id-type="pmid">8775975</pub-id></mixed-citation></ref><ref id="ref317"><mixed-citation publication-type="journal" id="cit317"><name><surname>Draper</surname><given-names>L. A.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>
<article-title>Lantibiotic
immunity</article-title>. <source>Curr. Protein Pept. Sci.</source>
<year>2008</year>, <volume>9</volume> (<issue>1</issue>), <fpage>39</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.2174/138920308783565750</pub-id>.<pub-id pub-id-type="pmid">18336322</pub-id></mixed-citation></ref><ref id="ref318"><mixed-citation publication-type="journal" id="cit318"><name><surname>Okuda</surname><given-names>K.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Structural and functional
diversity
of lantibiotic immunity proteins</article-title>. <source>Curr. Pharm.
Biotechnol.</source>
<year>2011</year>, <volume>12</volume> (<issue>8</issue>), <fpage>1231</fpage>&#x02013;<lpage>1239</lpage>. <pub-id pub-id-type="doi">10.2174/138920111796117274</pub-id>.<pub-id pub-id-type="pmid">21470153</pub-id></mixed-citation></ref><ref id="ref319"><mixed-citation publication-type="journal" id="cit319"><name><surname>Christ</surname><given-names>N. A.</given-names></name>; <name><surname>Bochmann</surname><given-names>S.</given-names></name>; <name><surname>Gottstein</surname><given-names>D.</given-names></name>; <name><surname>Duchardt-Ferner</surname><given-names>E.</given-names></name>; <name><surname>Hellmich</surname><given-names>U. A.</given-names></name>; <name><surname>Dusterhus</surname><given-names>S.</given-names></name>; <name><surname>Kotter</surname><given-names>P.</given-names></name>; <name><surname>Guntert</surname><given-names>P.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>; <name><surname>Wohnert</surname><given-names>J.</given-names></name>
<article-title>The first
structure of a lantibiotic immunity protein, SpaI from <italic>Bacillus
subtilis</italic>, reveals a novel fold</article-title>. <source>J.
Biol. Chem.</source>
<year>2012</year>, <volume>287</volume> (<issue>42</issue>), <fpage>35286</fpage>&#x02013;<lpage>35298</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.401620</pub-id>.<pub-id pub-id-type="pmid">22904324</pub-id></mixed-citation></ref><ref id="ref320"><mixed-citation publication-type="journal" id="cit320"><name><surname>Hacker</surname><given-names>C.</given-names></name>; <name><surname>Christ</surname><given-names>N. A.</given-names></name>; <name><surname>Duchardt-Ferner</surname><given-names>E.</given-names></name>; <name><surname>Korn</surname><given-names>S.</given-names></name>; <name><surname>Gobl</surname><given-names>C.</given-names></name>; <name><surname>Berninger</surname><given-names>L.</given-names></name>; <name><surname>Dusterhus</surname><given-names>S.</given-names></name>; <name><surname>Hellmich</surname><given-names>U. A.</given-names></name>; <name><surname>Madl</surname><given-names>T.</given-names></name>; <name><surname>Kotter</surname><given-names>P.</given-names></name>; et al. <article-title>The solution structure of the lantibiotic immunity protein NisI and
its interactions with nisin</article-title>. <source>J. Biol. Chem.</source>
<year>2015</year>, <volume>290</volume> (<issue>48</issue>), <fpage>28869</fpage>&#x02013;<lpage>28886</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.679969</pub-id>.<pub-id pub-id-type="pmid">26459561</pub-id></mixed-citation></ref><ref id="ref321"><mixed-citation publication-type="journal" id="cit321"><name><surname>Pozzi</surname><given-names>R.</given-names></name>; <name><surname>Coles</surname><given-names>M.</given-names></name>; <name><surname>Linke</surname><given-names>D.</given-names></name>; <name><surname>Kulik</surname><given-names>A.</given-names></name>; <name><surname>Nega</surname><given-names>M.</given-names></name>; <name><surname>Wohlleben</surname><given-names>W.</given-names></name>; <name><surname>Stegmann</surname><given-names>E.</given-names></name>
<article-title>Distinct mechanisms
contribute to immunity in the lantibiotic NAI-107 producer strain <italic>Microbispora</italic> ATCC PTA-5024</article-title>. <source>Environ.
Microbiol.</source>
<year>2016</year>, <volume>18</volume> (<issue>1</issue>), <fpage>118</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1111/1462-2920.12892</pub-id>.<pub-id pub-id-type="pmid">25923468</pub-id></mixed-citation></ref><ref id="ref322"><mixed-citation publication-type="journal" id="cit322"><name><surname>Froseth</surname><given-names>B. R.</given-names></name>; <name><surname>McKay</surname><given-names>L. L.</given-names></name>
<article-title>Molecular characterization of the
nisin resistance region of <italic>Lactococcus lactis</italic> subsp. <italic>lactis</italic> biovar diacetylactis DRC3</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1991</year>, <volume>57</volume> (<issue>3</issue>), <fpage>804</fpage>&#x02013;<lpage>811</lpage>.<pub-id pub-id-type="pmid">1903915</pub-id></mixed-citation></ref><ref id="ref323"><mixed-citation publication-type="journal" id="cit323"><name><surname>Tang</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Yang</surname><given-names>W.</given-names></name>; <name><surname>Chen</surname><given-names>M.</given-names></name>; <name><surname>Huan</surname><given-names>L.</given-names></name>
<article-title>Isolation and characterization of a plasmid pTS50, which encodes
nisin resistance determinant in <italic>Lactococcus lactis</italic> TS1640</article-title>. <source>Wei Sheng Wu Xue Bao</source>
<year>2001</year>, <volume>41</volume> (<issue>5</issue>), <fpage>536</fpage>&#x02013;<lpage>541</lpage>.<pub-id pub-id-type="pmid">12552799</pub-id></mixed-citation></ref><ref id="ref324"><mixed-citation publication-type="journal" id="cit324"><name><surname>Sun</surname><given-names>Z.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>; <name><surname>Liang</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Huan</surname><given-names>L.</given-names></name>
<article-title>Novel mechanism for nisin resistance
via proteolytic degradation
of nisin by the nisin resistance protein NSR</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2009</year>, <volume>53</volume> (<issue>5</issue>), <fpage>1964</fpage>&#x02013;<lpage>1973</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01382-08</pub-id>.<pub-id pub-id-type="pmid">19273681</pub-id></mixed-citation></ref><ref id="ref325"><mixed-citation publication-type="journal" id="cit325"><name><surname>Khosa</surname><given-names>S.</given-names></name>; <name><surname>Alkhatib</surname><given-names>Z.</given-names></name>; <name><surname>Smits</surname><given-names>S. H.</given-names></name>
<article-title>NSR from <italic>Streptococcus agalactiae</italic> confers resistance against nisin
and is encoded by a conserved nsr operon</article-title>. <source>Biol.
Chem.</source>
<year>2013</year>, <volume>394</volume> (<issue>11</issue>), <fpage>1543</fpage>&#x02013;<lpage>1549</lpage>. <pub-id pub-id-type="doi">10.1515/hsz-2013-0167</pub-id>.<pub-id pub-id-type="pmid">23893686</pub-id></mixed-citation></ref><ref id="ref326"><mixed-citation publication-type="journal" id="cit326"><name><surname>Liao</surname><given-names>D. I.</given-names></name>; <name><surname>Qian</surname><given-names>J.</given-names></name>; <name><surname>Chisholm</surname><given-names>D. A.</given-names></name>; <name><surname>Jordan</surname><given-names>D. B.</given-names></name>; <name><surname>Diner</surname><given-names>B. A.</given-names></name>
<article-title>Crystal structures of the photosystem II D1 C-terminal
processing protease</article-title>. <source>Nat. Struct. Biol.</source>
<year>2000</year>, <volume>7</volume> (<issue>9</issue>), <fpage>749</fpage>&#x02013;<lpage>753</lpage>. <pub-id pub-id-type="doi">10.1038/78973</pub-id>.<pub-id pub-id-type="pmid">10966643</pub-id></mixed-citation></ref><ref id="ref327"><mixed-citation publication-type="journal" id="cit327"><name><surname>Khosa</surname><given-names>S.</given-names></name>; <name><surname>Frieg</surname><given-names>B.</given-names></name>; <name><surname>Mulnaes</surname><given-names>D.</given-names></name>; <name><surname>Kleinschrodt</surname><given-names>D.</given-names></name>; <name><surname>Hoeppner</surname><given-names>A.</given-names></name>; <name><surname>Gohlke</surname><given-names>H.</given-names></name>; <name><surname>Smits</surname><given-names>S. H.</given-names></name>
<article-title>Structural
basis
of lantibiotic recognition by the nisin resistance protein from <italic>Streptococcus agalactiae</italic></article-title>. <source>Sci. Rep.</source>
<year>2016</year>, <volume>6</volume>, <fpage>18679</fpage><pub-id pub-id-type="doi">10.1038/srep18679</pub-id>.<pub-id pub-id-type="pmid">26727488</pub-id></mixed-citation></ref><ref id="ref328"><mixed-citation publication-type="journal" id="cit328"><name><surname>Widdick</surname><given-names>D. A.</given-names></name>; <name><surname>Dodd</surname><given-names>H. M.</given-names></name>; <name><surname>Barraille</surname><given-names>P.</given-names></name>; <name><surname>White</surname><given-names>J.</given-names></name>; <name><surname>Stein</surname><given-names>T. H.</given-names></name>; <name><surname>Chater</surname><given-names>K. F.</given-names></name>; <name><surname>Gasson</surname><given-names>M. J.</given-names></name>; <name><surname>Bibb</surname><given-names>M. J.</given-names></name>
<article-title>Cloning and engineering of the cinnamycin biosynthetic
gene cluster from <italic>Streptomyces cinnamoneus</italic> cinnamoneus
DSM 40005</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2003</year>, <volume>100</volume> (<issue>7</issue>), <fpage>4316</fpage>&#x02013;<lpage>4321</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0230516100</pub-id>.<pub-id pub-id-type="pmid">12642677</pub-id></mixed-citation></ref><ref id="ref329"><mixed-citation publication-type="journal" id="cit329"><name><surname>Doige</surname><given-names>C. A.</given-names></name>; <name><surname>Ames</surname><given-names>G. F.</given-names></name>
<article-title>ATP-dependent transport systems in
bacteria and humans: relevance to cystic fibrosis and multidrug resistance</article-title>. <source>Annu. Rev. Microbiol.</source>
<year>1993</year>, <volume>47</volume>, <fpage>291</fpage>&#x02013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.mi.47.100193.001451</pub-id>.<pub-id pub-id-type="pmid">7504904</pub-id></mixed-citation></ref><ref id="ref330"><mixed-citation publication-type="journal" id="cit330"><name><surname>Hollenstein</surname><given-names>K.</given-names></name>; <name><surname>Dawson</surname><given-names>R. J.</given-names></name>; <name><surname>Locher</surname><given-names>K. P.</given-names></name>
<article-title>Structure
and mechanism
of ABC transporter proteins</article-title>. <source>Curr. Opin. Struct.
Biol.</source>
<year>2007</year>, <volume>17</volume> (<issue>4</issue>), <fpage>412</fpage>&#x02013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2007.07.003</pub-id>.<pub-id pub-id-type="pmid">17723295</pub-id></mixed-citation></ref><ref id="ref331"><mixed-citation publication-type="journal" id="cit331"><name><surname>Uguen</surname><given-names>P.</given-names></name>; <name><surname>Hindr&#x000e9;</surname><given-names>T.</given-names></name>; <name><surname>Didelot</surname><given-names>S.</given-names></name>; <name><surname>Marty</surname><given-names>C.</given-names></name>; <name><surname>Haras</surname><given-names>D.</given-names></name>; <name><surname>Le Pennec</surname><given-names>J. P.</given-names></name>; <name><surname>Vallee-Rehel</surname><given-names>K.</given-names></name>; <name><surname>Dufour</surname><given-names>A.</given-names></name>
<article-title>Maturation by LctT is required for biosynthesis of
full-length lantibiotic lacticin 481</article-title>. <source>Appl.
Environ. Microbiol.</source>
<year>2005</year>, <volume>71</volume> (<issue>1</issue>), <fpage>562</fpage>&#x02013;<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.71.1.562-565.2005</pub-id>.<pub-id pub-id-type="pmid">15640237</pub-id></mixed-citation></ref><ref id="ref332"><mixed-citation publication-type="journal" id="cit332"><name><surname>Qiao</surname><given-names>M.</given-names></name>; <name><surname>Saris</surname><given-names>P. E. J.</given-names></name>
<article-title>Evidence for a role of NisT in transport
of the lantibiotic nisin produced by <italic>Lactococcus lactis</italic> N8</article-title>. <source>FEMS Microbiol. Lett.</source>
<year>1996</year>, <volume>144</volume> (<issue>1</issue>), <fpage>89</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.1996.tb08513.x</pub-id>.<pub-id pub-id-type="pmid">8870256</pub-id></mixed-citation></ref><ref id="ref333"><mixed-citation publication-type="journal" id="cit333"><name><surname>Page</surname><given-names>M. J.</given-names></name>; <name><surname>Di Cera</surname><given-names>E.</given-names></name>
<article-title>Serine peptidases:
classification,
structure and function</article-title>. <source>Cell. Mol. Life Sci.</source>
<year>2008</year>, <volume>65</volume> (<issue>7&#x02013;8</issue>), <fpage>1220</fpage>&#x02013;<lpage>1236</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-008-7565-9</pub-id>.<pub-id pub-id-type="pmid">18259688</pub-id></mixed-citation></ref><ref id="ref334"><mixed-citation publication-type="journal" id="cit334"><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name>; <name><surname>Ton-That</surname><given-names>H.</given-names></name>; <name><surname>Schneewind</surname><given-names>O.</given-names></name>
<article-title>Sortase-catalysed
anchoring of surface proteins to the cell wall of <italic>Staphylococcus
aureus</italic></article-title>. <source>Mol. Microbiol.</source>
<year>2001</year>, <volume>40</volume> (<issue>5</issue>), <fpage>1049</fpage>&#x02013;<lpage>1057</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02411.x</pub-id>.<pub-id pub-id-type="pmid">11401711</pub-id></mixed-citation></ref><ref id="ref335"><mixed-citation publication-type="journal" id="cit335"><name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Ni</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>H.</given-names></name>; <name><surname>Zhou</surname><given-names>W.</given-names></name>; <name><surname>Saris</surname><given-names>P. E.</given-names></name>; <name><surname>Yang</surname><given-names>W.</given-names></name>; et al. <article-title>Structure
of the nisin leader peptidase NisP revealing
a C-terminal autocleavage activity</article-title>. <source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<year>2014</year>, <volume>70</volume> (<issue>6</issue>), <fpage>1499</fpage>&#x02013;<lpage>1505</lpage>. <pub-id pub-id-type="doi">10.1107/S1399004714004234</pub-id>.<pub-id pub-id-type="pmid">24914961</pub-id></mixed-citation></ref><ref id="ref336"><mixed-citation publication-type="journal" id="cit336"><name><surname>Bryan</surname><given-names>P.</given-names></name>; <name><surname>Alexander</surname><given-names>P.</given-names></name>; <name><surname>Strausberg</surname><given-names>S.</given-names></name>; <name><surname>Schwarz</surname><given-names>F.</given-names></name>; <name><surname>Lan</surname><given-names>W.</given-names></name>; <name><surname>Gilliland</surname><given-names>G.</given-names></name>; <name><surname>Gallagher</surname><given-names>D. T.</given-names></name>
<article-title>Energetics of folding subtilisin BPN&#x02032;</article-title>. <source>Biochemistry</source>
<year>1992</year>, <volume>31</volume> (<issue>21</issue>), <fpage>4937</fpage>&#x02013;<lpage>4945</lpage>. <pub-id pub-id-type="doi">10.1021/bi00136a003</pub-id>.<pub-id pub-id-type="pmid">1599918</pub-id></mixed-citation></ref><ref id="ref337"><mixed-citation publication-type="journal" id="cit337"><name><surname>van der Donk</surname><given-names>W. A.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>
<article-title>Structure and mechanism
of lanthipeptide
biosynthetic enzymes</article-title>. <source>Curr. Opin. Struct. Biol.</source>
<year>2014</year>, <volume>29</volume>, <fpage>58</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2014.09.006</pub-id>.<pub-id pub-id-type="pmid">25460269</pub-id></mixed-citation></ref><ref id="ref338"><mixed-citation publication-type="journal" id="cit338"><name><surname>H&#x000e5;varstein</surname><given-names>L.
S.</given-names></name>; <name><surname>Diep</surname><given-names>D. B.</given-names></name>; <name><surname>Nes</surname><given-names>I. F.</given-names></name>
<article-title>A family of bacteriocin
ABC transporters carry out proteolytic processing of their substrates
concomitant with export</article-title>. <source>Mol. Microbiol.</source>
<year>1995</year>, <volume>16</volume> (<issue>2</issue>), <fpage>229</fpage>&#x02013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1995.tb02295.x</pub-id>.<pub-id pub-id-type="pmid">7565085</pub-id></mixed-citation></ref><ref id="ref339"><mixed-citation publication-type="journal" id="cit339"><name><surname>Franke</surname><given-names>C. M.</given-names></name>; <name><surname>Tiemersma</surname><given-names>J.</given-names></name>; <name><surname>Venema</surname><given-names>G.</given-names></name>; <name><surname>Kok</surname><given-names>J.</given-names></name>
<article-title>Membrane topology
of the lactococcal bacteriocin ATP-binding cassette transporter protein
LcnC. Involvement of LcnC in lactococcin A maturation</article-title>. <source>J. Biol. Chem.</source>
<year>1999</year>, <volume>274</volume> (<issue>13</issue>), <fpage>8484</fpage>&#x02013;<lpage>8490</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.13.8484</pub-id>.<pub-id pub-id-type="pmid">10085080</pub-id></mixed-citation></ref><ref id="ref340"><mixed-citation publication-type="journal" id="cit340"><name><surname>Rinc&#x000e9;</surname><given-names>A.</given-names></name>; <name><surname>Dufour</surname><given-names>A.</given-names></name>; <name><surname>Le Pogam</surname><given-names>S.</given-names></name>; <name><surname>Thuault</surname><given-names>D.</given-names></name>; <name><surname>Bourgeois</surname><given-names>C. M.</given-names></name>; <name><surname>Le Pennec</surname><given-names>J. P.</given-names></name>
<article-title>Cloning,
expression, and nucleotide
sequence of genes involved in production of lactococcin DR, a bacteriocin
from <italic>Lactococcus lactis</italic> subsp. lactis</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1994</year>, <volume>60</volume> (<issue>5</issue>), <fpage>1652</fpage>&#x02013;<lpage>1657</lpage>.<pub-id pub-id-type="pmid">8017945</pub-id></mixed-citation></ref><ref id="ref341"><mixed-citation publication-type="journal" id="cit341"><name><surname>Rawlings</surname><given-names>N. D.</given-names></name>; <name><surname>Waller</surname><given-names>M.</given-names></name>; <name><surname>Barrett</surname><given-names>A. J.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>
<article-title>MEROPS: the
database of proteolytic enzymes, their substrates and inhibitors</article-title>. <source>Nucleic Acids Res.</source>
<year>2014</year>, <volume>42</volume>, <fpage>D503</fpage>&#x02013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt953</pub-id>.<pub-id pub-id-type="pmid">24157837</pub-id></mixed-citation></ref><ref id="ref342"><mixed-citation publication-type="journal" id="cit342"><name><surname>Hynes</surname><given-names>W. L.</given-names></name>; <name><surname>Ferretti</surname><given-names>J. J.</given-names></name>; <name><surname>Tagg</surname><given-names>J. R.</given-names></name>
<article-title>Cloning of the gene
encoding Streptococcin A-FF22, a novel lantibiotic produced by <italic>Streptococcus pyogenes</italic>, and determination of its nucleotide
sequence</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>1993</year>, <volume>59</volume> (<issue>6</issue>), <fpage>1969</fpage>&#x02013;<lpage>1971</lpage>.<pub-id pub-id-type="pmid">8328813</pub-id></mixed-citation></ref><ref id="ref343"><mixed-citation publication-type="journal" id="cit343"><name><surname>Ross</surname><given-names>K. F.</given-names></name>; <name><surname>Ronson</surname><given-names>C. W.</given-names></name>; <name><surname>Tagg</surname><given-names>J. R.</given-names></name>
<article-title>Isolation
and characterization
of the lantibiotic salivaricin A and its structural gene salA from <italic>Streptococcus salivarius</italic> 20P3</article-title>. <source>Appl.
Environ. Microbiol.</source>
<year>1993</year>, <volume>59</volume> (<issue>7</issue>), <fpage>2014</fpage>&#x02013;<lpage>2021</lpage>.<pub-id pub-id-type="pmid">8357242</pub-id></mixed-citation></ref><ref id="ref344"><mixed-citation publication-type="journal" id="cit344"><name><surname>Gilmore</surname><given-names>M. S.</given-names></name>; <name><surname>Segarra</surname><given-names>R. A.</given-names></name>; <name><surname>Booth</surname><given-names>M. C.</given-names></name>; <name><surname>Bogie</surname><given-names>C. P.</given-names></name>; <name><surname>Hall</surname><given-names>L. R.</given-names></name>; <name><surname>Clewell</surname><given-names>D. B.</given-names></name>
<article-title>Genetic structure of the <italic>Enterococcus faecalis</italic> plasmid pAD1-encoded cytolytic toxin
system and its relationship to lantibiotic determinants</article-title>. <source>J. Bacteriol.</source>
<year>1994</year>, <volume>176</volume> (<issue>23</issue>), <fpage>7335</fpage>&#x02013;<lpage>7344</lpage>. <pub-id pub-id-type="doi">10.1128/jb.176.23.7335-7344.1994</pub-id>.<pub-id pub-id-type="pmid">7961506</pub-id></mixed-citation></ref><ref id="ref345"><mixed-citation publication-type="journal" id="cit345"><name><surname>Chen</surname><given-names>P.</given-names></name>; <name><surname>Qi</surname><given-names>F. X.</given-names></name>; <name><surname>Novak</surname><given-names>J.</given-names></name>; <name><surname>Krull</surname><given-names>R. E.</given-names></name>; <name><surname>Caufield</surname><given-names>P. W.</given-names></name>
<article-title>Effect of amino acid substitutions
in conserved residues
in the leader peptide on biosynthesis of the lantibiotic mutacin II</article-title>. <source>FEMS Microbiol. Lett.</source>
<year>2001</year>, <volume>195</volume> (<issue>2</issue>), <fpage>139</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2001.tb10511.x</pub-id>.<pub-id pub-id-type="pmid">11179642</pub-id></mixed-citation></ref><ref id="ref346"><mixed-citation publication-type="journal" id="cit346"><name><surname>Ishii</surname><given-names>S.</given-names></name>; <name><surname>Yano</surname><given-names>T.</given-names></name>; <name><surname>Hayashi</surname><given-names>H.</given-names></name>
<article-title>Expression
and characterization
of the peptidase domain of <italic>Streptococcus pneumoniae</italic> ComA, a bifunctional ATP-binding cassette transporter involved in
quorum sensing pathway</article-title>. <source>J. Biol. Chem.</source>
<year>2006</year>, <volume>281</volume> (<issue>8</issue>), <fpage>4726</fpage>&#x02013;<lpage>4731</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M512516200</pub-id>.<pub-id pub-id-type="pmid">16377622</pub-id></mixed-citation></ref><ref id="ref347"><mixed-citation publication-type="journal" id="cit347"><name><surname>Wu</surname><given-names>K. H.</given-names></name>; <name><surname>Tai</surname><given-names>P. C.</given-names></name>
<article-title>Cys32 and
His105 are the critical
residues for the calcium-dependent cysteine proteolytic activity of
CvaB, an ATP-binding cassette transporter</article-title>. <source>J.
Biol. Chem.</source>
<year>2004</year>, <volume>279</volume> (<issue>2</issue>), <fpage>901</fpage>&#x02013;<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M308296200</pub-id>.<pub-id pub-id-type="pmid">14570918</pub-id></mixed-citation></ref><ref id="ref348"><mixed-citation publication-type="journal" id="cit348"><name><surname>Ishii</surname><given-names>S.</given-names></name>; <name><surname>Yano</surname><given-names>T.</given-names></name>; <name><surname>Ebihara</surname><given-names>A.</given-names></name>; <name><surname>Okamoto</surname><given-names>A.</given-names></name>; <name><surname>Manzoku</surname><given-names>M.</given-names></name>; <name><surname>Hayashi</surname><given-names>H.</given-names></name>
<article-title>Crystal structure of the peptidase
domain of <italic>Streptococcus</italic> ComA, a bifunctional ATP-binding
cassette transporter involved in the quorum-sensing pathway</article-title>. <source>J. Biol. Chem.</source>
<year>2010</year>, <volume>285</volume> (<issue>14</issue>), <fpage>10777</fpage>&#x02013;<lpage>10785</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.093781</pub-id>.<pub-id pub-id-type="pmid">20100826</pub-id></mixed-citation></ref><ref id="ref349"><mixed-citation publication-type="journal" id="cit349"><name><surname>Furgerson Ihnken</surname><given-names>L. A.</given-names></name>; <name><surname>Chatterjee</surname><given-names>C.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title><italic>In vitro</italic> reconstitution and substrate
specificity of a lantibiotic
protease</article-title>. <source>Biochemistry</source>
<year>2008</year>, <volume>47</volume>, <fpage>7352</fpage>&#x02013;<lpage>7363</lpage>. <pub-id pub-id-type="doi">10.1021/bi800278n</pub-id>.<pub-id pub-id-type="pmid">18570436</pub-id></mixed-citation></ref><ref id="ref350"><mixed-citation publication-type="journal" id="cit350"><name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Teng</surname><given-names>K.</given-names></name>; <name><surname>Huan</surname><given-names>L.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>
<article-title>Dissection of the bridging
pattern of bovicin HJ50, a lantibiotic containing a characteristic
disulfide bridge</article-title>. <source>Microbiol. Res.</source>
<year>2011</year>, <volume>166</volume> (<issue>3</issue>), <fpage>146</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2010.05.001</pub-id>.<pub-id pub-id-type="pmid">20630724</pub-id></mixed-citation></ref><ref id="ref351"><mixed-citation publication-type="journal" id="cit351"><name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Meijer-Wierenga</surname><given-names>J.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>
<article-title>Mechanistic
dissection of the enzyme complexes involved
in biosynthesis of lacticin 3147 and nisin</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2008</year>, <volume>74</volume> (<issue>21</issue>), <fpage>6591</fpage>&#x02013;<lpage>6597</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01334-08</pub-id>.<pub-id pub-id-type="pmid">18791001</pub-id></mixed-citation></ref><ref id="ref352"><mixed-citation publication-type="journal" id="cit352"><name><surname>Nishie</surname><given-names>M.</given-names></name>; <name><surname>Sasaki</surname><given-names>M.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Zendo</surname><given-names>T.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Lantibiotic transporter
requires
cooperative functioning of the peptidase domain and the ATP binding
domain</article-title>. <source>J. Biol. Chem.</source>
<year>2011</year>, <volume>286</volume> (<issue>13</issue>), <fpage>11163</fpage>&#x02013;<lpage>11169</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.212704</pub-id>.<pub-id pub-id-type="pmid">21303905</pub-id></mixed-citation></ref><ref id="ref353"><mixed-citation publication-type="journal" id="cit353"><name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Aso</surname><given-names>Y.</given-names></name>; <name><surname>Sashihara</surname><given-names>T.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Adachi</surname><given-names>A.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Localization
and interaction of the biosynthetic proteins for the lantibiotic,
Nukacin ISK-1</article-title>. <source>Biosci., Biotechnol., Biochem.</source>
<year>2005</year>, <volume>69</volume> (<issue>7</issue>), <fpage>1341</fpage>&#x02013;<lpage>1347</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.69.1341</pub-id>.<pub-id pub-id-type="pmid">16041140</pub-id></mixed-citation></ref><ref id="ref354"><mixed-citation publication-type="journal" id="cit354"><name><surname>Nishie</surname><given-names>M.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Jikuya</surname><given-names>H.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>ATP-dependent
leader peptide cleavage by NukT, a bifunctional
ABC transporter, during lantibiotic biosynthesis</article-title>. <source>J. Biosci. Bioeng.</source>
<year>2009</year>, <volume>108</volume> (<issue>6</issue>), <fpage>460</fpage>&#x02013;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiosc.2009.06.002</pub-id>.<pub-id pub-id-type="pmid">19914576</pub-id></mixed-citation></ref><ref id="ref355"><mixed-citation publication-type="journal" id="cit355"><name><surname>Lin</surname><given-names>D. Y.</given-names></name>; <name><surname>Huang</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>
<article-title>Crystal structures
of a polypeptide processing and secretion transporter</article-title>. <source>Nature</source>
<year>2015</year>, <volume>523</volume> (<issue>7561</issue>), <fpage>425</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1038/nature14623</pub-id>.<pub-id pub-id-type="pmid">26201595</pub-id></mixed-citation></ref><ref id="ref356"><mixed-citation publication-type="journal" id="cit356"><name><surname>Holland</surname><given-names>I. B.</given-names></name>; <name><surname>Schmitt</surname><given-names>L.</given-names></name>; <name><surname>Young</surname><given-names>J.</given-names></name>
<article-title>Type 1 protein
secretion
in bacteria, the ABC-transporter dependent pathway</article-title>. <source>Mol. Membr. Biol.</source>
<year>2005</year>, <volume>22</volume> (<issue>1&#x02013;2</issue>), <fpage>29</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1080/09687860500042013</pub-id>.<pub-id pub-id-type="pmid">16092522</pub-id></mixed-citation></ref><ref id="ref357"><mixed-citation publication-type="journal" id="cit357"><name><surname>Pao</surname><given-names>S. S.</given-names></name>; <name><surname>Paulsen</surname><given-names>I. T.</given-names></name>; <name><surname>Saier</surname><given-names>M. H.</given-names><suffix>Jr.</suffix></name>
<article-title>Major facilitator superfamily</article-title>. <source>Microbiol. Mol.
Biol. Rev.</source>
<year>1998</year>, <volume>62</volume> (<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">9529885</pub-id></mixed-citation></ref><ref id="ref358"><mixed-citation publication-type="journal" id="cit358"><name><surname>Saidijam</surname><given-names>M.</given-names></name>; <name><surname>Bettaney</surname><given-names>K. E.</given-names></name>; <name><surname>Leng</surname><given-names>D.</given-names></name>; <name><surname>Ma</surname><given-names>P.</given-names></name>; <name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Keen</surname><given-names>J. N.</given-names></name>; <name><surname>Rutherford</surname><given-names>N. G.</given-names></name>; <name><surname>Ward</surname><given-names>A.</given-names></name>; <name><surname>Henderson</surname><given-names>P. J.</given-names></name>; <name><surname>Szakonyi</surname><given-names>G.</given-names></name>; et al. <article-title>The MFS efflux proteins of Gram-positive and
Gram-negative bacteria</article-title>. <source>Adv. Enzymol. Relat.
Areas Mol. Biol.</source>
<year>2011</year>, <volume>77</volume>, <fpage>147</fpage>&#x02013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1002/9780470920541.ch4</pub-id>.<pub-id pub-id-type="pmid">21692369</pub-id></mixed-citation></ref><ref id="ref359"><mixed-citation publication-type="journal" id="cit359"><name><surname>Yan</surname><given-names>N.</given-names></name>
<article-title>Structural advances for the major facilitator superfamily
(MFS) transporters</article-title>. <source>Trends Biochem. Sci.</source>
<year>2013</year>, <volume>38</volume> (<issue>3</issue>), <fpage>151</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2013.01.003</pub-id>.<pub-id pub-id-type="pmid">23403214</pub-id></mixed-citation></ref><ref id="ref360"><mixed-citation publication-type="journal" id="cit360"><name><surname>Booth</surname><given-names>M. C.</given-names></name>; <name><surname>Bogie</surname><given-names>C. P.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Siezen</surname><given-names>R. J.</given-names></name>; <name><surname>Hatter</surname><given-names>K. L.</given-names></name>; <name><surname>Gilmore</surname><given-names>M. S.</given-names></name>
<article-title>Structural analysis and proteolytic
activation of <italic>Enterococcus faecalis</italic> cytolysin, a
novel lantibiotic</article-title>. <source>Mol. Microbiol.</source>
<year>1996</year>, <volume>21</volume> (<issue>6</issue>), <fpage>1175</fpage>&#x02013;<lpage>1184</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.1996.831449.x</pub-id>.<pub-id pub-id-type="pmid">8898386</pub-id></mixed-citation></ref><ref id="ref361"><mixed-citation publication-type="journal" id="cit361"><name><surname>Lohans</surname><given-names>C. T.</given-names></name>; <name><surname>Li</surname><given-names>J. L.</given-names></name>; <name><surname>Vederas</surname><given-names>J. C.</given-names></name>
<article-title>Structure and biosynthesis
of carnolysin, a homologue of enterococcal cytolysin with D-amino
acids</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2014</year>, <volume>136</volume>, <fpage>13150</fpage>&#x02013;<lpage>13153</lpage>. <pub-id pub-id-type="doi">10.1021/ja5070813</pub-id>.<pub-id pub-id-type="pmid">25207953</pub-id></mixed-citation></ref><ref id="ref362"><mixed-citation publication-type="journal" id="cit362"><name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>Dong</surname><given-names>S.-H.</given-names></name>; <name><surname>Repka</surname><given-names>L. M.</given-names></name>; <name><surname>He</surname><given-names>C.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Applications of the class II lanthipeptide
protease LicP for sequence-specific, traceless peptide bond cleavage</article-title>. <source>Chem. Sci.</source>
<year>2015</year>, <volume>6</volume>, <fpage>6270</fpage>&#x02013;<lpage>6279</lpage>. <pub-id pub-id-type="doi">10.1039/C5SC02329G</pub-id>.<pub-id pub-id-type="pmid">30090246</pub-id></mixed-citation></ref><ref id="ref363"><mixed-citation publication-type="journal" id="cit363"><name><surname>Shenkarev</surname><given-names>Z. O.</given-names></name>; <name><surname>Finkina</surname><given-names>E. I.</given-names></name>; <name><surname>Nurmukhamedova</surname><given-names>E. K.</given-names></name>; <name><surname>Balandin</surname><given-names>S. V.</given-names></name>; <name><surname>Mineev</surname><given-names>K. S.</given-names></name>; <name><surname>Nadezhdin</surname><given-names>K. D.</given-names></name>; <name><surname>Yakimenko</surname><given-names>Z. A.</given-names></name>; <name><surname>Tagaev</surname><given-names>A. A.</given-names></name>; <name><surname>Temirov</surname><given-names>Y. V.</given-names></name>; <name><surname>Arseniev</surname><given-names>A. S.</given-names></name>; et al. <article-title>Isolation, structure elucidation, and synergistic
antibacterial activity
of a novel two-component lantibiotic lichenicidin from <italic>Bacillus
licheniformis</italic> VK21</article-title>. <source>Biochemistry</source>
<year>2010</year>, <volume>49</volume> (<issue>30</issue>), <fpage>6462</fpage>&#x02013;<lpage>6472</lpage>. <pub-id pub-id-type="doi">10.1021/bi100871b</pub-id>.<pub-id pub-id-type="pmid">20578714</pub-id></mixed-citation></ref><ref id="ref364"><mixed-citation publication-type="journal" id="cit364"><name><surname>Lee</surname><given-names>M. V.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A. F.</given-names></name>; <name><surname>You</surname><given-names>Y. O.</given-names></name>; <name><surname>McClerren</surname><given-names>A. L.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>
<article-title>Distributive and
directional behavior
of lantibiotic synthetases revealed by high-resolution tandem mass
spectrometry</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2009</year>, <volume>131</volume>, <fpage>12258</fpage>&#x02013;<lpage>12264</lpage>. <pub-id pub-id-type="doi">10.1021/ja9033507</pub-id>.<pub-id pub-id-type="pmid">19663480</pub-id></mixed-citation></ref><ref id="ref365"><mixed-citation publication-type="journal" id="cit365"><name><surname>Thibodeaux</surname><given-names>C. J.</given-names></name>; <name><surname>Ha</surname><given-names>T.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>A price
to pay for relaxed substrate specificity: a comparative kinetic analysis
of the class II lanthipeptide synthetases ProcM and HalM2</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2014</year>, <volume>136</volume> (<issue>50</issue>), <fpage>17513</fpage>&#x02013;<lpage>17529</lpage>. <pub-id pub-id-type="doi">10.1021/ja5089452</pub-id>.<pub-id pub-id-type="pmid">25409537</pub-id></mixed-citation></ref><ref id="ref366"><mixed-citation publication-type="journal" id="cit366"><name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Kelly</surname><given-names>W. L.</given-names></name>
<article-title>Recent advances
in thiopeptide antibiotic biosynthesis</article-title>. <source>Nat.
Prod. Rep.</source>
<year>2010</year>, <volume>27</volume> (<issue>2</issue>), <fpage>153</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1039/B922434C</pub-id>.<pub-id pub-id-type="pmid">20111801</pub-id></mixed-citation></ref><ref id="ref367"><mixed-citation publication-type="journal" id="cit367"><name><surname>Freeman</surname><given-names>M. F.</given-names></name>; <name><surname>Gurgui</surname><given-names>C.</given-names></name>; <name><surname>Helf</surname><given-names>M. J.</given-names></name>; <name><surname>Morinaka</surname><given-names>B. I.</given-names></name>; <name><surname>Uria</surname><given-names>A. R.</given-names></name>; <name><surname>Oldham</surname><given-names>N. J.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Matsunaga</surname><given-names>S.</given-names></name>; <name><surname>Piel</surname><given-names>J.</given-names></name>
<article-title>Metagenome mining reveals polytheonamides as posttranslationally
modified ribosomal peptides</article-title>. <source>Science</source>
<year>2012</year>, <volume>338</volume>, <fpage>387</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1126/science.1226121</pub-id>.<pub-id pub-id-type="pmid">22983711</pub-id></mixed-citation></ref><ref id="ref368"><mixed-citation publication-type="journal" id="cit368"><name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>High divergence of the precursor peptides in combinatorial
lanthipeptide biosynthesis</article-title>. <source>ACS Chem. Biol.</source>
<year>2014</year>, <volume>9</volume> (<issue>11</issue>), <fpage>2686</fpage>&#x02013;<lpage>2694</lpage>. <pub-id pub-id-type="doi">10.1021/cb500622c</pub-id>.<pub-id pub-id-type="pmid">25244001</pub-id></mixed-citation></ref><ref id="ref369"><mixed-citation publication-type="journal" id="cit369"><name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>Mukherjee</surname><given-names>S.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Product formation by the promiscuous
lanthipeptide synthetase ProcM is under kinetic control</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2015</year>, <volume>137</volume> (<issue>15</issue>), <fpage>5140</fpage>&#x02013;<lpage>5148</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b01409</pub-id>.<pub-id pub-id-type="pmid">25803126</pub-id></mixed-citation></ref><ref id="ref370"><mixed-citation publication-type="journal" id="cit370"><name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Structural
characterization of four
prochlorosins: a novel class of lantipeptides produced by planktonic
marine cyanobacteria</article-title>. <source>Biochemistry</source>
<year>2012</year>, <volume>51</volume> (<issue>21</issue>), <fpage>4271</fpage>&#x02013;<lpage>4279</lpage>. <pub-id pub-id-type="doi">10.1021/bi300255s</pub-id>.<pub-id pub-id-type="pmid">22574919</pub-id></mixed-citation></ref><ref id="ref371"><mixed-citation publication-type="journal" id="cit371"><name><surname>Haft</surname><given-names>D. H.</given-names></name>; <name><surname>Basu</surname><given-names>M. K.</given-names></name>; <name><surname>Mitchell</surname><given-names>D. A.</given-names></name>
<article-title>Expansion
of ribosomally
produced natural products: a nitrile hydratase- and Nif11-related
precursor family</article-title>. <source>BMC Biol.</source>
<year>2010</year>, <volume>8</volume>, <fpage>70</fpage><pub-id pub-id-type="doi">10.1186/1741-7007-8-70</pub-id>.<pub-id pub-id-type="pmid">20500830</pub-id></mixed-citation></ref><ref id="ref372"><mixed-citation publication-type="journal" id="cit372"><name><surname>Haft</surname><given-names>D. H.</given-names></name>; <name><surname>Basu</surname><given-names>M. K.</given-names></name>
<article-title>Biological systems discovery in silico:
radical S-adenosylmethionine protein families and their target peptides
for posttranslational modification</article-title>. <source>J. Bacteriol.</source>
<year>2011</year>, <volume>193</volume> (<issue>11</issue>), <fpage>2745</fpage>&#x02013;<lpage>2755</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00040-11</pub-id>.<pub-id pub-id-type="pmid">21478363</pub-id></mixed-citation></ref><ref id="ref373"><mixed-citation publication-type="journal" id="cit373"><name><surname>Dufour</surname><given-names>A.</given-names></name>; <name><surname>Hindr&#x000e9;</surname><given-names>T.</given-names></name>; <name><surname>Haras</surname><given-names>D.</given-names></name>; <name><surname>Le Pennec</surname><given-names>J. P.</given-names></name>
<article-title>The biology
of the lantibiotics of the lacticin 481 subgroup is coming of age</article-title>. <source>FEMS Microbiol. Rev.</source>
<year>2007</year>, <volume>31</volume>, <fpage>134</fpage>&#x02013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6976.2006.00045.x</pub-id>.<pub-id pub-id-type="pmid">17096664</pub-id></mixed-citation></ref><ref id="ref374"><mixed-citation publication-type="journal" id="cit374"><name><surname>Chatterjee</surname><given-names>C.</given-names></name>; <name><surname>Miller</surname><given-names>L. M.</given-names></name>; <name><surname>Leung</surname><given-names>Y. L.</given-names></name>; <name><surname>Xie</surname><given-names>L.</given-names></name>; <name><surname>Yi</surname><given-names>M.</given-names></name>; <name><surname>Kelleher</surname><given-names>N. L.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Lacticin
481 synthetase phosphorylates
its substrate during lantibiotic production</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2005</year>, <volume>127</volume>, <fpage>15332</fpage>&#x02013;<lpage>15333</lpage>. <pub-id pub-id-type="doi">10.1021/ja0543043</pub-id>.<pub-id pub-id-type="pmid">16262372</pub-id></mixed-citation></ref><ref id="ref375"><mixed-citation publication-type="journal" id="cit375"><name><surname>Thibodeaux</surname><given-names>C. J.</given-names></name>; <name><surname>Wagoner</surname><given-names>J.</given-names></name>; <name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Leader peptide establishes dehydration order, promotes
efficiency, and ensures fidelity during lacticin 481 biosynthesis</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2016</year>, <volume>138</volume> (<issue>20</issue>), <fpage>6436</fpage>&#x02013;<lpage>6444</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.6b00163</pub-id>.<pub-id pub-id-type="pmid">27123925</pub-id></mixed-citation></ref><ref id="ref376"><mixed-citation publication-type="journal" id="cit376"><name><surname>Uguen</surname><given-names>P.</given-names></name>; <name><surname>Le Pennec</surname><given-names>J. P.</given-names></name>; <name><surname>Dufour</surname><given-names>A.</given-names></name>
<article-title>Lantibiotic biosynthesis:
interactions between prelacticin 481 and its putative modification
enzyme, LctM</article-title>. <source>J. Bacteriol.</source>
<year>2000</year>, <volume>182</volume> (<issue>18</issue>), <fpage>5262</fpage>&#x02013;<lpage>5266</lpage>. <pub-id pub-id-type="doi">10.1128/JB.182.18.5262-5266.2000</pub-id>.<pub-id pub-id-type="pmid">10960114</pub-id></mixed-citation></ref><ref id="ref377"><mixed-citation publication-type="journal" id="cit377"><name><surname>You</surname><given-names>Y. O.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Mechanistic
investigations of the
dehydration reaction of lacticin 481 synthetase using site-directed
mutagenesis</article-title>. <source>Biochemistry</source>
<year>2007</year>, <volume>46</volume>, <fpage>5991</fpage>&#x02013;<lpage>6000</lpage>. <pub-id pub-id-type="doi">10.1021/bi602663x</pub-id>.<pub-id pub-id-type="pmid">17455908</pub-id></mixed-citation></ref><ref id="ref378"><mixed-citation publication-type="journal" id="cit378"><name><surname>You</surname><given-names>Y. O.</given-names></name>; <name><surname>Levengood</surname><given-names>M. R.</given-names></name>; <name><surname>Ihnken</surname><given-names>L. A.</given-names></name>; <name><surname>Knowlton</surname><given-names>A. K.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Lacticin
481 synthetase as a general serine/threonine
kinase</article-title>. <source>ACS Chem. Biol.</source>
<year>2009</year>, <volume>4</volume> (<issue>5</issue>), <fpage>379</fpage>&#x02013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1021/cb800309v</pub-id>.<pub-id pub-id-type="pmid">19292452</pub-id></mixed-citation></ref><ref id="ref379"><mixed-citation publication-type="journal" id="cit379"><name><surname>Ma</surname><given-names>H.</given-names></name>; <name><surname>Gao</surname><given-names>Y.</given-names></name>; <name><surname>Zhao</surname><given-names>F.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Teng</surname><given-names>K.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>
<article-title>Dissecting
the catalytic and substrate
binding activity of a class II lanthipeptide synthetase BovM</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<year>2014</year>, <volume>450</volume> (<issue>2</issue>), <fpage>1126</fpage>&#x02013;<lpage>1132</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2014.06.129</pub-id>.<pub-id pub-id-type="pmid">24998443</pub-id></mixed-citation></ref><ref id="ref380"><mixed-citation publication-type="journal" id="cit380"><name><surname>Thibodeaux</surname><given-names>G. N.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>An engineered
lantipeptide synthetase
serves as a general leader peptide-dependent kinase</article-title>. <source>Chem. Commun.</source>
<year>2012</year>, <volume>48</volume> (<issue>86</issue>), <fpage>10615</fpage>&#x02013;<lpage>10617</lpage>. <pub-id pub-id-type="doi">10.1039/c2cc34138g</pub-id>.</mixed-citation></ref><ref id="ref381"><mixed-citation publication-type="journal" id="cit381"><name><surname>Lawton</surname><given-names>E. M.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>
<article-title>Two-peptide
lantibiotics: a medical perspective</article-title>. <source>Mini-Rev.
Med. Chem.</source>
<year>2007</year>, <volume>7</volume> (<issue>12</issue>), <fpage>1236</fpage>&#x02013;<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.2174/138955707782795638</pub-id>.<pub-id pub-id-type="pmid">18220976</pub-id></mixed-citation></ref><ref id="ref382"><mixed-citation publication-type="journal" id="cit382"><name><surname>Morgan</surname><given-names>S. M.</given-names></name>; <name><surname>O&#x02019;Connor</surname><given-names>P. M.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>
<article-title>Sequential actions of the two component peptides of the lantibiotic
lacticin 3147 explain its antimicrobial activity at nanomolar concentrations</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2005</year>, <volume>49</volume> (<issue>7</issue>), <fpage>2606</fpage>&#x02013;<lpage>2611</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.49.7.2606-2611.2005</pub-id>.<pub-id pub-id-type="pmid">15980326</pub-id></mixed-citation></ref><ref id="ref383"><mixed-citation publication-type="journal" id="cit383"><name><surname>Oman</surname><given-names>T. J.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Insights
into the mode of action
of the two-peptide lantibiotic haloduracin</article-title>. <source>ACS Chem. Biol.</source>
<year>2009</year>, <volume>4</volume>, <fpage>865</fpage>&#x02013;<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1021/cb900194x</pub-id>.<pub-id pub-id-type="pmid">19678697</pub-id></mixed-citation></ref><ref id="ref384"><mixed-citation publication-type="journal" id="cit384"><name><surname>McAuliffe</surname><given-names>O.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Each peptide of
the two-component lantibiotic lacticin 3147 requires a separate modification
enzyme for activity</article-title>. <source>Microbiology</source>
<year>2000</year>, <volume>146</volume> (<issue>9</issue>), <fpage>2147</fpage>&#x02013;<lpage>2154</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-146-9-2147</pub-id>.<pub-id pub-id-type="pmid">10974102</pub-id></mixed-citation></ref><ref id="ref385"><mixed-citation publication-type="journal" id="cit385"><name><surname>Thibodeaux</surname><given-names>G. N.</given-names></name>; <name><surname>McClerren</surname><given-names>A. L.</given-names></name>; <name><surname>Ma</surname><given-names>Y.</given-names></name>; <name><surname>Gancayco</surname><given-names>M. R.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Synergistic binding of the leader and core peptides
by the lantibiotic synthetase HalM2</article-title>. <source>ACS Chem.
Biol.</source>
<year>2015</year>, <volume>10</volume> (<issue>4</issue>), <fpage>970</fpage>&#x02013;<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1021/cb5009876</pub-id>.<pub-id pub-id-type="pmid">25619528</pub-id></mixed-citation></ref><ref id="ref386"><mixed-citation publication-type="journal" id="cit386"><name><surname>Cox</surname><given-names>C. R.</given-names></name>; <name><surname>Coburn</surname><given-names>P. S.</given-names></name>; <name><surname>Gilmore</surname><given-names>M. S.</given-names></name>
<article-title>Enterococcal cytolysin:
a novel two component peptide system that serves as a bacterial defense
against eukaryotic and prokaryotic cells</article-title>. <source>Curr.
Protein Pept. Sci.</source>
<year>2005</year>, <volume>6</volume> (<issue>1</issue>), <fpage>77</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.2174/1389203053027557</pub-id>.<pub-id pub-id-type="pmid">15638770</pub-id></mixed-citation></ref><ref id="ref387"><mixed-citation publication-type="journal" id="cit387"><name><surname>Van Tyne</surname><given-names>D.</given-names></name>; <name><surname>Martin</surname><given-names>M. J.</given-names></name>; <name><surname>Gilmore</surname><given-names>M. S.</given-names></name>
<article-title>Structure, function,
and biology of the <italic>Enterococcus faecalis</italic> cytolysin</article-title>. <source>Toxins</source>
<year>2013</year>, <volume>5</volume> (<issue>5</issue>), <fpage>895</fpage>&#x02013;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.3390/toxins5050895</pub-id>.<pub-id pub-id-type="pmid">23628786</pub-id></mixed-citation></ref><ref id="ref388"><mixed-citation publication-type="journal" id="cit388"><name><surname>Dong</surname><given-names>S. H.</given-names></name>; <name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>Lukk</surname><given-names>T.</given-names></name>; <name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>The enterococcal cytolysin synthetase
has an unanticipated lipid kinase fold</article-title>. <source>eLife</source>
<year>2015</year>, <volume>4</volume>, <fpage>e07607</fpage><pub-id pub-id-type="doi">10.7554/eLife.07607</pub-id>.</mixed-citation></ref><ref id="ref389"><mixed-citation publication-type="journal" id="cit389"><name><surname>Shimafuji</surname><given-names>C.</given-names></name>; <name><surname>Noguchi</surname><given-names>M.</given-names></name>; <name><surname>Nishie</surname><given-names>M.</given-names></name>; <name><surname>Nagao</surname><given-names>J. I.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Zendo</surname><given-names>T.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>In vitro catalytic
activity of N-terminal and C-terminal domains in NukM, the post-translational
modification enzyme of nukacin ISK-1</article-title>. <source>J. Biosci.
Bioeng.</source>
<year>2015</year>, <volume>120</volume> (<issue>6</issue>), <fpage>624</fpage>&#x02013;<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiosc.2015.03.020</pub-id>.<pub-id pub-id-type="pmid">25971839</pub-id></mixed-citation></ref><ref id="ref390"><mixed-citation publication-type="journal" id="cit390"><name><surname>Ma</surname><given-names>H.</given-names></name>; <name><surname>Gao</surname><given-names>Y.</given-names></name>; <name><surname>Zhao</surname><given-names>F.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>
<article-title>Individual
catalytic
activity of two functional domains of bovicin HJ50 synthase BovM</article-title>. <source>Wei Sheng Wu Xue Bao</source>
<year>2015</year>, <volume>55</volume> (<issue>1</issue>), <fpage>50</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="pmid">25958682</pub-id></mixed-citation></ref><ref id="ref391"><mixed-citation publication-type="journal" id="cit391"><name><surname>S&#x000f6;ding</surname><given-names>J.</given-names></name>; <name><surname>Biegert</surname><given-names>A.</given-names></name>; <name><surname>Lupas</surname><given-names>A. N.</given-names></name>
<article-title>The HHpred interactive
server for protein homology detection and structure prediction</article-title>. <source>Nucleic Acids Res.</source>
<year>2005</year>, <volume>33</volume> (<issue>Web Server</issue>), <fpage>W244</fpage>&#x02013;<lpage>W248</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki408</pub-id>.<pub-id pub-id-type="pmid">15980461</pub-id></mixed-citation></ref><ref id="ref392"><mixed-citation publication-type="thesis" id="cit392"><person-group person-group-type="allauthors"><name><surname>Furgerson Ihnken</surname><given-names>L. A.</given-names></name></person-group> Ph.D. Thesis; <publisher-name>University of Illinois at Urbana-Champaign</publisher-name>, <year>2009</year>. Accessible through <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ideals.illinois.edu/">https://www.ideals.illinois.edu/</uri>.</mixed-citation></ref><ref id="ref393"><mixed-citation publication-type="journal" id="cit393"><name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>Jim&#x000e9;nez-Os&#x000e9;s</surname><given-names>G.</given-names></name>; <name><surname>Houk</surname><given-names>K. N.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Substrate control in stereoselective
lanthionine biosynthesis</article-title>. <source>Nat. Chem.</source>
<year>2014</year>, <volume>7</volume> (<issue>1</issue>), <fpage>57</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.2113</pub-id>.<pub-id pub-id-type="pmid">25515891</pub-id></mixed-citation></ref><ref id="ref394"><mixed-citation publication-type="journal" id="cit394"><name><surname>Garg</surname><given-names>N.</given-names></name>; <name><surname>Goto</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>T.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Characterization of the stereochemical configuration
of lanthionines formed by the lanthipeptide synthetase GeoM</article-title>. <source>Biopolymers</source>
<year>2016</year>, <volume>106</volume> (<issue>6</issue>), <fpage>834</fpage>&#x02013;<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1002/bip.22876</pub-id>.<pub-id pub-id-type="pmid">27178086</pub-id></mixed-citation></ref><ref id="ref395"><mixed-citation publication-type="journal" id="cit395"><name><surname>Paul</surname><given-names>M.</given-names></name>; <name><surname>Patton</surname><given-names>G. C.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Mutants
of the zinc ligands of lacticin 481 synthetase retain dehydration
activity but have impaired cyclization activity</article-title>. <source>Biochemistry</source>
<year>2007</year>, <volume>46</volume>, <fpage>6268</fpage>&#x02013;<lpage>6276</lpage>. <pub-id pub-id-type="doi">10.1021/bi7000104</pub-id>.<pub-id pub-id-type="pmid">17480057</pub-id></mixed-citation></ref><ref id="ref396"><mixed-citation publication-type="journal" id="cit396"><name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>Thibodeaux</surname><given-names>G. N.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>The enterococcal
cytolysin synthetase coevolves with substrate for stereoselective
lanthionine synthesis</article-title>. <source>ACS Chem. Biol.</source>
<year>2016</year>, <volume>11</volume> (<issue>9</issue>), <fpage>2438</fpage>&#x02013;<lpage>2446</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.6b00397</pub-id>.<pub-id pub-id-type="pmid">27348535</pub-id></mixed-citation></ref><ref id="ref397"><mixed-citation publication-type="journal" id="cit397"><name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>Ni</surname><given-names>W.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>On the
regioselectivity of thioether formation by lacticin 481 synthetase</article-title>. <source>Org. Lett.</source>
<year>2007</year>, <volume>9</volume>, <fpage>3343</fpage>&#x02013;<lpage>3346</lpage>. <pub-id pub-id-type="doi">10.1021/ol071301h</pub-id>.<pub-id pub-id-type="pmid">17650008</pub-id></mixed-citation></ref><ref id="ref398"><mixed-citation publication-type="journal" id="cit398"><name><surname>Knerr</surname><given-names>P. J.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Chemical synthesis of the lantibiotic
lacticin 481 reveals the importance of lanthionine stereochemistry</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2013</year>, <volume>135</volume> (<issue>19</issue>), <fpage>7094</fpage>&#x02013;<lpage>7097</lpage>. <pub-id pub-id-type="doi">10.1021/ja4014024</pub-id>.<pub-id pub-id-type="pmid">23621626</pub-id></mixed-citation></ref><ref id="ref399"><mixed-citation publication-type="journal" id="cit399"><name><surname>Mukherjee</surname><given-names>S.</given-names></name>; <name><surname>Huo</surname><given-names>L.</given-names></name>; <name><surname>Thibodeaux</surname><given-names>G. N.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Synthesis and bioactivity of diastereomers of the virulence
lanthipeptide cytolysin</article-title>. <source>Org. Lett.</source>
<year>2016</year>, <volume>18</volume>, <fpage>6188</fpage><pub-id pub-id-type="doi">10.1021/acs.orglett.6b03246</pub-id>.<pub-id pub-id-type="pmid">27934350</pub-id></mixed-citation></ref><ref id="ref400"><mixed-citation publication-type="journal" id="cit400"><name><surname>Huo</surname><given-names>L.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Discovery
and characterization of
bicereucin, an unusual D-amino acid-containing mixed two-component
lantibiotic</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2016</year>, <volume>138</volume> (<issue>16</issue>), <fpage>5254</fpage>&#x02013;<lpage>5257</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.6b02513</pub-id>.<pub-id pub-id-type="pmid">27074593</pub-id></mixed-citation></ref><ref id="ref401"><mixed-citation publication-type="journal" id="cit401"><name><surname>Krawczyk</surname><given-names>B.</given-names></name>; <name><surname>Ensle</surname><given-names>P.</given-names></name>; <name><surname>M&#x000fc;ller</surname><given-names>W. M.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Deuterium
labeled peptides give insights into the directionality
of class III lantibiotic synthetase LabKC</article-title>. <source>J.
Am. Chem. Soc.</source>
<year>2012</year>, <volume>134</volume>, <fpage>9922</fpage><pub-id pub-id-type="doi">10.1021/ja3040224</pub-id>.<pub-id pub-id-type="pmid">22687055</pub-id></mixed-citation></ref><ref id="ref402"><mixed-citation publication-type="journal" id="cit402"><name><surname>Rocap</surname><given-names>G.</given-names></name>; <name><surname>Larimer</surname><given-names>F. W.</given-names></name>; <name><surname>Lamerdin</surname><given-names>J.</given-names></name>; <name><surname>Malfatti</surname><given-names>S.</given-names></name>; <name><surname>Chain</surname><given-names>P.</given-names></name>; <name><surname>Ahlgren</surname><given-names>N. A.</given-names></name>; <name><surname>Arellano</surname><given-names>A.</given-names></name>; <name><surname>Coleman</surname><given-names>M.</given-names></name>; <name><surname>Hauser</surname><given-names>L.</given-names></name>; <name><surname>Hess</surname><given-names>W. R.</given-names></name>; et al. <article-title>Genome
divergence in
two Prochlorococcus ecotypes reflects oceanic niche differentiation</article-title>. <source>Nature</source>
<year>2003</year>, <volume>424</volume> (<issue>6952</issue>), <fpage>1042</fpage>&#x02013;<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1038/nature01947</pub-id>.<pub-id pub-id-type="pmid">12917642</pub-id></mixed-citation></ref><ref id="ref403"><mixed-citation publication-type="journal" id="cit403"><name><surname>Biller</surname><given-names>S. J.</given-names></name>; <name><surname>Berube</surname><given-names>P. M.</given-names></name>; <name><surname>Lindell</surname><given-names>D.</given-names></name>; <name><surname>Chisholm</surname><given-names>S. W.</given-names></name>
<article-title>Prochlorococcus:
the structure and function of collective diversity</article-title>. <source>Nat. Rev. Microbiol.</source>
<year>2014</year>, <volume>13</volume> (<issue>1</issue>), <fpage>13</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3378</pub-id>.<pub-id pub-id-type="pmid">25435307</pub-id></mixed-citation></ref><ref id="ref404"><mixed-citation publication-type="journal" id="cit404"><name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Insights into the evolution of lanthipeptide
biosynthesis</article-title>. <source>Protein Sci.</source>
<year>2013</year>, <volume>22</volume> (<issue>11</issue>), <fpage>1478</fpage>&#x02013;<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1002/pro.2358</pub-id>.<pub-id pub-id-type="pmid">24038659</pub-id></mixed-citation></ref><ref id="ref405"><mixed-citation publication-type="thesis" id="cit405"><person-group person-group-type="allauthors"><name><surname>Yang</surname><given-names>X.</given-names></name></person-group> Ph.D.
Thesis; <publisher-name>University of Illinois at Urbana-Champaign</publisher-name>, June <year>2015</year>. Accessible through <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ideals.illinois.edu/">https://www.ideals.illinois.edu/</uri>.</mixed-citation></ref><ref id="ref406"><mixed-citation publication-type="journal" id="cit406"><name><surname>Patton</surname><given-names>G. C.</given-names></name>; <name><surname>Paul</surname><given-names>M.</given-names></name>; <name><surname>Cooper</surname><given-names>L. E.</given-names></name>; <name><surname>Chatterjee</surname><given-names>C.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>The importance of the leader sequence
for directing
lanthionine formation in lacticin 481</article-title>. <source>Biochemistry</source>
<year>2008</year>, <volume>47</volume>, <fpage>7342</fpage>&#x02013;<lpage>7351</lpage>. <pub-id pub-id-type="doi">10.1021/bi800277d</pub-id>.<pub-id pub-id-type="pmid">18570437</pub-id></mixed-citation></ref><ref id="ref407"><mixed-citation publication-type="journal" id="cit407"><name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Morinaga</surname><given-names>Y.</given-names></name>; <name><surname>Islam</surname><given-names>M. R.</given-names></name>; <name><surname>Asaduzzaman</surname><given-names>S. M.</given-names></name>; <name><surname>Aso</surname><given-names>Y.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Mapping and
identification of the
region and secondary structure required for the maturation of the
nukacin ISK-1 prepeptide</article-title>. <source>Peptides</source>
<year>2009</year>, <volume>30</volume> (<issue>8</issue>), <fpage>1412</fpage>&#x02013;<lpage>1420</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2009.05.021</pub-id>.<pub-id pub-id-type="pmid">19481127</pub-id></mixed-citation></ref><ref id="ref408"><mixed-citation publication-type="journal" id="cit408"><name><surname>Oman</surname><given-names>T. J.</given-names></name>; <name><surname>Knerr</surname><given-names>P. J.</given-names></name>; <name><surname>Bindman</surname><given-names>N. A.</given-names></name>; <name><surname>Velasquez</surname><given-names>J. E.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>An engineered lantibiotic synthetase that does not
require a leader peptide on its substrate</article-title>. <source>J.
Am. Chem. Soc.</source>
<year>2012</year>, <volume>134</volume>, <fpage>6952</fpage>&#x02013;<lpage>6955</lpage>. <pub-id pub-id-type="doi">10.1021/ja3017297</pub-id>.<pub-id pub-id-type="pmid">22480178</pub-id></mixed-citation></ref><ref id="ref409"><mixed-citation publication-type="journal" id="cit409"><name><surname>Levengood</surname><given-names>M. R.</given-names></name>; <name><surname>Patton</surname><given-names>G. C.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>The leader
peptide is not required for post-translational modification by lacticin
481 synthetase</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2007</year>, <volume>129</volume>, <fpage>10314</fpage>&#x02013;<lpage>10315</lpage>. <pub-id pub-id-type="doi">10.1021/ja072967+</pub-id>.<pub-id pub-id-type="pmid">17676843</pub-id></mixed-citation></ref><ref id="ref410"><mixed-citation publication-type="journal" id="cit410"><name><surname>Martin</surname><given-names>N. I.</given-names></name>; <name><surname>Sprules</surname><given-names>T.</given-names></name>; <name><surname>Carpenter</surname><given-names>M. R.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Vederas</surname><given-names>J. C.</given-names></name>
<article-title>Structural
characterization of lacticin 3147, a two-peptide lantibiotic with
synergistic activity</article-title>. <source>Biochemistry</source>
<year>2004</year>, <volume>43</volume> (<issue>11</issue>), <fpage>3049</fpage>&#x02013;<lpage>3056</lpage>. <pub-id pub-id-type="doi">10.1021/bi0362065</pub-id>.<pub-id pub-id-type="pmid">15023056</pub-id></mixed-citation></ref><ref id="ref411"><mixed-citation publication-type="journal" id="cit411"><name><surname>Liu</surname><given-names>G.</given-names></name>; <name><surname>Zhong</surname><given-names>J.</given-names></name>; <name><surname>Ni</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>M.</given-names></name>; <name><surname>Xiao</surname><given-names>H.</given-names></name>; <name><surname>Huan</surname><given-names>L.</given-names></name>
<article-title>Characteristics of
the bovicin HJ50 gene cluster in <italic>Streptococcus
bovis</italic> HJ50</article-title>. <source>Microbiology</source>
<year>2009</year>, <volume>155</volume> (<issue>2</issue>), <fpage>584</fpage>&#x02013;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.022707-0</pub-id>.<pub-id pub-id-type="pmid">19202107</pub-id></mixed-citation></ref><ref id="ref412"><mixed-citation publication-type="journal" id="cit412"><name><surname>Kreil</surname><given-names>G.</given-names></name>
<article-title>D-amino acids
in animal peptides</article-title>. <source>Annu. Rev.
Biochem.</source>
<year>1997</year>, <volume>66</volume>, <fpage>337</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.66.1.337</pub-id>.<pub-id pub-id-type="pmid">9242910</pub-id></mixed-citation></ref><ref id="ref413"><mixed-citation publication-type="journal" id="cit413"><name><surname>Kreil</surname><given-names>G.</given-names></name>
<article-title>Peptides containing
a D-amino acid from frogs and molluscs</article-title>. <source>J. Biol.
Chem.</source>
<year>1994</year>, <volume>269</volume> (<issue>15</issue>), <fpage>10967</fpage>&#x02013;<lpage>10970</lpage>.<pub-id pub-id-type="pmid">8157620</pub-id></mixed-citation></ref><ref id="ref414"><mixed-citation publication-type="journal" id="cit414"><name><surname>Heck</surname><given-names>S. D.</given-names></name>; <name><surname>Siok</surname><given-names>C. J.</given-names></name>; <name><surname>Krapcho</surname><given-names>K. J.</given-names></name>; <name><surname>Kelbaugh</surname><given-names>P. R.</given-names></name>; <name><surname>Thadeio</surname><given-names>P. F.</given-names></name>; <name><surname>Welch</surname><given-names>M. J.</given-names></name>; <name><surname>Williams</surname><given-names>R. D.</given-names></name>; <name><surname>Ganong</surname><given-names>A. H.</given-names></name>; <name><surname>Kelly</surname><given-names>M. E.</given-names></name>; <name><surname>Lanzetti</surname><given-names>A. J.</given-names></name>; et al. <article-title>Functional consequences
of posttranslational isomerization of Ser46 in a calcium channel toxin</article-title>. <source>Science</source>
<year>1994</year>, <volume>266</volume> (<issue>5187</issue>), <fpage>1065</fpage>&#x02013;<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1126/science.7973665</pub-id>.<pub-id pub-id-type="pmid">7973665</pub-id></mixed-citation></ref><ref id="ref415"><mixed-citation publication-type="journal" id="cit415"><name><surname>Jilek</surname><given-names>A.</given-names></name>; <name><surname>Mollay</surname><given-names>C.</given-names></name>; <name><surname>Tippelt</surname><given-names>C.</given-names></name>; <name><surname>Grassi</surname><given-names>J.</given-names></name>; <name><surname>Mignogna</surname><given-names>G.</given-names></name>; <name><surname>Mullegger</surname><given-names>J.</given-names></name>; <name><surname>Sander</surname><given-names>V.</given-names></name>; <name><surname>Fehrer</surname><given-names>C.</given-names></name>; <name><surname>Barra</surname><given-names>D.</given-names></name>; <name><surname>Kreil</surname><given-names>G.</given-names></name>
<article-title>Biosynthesis
of a D-amino acid in
peptide linkage by an enzyme from frog skin secretions</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2005</year>, <volume>102</volume> (<issue>12</issue>), <fpage>4235</fpage>&#x02013;<lpage>4239</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0500789102</pub-id>.<pub-id pub-id-type="pmid">15758070</pub-id></mixed-citation></ref><ref id="ref416"><mixed-citation publication-type="journal" id="cit416"><name><surname>Shikata</surname><given-names>Y.</given-names></name>; <name><surname>Watanabe</surname><given-names>T.</given-names></name>; <name><surname>Teramoto</surname><given-names>T.</given-names></name>; <name><surname>Inoue</surname><given-names>A.</given-names></name>; <name><surname>Kawakami</surname><given-names>Y.</given-names></name>; <name><surname>Nishizawa</surname><given-names>Y.</given-names></name>; <name><surname>Katayama</surname><given-names>K.</given-names></name>; <name><surname>Kuwada</surname><given-names>M.</given-names></name>
<article-title>Isolation
and characterization of a peptide isomerase from funnel web spider
venom</article-title>. <source>J. Biol. Chem.</source>
<year>1995</year>, <volume>270</volume> (<issue>28</issue>), <fpage>16719</fpage>&#x02013;<lpage>16723</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.28.16719</pub-id>.<pub-id pub-id-type="pmid">7622482</pub-id></mixed-citation></ref><ref id="ref417"><mixed-citation publication-type="journal" id="cit417"><name><surname>Jungheim</surname><given-names>L. N.</given-names></name>; <name><surname>Shepherd</surname><given-names>T. A.</given-names></name>; <name><surname>Baxter</surname><given-names>A. J.</given-names></name>; <name><surname>Burgess</surname><given-names>J.</given-names></name>; <name><surname>Hatch</surname><given-names>S. D.</given-names></name>; <name><surname>Lubbehusen</surname><given-names>P.</given-names></name>; <name><surname>Wiskerchen</surname><given-names>M.</given-names></name>; <name><surname>Muesing</surname><given-names>M. A.</given-names></name>
<article-title>Potent human immunodeficiency virus
type 1 protease
inhibitors that utilize noncoded D-amino acids as p-2/p-3 ligands</article-title>. <source>J. Med. Chem.</source>
<year>1996</year>, <volume>39</volume> (<issue>1</issue>), <fpage>96</fpage>&#x02013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1021/jm950576c</pub-id>.<pub-id pub-id-type="pmid">8568831</pub-id></mixed-citation></ref><ref id="ref418"><mixed-citation publication-type="journal" id="cit418"><name><surname>Tugyi</surname><given-names>R.</given-names></name>; <name><surname>Uray</surname><given-names>K.</given-names></name>; <name><surname>Ivan</surname><given-names>D.</given-names></name>; <name><surname>Fellinger</surname><given-names>E.</given-names></name>; <name><surname>Perkins</surname><given-names>A.</given-names></name>; <name><surname>Hudecz</surname><given-names>F.</given-names></name>
<article-title>Partial D-amino acid
substitution:
Improved enzymatic stability and preserved Ab recognition of a MUC2
epitope peptide</article-title>. <source>Proc. Natl. Acad. Sci. U. S.
A.</source>
<year>2005</year>, <volume>102</volume> (<issue>2</issue>), <fpage>413</fpage>&#x02013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0407677102</pub-id>.<pub-id pub-id-type="pmid">15630090</pub-id></mixed-citation></ref><ref id="ref419"><mixed-citation publication-type="journal" id="cit419"><name><surname>Chatterjee</surname><given-names>S.</given-names></name>; <name><surname>Gu</surname><given-names>Z. Q.</given-names></name>; <name><surname>Dunn</surname><given-names>D.</given-names></name>; <name><surname>Tao</surname><given-names>M.</given-names></name>; <name><surname>Josef</surname><given-names>K.</given-names></name>; <name><surname>Tripathy</surname><given-names>R.</given-names></name>; <name><surname>Bihovsky</surname><given-names>R.</given-names></name>; <name><surname>Senadhi</surname><given-names>S. E.</given-names></name>; <name><surname>O&#x02019;Kane</surname><given-names>T. M.</given-names></name>; <name><surname>McKenna</surname><given-names>B. A.</given-names></name>; et al. <article-title>D-amino acid containing,
high-affinity inhibitors of recombinant human calpain I</article-title>. <source>J. Med. Chem.</source>
<year>1998</year>, <volume>41</volume> (<issue>15</issue>), <fpage>2663</fpage>&#x02013;<lpage>2666</lpage>. <pub-id pub-id-type="doi">10.1021/jm980035y</pub-id>.<pub-id pub-id-type="pmid">9667954</pub-id></mixed-citation></ref><ref id="ref420"><mixed-citation publication-type="journal" id="cit420"><name><surname>Imperiali</surname><given-names>B.</given-names></name>; <name><surname>Fisher</surname><given-names>S. L.</given-names></name>; <name><surname>Moats</surname><given-names>R. A.</given-names></name>; <name><surname>Prins</surname><given-names>T. J.</given-names></name>
<article-title>A conformational
study of peptides with the general structure Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2
- spectroscopic evidence for a peptide with significant beta-turn
character in water and in dimethyl-sulfoxide</article-title>. <source>J. Am. Chem. Soc.</source>
<year>1992</year>, <volume>114</volume> (<issue>9</issue>), <fpage>3182</fpage>&#x02013;<lpage>3188</lpage>. <pub-id pub-id-type="doi">10.1021/ja00035a002</pub-id>.</mixed-citation></ref><ref id="ref421"><mixed-citation publication-type="journal" id="cit421"><name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>O&#x02019;Connor</surname><given-names>P. M.</given-names></name>; <name><surname>Draper</surname><given-names>L. A.</given-names></name>; <name><surname>Lawton</surname><given-names>E. M.</given-names></name>; <name><surname>Deegan</surname><given-names>L. H.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Posttranslational
conversion of L-serines to D-alanines is vital for optimal production
and activity of the lantibiotic lacticin 3147</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2005</year>, <volume>102</volume> (<issue>51</issue>), <fpage>18584</fpage>&#x02013;<lpage>18589</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0509371102</pub-id>.<pub-id pub-id-type="pmid">16339304</pub-id></mixed-citation></ref><ref id="ref422"><mixed-citation publication-type="journal" id="cit422"><name><surname>Heck</surname><given-names>S. D.</given-names></name>; <name><surname>Faraci</surname><given-names>W. S.</given-names></name>; <name><surname>Kelbaugh</surname><given-names>P. R.</given-names></name>; <name><surname>Saccomano</surname><given-names>N. A.</given-names></name>; <name><surname>Thadeio</surname><given-names>P. F.</given-names></name>; <name><surname>Volkmann</surname><given-names>R. A.</given-names></name>
<article-title>Posttranslational
amino acid epimerization:
enzyme-catalyzed isomerization of amino acid residues in peptide chains</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>1996</year>, <volume>93</volume> (<issue>9</issue>), <fpage>4036</fpage>&#x02013;<lpage>4039</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.9.4036</pub-id>.<pub-id pub-id-type="pmid">8633012</pub-id></mixed-citation></ref><ref id="ref423"><mixed-citation publication-type="journal" id="cit423"><name><surname>Murkin</surname><given-names>A. S.</given-names></name>; <name><surname>Tanner</surname><given-names>M. E.</given-names></name>
<article-title>Dehydroalanine-based
inhibition of
a peptide epimerase from spider venom</article-title>. <source>J. Org.
Chem.</source>
<year>2002</year>, <volume>67</volume>, <fpage>8389</fpage>&#x02013;<lpage>8394</lpage>. <pub-id pub-id-type="doi">10.1021/jo0204653</pub-id>.<pub-id pub-id-type="pmid">12444615</pub-id></mixed-citation></ref><ref id="ref424"><mixed-citation publication-type="journal" id="cit424"><name><surname>Morinaka</surname><given-names>B. I.</given-names></name>; <name><surname>Vagstad</surname><given-names>A. L.</given-names></name>; <name><surname>Helf</surname><given-names>M. J.</given-names></name>; <name><surname>Gugger</surname><given-names>M.</given-names></name>; <name><surname>Kegler</surname><given-names>C.</given-names></name>; <name><surname>Freeman</surname><given-names>M. F.</given-names></name>; <name><surname>Bode</surname><given-names>H. B.</given-names></name>; <name><surname>Piel</surname><given-names>J.</given-names></name>
<article-title>Radical S-adenosyl
methionine epimerases: regioselective introduction of diverse D-amino
acid patterns into peptide natural products</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2014</year>, <volume>53</volume> (<issue>32</issue>), <fpage>8503</fpage>&#x02013;<lpage>8507</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201400478</pub-id>.</mixed-citation></ref><ref id="ref425"><mixed-citation publication-type="journal" id="cit425"><name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Post-translational
introduction of
D-alanine into ribosomally synthesized peptides by the dehydroalanine
reductase NpnJ</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2015</year>, <volume>137</volume> (<issue>39</issue>), <fpage>12426</fpage>&#x02013;<lpage>12429</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b05207</pub-id>.<pub-id pub-id-type="pmid">26361061</pub-id></mixed-citation></ref><ref id="ref426"><mixed-citation publication-type="journal" id="cit426"><name><surname>Ryan</surname><given-names>M. P.</given-names></name>; <name><surname>Jack</surname><given-names>R. W.</given-names></name>; <name><surname>Josten</surname><given-names>M.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>
<article-title>Extensive post-translational
modification, including serine to D-alanine conversion, in the two-component
lantibiotic, lacticin 3147</article-title>. <source>J. Biol. Chem.</source>
<year>1999</year>, <volume>274</volume> (<issue>53</issue>), <fpage>37544</fpage>&#x02013;<lpage>37550</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.53.37544</pub-id>.<pub-id pub-id-type="pmid">10608807</pub-id></mixed-citation></ref><ref id="ref427"><mixed-citation publication-type="journal" id="cit427"><name><surname>Navaratna</surname><given-names>M. A.</given-names></name>; <name><surname>Sahl</surname><given-names>H. G.</given-names></name>; <name><surname>Tagg</surname><given-names>J. R.</given-names></name>
<article-title>Two-component anti-<italic>Staphylococcus
aureus</italic> lantibiotic activity produced by <italic>Staphylococcus
aureus</italic> C55</article-title>. <source>Appl. Environ.
Microbiol.</source>
<year>1998</year>, <volume>64</volume> (<issue>12</issue>), <fpage>4803</fpage>&#x02013;<lpage>4808</lpage>.<pub-id pub-id-type="pmid">9835565</pub-id></mixed-citation></ref><ref id="ref428"><mixed-citation publication-type="journal" id="cit428"><name><surname>Giacomini</surname><given-names>A.</given-names></name>; <name><surname>Squartini</surname><given-names>A.</given-names></name>; <name><surname>Nuti</surname><given-names>M. P.</given-names></name>
<article-title>Nucleotide sequence
and analysis of plasmid pMD136 from <italic>Pediococcus pentosaceus</italic> FBB61 (ATCC43200) involved in pediocin A production</article-title>. <source>Plasmid</source>
<year>2000</year>, <volume>43</volume> (<issue>2</issue>), <fpage>111</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1006/plas.1999.1447</pub-id>.<pub-id pub-id-type="pmid">10686129</pub-id></mixed-citation></ref><ref id="ref429"><mixed-citation publication-type="journal" id="cit429"><name><surname>Suda</surname><given-names>S.</given-names></name>; <name><surname>Lawton</surname><given-names>E. M.</given-names></name>; <name><surname>Wistuba</surname><given-names>D.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Homologues and bioengineered derivatives
of LtnJ vary in ability to form D-alanine in the lantibiotic lacticin
3147</article-title>. <source>J. Bacteriol.</source>
<year>2012</year>, <volume>194</volume> (<issue>3</issue>), <fpage>708</fpage>&#x02013;<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1128/JB.06185-11</pub-id>.<pub-id pub-id-type="pmid">22123251</pub-id></mixed-citation></ref><ref id="ref430"><mixed-citation publication-type="journal" id="cit430"><name><surname>van Heel</surname><given-names>A. J.</given-names></name>; <name><surname>Mu</surname><given-names>D.</given-names></name>; <name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>; <name><surname>Hendriks</surname><given-names>D.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Designing and producing modified,
new-to-nature peptides with antimicrobial activity by use of a combination
of various lantibiotic modification enzymes</article-title>. <source>ACS Synth. Biol.</source>
<year>2013</year>, <volume>2</volume> (<issue>7</issue>), <fpage>397</fpage>&#x02013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1021/sb3001084</pub-id>.<pub-id pub-id-type="pmid">23654279</pub-id></mixed-citation></ref><ref id="ref431"><mixed-citation publication-type="journal" id="cit431"><name><surname>Mu</surname><given-names>D.</given-names></name>; <name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name>; <name><surname>Deng</surname><given-names>J.</given-names></name>; <name><surname>Kuipers</surname><given-names>O. P.</given-names></name>
<article-title>Substrate
selectivity of the lantibiotic reductase LtnJ assessed by a collection
of nisin derivatives as substrate</article-title>. <source>Appl. Environ.
Microbiol.</source>
<year>2015</year>, <volume>81</volume> (<issue>11</issue>), <fpage>3679</fpage>&#x02013;<lpage>3687</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00475-15</pub-id>.<pub-id pub-id-type="pmid">25795677</pub-id></mixed-citation></ref><ref id="ref432"><mixed-citation publication-type="journal" id="cit432"><name><surname>Benedict</surname><given-names>R. G.</given-names></name>; <name><surname>Dvonch</surname><given-names>W.</given-names></name>; <name><surname>Shotwell</surname><given-names>O. L.</given-names></name>; <name><surname>Pridham</surname><given-names>T.</given-names></name>; <name><surname>Lindenfelser</surname><given-names>L. A.</given-names></name>
<article-title>Cinnamycin, an antibiotic from <italic>Streptomyces
cinnamoneus</italic></article-title>. <source>Antibiot. Chemother.</source>
<year>1952</year>, <volume>2</volume>, <fpage>591</fpage>&#x02013;<lpage>594</lpage>.</mixed-citation></ref><ref id="ref433"><mixed-citation publication-type="journal" id="cit433"><name><surname>Kessler</surname><given-names>H.</given-names></name>; <name><surname>Steuernagel</surname><given-names>S.</given-names></name>; <name><surname>Will</surname><given-names>M.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>; <name><surname>Kellner</surname><given-names>R.</given-names></name>; <name><surname>Gillessen</surname><given-names>D.</given-names></name>; <name><surname>Kamiyama</surname><given-names>T.</given-names></name>
<article-title>The structure of the
polycyclic nonadecapeptide Ro 09&#x02013;0198</article-title>. <source>Helv. Chim. Acta</source>
<year>1988</year>, <volume>71</volume> (<issue>8</issue>), <fpage>1924</fpage>&#x02013;<lpage>1929</lpage>. <pub-id pub-id-type="doi">10.1002/hlca.19880710811</pub-id>.</mixed-citation></ref><ref id="ref434"><mixed-citation publication-type="journal" id="cit434"><name><surname>Wakamiya</surname><given-names>T.</given-names></name>; <name><surname>Fukase</surname><given-names>K.</given-names></name>; <name><surname>Naruse</surname><given-names>N.</given-names></name>; <name><surname>Konishi</surname><given-names>M.</given-names></name>; <name><surname>Shiba</surname><given-names>T.</given-names></name>
<article-title>Lanthiopeptin, a new peptide effective
against herpes-simplex virus
- structural determination and comparison with Ro 09&#x02013;0198,
an immunopotentiating peptide</article-title>. <source>Tetrahedron Lett.</source>
<year>1988</year>, <volume>29</volume> (<issue>37</issue>), <fpage>4771</fpage>&#x02013;<lpage>4772</lpage>. <pub-id pub-id-type="doi">10.1016/S0040-4039(00)80604-8</pub-id>.</mixed-citation></ref><ref id="ref435"><mixed-citation publication-type="journal" id="cit435"><name><surname>Kaletta</surname><given-names>C.</given-names></name>; <name><surname>Entian</surname><given-names>K. D.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>
<article-title>Prepeptide sequence
of cinnamycin (Ro 09&#x02013;0198): the first structural gene of a
duramycin-type lantibiotic</article-title>. <source>Eur. J. Biochem.</source>
<year>1991</year>, <volume>199</volume> (<issue>2</issue>), <fpage>411</fpage>&#x02013;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1991.tb16138.x</pub-id>.<pub-id pub-id-type="pmid">2070795</pub-id></mixed-citation></ref><ref id="ref436"><mixed-citation publication-type="journal" id="cit436"><name><surname>Kodani</surname><given-names>S.</given-names></name>; <name><surname>Komaki</surname><given-names>H.</given-names></name>; <name><surname>Ishimura</surname><given-names>S.</given-names></name>; <name><surname>Hemmi</surname><given-names>H.</given-names></name>; <name><surname>Ohnishi-Kameyama</surname><given-names>M.</given-names></name>
<article-title>Isolation
and structure determination of a new lantibiotic
cinnamycin B from <italic>Actinomadura atramentaria</italic> based
on genome mining</article-title>. <source>J. Ind. Microbiol. Biotechnol.</source>
<year>2016</year>, <volume>43</volume> (<issue>8</issue>), <fpage>1159</fpage>&#x02013;<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1007/s10295-016-1788-9</pub-id>.<pub-id pub-id-type="pmid">27255974</pub-id></mixed-citation></ref><ref id="ref437"><mixed-citation publication-type="journal" id="cit437"><name><surname>Kondo</surname><given-names>S.</given-names></name>; <name><surname>Sezaki</surname><given-names>M.</given-names></name>; <name><surname>Shimura</surname><given-names>M.</given-names></name>; <name><surname>Sato</surname><given-names>K.</given-names></name>; <name><surname>Hara</surname><given-names>T.</given-names></name>
<article-title>Leucopeptin,
a new peptide antibiotic</article-title>. <source>J. Antibiot.</source>
<year>1964</year>, <volume>17</volume> (<issue>6</issue>), <fpage>262</fpage>&#x02013;<lpage>263</lpage>.<pub-id pub-id-type="pmid">14236206</pub-id></mixed-citation></ref><ref id="ref438"><mixed-citation publication-type="journal" id="cit438"><name><surname>Fredenhagen</surname><given-names>A.</given-names></name>; <name><surname>Fendrich</surname><given-names>G.</given-names></name>; <name><surname>Marki</surname><given-names>F.</given-names></name>; <name><surname>Marki</surname><given-names>W.</given-names></name>; <name><surname>Gruner</surname><given-names>J.</given-names></name>; <name><surname>Raschdorf</surname><given-names>F.</given-names></name>; <name><surname>Peter</surname><given-names>H. H.</given-names></name>
<article-title>Duramycins B and
C, two new lanthionine containing antibiotics as inhibitors of phospholipase
A2. Structural revision of duramycin and cinnamycin</article-title>. <source>J. Antibiot.</source>
<year>1990</year>, <volume>43</volume> (<issue>11</issue>), <fpage>1403</fpage>&#x02013;<lpage>1412</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.43.1403</pub-id>.<pub-id pub-id-type="pmid">2125590</pub-id></mixed-citation></ref><ref id="ref439"><mixed-citation publication-type="book" id="cit439"><person-group person-group-type="allauthors"><name><surname>Fredenhagen</surname><given-names>A.</given-names></name>; <name><surname>Maerki</surname><given-names>F.</given-names></name>; <name><surname>Fendrich</surname><given-names>G.</given-names></name>; <name><surname>Maerki</surname><given-names>W.</given-names></name>; <name><surname>Gruner</surname><given-names>J.</given-names></name>; <name><surname>Van Oostrum</surname><given-names>J.</given-names></name>; <name><surname>Raschdorf</surname><given-names>F.</given-names></name>; <name><surname>Peter</surname><given-names>H. H.</given-names></name></person-group> In <source>Nisin and Novel
Lantibiotics</source>; <person-group person-group-type="editor"><name><surname>Jung</surname><given-names>G.</given-names></name>, <name><surname>Sahl</surname><given-names>H.-G.</given-names></name></person-group>,
Eds.; <publisher-name>ESCOM</publisher-name>: <publisher-loc>Leiden,
The Netherlands</publisher-loc>, <year>1991</year>; pp <fpage>131</fpage>&#x02013;<lpage>140</lpage>.</mixed-citation></ref><ref id="ref440"><mixed-citation publication-type="journal" id="cit440"><name><surname>Kessler</surname><given-names>H.</given-names></name>; <name><surname>Steuernagel</surname><given-names>S.</given-names></name>; <name><surname>Gillessen</surname><given-names>D.</given-names></name>; <name><surname>Kamiyama</surname><given-names>T.</given-names></name>
<article-title>Complete sequence determination
and localization of
one imino and three sulfide bridges of the nonadecapeptide Ro 09&#x02013;0198
by homonuclear 2D-NMR spectroscopy. The DQF-RELAYED-NOESY-experiment</article-title>. <source>Helv. Chim. Acta</source>
<year>1987</year>, <volume>70</volume> (<issue>3</issue>), <fpage>726</fpage>&#x02013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1002/hlca.19870700322</pub-id>.</mixed-citation></ref><ref id="ref441"><mixed-citation publication-type="journal" id="cit441"><name><surname>Zimmermann</surname><given-names>N.</given-names></name>; <name><surname>Freund</surname><given-names>S.</given-names></name>; <name><surname>Fredenhagen</surname><given-names>A.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>
<article-title>Solution structures of the lantibiotics duramycin B and C</article-title>. <source>Eur. J. Biochem.</source>
<year>1993</year>, <volume>216</volume> (<issue>2</issue>), <fpage>419</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1993.tb18159.x</pub-id>.<pub-id pub-id-type="pmid">8375380</pub-id></mixed-citation></ref><ref id="ref442"><mixed-citation publication-type="journal" id="cit442"><name><surname>Hayashi</surname><given-names>F.</given-names></name>; <name><surname>Nagashima</surname><given-names>K.</given-names></name>; <name><surname>Terui</surname><given-names>Y.</given-names></name>; <name><surname>Kawamura</surname><given-names>Y.</given-names></name>; <name><surname>Matsumoto</surname><given-names>K.</given-names></name>; <name><surname>Itazaki</surname><given-names>H.</given-names></name>
<article-title>The structure of PA48009: the revised
structure of duramycin</article-title>. <source>J. Antibiot.</source>
<year>1990</year>, <volume>43</volume> (<issue>11</issue>), <fpage>1421</fpage>&#x02013;<lpage>1430</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.43.1421</pub-id>.<pub-id pub-id-type="pmid">2272918</pub-id></mixed-citation></ref><ref id="ref443"><mixed-citation publication-type="book" id="cit443"><person-group person-group-type="allauthors"><name><surname>Kessler</surname><given-names>H.</given-names></name>; <name><surname>Seip</surname><given-names>S.</given-names></name>; <name><surname>Wein</surname><given-names>T.</given-names></name>; <name><surname>Steuernagel</surname><given-names>S.</given-names></name>; <name><surname>Will</surname><given-names>M.</given-names></name></person-group> In <source>Nisin and Novel Lantibiotics</source>; <person-group person-group-type="editor"><name><surname>Jung</surname><given-names>G.</given-names></name>, <name><surname>Sahl</surname><given-names>H.-G.</given-names></name></person-group>, Eds.; <publisher-name>ESCOM</publisher-name>: <publisher-loc>Leiden, The Netherlands</publisher-loc>, <year>1991</year>; pp <fpage>76</fpage>&#x02013;<lpage>90</lpage>.</mixed-citation></ref><ref id="ref444"><mixed-citation publication-type="journal" id="cit444"><name><surname>Wang</surname><given-names>Q. P.</given-names></name>; <name><surname>VanDusen</surname><given-names>W. J.</given-names></name>; <name><surname>Petroski</surname><given-names>C. J.</given-names></name>; <name><surname>Garsky</surname><given-names>V. M.</given-names></name>; <name><surname>Stern</surname><given-names>A. M.</given-names></name>; <name><surname>Friedman</surname><given-names>P. A.</given-names></name>
<article-title>Bovine liver aspartyl beta-hydroxylase.
Purification and characterization</article-title>. <source>J. Biol.
Chem.</source>
<year>1991</year>, <volume>266</volume> (<issue>21</issue>), <fpage>14004</fpage>&#x02013;<lpage>14010</lpage>.<pub-id pub-id-type="pmid">1856229</pub-id></mixed-citation></ref><ref id="ref445"><mixed-citation publication-type="journal" id="cit445"><name><surname>Friedman</surname><given-names>M.</given-names></name>
<article-title>Chemistry,
biochemistry, nutrition, and microbiology
of lysinoalanine, lanthionine, and histidinoalanine in food and other
proteins</article-title>. <source>J. Agric. Food Chem.</source>
<year>1999</year>, <volume>47</volume> (<issue>4</issue>), <fpage>1295</fpage>&#x02013;<lpage>1319</lpage>. <pub-id pub-id-type="doi">10.1021/jf981000+</pub-id>.<pub-id pub-id-type="pmid">10563973</pub-id></mixed-citation></ref><ref id="ref446"><mixed-citation publication-type="journal" id="cit446"><name><surname>Hullin-Matsuda</surname><given-names>F.</given-names></name>; <name><surname>Makino</surname><given-names>A.</given-names></name>; <name><surname>Murate</surname><given-names>M.</given-names></name>; <name><surname>Kobayashi</surname><given-names>T.</given-names></name>
<article-title>Probing phosphoethanolamine-containing
lipids in membranes with duramycin/cinnamycin and aegerolysin proteins</article-title>. <source>Biochimie</source>
<year>2016</year>, <volume>130</volume>, <fpage>81</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2016.09.020</pub-id>.<pub-id pub-id-type="pmid">27693589</pub-id></mixed-citation></ref><ref id="ref447"><mixed-citation publication-type="journal" id="cit447"><name><surname>Zhao</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Bugenhagen</surname><given-names>S.</given-names></name>
<article-title>99mTc-labeled
duramycin as a novel phosphatidylethanolamine-binding molecular probe</article-title>. <source>J. Nucl. Med.</source>
<year>2008</year>, <volume>49</volume> (<issue>8</issue>), <fpage>1345</fpage>&#x02013;<lpage>1352</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.107.048603</pub-id>.<pub-id pub-id-type="pmid">18632826</pub-id></mixed-citation></ref><ref id="ref448"><mixed-citation publication-type="journal" id="cit448"><name><surname>Richard</surname><given-names>A. S.</given-names></name>; <name><surname>Zhang</surname><given-names>A.</given-names></name>; <name><surname>Park</surname><given-names>S. J.</given-names></name>; <name><surname>Farzan</surname><given-names>M.</given-names></name>; <name><surname>Zong</surname><given-names>M.</given-names></name>; <name><surname>Choe</surname><given-names>H.</given-names></name>
<article-title>Virion-associated phosphatidylethanolamine
promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2015</year>, <volume>112</volume> (<issue>47</issue>), <fpage>14682</fpage>&#x02013;<lpage>14687</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1508095112</pub-id>.<pub-id pub-id-type="pmid">26575624</pub-id></mixed-citation></ref><ref id="ref449"><mixed-citation publication-type="journal" id="cit449"><name><surname>Broughton</surname><given-names>L. J.</given-names></name>; <name><surname>Crow</surname><given-names>C.</given-names></name>; <name><surname>Maraveyas</surname><given-names>A.</given-names></name>; <name><surname>Madden</surname><given-names>L. A.</given-names></name>
<article-title>Duramycin-induced calcium release in cancer cells</article-title>. <source>Anti-Cancer Drugs</source>
<year>2016</year>, <volume>27</volume> (<issue>3</issue>), <fpage>173</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1097/CAD.0000000000000313</pub-id>.<pub-id pub-id-type="pmid">26512767</pub-id></mixed-citation></ref><ref id="ref450"><mixed-citation publication-type="journal" id="cit450"><name><surname>&#x000d6;kesli</surname><given-names>A.</given-names></name>; <name><surname>Cooper</surname><given-names>L. E.</given-names></name>; <name><surname>Fogle</surname><given-names>E. J.</given-names></name>; <name><surname>van der
Donk</surname><given-names>W. A.</given-names></name>
<article-title>Nine post-translational modifications during the biosynthesis
of cinnamycin</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2011</year>, <volume>133</volume> (<issue>34</issue>), <fpage>13753</fpage>&#x02013;<lpage>13760</lpage>. <pub-id pub-id-type="doi">10.1021/ja205783f</pub-id>.<pub-id pub-id-type="pmid">21770392</pub-id></mixed-citation></ref><ref id="ref451"><mixed-citation publication-type="journal" id="cit451"><person-group person-group-type="allauthors"><name><surname>Huo</surname><given-names>L.</given-names></name>; <name><surname>&#x000d6;kesli</surname><given-names>A.</given-names></name>; <name><surname>Zhao</surname><given-names>M.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name></person-group><article-title>Insights into the biosynthesis
of duramycin</article-title>. <source>Appl. Environ. Microbiol.</source><year>2017</year>, DOI: <pub-id pub-id-type="doi">10.1128/AEM.02698-16</pub-id></mixed-citation></ref><ref id="ref452"><mixed-citation publication-type="journal" id="cit452"><name><surname>Somma</surname><given-names>S.</given-names></name>; <name><surname>Merati</surname><given-names>W.</given-names></name>; <name><surname>Parenti</surname><given-names>F.</given-names></name>
<article-title>Gardimycin, a new antibiotic
inhibiting peptidoglycan synthesis</article-title>. <source>Antimicrob.
Agents Chemother.</source>
<year>1977</year>, <volume>11</volume> (<issue>3</issue>), <fpage>396</fpage>&#x02013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.11.3.396</pub-id>.<pub-id pub-id-type="pmid">404960</pub-id></mixed-citation></ref><ref id="ref453"><mixed-citation publication-type="journal" id="cit453"><name><surname>V&#x000e9;rtesy</surname><given-names>L.</given-names></name>; <name><surname>Aretz</surname><given-names>W.</given-names></name>; <name><surname>Bonnefoy</surname><given-names>A.</given-names></name>; <name><surname>Ehlers</surname><given-names>E.</given-names></name>; <name><surname>Kurz</surname><given-names>M.</given-names></name>; <name><surname>Markus</surname><given-names>A.</given-names></name>; <name><surname>Schiell</surname><given-names>M.</given-names></name>; <name><surname>Vogel</surname><given-names>M.</given-names></name>; <name><surname>Wink</surname><given-names>J.</given-names></name>; <name><surname>Kogler</surname><given-names>H.</given-names></name>
<article-title>Ala(0)-actagardine, a new lantibiotic from cultures
of <italic>Actinoplanes liguriae</italic> ATCC 31048</article-title>. <source>J. Antibiot.</source>
<year>1999</year>, <volume>52</volume> (<issue>8</issue>), <fpage>730</fpage>&#x02013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.52.730</pub-id>.<pub-id pub-id-type="pmid">10580386</pub-id></mixed-citation></ref><ref id="ref454"><mixed-citation publication-type="journal" id="cit454"><name><surname>Zimmermann</surname><given-names>N.</given-names></name>; <name><surname>Metzger</surname><given-names>J. W.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>
<article-title>The tetracyclic lantibiotic
actagardine. 1H-NMR and 13C-NMR assignments and revised primary structure</article-title>. <source>Eur. J. Biochem.</source>
<year>1995</year>, <volume>228</volume> (<issue>3</issue>), <fpage>786</fpage>&#x02013;<lpage>797</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1995.tb20324.x</pub-id>.<pub-id pub-id-type="pmid">7737178</pub-id></mixed-citation></ref><ref id="ref455"><mixed-citation publication-type="journal" id="cit455"><name><surname>Zimmermann</surname><given-names>N.</given-names></name>; <name><surname>Jung</surname><given-names>G.</given-names></name>
<article-title>The three-dimensional
solution structure
of the lantibiotic murein-biosynthesis-inhibitor actagardine determined
by NMR</article-title>. <source>Eur. J. Biochem.</source>
<year>1997</year>, <volume>246</volume> (<issue>3</issue>), <fpage>809</fpage>&#x02013;<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1997.00809.x</pub-id>.<pub-id pub-id-type="pmid">9219543</pub-id></mixed-citation></ref><ref id="ref456"><mixed-citation publication-type="journal" id="cit456"><name><surname>Kettenring</surname><given-names>J. K.</given-names></name>; <name><surname>Malabarba</surname><given-names>A.</given-names></name>; <name><surname>Vekey</surname><given-names>K.</given-names></name>; <name><surname>Cavalleri</surname><given-names>B.</given-names></name>
<article-title>Sequence determination
of actagardine, a novel lantibiotic, by homonuclear 2D NMR spectroscopy</article-title>. <source>J. Antibiot.</source>
<year>1990</year>, <volume>43</volume> (<issue>9</issue>), <fpage>1082</fpage>&#x02013;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.43.1082</pub-id>.<pub-id pub-id-type="pmid">2211371</pub-id></mixed-citation></ref><ref id="ref457"><mixed-citation publication-type="journal" id="cit457"><name><surname>Holtsmark</surname><given-names>I.</given-names></name>; <name><surname>Mantzilas</surname><given-names>D.</given-names></name>; <name><surname>Eijsink</surname><given-names>V. G.</given-names></name>; <name><surname>Brurberg</surname><given-names>M. B.</given-names></name>
<article-title>Purification,
characterization, and gene sequence of michiganin A, an actagardine-like
lantibiotic produced by the tomato pathogen <italic>Clavibacter michiganensis</italic> subsp. michiganensis</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2006</year>, <volume>72</volume> (<issue>9</issue>), <fpage>5814</fpage>&#x02013;<lpage>5821</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00639-06</pub-id>.<pub-id pub-id-type="pmid">16957199</pub-id></mixed-citation></ref><ref id="ref458"><mixed-citation publication-type="journal" id="cit458"><name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Bueno</surname><given-names>A.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Heterologous production of the lantibiotic
Ala(0)actagardine in <italic>Escherichia coli</italic></article-title>. <source>Chem. Commun.</source>
<year>2012</year>, <volume>48</volume> (<issue>89</issue>), <fpage>10966</fpage>&#x02013;<lpage>10968</lpage>. <pub-id pub-id-type="doi">10.1039/c2cc36336d</pub-id>.</mixed-citation></ref><ref id="ref459"><mixed-citation publication-type="journal" id="cit459"><name><surname>van Berkel</surname><given-names>W. J.</given-names></name>; <name><surname>Kamerbeek</surname><given-names>N. M.</given-names></name>; <name><surname>Fraaije</surname><given-names>M. W.</given-names></name>
<article-title>Flavoprotein monooxygenases,
a diverse class of oxidative biocatalysts</article-title>. <source>J.
Biotechnol.</source>
<year>2006</year>, <volume>124</volume> (<issue>4</issue>), <fpage>670</fpage>&#x02013;<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2006.03.044</pub-id>.<pub-id pub-id-type="pmid">16712999</pub-id></mixed-citation></ref><ref id="ref460"><mixed-citation publication-type="journal" id="cit460"><name><surname>Boden</surname><given-names>R.</given-names></name>; <name><surname>Borodina</surname><given-names>E.</given-names></name>; <name><surname>Wood</surname><given-names>A. P.</given-names></name>; <name><surname>Kelly</surname><given-names>D. P.</given-names></name>; <name><surname>Murrell</surname><given-names>J. C.</given-names></name>; <name><surname>Schafer</surname><given-names>H.</given-names></name>
<article-title>Purification and characterization
of dimethylsulfide monooxygenase from <italic>Hyphomicrobium sulfonivorans</italic></article-title>. <source>J. Bacteriol.</source>
<year>2011</year>, <volume>193</volume> (<issue>5</issue>), <fpage>1250</fpage>&#x02013;<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00977-10</pub-id>.<pub-id pub-id-type="pmid">21216999</pub-id></mixed-citation></ref><ref id="ref461"><mixed-citation publication-type="journal" id="cit461"><name><surname>Krueger</surname><given-names>S. K.</given-names></name>; <name><surname>Williams</surname><given-names>D. E.</given-names></name>
<article-title>Mammalian flavin-containing
monooxygenases:
structure/function, genetic polymorphisms and role in drug metabolism</article-title>. <source>Pharmacol. Ther.</source>
<year>2005</year>, <volume>106</volume> (<issue>3</issue>), <fpage>357</fpage>&#x02013;<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.01.001</pub-id>.<pub-id pub-id-type="pmid">15922018</pub-id></mixed-citation></ref><ref id="ref462"><mixed-citation publication-type="journal" id="cit462"><name><surname>McAuliffe</surname><given-names>O.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Identification
and
overexpression of ltnl, a novel gene which confers immunity to the
two-component lantibiotic lacticin 3147</article-title>. <source>Microbiology</source>
<year>2000</year>, <volume>146</volume> (<issue>1</issue>), <fpage>129</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-146-1-129</pub-id>.<pub-id pub-id-type="pmid">10658659</pub-id></mixed-citation></ref><ref id="ref463"><mixed-citation publication-type="journal" id="cit463"><name><surname>Draper</surname><given-names>L. A.</given-names></name>; <name><surname>Deegan</surname><given-names>L. H.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>
<article-title>Insights
into lantibiotic immunity provided by bioengineering
of LtnI</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2012</year>, <volume>56</volume> (<issue>10</issue>), <fpage>5122</fpage>&#x02013;<lpage>5133</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00979-12</pub-id>.<pub-id pub-id-type="pmid">22802258</pub-id></mixed-citation></ref><ref id="ref464"><mixed-citation publication-type="journal" id="cit464"><name><surname>Aso</surname><given-names>Y.</given-names></name>; <name><surname>Okuda</surname><given-names>K.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Kanemasa</surname><given-names>Y.</given-names></name>; <name><surname>Thi Bich
Phuong</surname><given-names>N.</given-names></name>; <name><surname>Koga</surname><given-names>H.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Sashihara</surname><given-names>T.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>A novel type of immunity protein,
NukH, for the lantibiotic nukacin ISK-1 produced by <italic>Staphylococcus
warneri</italic> ISK-1</article-title>. <source>Biosci., Biotechnol.,
Biochem.</source>
<year>2005</year>, <volume>69</volume> (<issue>7</issue>), <fpage>1403</fpage>&#x02013;<lpage>1410</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.69.1403</pub-id>.<pub-id pub-id-type="pmid">16041148</pub-id></mixed-citation></ref><ref id="ref465"><mixed-citation publication-type="journal" id="cit465"><name><surname>Okuda</surname><given-names>K.</given-names></name>; <name><surname>Aso</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Kanemasa</surname><given-names>Y.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Characterization of
functional domains of lantibiotic-binding immunity protein, NukH,
from <italic>Staphylococcus warneri</italic> ISK-1</article-title>. <source>FEMS Microbiol. Lett.</source>
<year>2005</year>, <volume>250</volume> (<issue>1</issue>), <fpage>19</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.femsle.2005.06.039</pub-id>.<pub-id pub-id-type="pmid">16009508</pub-id></mixed-citation></ref><ref id="ref466"><mixed-citation publication-type="journal" id="cit466"><name><surname>Okuda</surname><given-names>K.</given-names></name>; <name><surname>Yanagihara</surname><given-names>S.</given-names></name>; <name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Harada</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Aso</surname><given-names>Y.</given-names></name>; <name><surname>Zendo</surname><given-names>T.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Binding specificity
of the lantibiotic-binding immunity
protein NukH</article-title>. <source>Appl. Environ. Microbiol.</source>
<year>2008</year>, <volume>74</volume> (<issue>24</issue>), <fpage>7613</fpage>&#x02013;<lpage>7619</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00789-08</pub-id>.<pub-id pub-id-type="pmid">18978082</pub-id></mixed-citation></ref><ref id="ref467"><mixed-citation publication-type="journal" id="cit467"><person-group person-group-type="allauthors"><name><surname>O&#x02019;Rourke</surname><given-names>S.</given-names></name>; <name><surname>Widdick</surname><given-names>D.</given-names></name>; <name><surname>Bibb</surname><given-names>M.</given-names></name></person-group><article-title>A novel mechanism
of immunity controls the onset of cinnamycin biosynthesis in <italic>Streptomyces cinnamoneus</italic> DSM 40646</article-title>. <source>J. Ind. Microbiol. Biotechnol.</source><year>2016</year>, DOI: <pub-id pub-id-type="doi">10.1007/s10295-016-1869-9</pub-id>.</mixed-citation></ref><ref id="ref468"><mixed-citation publication-type="journal" id="cit468"><name><surname>Hosoda</surname><given-names>K.</given-names></name>; <name><surname>Ohya</surname><given-names>M.</given-names></name>; <name><surname>Kohno</surname><given-names>T.</given-names></name>; <name><surname>Maeda</surname><given-names>T.</given-names></name>; <name><surname>Endo</surname><given-names>S.</given-names></name>; <name><surname>Wakamatsu</surname><given-names>K.</given-names></name>
<article-title>Structure determination of an immunopotentiator
peptide, cinnamycin, complexed with lysophosphatidylethanolamine by <sup>1</sup>H-NMR</article-title>. <source>J. Biochem.</source>
<year>1996</year>, <volume>119</volume> (<issue>2</issue>), <fpage>226</fpage>&#x02013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a021226</pub-id>.<pub-id pub-id-type="pmid">8882709</pub-id></mixed-citation></ref><ref id="ref469"><mixed-citation publication-type="journal" id="cit469"><name><surname>Wakamatsu</surname><given-names>K.</given-names></name>; <name><surname>Choung</surname><given-names>S. Y.</given-names></name>; <name><surname>Kobayashi</surname><given-names>T.</given-names></name>; <name><surname>Inoue</surname><given-names>K.</given-names></name>; <name><surname>Higashijima</surname><given-names>T.</given-names></name>; <name><surname>Miyazawa</surname><given-names>T.</given-names></name>
<article-title>Complex formation of
peptide antibiotic Ro09&#x02013;0198 with lysophosphatidylethanolamine:
proton NMR analyses in dimethyl sulfoxide solution</article-title>. <source>Biochemistry</source>
<year>1990</year>, <volume>29</volume> (<issue>1</issue>), <fpage>113</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1021/bi00453a013</pub-id>.<pub-id pub-id-type="pmid">2157477</pub-id></mixed-citation></ref><ref id="ref470"><mixed-citation publication-type="journal" id="cit470"><name><surname>Shotwell</surname><given-names>O. L.</given-names></name>; <name><surname>Stodola</surname><given-names>F. H.</given-names></name>; <name><surname>Michael</surname><given-names>W. R.</given-names></name>; <name><surname>Lindenfelser</surname><given-names>L. A.</given-names></name>; <name><surname>Dworschack</surname><given-names>R. G.</given-names></name>; <name><surname>Pridham</surname><given-names>T. G.</given-names></name>
<article-title>Antibiotics against plant disease.
III. Duramycin, a new antibiotic from <italic>Streptomyces cinnamomeus</italic> forma azacoluta</article-title>. <source>J. Am. Chem. Soc.</source>
<year>1958</year>, <volume>80</volume>, <fpage>3912</fpage>&#x02013;<lpage>3915</lpage>. <pub-id pub-id-type="doi">10.1021/ja01548a029</pub-id>.</mixed-citation></ref><ref id="ref471"><mixed-citation publication-type="journal" id="cit471"><name><surname>Willey</surname><given-names>J. M.</given-names></name>; <name><surname>Gaskell</surname><given-names>A. A.</given-names></name>
<article-title>Morphogenetic signaling
molecules
of the streptomycetes</article-title>. <source>Chem. Rev.</source>
<year>2011</year>, <volume>111</volume> (<issue>1</issue>), <fpage>174</fpage>&#x02013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1021/cr1000404</pub-id>.<pub-id pub-id-type="pmid">21090718</pub-id></mixed-citation></ref><ref id="ref472"><mixed-citation publication-type="journal" id="cit472"><name><surname>Ma</surname><given-names>H.</given-names></name>; <name><surname>Kendall</surname><given-names>K.</given-names></name>
<article-title>Cloning and analysis
of a gene cluster from <italic>Streptomyces coelicolor</italic> that
causes accelerated aerial mycelium
formation in <italic>Streptomyces lividans</italic></article-title>. <source>J. Bacteriol.</source>
<year>1994</year>, <volume>176</volume> (<issue>12</issue>), <fpage>3800</fpage>&#x02013;<lpage>3811</lpage>. <pub-id pub-id-type="doi">10.1128/jb.176.12.3800-3811.1994</pub-id>.<pub-id pub-id-type="pmid">8206859</pub-id></mixed-citation></ref><ref id="ref473"><mixed-citation publication-type="journal" id="cit473"><name><surname>O&#x02019;Connor</surname><given-names>T. J.</given-names></name>; <name><surname>Kanellis</surname><given-names>P.</given-names></name>; <name><surname>Nodwell</surname><given-names>J. R.</given-names></name>
<article-title>The ramC
gene is
required for morphogenesis in <italic>Streptomyces coelicolor</italic> and expressed in a cell type-specific manner under the direct control
of RamR</article-title>. <source>Mol. Microbiol.</source>
<year>2002</year>, <volume>45</volume> (<issue>1</issue>), <fpage>45</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03004.x</pub-id>.<pub-id pub-id-type="pmid">12100547</pub-id></mixed-citation></ref><ref id="ref474"><mixed-citation publication-type="journal" id="cit474"><name><surname>Hudson</surname><given-names>M. E.</given-names></name>; <name><surname>Zhang</surname><given-names>D.</given-names></name>; <name><surname>Nodwell</surname><given-names>J. R.</given-names></name>
<article-title>Membrane
association
and kinase-like motifs of the RamC protein of <italic>Streptomyces
coelicolor</italic></article-title>. <source>J. Bacteriol.</source>
<year>2002</year>, <volume>184</volume> (<issue>17</issue>), <fpage>4920</fpage>&#x02013;<lpage>4924</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.17.4920-4924.2002</pub-id>.<pub-id pub-id-type="pmid">12169618</pub-id></mixed-citation></ref><ref id="ref475"><mixed-citation publication-type="journal" id="cit475"><name><surname>Ueda</surname><given-names>K.</given-names></name>; <name><surname>Miyake</surname><given-names>K.</given-names></name>; <name><surname>Horinouchi</surname><given-names>S.</given-names></name>; <name><surname>Beppu</surname><given-names>T.</given-names></name>
<article-title>A gene cluster involved
in aerial mycelium formation in <italic>Streptomyces
griseus</italic> encodes proteins similar to the response regulators
of two-component regulatory systems and membrane translocators</article-title>. <source>J. Bacteriol.</source>
<year>1993</year>, <volume>175</volume> (<issue>7</issue>), <fpage>2006</fpage>&#x02013;<lpage>2016</lpage>. <pub-id pub-id-type="doi">10.1128/jb.175.7.2006-2016.1993</pub-id>.<pub-id pub-id-type="pmid">8458843</pub-id></mixed-citation></ref><ref id="ref476"><mixed-citation publication-type="journal" id="cit476"><name><surname>Ueda</surname><given-names>K.</given-names></name>; <name><surname>Oinuma</surname><given-names>K.</given-names></name>; <name><surname>Ikeda</surname><given-names>G.</given-names></name>; <name><surname>Hosono</surname><given-names>K.</given-names></name>; <name><surname>Ohnishi</surname><given-names>Y.</given-names></name>; <name><surname>Horinouchi</surname><given-names>S.</given-names></name>; <name><surname>Beppu</surname><given-names>T.</given-names></name>
<article-title>AmfS, an extracellular
peptidic morphogen in <italic>Streptomyces griseus</italic></article-title>. <source>J. Bacteriol.</source>
<year>2002</year>, <volume>184</volume> (<issue>5</issue>), <fpage>1488</fpage>&#x02013;<lpage>1492</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.5.1488-1492.2002</pub-id>.<pub-id pub-id-type="pmid">11844785</pub-id></mixed-citation></ref><ref id="ref477"><mixed-citation publication-type="journal" id="cit477"><name><surname>M&#x000fc;ller</surname><given-names>W. M.</given-names></name>; <name><surname>Schmiederer</surname><given-names>T.</given-names></name>; <name><surname>Ensle</surname><given-names>P.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>In vitro
biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin
A2 including formation of a C-C bond as a post-translational modification</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2010</year>, <volume>49</volume> (<issue>13</issue>), <fpage>2436</fpage>&#x02013;<lpage>2440</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200905909</pub-id>.</mixed-citation></ref><ref id="ref478"><mixed-citation publication-type="journal" id="cit478"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>H.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Long</surname><given-names>C.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Zhou</surname><given-names>J. M.</given-names></name>; <name><surname>Shao</surname><given-names>F.</given-names></name>
<article-title>The phosphothreonine
lyase activity of a bacterial type III effector family</article-title>. <source>Science</source>
<year>2007</year>, <volume>315</volume> (<issue>5814</issue>), <fpage>1000</fpage>&#x02013;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1126/science.1138960</pub-id>.<pub-id pub-id-type="pmid">17303758</pub-id></mixed-citation></ref><ref id="ref479"><mixed-citation publication-type="journal" id="cit479"><name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Shao</surname><given-names>F.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Cui</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Zou</surname><given-names>Y.</given-names></name>; <name><surname>Long</surname><given-names>C.</given-names></name>; <name><surname>Lan</surname><given-names>L.</given-names></name>; <name><surname>Chai</surname><given-names>J.</given-names></name>; et al. <article-title>A <italic>Pseudomonas syringae</italic> effector
inactivates MAPKs to suppress PAMP-induced immunity in plants</article-title>. <source>Cell Host Microbe</source>
<year>2007</year>, <volume>1</volume> (<issue>3</issue>), <fpage>175</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2007.03.006</pub-id>.<pub-id pub-id-type="pmid">18005697</pub-id></mixed-citation></ref><ref id="ref480"><mixed-citation publication-type="journal" id="cit480"><name><surname>Chen</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Gu</surname><given-names>L.</given-names></name>; <name><surname>Huang</surname><given-names>N.</given-names></name>; <name><surname>Zhou</surname><given-names>J. M.</given-names></name>; <name><surname>Chai</surname><given-names>J.</given-names></name>
<article-title>Structural basis for
the catalytic mechanism of phosphothreonine lyase</article-title>. <source>Nat. Struct. Mol. Biol.</source>
<year>2008</year>, <volume>15</volume> (<issue>1</issue>), <fpage>101</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb1329</pub-id>.<pub-id pub-id-type="pmid">18084305</pub-id></mixed-citation></ref><ref id="ref481"><mixed-citation publication-type="journal" id="cit481"><name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Long</surname><given-names>C.</given-names></name>; <name><surname>Hu</surname><given-names>L.</given-names></name>; <name><surname>Xu</surname><given-names>H.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>D. C.</given-names></name>; <name><surname>Shao</surname><given-names>F.</given-names></name>
<article-title>Structural insights
into the enzymatic mechanism of the pathogenic MAPK phosphothreonine
lyase</article-title>. <source>Mol. Cell</source>
<year>2007</year>, <volume>28</volume> (<issue>5</issue>), <fpage>899</fpage>&#x02013;<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.11.011</pub-id>.<pub-id pub-id-type="pmid">18060821</pub-id></mixed-citation></ref><ref id="ref482"><mixed-citation publication-type="journal" id="cit482"><name><surname>Young</surname><given-names>T. A.</given-names></name>; <name><surname>Delagoutte</surname><given-names>B.</given-names></name>; <name><surname>Endrizzi</surname><given-names>J. A.</given-names></name>; <name><surname>Falick</surname><given-names>A. M.</given-names></name>; <name><surname>Alber</surname><given-names>T.</given-names></name>
<article-title>Structure of <italic>Mycobacterium tuberculosis</italic> PknB supports
a universal activation mechanism for Ser/Thr protein kinases</article-title>. <source>Nat. Struct. Biol.</source>
<year>2003</year>, <volume>10</volume> (<issue>3</issue>), <fpage>168</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1038/nsb897</pub-id>.<pub-id pub-id-type="pmid">12548283</pub-id></mixed-citation></ref><ref id="ref483"><mixed-citation publication-type="journal" id="cit483"><name><surname>Pereira</surname><given-names>S. F.</given-names></name>; <name><surname>Goss</surname><given-names>L.</given-names></name>; <name><surname>Dworkin</surname><given-names>J.</given-names></name>
<article-title>Eukaryote-like
serine/threonine
kinases and phosphatases in bacteria</article-title>. <source>Microbiol.
Mol. Biol. Rev.</source>
<year>2011</year>, <volume>75</volume> (<issue>1</issue>), <fpage>192</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00042-10</pub-id>.<pub-id pub-id-type="pmid">21372323</pub-id></mixed-citation></ref><ref id="ref484"><mixed-citation publication-type="journal" id="cit484"><name><surname>Jungmann</surname><given-names>N. A.</given-names></name>; <name><surname>van Herwerden</surname><given-names>E. F.</given-names></name>; <name><surname>H&#x000fc;gelland</surname><given-names>M.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>The supersized class III lanthipeptide stackepeptin
displays motif multiplication in the core peptide</article-title>. <source>ACS Chem. Biol.</source>
<year>2016</year>, <volume>11</volume> (<issue>1</issue>), <fpage>69</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.5b00651</pub-id>.<pub-id pub-id-type="pmid">26488920</pub-id></mixed-citation></ref><ref id="ref485"><mixed-citation publication-type="journal" id="cit485"><name><surname>Goto</surname><given-names>Y.</given-names></name>; <name><surname>&#x000d6;kesli</surname><given-names>A.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Mechanistic
studies of Ser/Thr dehydration catalyzed by a member of the LanL lanthionine
synthetase family</article-title>. <source>Biochemistry</source>
<year>2011</year>, <volume>50</volume> (<issue>5</issue>), <fpage>891</fpage>&#x02013;<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1021/bi101750r</pub-id>.<pub-id pub-id-type="pmid">21229987</pub-id></mixed-citation></ref><ref id="ref486"><mixed-citation publication-type="journal" id="cit486"><name><surname>Garg</surname><given-names>N.</given-names></name>; <name><surname>Tang</surname><given-names>W.</given-names></name>; <name><surname>Goto</surname><given-names>Y.</given-names></name>; <name><surname>Nair</surname><given-names>S. K.</given-names></name>; <name><surname>van der Donk</surname><given-names>W. A.</given-names></name>
<article-title>Lantibiotics from <italic>Geobacillus
thermodenitrificans</italic></article-title>. <source>Proc. Natl. Acad.
Sci. U. S. A.</source>
<year>2012</year>, <volume>109</volume> (<issue>14</issue>), <fpage>5241</fpage>&#x02013;<lpage>5246</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1116815109</pub-id>.<pub-id pub-id-type="pmid">22431611</pub-id></mixed-citation></ref><ref id="ref487"><mixed-citation publication-type="journal" id="cit487"><name><surname>Grishin</surname><given-names>A. M.</given-names></name>; <name><surname>Beyrakhova</surname><given-names>K. A.</given-names></name>; <name><surname>Cygler</surname><given-names>M.</given-names></name>
<article-title>Structural insight
into effector proteins of Gram-negative bacterial pathogens that modulate
the phosphoproteome of their host</article-title>. <source>Protein Sci.</source>
<year>2015</year>, <volume>24</volume> (<issue>5</issue>), <fpage>604</fpage>&#x02013;<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1002/pro.2636</pub-id>.<pub-id pub-id-type="pmid">25565677</pub-id></mixed-citation></ref><ref id="ref488"><mixed-citation publication-type="journal" id="cit488"><name><surname>Krawczyk</surname><given-names>J. M.</given-names></name>; <name><surname>V&#x000f6;ller</surname><given-names>G. H.</given-names></name>; <name><surname>Krawczyk</surname><given-names>B.</given-names></name>; <name><surname>Kretz</surname><given-names>J.</given-names></name>; <name><surname>Br&#x000f6;nstrup</surname><given-names>M.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Heterologous expression and engineering
studies of labyrinthopeptins, class III lantibiotics from <italic>Actinomadura namibiensis</italic></article-title>. <source>Chem. Biol.</source>
<year>2013</year>, <volume>20</volume> (<issue>1</issue>), <fpage>111</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2012.10.023</pub-id>.<pub-id pub-id-type="pmid">23352145</pub-id></mixed-citation></ref><ref id="ref489"><mixed-citation publication-type="journal" id="cit489"><name><surname>Pesic</surname><given-names>A.</given-names></name>; <name><surname>Henkel</surname><given-names>M.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Identification
of the amino acid labionin and its desulfurised derivative in the
type-III lantibiotic LabA2 by means of GC/MS</article-title>. <source>Chem. Commun.</source>
<year>2011</year>, <volume>47</volume>, <fpage>7401</fpage>&#x02013;<lpage>7403</lpage>. <pub-id pub-id-type="doi">10.1039/c1cc11573a</pub-id>.</mixed-citation></ref><ref id="ref490"><mixed-citation publication-type="journal" id="cit490"><name><surname>Ross</surname><given-names>A. C.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Pattabiraman</surname><given-names>V. R.</given-names></name>; <name><surname>Vederas</surname><given-names>J. C.</given-names></name>
<article-title>Synthesis of the
lantibiotic lactocin S using peptide
cyclizations on solid phase</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2010</year>, <volume>132</volume> (<issue>2</issue>), <fpage>462</fpage>&#x02013;<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1021/ja9095945</pub-id>.<pub-id pub-id-type="pmid">20017553</pub-id></mixed-citation></ref><ref id="ref491"><mixed-citation publication-type="journal" id="cit491"><name><surname>Houssen</surname><given-names>W.
E.</given-names></name>; <name><surname>Wright</surname><given-names>S. H.</given-names></name>; <name><surname>Kalverda</surname><given-names>A. P.</given-names></name>; <name><surname>Thompson</surname><given-names>G. S.</given-names></name>; <name><surname>Kelly</surname><given-names>S. M.</given-names></name>; <name><surname>Jaspars</surname><given-names>M.</given-names></name>
<article-title>Solution structure
of the leader
sequence of the patellamide precursor peptide, PatE1&#x02013;34</article-title>. <source>ChemBioChem</source>
<year>2010</year>, <volume>11</volume> (<issue>13</issue>), <fpage>1867</fpage>&#x02013;<lpage>1873</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201000305</pub-id>.<pub-id pub-id-type="pmid">20715266</pub-id></mixed-citation></ref><ref id="ref492"><mixed-citation publication-type="journal" id="cit492"><name><surname>Roy</surname><given-names>R. S.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Baleja</surname><given-names>J. D.</given-names></name>; <name><surname>Walsh</surname><given-names>C. T.</given-names></name>
<article-title>Role of
the microcin B17 propeptide in substrate recognition: solution structure
and mutational analysis of McbA1&#x02013;26</article-title>. <source>Chem. Biol.</source>
<year>1998</year>, <volume>5</volume> (<issue>4</issue>), <fpage>217</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(98)90635-4</pub-id>.<pub-id pub-id-type="pmid">9545435</pub-id></mixed-citation></ref><ref id="ref493"><mixed-citation publication-type="journal" id="cit493"><name><surname>V&#x000f6;ller</surname><given-names>G. H.</given-names></name>; <name><surname>Krawczyk</surname><given-names>B.</given-names></name>; <name><surname>Ensle</surname><given-names>P.</given-names></name>; <name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name>
<article-title>Involvement
and unusual substrate specificity of a prolyl oligopeptidase in class
III lanthipeptide maturation</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2013</year>, <volume>135</volume> (<issue>20</issue>), <fpage>7426</fpage>&#x02013;<lpage>7429</lpage>. <pub-id pub-id-type="doi">10.1021/ja402296m</pub-id>.<pub-id pub-id-type="pmid">23651048</pub-id></mixed-citation></ref><ref id="ref494"><mixed-citation publication-type="journal" id="cit494"><name><surname>Luo</surname><given-names>H.</given-names></name>; <name><surname>Hong</surname><given-names>S. Y.</given-names></name>; <name><surname>Sgambelluri</surname><given-names>R. M.</given-names></name>; <name><surname>Angelos</surname><given-names>E.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Walton</surname><given-names>J. D.</given-names></name>
<article-title>Peptide macrocyclization
catalyzed by a prolyl oligopeptidase
involved in alpha-amanitin biosynthesis</article-title>. <source>Chem.
Biol.</source>
<year>2014</year>, <volume>21</volume> (<issue>12</issue>), <fpage>1610</fpage>&#x02013;<lpage>1617</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2014.10.015</pub-id>.<pub-id pub-id-type="pmid">25484237</pub-id></mixed-citation></ref><ref id="ref495"><mixed-citation publication-type="journal" id="cit495"><name><surname>Kluskens</surname><given-names>L. D.</given-names></name>; <name><surname>Nelemans</surname><given-names>S. A.</given-names></name>; <name><surname>Rink</surname><given-names>R.</given-names></name>; <name><surname>de Vries</surname><given-names>L.</given-names></name>; <name><surname>Meter-Arkema</surname><given-names>A.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Walther</surname><given-names>T.</given-names></name>; <name><surname>Kuipers</surname><given-names>A.</given-names></name>; <name><surname>Moll</surname><given-names>G. N.</given-names></name>; <name><surname>Haas</surname><given-names>M.</given-names></name>
<article-title>Angiotensin-(1&#x02013;7)
with thioether
bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1&#x02013;7)
analog</article-title>. <source>J. Pharmacol. Exp. Ther.</source>
<year>2009</year>, <volume>328</volume> (<issue>3</issue>), <fpage>849</fpage>&#x02013;<lpage>854</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.108.146431</pub-id>.<pub-id pub-id-type="pmid">19038778</pub-id></mixed-citation></ref><ref id="ref496"><mixed-citation publication-type="journal" id="cit496"><name><surname>Suda</surname><given-names>S.</given-names></name>; <name><surname>Westerbeek</surname><given-names>A.</given-names></name>; <name><surname>O&#x02019;Connor</surname><given-names>P. M.</given-names></name>; <name><surname>Ross</surname><given-names>R. P.</given-names></name>; <name><surname>Hill</surname><given-names>C.</given-names></name>; <name><surname>Cotter</surname><given-names>P. D.</given-names></name>
<article-title>Effect of bioengineering
lacticin 3147 lanthionine bridges on specific activity and resistance
to heat and proteases</article-title>. <source>Chem. Biol.</source>
<year>2010</year>, <volume>17</volume> (<issue>10</issue>), <fpage>1151</fpage>&#x02013;<lpage>1160</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2010.08.011</pub-id>.<pub-id pub-id-type="pmid">21035738</pub-id></mixed-citation></ref><ref id="ref497"><mixed-citation publication-type="journal" id="cit497"><name><surname>Hsu</surname><given-names>S. T.</given-names></name>; <name><surname>Breukink</surname><given-names>E.</given-names></name>; <name><surname>Tischenko</surname><given-names>E.</given-names></name>; <name><surname>Lutters</surname><given-names>M. A.</given-names></name>; <name><surname>De Kruijff</surname><given-names>B.</given-names></name>; <name><surname>Kaptein</surname><given-names>R.</given-names></name>; <name><surname>Bonvin</surname><given-names>A. M.</given-names></name>; <name><surname>Van Nuland</surname><given-names>N. A.</given-names></name>
<article-title>The nisin-lipid
II complex reveals a pyrophosphate
cage that provides a blueprint for novel antibiotics</article-title>. <source>Nat. Struct. Mol. Biol.</source>
<year>2004</year>, <volume>11</volume> (<issue>10</issue>), <fpage>963</fpage>&#x02013;<lpage>967</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb830</pub-id>.<pub-id pub-id-type="pmid">15361862</pub-id></mixed-citation></ref><ref id="ref498"><mixed-citation publication-type="journal" id="cit498"><name><surname>Shioya</surname><given-names>K.</given-names></name>; <name><surname>Harada</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>J.</given-names></name>; <name><surname>Nakayama</surname><given-names>J.</given-names></name>; <name><surname>Sonomoto</surname><given-names>K.</given-names></name>
<article-title>Characterization of modification
enzyme NukM and engineering
of a novel thioether bridge in lantibiotic nukacin ISK-1</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<year>2010</year>, <volume>86</volume> (<issue>3</issue>), <fpage>891</fpage>&#x02013;<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-009-2334-8</pub-id>.<pub-id pub-id-type="pmid">19915831</pub-id></mixed-citation></ref></ref-list></back></article>